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Abstract 
 
 
 
 
Within all cells, complex molecular systems exist that are responsible for maintaining genome 
stability by detecting and repairing dangerous alterations in DNA.  Ensuring the accurate and 
efficient functioning of such systems is necessary for the preservation of DNA integrity and 
avoidance of disease. 
 
The flexible and diverse modes of DNA-binding exhibited by human p53 permits this 
‘guardian of the genome’ to elicit versatile cellular activities that are crucial in monitoring 
threats to genome dynamics and conducting appropriate responses.  In conjunction with its 
sequence-specific DNA-binding activity that is essential to target gene transactivation, p53 
can bind to unusual DNA structures independent of DNA sequence and it has been proposed 
this activity may allow p53 to interact with detrimental secondary structures that arise in 
unstable genomic regions.  To provide further insight into p53-DNA interactions, an in vitro 
DNA binding assay was developed that was used to characterise binding properties towards 
several DNA molecules to allow comparison of non-specific, sequence-specific and structure-
specific binding.  It was determined that unusual structures in DNA significantly enhanced 
p53 binding in non-sequence specific DNA and that the presence of internal hairpin regions 
induced binding comparable to sequence-specific binding.  In vivo p53-DNA interactions 
were also quantified using chromatin immunoprecipitation and variations in preference to 
different response element sequences was ascertained. 
 
DNA binding is also central to the ability of Ku proteins to function as essential components 
of non-homologous end joining and telomere maintenance in eukaryotes.  Prokaryotic 
homologues of Ku proteins that function as homodimers in two-component repair systems 
have also been identified.  Recently, 3 Ku homologues in Streptomyces coelicolor were 
reported, but very little is currently known regarding their biological activity.  It was 
discovered that all 3 Ku proteins exhibited varied independent DNA-binding properties that 
were influenced by DNA topology, size and end-structure.  Unusually for Ku, it was found 1 
of these proteins exhibited strong binding to single-stranded DNA.  Precipitation assays 
determined that these proteins may act as DNA end synapsis mediators during the DNA end-
joining process and ligation experiments revealed Ku was responsible for rigidifying DNAs 
or completely inhibiting ligation activity, probably via DNA end-protection activity. 
Experimental evidence indicated that specific interactions could occur between S. coelicolor 
Ku suggesting these proteins form both homodimers and heterodimers.  
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CHAPTER 1 
 
Introduction 
 
 
 
 
1.1 Structure and Function of DNA and Proteins. 
 
Genetic information encoded by deoxyribonucleic acid (DNA) is used in the development and 
orchestration of cellular functions of most living organisms.  A well recognised activity of 
DNA is as a long-term storage molecule that contains the instructions necessary for the 
production of other cellular components including proteins and RNA molecules.  DNA is 
generally composed of 2 anti-parallel polymers of nucleotides that are supported by a 
phosphodiester backbone.  The nucleotides consist of sugar molecules and the nitrogenous 
bases adenine, thymine, guanine and cytosine, of which coalesce into various combinations to 
produce precise genetic codes that are read in a 5’ to 3’ directional manner.    The structural 
properties of DNA dictate its function and hence govern extensive cellular characteristics.  In 
most instances, DNA in biological systems adopts the renowned anti-parallel right-handed 
double-helix, referred to as B-DNA (Watson and Crick, 1953), that results in a charged 
structure with a hydrophobic centre and hydrophilic backbone stabilised by hydrogen bonds 
(Bates and Maxwell, 2005).  B-DNA exhibits both major and minor grooves that are 22 Å and 
12 Å wide respectively.  Factors such as DNA sequence, chemical modification, hydration 
and supercoiling can induce structural alterations so that DNA adopts non-B conformations 
including A-DNA (alternate groove sizes) and Z-DNA (left-handed double-helix that is 
implicated in transcription regulation (Oh et al., 2002)).  Other unusual conformations of 
DNA include quadruplex formation, branched DNA, hairpin structures, Holliday junctions 
and single-stranded DNA (ssDNA) that are described in more detail later in this chapter. 
 
As stated, a key role of DNA is the storage of genetic information that can be used to produce 
protein molecules following transcription and translation events.  These biological 
macromolecules are essential to all organisms and participate in a myriad of cellular 
processes.  Proteins are organic compounds that consist of various amino acid residues 
dictated by the gene sequence of bases of the transcribed DNA.  Amino acid residues are 
commonly subject to chemical post-translational modifications that ultimately influence 
protein folding, stability and activity.  The large majority of proteins naturally fold into native 
three-dimensional conformations that are crucial for activity, a process that can occur 
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unassisted or via the cooperation of molecular chaperones (Kroll, 2002).  Overall protein 
structure is generally dictated by 4 principle aspects that are illustrated in Figure 1.1. 
 
 
 
Figure 1.1 The 4 levels of complexity that determine protein structure and function.  The 
primary determinant of a protein is the sequence of amino acid residues that are arranged in a 
linear chain connected by peptide bonds.  The secondary structure of a protein is formation of 
local structures such as alpha helices and beta sheets that chains of amino acids can adopt.  
The tertiary structure of a protein is the overall three-dimensional shape of the protein that is 
determined by the spatial relationship between secondary structures and is responsible for 
dictating its basic function.  Quaternary structure is the formation of a multi-polypeptide 
complex that functions as a single protein complex. 
 
 
The sequence of amino acid residues and any post-translational modifications determine the 
formation of local secondary structures that are stabilised by hydrogen bonds.  One such 
structure is the alpha helix whereby the protein polypeptide backbone is tightly wound around 
a central axis with amino acid R groups protruding outwards.  Polypeptides can also extend 
into zigzag structures known as beta sheets that as with alpha helices are dependent on the 
amino acid composition of the protein.  Other important secondary structures include beta 
turns that comprise connecting elements between alpha helices and beta sheets.  The spatial 
arrangement of these local structures is referred to as a proteins tertiary structure that is 
stabilised by several elements including formation of a hydrophobic core, salt bridges, 
hydrogen bonds and disulfide bonds (Nelson and Cox, 2000).  Amino acids that are relatively 
far apart in protein sequence may directly interact in the fully folded three-dimensional 
protein conformation.  The fourth and final level of protein structure is the quaternary 
structure whereby multiple polypeptide chains or subunits combine into three-dimensional 
multicomplexes.  Simple protein multimers can be composed of 2 identical (homodimers) or 
different (heterodimers) proteins whereas some functional proteins require much larger 
complexes that contain hundreds of protein subunits. 
 
An important characteristic of several proteins is the ability to directly interact with DNA and 
to modulate various cellular processes including DNA replication, transcription and DNA 
repair and maintenance.  Protein-DNA interactions show high variation in specificity and 
Primary                  Secondary                          Tertiary                                    Quaternary 
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flexibility with certain proteins, such as structural proteins, able to bind non-specifically to 
any DNA sequence, and other proteins, such as transcription factors, only able to bind to 
precise genomic regions.  Other DNA-binding proteins can detect and interact with specific 
types of DNA damage that can be a significant threat to cell or organism viability.  As each of 
the ~1013 cells in the human body receives tens of thousands of insults to DNA every day 
(Jackson and Bartek, 2009), the efficient detection and removal processes performed by these 
specialised proteins is essential for maintaining genomic integrity. 
 
1.2 Protein-DNA Interactions. 
 
As our current knowledge regarding protein-nucleic acid complex assembly continues to 
expand, the diversity and intricacy involved in these interactions becomes increasingly 
apparent.  Prior to formation of macromolecular protein-DNA complexes, the individual 
formation of specific and homogenous three-dimensional structures of both protein and DNA 
components are required.  The thermodynamic tendency to bury nonpolar residues into the 
interior of a protein is a principal factor in stabilising protein folding.  Similarly, restricting 
the surface exposure of planar surfaces of nucleic acid bases by base stacking is instrumental 
in duplex DNA stabilisation (Calladine, 1982).  The resulting conformation exposes polar and 
charged residues on the DNA surface and buries nonpolar groups internally (von Hippel, 
2007).  The energies required for the formation of these folded entities must exceed the 
opposing force that is the decrease in configurational entropy.  Crucially, the specificity of 
protein folding means individual types of amino acid residues are likely to be located at 
precise positions within the folded macromolecule (Hartl and Hayer-Hartl, 2009).  Internal 
hydrogen-bonding alignments provide fundamental stability to the tertiary protein structure in 
conjunction with dipole-dipole and van der Waals interactions. 
 
As mentioned, proteins can further assemble into multi-subunit complexes consisting of other 
proteins and also with nucleic acid components through interactions with specific 
intermolecular interfaces.  Electrostatic forces often significantly influences these interactions 
alongside hydrophobic bonding and, in some instances, ligand or ion binding (Teilum et al., 
2009).  The equilibrium stability of multi-subunit complexes is also dependent on the 
concentration of the individual components and the solvent environment.  Additionally, 
solvents, such as ethanol, can be added to the aqueous solution to promote protein-protein and 
protein-nucleic acid interactions and salts also have significant effects on the solvent 
conditions (von Hippel, 2007).  Crowding by other non-interacting molecular components  
such as synthetic polymers or BSA can help to stabilise multi-subunit complexes by 
occupying elements of the solution that assemblies could potentially unfold or dissociate into 
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(Batra et al., 2009).  Intracellular salt concentrations vary between organisms but generally 
fluctuate around 1 – 200 mM (Dominy et al., 2002).  The highly negatively charged 
phosphate backbone of DNA destabilises nucleic acid structures and promotes denaturing of 
double-stranded DNA (dsDNA).  Addition of salt neutralises this negative repulsive charge 
and so nucleic acid structures are stabilised at optimal ionic strengths (Schildkraut, 1965).  
The effect of salt on protein structure can either be stabilising or destabilising, depending on 
the specific charge distribution within the protein (Kohn et al., 1997). 
 
Protein-DNA interactions are generally flexible in nature and this is evident as upon protein 
binding, the DNA structure is often significantly perturbed yet the protein can still remain 
bound (N'Soukpoe-Kossi et al., 2008).  Supercoiling, local unwinding and base-pair breathing 
of DNA can occur following attachment of protein partners and this must also be endured by 
the protein in order to maintain the complex.  Perhaps the best understood mode of protein-
DNA interaction is the binding of a protein to a specific nucleic acid sequence.  Proteins that 
bind in this sequence-specific manner are often able to overcome slight base-pair alterations 
in the DNA (Coulocheri et al., 2007), again demonstrating considerable flexibility. 
 
Specific binding can be defined as a molecular association in which a particular molecule is 
bound tightly and exclusively in an energetically and kinetically stabilised complex (Oda and 
Nakamura, 2000).  This type of interaction is crucial for the functions of various regulatory 
proteins that act at precise locations on the genome.  During sequence-specific DNA binding, 
protein interactions with specific nucleic acid sequences is primarily determined by 
recognition of hydrogen-bonding determinants situated in the major and minor grooves of the 
dsDNA that interact with complementary recognition amino acids of the protein itself 
(Seeman et al., 1976).  Hence, interactions are promoted when DNA bases are arranged in an 
optimal sequence.  The hydrogen bond donor and acceptor patterns in the dsDNA grooves are 
recognised by complementary hydrogen bond donor and acceptors on the protein surface.  
The protein displaces water molecules and forms interfaces of complementary hydrogen-
bonding patterns that are separated from the surrounding aqueous environment (von Hippel, 
1994; von Hippel, 2007).  Electrostatic interactions between the hydrophilic and negatively 
charged DNA backbone and positively charged and dipolar amino acids provide energy that 
stabilises the recognition surfaces.  This type of interaction is heavily determined by structure 
and flexibility of both the DNA and protein.  Although sequence-specific proteins associate 
tightly with recognition sites, the strength of binding does not prevent the protein from 
eventually dissociating from the substrate DNA once the downstream events of the interaction 
have been processed (Rhodes et al., 1996). 
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A 
B 
C 
As described, certain proteins have strong binding affinity for target sequences, however 
most, if not all, DNA binding proteins have the ability to bind non-specifically to DNA.  This 
binding can be said to be a random molecular association as there is no exclusive determinant 
required.  The main component providing the necessary free energy to stabilise the interaction 
is the electrostatic attraction between positively charged amino acids and the negatively 
charged phosphodiester DNA backbone (Jen-Jacobson, 1997).  This electrostatic, non-
specific binding affinity, based on the displacement of counter-ions from the DNA, is not as 
tight as the previously described sequence-specific interaction.  Consequently, proteins are 
able to move along DNA (von Hippel, 1994) by thermal motion in an exploratory fashion 
until the target binding site is located.  Location of unique sites in the genome by regulatory 
proteins that are present in limited numbers would be considerably slower without the ability 
to translocate along DNA via this non-specific interaction.  The process of protein diffusion in 
reduced dimensions includes short-range hopping along the same DNA strand and direct 
interstrand transfer as well as one-dimensional sliding (Figure 1.2). These processes reduce 
the volume through which the protein has to conduct its search for its target (Kabata et al., 
1993; Kampmann, 2004; Winter et al., 1981).  Upon recognition of the target sequence, 
proteins undergo reversible conformational changes and change from a non-specific complex 
dominated by electrostatic interactions to a conformation specific for tight association with 
target DNA base pairs (Coulocheri et al., 2007).  A general consensus is that the rate of target 
site location is optimal when protein diffusion involves both sliding and hoping movements in 
combination (Halford, 2009). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.2 Diffusion in reduced dimensions.  DNA binding proteins can interact non-
specifically with DNA, which facilitates location of specific target sites (in red) by reducing 
excursions of the protein away from the DNA.  Three modes of protein translocation along 
nonspecific DNA are shown: A. One-dimensional sliding. B. Intrastrand hopping. C. 
Interstrand transfer.  The protein undergoes a conformational change once bound to specific 
DNA resulting in a tighter association. 
Chapter 1 - Introduction 
 6 
It is recognised that the structure of DNA directly influences sequence-specific protein 
binding as molecular interfaces between interacting proteins and DNA are complementary in 
shape, allowing a close-fit association of the protein surface to the structure of the DNA 
(Pabo and Nekludova, 2000; Yeh et al., 2003).  This complementation in shape is determined 
by chemical contacts including hydrogen bonding, electrostatic interactions, van der Waals 
forces and hydrophobic interactions.  DNA structure is not only a significant determinant of 
sequence-specific protein-DNA complexes, but certain proteins can recognise and bind with 
strong affinity to specific DNA structures in a sequence-independent fashion.  Such DNA 
regions can be essential specialised sites that require a non-B structure, some arise accidently 
during various cellular processes and others can be damage induced and can be very 
detrimental.   
 
An example of an important structure-dependent protein-DNA interaction involves the 
recognition of single-stranded genomic regions that can be important for DNA metabolism.   
Denaturing of B-form DNA can occur following thermal fluctuations that induce base-pair 
breathing whereby dsDNA opens and closes spontaneously (McConnell and von Hippel, 
1970).  Specialised ssDNA binding proteins interact specifically with open single-stranded 
regions, independent of sequence, and act to stabilise the ssDNA and allow initiation of 
events such as replication (Kur et al., 2005).  Similarly to nonspecific binding, the 
predominant component of this interaction is electrostatic.  
 
Certain damage inducing reagents are capable of creating double-strand breaks (DSBs) in 
DNA that can significantly reduce genomic stability.  As discussed below, DNA repair 
mechanisms have developed that are capable of recognising and repairing resulting DNA 
ends.  However, in order to prevent catastrophic chromosomal rearrangements, it is essential 
that the natural ends of linear chromosomes must be excluded from this activity (Riha et al., 
2006).  This is achieved by the formation of unique high order nucleoprotein structures called 
telomeres that consist of extended repeat DNA sequences bound by specific proteins.  In most 
eukaryotes, the G-rich repeat forms a 3’ single-stranded overhang that mediates formation of 
a complex structure, referred to as a t-loop.  Although many of the proteins that interact with 
telomeres are believed to be sequence-dependent, the telomere-end protection family of 
proteins bind to the 3’ single-stranded region independent of sequence (Croy and Wuttke, 
2006).   
 
Various structurally and functionally unrelated proteins have been shown to interact tightly 
with four-way Holliday junctions in DNA that arise during recombination and replication-
related events.  Resolving of these junctions is essential to allow DNA to conform back into 2 
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separate duplexes.  This separation of Holliday junctions is performed by resolvase proteins 
such as GEN1 (Ip et al., 2008) that specifically recognise and bind to four-way junctions, 
again sequence-independently.  Aside from proteins involved in recombination, HMG1 box 
proteins, SWI/SNF complex and unrelated prokaryotic proteins also recognise and bind to 
four-way junctions (Lilley, 1997).  The ability to interact with bent DNA and capacity to 
increase DNA bending following binding (Zlatanova and van Holde, 1998) are common 
properties of such proteins. 
 
Although recent studies have enhanced our understanding of the wide scope of protein-
nucleic acid interactions, several important areas remain poorly understood.  The energetic 
nature of protein-DNA interactions during conformational changes, the dynamic recognition 
of sequence-specific DNA by proteins and the interactions between protein-DNA complexes 
with water and counter-ions are yet to be fully understood. 
 
1.3 DNA Damage and Repair. 
1.3.1 DNA Damage. 
 
Cells are continuously subjected to potentially catastrophic insults throughout their lifetimes 
that can lead to mutations, disease and death.  The primary structure of DNA is continuously 
modified by endogenous and exogenous DNA damaging agents that can cause various 
alterations, ranging from base damage and nucleotide substitutions to more complex 
chromosomal rearrangements.  The majority of DNA damage affects the primary structure of 
DNA, usually via chemical modifications to nucleotides, which can introduce errors including 
non-native base chemical bonding and formation of bulky adducts that perturb the helical 
structure (Kulkarni and Wilson, 2008).  Exogenous damaging agents are physical or chemical 
agents in the external environment, including ultraviolet (UV) light, ionising radiation and 
extremes in pH and temperature.  Sources of endogenous agents derive from the cell itself and 
include alkylating metabolites, water, reactive oxygen species and reactive nitrogen species 
(Lombard et al., 2005).  DNA can also become damaged when errors occur during cellular 
processes that result in DNA alterations.  In eukaryotes, and to an extent in prokaryotes, 
damage to DNA can be recognised by global surveillance mechanisms that initiate 
biochemical pathways such as DNA repair, cell cycle arrest, alterations in gene expression 
and induction of apoptosis in multi-cellular organisms (Figure 1.3).   
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Figure 1.3 Responses to DNA damage in mammalian cells.  These responses may function 
independently but often extensive cross-talk occurs between processes, usually by proteins 
participating in more than 1 response. 
 
 
Defects in any of the responses shown in Figure 1.3 can compromise genomic stability.  
Recognition of DNA damage is the fundamental step in the initiation of subsequent 
downstream responses and this is often performed directly by surveillance proteins that have 
complementarity towards particular DNA damage induced structures (Sancar et al., 2004). 
 
1.3.2 Non-B DNA. 
 
DNA itself can be a causative factor for genomic instability.  The three-dimensional 
conformations adopted by polymorphic sections of DNA can lead to the expansion of repeat 
tracts or the induction of gross genomic rearrangements that can cause severe diseases in 
humans (Bacolla and Wells, 2009).  Although the majority of DNA exists in an orthodox B-
form as a right-handed anti-parallel double helix with Watson-Crick (WC) base pairing, some 
sequences of DNA can exist in multiple conformations (Figure 1.4).  It is predicted that more 
than ten non-B conformations can be formed at specific sequence motifs as a function of 
negative supercoiling density (Bacolla and Wells, 2004).  Structures such as hairpins, 
cruciforms and Z-DNA maintain WC base pairing, however other non-B DNA molecules, 
including tetraplexes and slipped-strand structures, contain non-WC base pairs.  These 
unusual structures often have higher energy states that are maintained by free energy derived 
from negative supercoiling, alongside other factors (Bacolla and Wells, 2009). 
 
DNA DAMAGE 
DNA DAMAGE SENSORS 
  DNA REPAIR   APOPTOSIS 
 CELL CYCLE ARREST GENE EXPRESSION 
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Figure 1.4 Non-B DNA structures involved in genetic instability.  Natural genomic 
sequences can conform to unusual structures that demonstrate characteristics that differ from 
standard B-DNA.  These unusual structures can significantly reduce genomic integrity and 
can also induce chromosomal rearrangements.  Taken from (Bacolla et al., 2004). 
 
 
Various non-B DNA structures arise at repeating sequences that naturally occur in genomes 
that can vary substantially in size, location and sequence composition (Wang and Vasquez, 
2009).  Hairpins and cruciforms form within inverted repeat sequences, when the duplex 
denatures to ssDNA during events such as replication, transcription or repair.  These events 
provide an opportunity for a single-stranded inverted repeat sequence to form intramolecular 
base pairs with itself, forming a new B-helix capped by a single-stranded loop.  Cruciform 
structures are highly comparable to Holliday junction recombination intermediates, with the 
four-way junction either in an open conformation to allow migration, or in a locked stacked 
assembly (Bacolla and Wells, 2004; Watson et al., 2004).  These types of structures can be 
very detrimental to processes acting on DNA and can induce damage including DSBs and 
translocations (Collins et al., 1982). 
 
Polypurine-polypyrimidine repeating elements have the propensity to adopt unusual triplex 
DNA structures consisting of 3 DNA strands.  This occurs when part of the duplex denatures 
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and allows 1 of the single-strands to pair with the purine strand in the remaining duplex via 
Hoogsteen hydrogen bonds in the major groove (Wang and Vasquez, 2009).  Sites containing 
triplex DNA show a significant increase in mutation frequency (Wang and Vasquez, 2004). 
 
Nucleic acid sequences rich in guanines, such as telomeric DNA, can adopt a tetrad structure, 
consisting of square arrays of 4 guanine residues.  Each guanine donates 2 Hoogsteen 
hydrogen bonds to an adjacent base, and receives 2 bonds from another in a cyclic 
arrangement (Bacolla and Wells, 2004).  Four-stranded DNA is composed of multiple stacked 
guanine tetrads and so requires sequences that contain at least 4 copies of multiple guanines.  
The resulting structures are highly polymorphic and can vary regarding polarity, groove size, 
and strand stoichiometry.  Alternative base-pairing has also been observed in some in vitro 
tetrads (Zhang et al., 2001). 
 
Left-handed Z-DNA forms in sequences containing alternating pyrimidine-purine base-pairs.  
The bases flip 180° through a rotation of purines from anti to syn conformation.  Z-DNA only 
contains 1 type of groove, unlike B-DNA that contains both major and minor grooves 
(Watson et al., 2004). 
 
Tandem repeat sequences are prone to strand-slippage, where looped-out bases form duplexes 
stabilised by unusual base-pairing.  These structures can cause contraction or expansion of 
tandem repeats, events that are associated with at least 20 human neurological diseases 
(Myers, 2004; Rass et al., 2007; Wells et al., 2005; Wojciechowska et al., 2005).  Repeat tract 
expansion is also related to fragile sites in the genome that are predisposed to DNA breaks, 
chromosomal translocations and amplifications.  Repeat sequence expansion and 
consequences are discussed further in Section 1.3.3. 
 
Breakpoints of gross chromosomal rearrangements including translocations and deletions 
coincide with sequences prone to adopt non-B DNA structures, demonstrating that they can 
act as initiators for such potentially catastrophic events.  Slipped-strand structures, triplexes, 
tetraplexes and Z-DNA are able to elicit dramatic genetic alterations by recombination and 
repair mechanisms (Bacolla and Wells, 2009).  The resulting rearrangements of genetic 
material are the foundation for many human genomic diseases. 
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1.3.3 Triplet Repeat Sequences. 
 
A direct genetic link exists between defects in DNA repair pathways and some neurological 
abnormalities.  Defects in repair pathways can lead to loss of genomic integrity, which can 
consequently result in severe outcomes, including apoptosis.  In non-replicating fully 
differentiated cells, such as neuronal tissue, apoptosis induced by genomic instability can lead 
to tissue degeneration and atrophy (Kulkarni and Wilson, 2008; Rass et al., 2007).  Repetitive 
sequences are common within eukaryotic genomes and are regions that are often subjected to 
recombination and random integrations.  Therefore, these regions are thought to have been 
instrumental during genome evolution for the creation of sequence diversity, however, some 
alterations in these regions can significantly perturb homeostasis of genome dynamics 
(Kovtun and McMurray, 2008).  Trinucleotide repeat sequences (TRS) are of considerable 
importance as genomic amplifications of TRS cause various human disorders, including 
neuromuscular and neurodegenerative diseases (Gatchel and Zoghbi, 2005). 
 
Hereditary neurological diseases in humans that result from TRS expansion include 
Huntington’s disease, myotonic dystrophy, fragile X syndrome and several spinocerebellar 
ataxias (Bowater and Wells, 2001).  For all TRS diseases, the disease phenotype severity 
increases in proportion to the TRS expansion length.  Most triplet repeat diseases also 
demonstrate anticipation, whereby the disease is more severe and has an earlier age of onset 
with successive family generations, which is attributed to incorporation of longer repeats 
during transmission to the offspring.  TRS diseases have been characterised into 2 groups;  
Type 1 diseases, such as Huntington’s disease, are determined by relatively small TRS 
expansions (less than 100) located in coding regions of genes and large polyamino acid tracts 
(usually glutamine) are produced.  Type 2 diseases, including myotonic dystrophy (DM), 
result from expansions that are significantly larger than those of type 1, and they usually 
occur in untranslated regions of mRNA (Lee and Kim, 2006).  Expansions and deletions are 
thought to arise in TRS following errors during DNA metabolism that result in slippage of 
either the complementary strand or the newly synthesised strand (Pearson et al., 2002).  
Initial studies suggested unrepaired strand slippage in the nascent DNA strand could be 
converted into expanded repeats following a second round of DNA replication.  However, it 
was not known how this happened, why not all repeat tracts expanded and why slippage 
usually only caused limited repeat length polymorphisms (Mirkin, 2006).   
 
Once TRS tracts exceed a threshold of around 35 repeats, the tract becomes highly prone to 
further expansions (Leeflang et al., 1999) that can conform to non-B DNA that may adversely 
affect genomic stability (Figure 1.5).  These secondary structures can be incorporated during 
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DNA processing events, but the exact process of this secondary structure formation remains 
poorly understood.  Denaturing and renaturing of TRS, such as during DNA synthesis in 
replication, transcription or repair, is accepted to be important to create unusually stable 
hairpin structures that kinetically trap repetitive DNA in this otherwise unfavourable 
conformation (Panigrahi et al., 2005; Pearson and Sinden, 1996). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 Slipped-stranded DNA structures that can be formed by expandable repeats.  
This diagram represents slipped-stranded structures formed by CTG •CAG tracts.  In reality 
these TRS can consist of thousands of nucleotides that can form very large and flexible 
secondary structures. 
 
 
Recent studies have attempted to elucidate the potential mechanisms for increases in repeat 
tracts.  It is likely expansions occur during DNA replication as rapid accumulation of 
repetitive DNA requires the synthesis of large amounts of DNA and also because a portion of 
the lagging-strand template, known as the Okazaki initiation zone, is single-stranded and so 
may fold into unusual secondary structures (Mirkin, 2006; Mirkin, 2007).  TRS instability 
commonly occurs in rapidly dividing cells or highly proliferative tissues, but are relatively 
stable in differentiated cells (Wohrle et al., 1995), supporting a direct role for replication in 
expansion.  Stalling of various DNA polymerases by stable secondary DNA structures may 
lead to misalignment of repeats that can cause expansion or deletion events as coordination 
between lagging-strand and leading-strand synthesis can be disrupted (Usdin and Woodford, 
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1995).  If synthesis continues on the leading-strand while lagging-strand synthesis resumes 
after skipping 1 or more Okazaki fragments due to stalling, gaps in the new lagging strand 
will arise that must be filled in.  A contraction of repeating DNA can occur if, as DNA 
polymerase repairs the gap, it skips the structural element portion of the lagging-strand 
template, leading to loss of repeats.  Alternatively, stalling in a repeat tract can initiate 
replication fork reversal, creating a ‘chicken-foot’ structure with single-stranded repeats in the 
new leading strand.  This ssDNA could fold back on itself into a hairpin structure and induce 
repeat expansion in newly synthesised DNA (Figure 1.6) (Mirkin, 2007).  
 
 
 
Figure 1.6 Potential mechanisms for repeat contraction and expansion.  These 
mechanisms depend on replication fork stalling and restarting within TRS tracts.  TRS (red), 
complementary DNA (green), Okazaki primers (pink) and DNA polymerase (blue) are 
shown.  A. This pathway demonstrates how contractions may occur when lagging-strand 
synthesis replication machinery skips a secondary hairpin on the lagging-strand template. B.  
Expansions in TRS tracts may occur during replication fork reversal and restarting. A hairpin 
structure can then form on nascent leading-strand DNA as a consequence.  Increases in 
expansions can result in larger hairpin structures.  Image taken from (Mirkin, 2007). 
 
 
Although the replication slippage model is considered to be a major mechanism of repeat 
instability, sequences capable of adopting non-B structures are also able to induce instability 
in non-proliferative cells, such as CAG repeat expansions in the brain (Hashida et al., 1997). 
This indicates a replication-independent mechanism, such as DNA repair can also induce 
DNA structure-related instability (Kovtun and McMurray, 2008). 
 
Unusual secondary structures alter overall DNA conformation and, as a result, directly affect 
its biological behaviour by influencing processes involving interactions with DNA.  
Therefore, spontaneous formation of unusual secondary structures often significantly alter 
cellular properties and compromise cellular integrity.  As discussed above, genomic stability 
 
A 
B 
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is not only crucial for survival of a cell, but it can also be crucial for survival of the entire 
organism.  Global repair mechanisms may recognise certain structures as damaged DNA and, 
if the damage is deemed too extensive, then mechanisms will be triggered which will lead to 
apoptosis of the cell in multi-cellular organisms.  If too many cells of a particular cell type are 
destroyed, the function of a particular organ essential for organism survival may be 
compromised. 
 
1.3.4 DNA Repair Pathways. 
 
As described, the various DNA-damage inducing agents and errors that occur during cellular 
metabolism can create dangerous base modifications, abasic sites, helix-distorting adducts, 
breaks in DNA and unusual structural conformations.  These lesions can introduce further 
detrimental features such as transversions, base transitions, frameshift mutations or gross 
chromosomal aberrations (Kulkarni and Wilson, 2008).  To protect against DNA-damage, 
cells contain proteins that specifically recognise and remove damaged DNA to prevent 
cellular dysfunction and help restore genomic stability. 
 
Single bases can be chemically altered by modifications such as deamination and alkylation.  
The resulting lesions can be very mutagenic as they can cause mis-incorporation of incorrect 
nucleotides during DNA replication and transcription.  To counteract this, cells have evolved 
a pathway termed base excision repair (BER) for removal of damaged bases.  BER consists of 
2 sub-pathways:  short-patch BER, where a single nucleotide is replaced, and long-patch 
BER, where 2-13 nucleotides are replaced (Hakem, 2008).  For both pathways, the initial step 
is removal of the damaged base by a specific DNA glycosylase, which occurs following DNA 
backbone compression and repositioning of the damaged base so that it becomes accessible 
for the enzyme (Berti and McCann, 2006).  In mammalian cells, strand incision by APE1 
endonuclease is followed by gap filling by DNA polymerase-β (short-patch) or DNA 
polymerase-β, ε or δ (long-patch) and, finally, ligation by DNA ligases I or III.  Long-patch 
BER requires the participation of other proteins during removal and replacement of several 
nucleotides.  Proteins involved in bacterial BER are similar to those in eukaryotic BER. 
 
Nucleotide excision repair (NER) is an important mechanism for removing damaged 
nucleotides, particularly those damaged by UV light, through the activity of proteins that 
recognise and remove bulky distortions in the DNA double helix.  NER is comprised of 
several subpathways of which 2 have been best characterised: global genomic-NER (GG-
NER) and transcription-coupled NER (TC-NER).  The only difference between these 2 
pathways regards DNA lesion recognition as GG-NER repairs genome-wide damage and TC-
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NER specifically repairs damage on the coding strand that inhibits RNA polymerase (Shuck 
et al., 2008).  In humans, XPC (during GG-NER) or RNA polymerase II (during TC-NER) 
recognises bulky distortions in duplex DNA.  This recognition stimulates DNA unwinding by 
transcription factor II H (TFIIH) and other cofactors.  XPA, XPG and RPA stabilise the 
resulting complex prior to incisions 3’ (by XPG) and 5’ (by XPF) of the damage, and the 
resulting gap is filled by DNA polymerase and DNA ligase activity (Fleck and Nielsen, 2004; 
Hoeijmakers, 2001).  Bacteria also posses both GG-NER and TC-NER, with a complex 
consisting of UvrA and UvrB responsible for the detection and verification in both pathways.  
The UvrB-DNA complex is bound by UvrC which causes incisions either side of the 
damaged nucleotide allowing a separate UvrD protein to subsequently remove the damaged 
lesion and DNA polymerase I and a DNA ligase complete the repair process.  During TC-
NER, the multifunctional Mfd transcription-repair coupling factor overcomes the inhibitory 
effect of the stalled RNA polymerase to enhance the rate of lesion repair on the template 
DNA strand (Savery, 2007). 
 
Mismatch repair (MMR) is central to the repair of base insertions, deletions and mis-
incorporation of bases that arise during DNA replication and recombination.  Defects in 
MMR often result in alterations in DNA sequences that induce changes in amino acid 
sequences of peptides and affect protein function which can significantly affect cell viability 
(Iyer et al., 2006).  Although not directly part of the MMR process, the 3’-5’ exonuclease 
proofreading activity of DNA polymerase corrects most mismatches, but errors that are not 
fixed can be repaired by MMR.  The importance of MMR is evident as mutation of certain 
MMR genes in humans can cause severe disorders, including hereditary non-polyposis 
colorectal cancer (Hakem, 2008).  MMR is bidirectional, allowing degradation of the 
mismatch in either a 5’ or 3’ direction.  In bacteria, the reaction begins by recognition of a 
mismatch by a MutS homodimer, followed by ATP binding to the MutS dimer and 
recruitment of MutL to the complex.  ATP hydrolysis then induces the MutS-MutL complex 
to translocate along the DNA and leads to subsequent activation of MutH, which causes an 
incision in the non-methylated daughter strand DNA.  MutS-MutL can then activate DNA 
helicase II to initiate unwinding of the DNA double helix, producing a single-strand of DNA 
containing the mismatch.  Exonucleases then remove this single-stranded region and DNA 
polymerase III and DNA ligase complete the repair process (Jun et al., 2006).  In humans, 
mismatches or modified bases are recognised by a MutSα heterodimer, which is comprised of 
MSH2 and MSH6, or a MutSβ heterodimer, which is a complex of MSH2 and MSH3.  Both 
complexes have different substrate specificities and can induce varied downstream responses.  
Recognition of DNA lesions primarily occurs via MutSα (Umar et al., 1994) according to a 
‘molecular switch model’ (Christmann et al., 2003) and, once bound to a lesion, MutSα-ADP 
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stimulates ADP to ATP transition and intrinsic ATPase activity.  This in turn induces a 
conformational change that permits passive sliding and association with the heterodimer 
MutLα complex.  The DNA strand that contains the mismatch is then excised by exonuclease 
I (Genschel et al., 2002) followed by DNA synthesis by DNA polymerase δ (Longley et al., 
1997). 
 
1.3.5 Double-strand Break Repair. 
 
A single inappropriate DSB poses a significant threat to genomic stability and so the efficient 
recognition and removal of such aberrations is of the highest priority.  Cells have evolved 
different mechanisms to repair DSBs depending on the cell cycle phase and type of break.  
When a homologous DNA template is available, homologous recombination (HR) can be 
performed, resulting in accurate repair of DSBs.  Other processes, such as non-homologous 
end joining (NHEJ) and microhomology-mediated end joining, are error-prone repair 
mechanisms that can lead to alterations in the genetic material following repair.  Choice of 
DSB repair mechanism is also species-dependent with over 90% of DSBs in mammalian cells 
repaired by NHEJ, but in both yeast and bacteria, HR is the preferred repair mechanism 
(Hakem, 2008).  The type of DSB sustained also dictates which repair pathway will be 
selected.  An endonuclease induced DSB occurring in G1 phase of the cell cycle would be 
repaired through the NHEJ (Zierhut and Diffley, 2008), however ionising radiation induced 
damage would be preferentially repaired by HR (Barlow et al., 2008), with repair delayed if 
no homologous template is available. 
 
In humans, DSB recognition is performed by ataxia telangiectasia mutated (ATM), ataxia 
telangiectasia related (ATR) and the DNA protein kinase catalytic subunit (DNA-PKcs).  
ATM and ATR attach to damaged DNA ends, which leads to kinase domain activation and 
subsequent activation of proteins involved in cell cycle regulation and DNA repair that share 
a Ser-Thr-Gln-Glu consensus sequence (Kim et al., 1999).  Generally, ATM/ATR-mediated 
phosphorylation of target proteins such as Chk1, Chk2 and p53 is crucial in controlling G1/S 
and G2/M cell cycle arrest, initiation of DNA repair and apoptosis (Christmann et al., 2003). 
 
HR is a highly accurate process that uses a homologous DNA template to repair breaks during 
the S or G2 phases of the eukaryotic cell cycle.  In this repair pathway, the first proteins 
recruited  to a DSB is the MRX/MRN complex, consisting of Mre11-Rad50-Xrs2 (MRX) in 
yeast and MRE11-Rad50-NBS1 (MRN) in humans (Bernstein and Rothstein, 2009).  These 
complexes perform the initial processing of damaged DNA ends by producing 3’ ssDNA at 
each end of the break.  RAD51 is then recruited, which binds to the 3’ single-stranded ends 
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and invades a homologous dsDNA, usually from a sister chromosome, forming a Holliday 
junction following polymerase activity.  Separation of repaired DNA is achieved by resolvase 
enzymes and the repair is completed by ligation of the broken strands (Fleck and Nielsen, 
2004). 
 
In contrast to the accurate repair of DSBs by HR, NHEJ is error-prone and can lead to 
dramatic genetic alterations (Pitcher et al., 2005).  During processing and ligation of the 
damaged DNA termini, nucleotides can be lost and the integrity of the genome may be 
significantly reduced.  Initially it was believed NHEJ was restricted to eukaryotes, but 
evolutionarily NHEJ related mechanisms in prokaryotes have also been identified (Doherty et 
al., 2001).  Unlike HR, which requires a homologous template, NHEJ can progress 
independent of homology between DNA duplexes, however, microhomology alignment of 
DNA ends is thought to facilitate the process.  The NHEJ reaction requires tight coordination 
between several key proteins and many of these interactions are yet to be fully understood 
(Weterings and Chen, 2008). In eukaryotes, NHEJ is initiated by a Ku70/Ku80 dimer that 
recognises and binds in a ring-like structure to a variety of DSBs.  In mammalian cells, once 
bound, Ku70/Ku80 is believed to act as a scaffold that recruits and activates DNA-PKcs and 
the DNA ligase IV/XRCC4 complex. DNA-PKcs has many roles, including regulation of the 
synaptic complex, which brings both DNA ends together and leads to activation of other 
proteins integral to NHEJ.  For the production of ligatable ends, the DNA may need to be 
processed by factors such as polymerases and nucleases.  It is during this processing that 
changes to nucleotide sequence can occur that can threaten genomic integrity (Weterings and 
Chen, 2008).  These processing proteins are usually recruited via direct interactions with Ku 
or DNA-PKcs (Hoeijmakers, 2001; Pitcher et al., 2007).   Once ends have been processed, 
ligase IV/XRCC4 joins the 2 ends together, facilitated by other proteins including 
XLF/Cernunnos. 
 
The MRX complex is involved in both HR and NHEJ and its activity may determine whether 
repair proceeds via HR or NHEJ, at least in yeast (Daley et al., 2005).  It is still unknown how 
HR and NHEJ are regulated in bacteria (Pitcher et al., 2007), however cell cycle status or 
regulation of the HR pathway by NHEJ proteins are likely to be important. 
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1.4 Protein Components of Non-homologous End Joining. 
1.4.1 Activities of Ku Proteins. 
 
Ku proteins were originally discovered as targets of autoantibodies in patients with 
polymyositis-scleroderma overlap (Mimori et al., 1981).  They are now recognised as 
essential proteins associated with various cellular processes including NHEJ, 
retrotransposition and telomere maintenance (Friedl, 2002).  Ku is a highly abundant nuclear 
protein present in all eukaryotes that is likely to be one of the first proteins to interact with 
DNA ends following a DSB.  As mentioned, Ku are integral in detecting and interacting with 
DSBs and they have also been implicated in alignment and synapse formation of DNA 
termini. The eukaryotic Ku70/80 heterodimer exhibits high affinity binding for dsDNA ends 
and also to hairpin structures (Falzon et al., 1993).  This affinity for DNA ends does not seem 
to be dependent on sequence or overhangs, allowing Ku to bind to a variety of DSB that result 
from DNA damage (Doherty et al., 2001).  Such flexibility in substrate binding is thought to 
occur as Ku makes no contacts with DNA bases and only a few contacts with the DNA sugar-
phosphate backbone (Riha et al., 2006).  Ku binding is dependent on the DNA substrate 
length and it has been suggested that it can passively translocate along DNA, allowing 
multiple Ku proteins to bind to the same DNA molecule like beads on a string (Dynan and 
Yoo, 1998).  This ability of Ku to translocate inwards away from the DNA end may be crucial 
in allowing the efficient processing and subsequent ligation of DNA termini during NHEJ. 
Binding affinity of Ku proteins to ssDNA is believed to be low, but there is evidence that Ku 
may have some binding affinity for RNA and, in some cases, binding affinity for small RNA 
molecules equals that of dsDNA ends (Yoo and Dynan, 1998). 
 
Following DSB formation, DNA termini are at risk of excessive nucleolytic degradation, 
which could lead to the loss of important genetic information.  Ku has been implicated in 
protection of the resulting DNA ends from this degradation as studies investigating Chinese 
hamster ovary cell lines lacking Ku identified deletions of hundreds of nucleotides around 
DSB sites (Liang and Jasin, 1996).  Alongside DSB protection, Ku facilitates ligation of 
breaks through juxtaposition of both DNA strands and recruitment of DNA ligase IV/XRCC4 
by direct protein-protein interactions (Kysela et al., 2003). 
 
X-ray crystallographic structures demonstrated that although Ku70 and Ku80 do not share 
high sequence homology, the overall folding of each protein during DNA binding is similar 
(Walker et al., 2001).  Both Ku70 and Ku80 share a similar three-domain topology - an α/β-
domain at the amino-terminus, a central β-barrel domain and an α-helical arm at the carboxyl-
terminus (Figure 1.7).  The amino-terminal α/β-domains and helical carboxyl-terminus are 
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located on the Ku complex periphery and are thought not to significantly contribute to 
heterodimer formation or DNA binding.  Instead, these regions are essential for interactions 
with other DNA repair proteins (Cary et al., 1997; Weller et al., 2002). The eukaryotic 
heterodimer forms a unique structure containing a hollow preformed channel in the centre of 
the ring-like structure.  This region is termed the bridge and pillar region and is where DNA 
can thread through (Lehman et al., 2008).  DNA binding is achieved using direct interactions 
between positively charged and hydrophobic amino acids on both Ku70 and Ku80 and the 
DNA sugar-phosphate backbone.  Recent studies have suggested conformational changes 
occur to Ku once bound to DNA, which were previously unknown (Lehman et al., 2008).  
Other structural features of Ku include vonWillebrand factor A (vWA) domains on both Ku70 
and Ku80 that become positioned near the DNA break, and 6 α-helices on the Ku80 carboxyl-
terminus to which DNA-PKcs is thought to bind (Zhang et al., 2004).  The vWA is involved 
in protein-protein interactions and is thought to be crucial in recruiting other proteins to 
DSBs.  Other structural features of eukaryotic Ku include a SAF-A/B Acinus and PIAS (SAP) 
domain (carboxyl-terminus of Ku70), a domain implicated in protein-DNA interactions.  SAP 
motifs contain a distribution of hydrophobic, polar and bulky amino acids and several 
positions rich in positively charged amino acids that contact the DNA backbone (Aravind and 
Koonin, 2000).  The SAP domain is also a distant relative of the Myb DNA binding domain, 
which is a common feature of proteins implicated in telomere maintenance (Riha et al., 2006). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.6 Structure of human Ku70/Ku80 bound to DNA.  Ku70 is blue, Ku80 is pink 
and DNA is grey.  A.  Side view of Ku-DNA complex viewed down the DNA helical axis.    
B.  Ku-DNA complex viewed from the top.  A narrow bridge formed by 2 strands that 
extends across the DNA can be seen.  The top of the DNA is exposed which may allow access 
for other proteins such as DNA ligase IV to bind directly.  Ku70 SAP and Ku80 DNA-PKcs 
binding domain relative positions are indicated.  Image taken from (Doherty and Jackson, 
2001). 
 
 
As well as its essential function during NHEJ, Ku plays a pivotal role in the maintenance of 
telomeres.  As mentioned in Section 1.2, chromosome ends of linear genomes must be 
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excluded from DSB repair to prevent catastrophic chromosomal rearrangements.  Telomere-
specialised architecture, consisting of extended G-rich repeat arrays bound by specific 
telomeric DNA binding proteins, form higher-order non-nucleosomal structures that act as 
protective caps that allow telomeres to be distinguished from damage-induced DSBs (Riha et 
al., 2006).  In most eukaryotes, the G-rich repeat forms a 3’ single-stranded overhang that 
mediates formation of a complex t-loop structure.  It is known that Ku70/Ku80 contributes to 
telomere end protection but the precise mode of interaction has yet to be fully elucidated.  
Interactions may be achieved via protein-protein interactions or by direct Ku-DNA binding.  
Ku deficiency can lead to a range of telomeric phenotypes in different organisms, which 
suggests there is no uniform model for Ku activity at telomeres.  Ku has been found to protect 
telomeres from interchromosomal recombination and degradation, regulate telomerase 
activity and also aid telomere tethering to the nuclear periphery (Wang et al., 2009b). 
 
Even though Ku appears to have important conserved roles across many species, it is only in 
humans where Ku is found to be an essential protein (Li et al., 2002).  It was recently 
identified that this essential function is because of the role of Ku in telomere formation, rather 
than its activity during NHEJ (Wang et al., 2009b).  Currently there is still no proof of direct 
Ku-telomere DNA binding, however, this activity would provide mechanistic explanations for 
the diverse functions Ku is believed to perform at telomeres. 
 
1.4.2 Current Understanding of Prokaryotic NHEJ and Ku. 
 
Evidence for NHEJ in prokaryotes was first obtained from the discoveries of genes in bacteria 
that were homologous to those involved in eukaryotic NHEJ.  In contrast to eukaryotic NHEJ 
involving several proteins with specific roles, the best characterised bacterial NHEJ is from 
mycobacteria and consists of a two-component system that contains the break recognition, 
end-processing and ligation activity needed for NHEJ (Della et al., 2004; Weller et al., 2002).  
This system consists of Ku proteins that have DNA end recognition and binding ability and an 
associated ligase (LigD) that contains domains associated with end-processing and ligation 
activities.  As with eukaryotic NHEJ, the bacterial NHEJ complex has the ability to synapse 2 
independent DNA ends, process the termini and ligate the two strands together.  There is 
evidence that suggests microhomologies between DNA molecules can facilitate bacterial 
NHEJ (Della et al., 2004) as identified with eukaryotic NHEJ, although such similarities 
between DNAs are not essential.  A generalised schematic of NHEJ is shown in Figure 1.8. 
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Figure 1.8 A generalised view of DSB repair by the NHEJ complex.  For initiation of DSB 
repair, Ku dimers (blue) recognise and bind to DSB, where they may function as end-bridging 
and DNA alignment factors.  Ku may then translocate along the DNA and allow recruitment 
of additional processing enzymes to the break site.  Often DNA ends are not complementary 
and DNA end-processing, including nucleolytic activities (yellow) and gap-filling (grey), may 
be required to generate termini capable of ligation by DNA ligase (green).  Once DNA ends 
have been joined, the complexes dissociate, however the mode of Ku dissociation remains 
unclear. 
 
 
The bacterial NHEJ mechanism is yet to be fully understood.  It is also unknown how much 
variation exists in NHEJ between different prokaryotes.  Many prokaryotes that demonstrate 
NHEJ machinery are known to exist predominantly in a non-dividing phase of their life 
cycles when DNA replication is reduced or absent (Wilson et al., 2003).  For example, in 
Bacillus subtilis, expression of ykoU (LigD) and ykoV (Ku) is controlled by the forespore 
specific sigma factor for RNA polymerase σG, so that expression is only induced during spore 
development (Wang et al., 2006).  During this time, cells may be exposed to various DNA 
damaging agents and other factors such as desiccation that could induce DSBs.  In bacteria 
with only 1 chromosome, the absence of a homologous DNA template means the evolution of 
NHEJ pathways may have been important for many prokaryotic species (Bowater and 
Doherty, 2006).  The error-prone nature of NHEJ may also have facilitated with increased 
genetic diversity, which can ultimately provide selective advantages under stressful 
conditions by generating mutations during stationary-phase (Heidenreich et al., 2003).  The 
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observation that several bacteria that chronically infect eukaryotic hosts contain ku and ligD 
homologues has lead to suggestions that NHEJ may be important during infection for repair 
of DSBs induced by the hosts genotoxic defence or by increasing the mutation frequency by 
error-prone repair (Kobayashi et al., 2008).  
 
In eukaryotic NHEJ, it is thought formation of a synapse between the 2 DNA strands is 
mainly regulated by DNA-PKcs with cooperation by Ku70/80 (Riha et al., 2006). However, a 
degree of uncertainty remains over which protein component is integral to DNA alignment.  
Initially, studies indicated that Ku alone could synapse 2 independent DNA molecules (Cary 
et al., 1997; Ramsden and Gellert, 1998) but later investigations established that DNA-PKcs 
was integral to this process (DeFazio et al., 2002; Lees-Miller and Meek, 2003).  Although 
DNA synapsis during NHEJ in eukaryotes may remain cryptic, it is clear that synapsis in 
prokaryotes must be DNA-PKcs independent as no homologous protein has been detected in 
any prokaryote.  Feasibly, prokaryotic Ku may perform this activity alone as previous studies 
on eukaryotic Ku have alluded to, or alternatively, other NHEJ components may contribute to 
alignment.  Studies of Mycobacterium tuberculosis recombinant NHEJ proteins have shown 
that the polymerase domain of the LigD protein (which comprises the two-component system 
alongside Ku) contains a functionally analogous structural element found in other NHEJ 
polymerases.  This element is thought to facilitate connectivity between 2 discontinuous DNA 
ends (Juarez et al., 2006; Pitcher et al., 2007) and indicates this protein may participate in 
formation of a synaptic complex.  It has been proposed that Ku may facilitate synaptic 
complex formation alongside regions of microhomology between DNAs. 
 
Unlike the heterodimeric eukaryotic Ku that is produced from 2 separate genes, prokaryotic 
Ku orthologues have been characterised that are encoded by single gene and subsequent 
biochemical studies revealed this protein could bind as a homodimer to DSBs (Doherty et al., 
2001).  In addition, a number of bacteria also encode Ku proteins that have potential to form 
heterodimers (Pitcher et al., 2005), such as Mesorhizobium loti, Streptomyces coelicolor and 
Sinohizobium meliloti (Kobayashi et al., 2008), as they contain multiple genes with homology 
to ku, indicating that NHEJ may show variation between different prokaryotic organisms. 
Interestingly, bacterial ku genes are often genetically linked to operons containing an ATP-
dependent DNA ligase gene, which together may form the two-component system.  These 
Ku-associated ligases frequently possess domains that demonstrate sequence homology with 
eukaryotic nucleases and polymerases and could explain how bacterial NHEJ compensates for 
absent end processing factors that are found in eukaryotic NHEJ (Weller and Doherty, 2001).  
Although ku homologues have been characterised in bacteria, certain strains such as 
Escherichia coli K12 (enterobacteria) show no evidence of ku related genes.  This lack of any 
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obvious phylogenetic pattern between bacteria with or without NHEJ apparatus indicates 
these genes are likely to have been passed between organisms through horizontal gene-
transfer (Bowater and Doherty, 2006). 
 
The bacterial Ku homologues are significantly smaller (30-40 kDa) than their eukaryotic 
counterparts and generally only contain domains similar to the central core DNA binding and 
dimerisation region of Ku70/Ku80 (Figure 1.9).  They also usually lack other domains 
associated with eukaryotic Ku proteins, including the SAP (located on the carboxyl-terminal 
domain (CTD) of Ku70) and the vWA domain (located on the amino-terminal domain (NTD) 
extension of Ku70/Ku80) (Pitcher et al., 2007), which are involved in protein-DNA and 
protein-protein interactions respectively.  Structural information regarding bacterial Ku 
binding has not been fully identified, but sequence analysis predicts these proteins form 
dimeric complexes that are structurally related to eukaryotic Ku, with a central ring-like 
structure.  These similarities suggest prokaryotic and eukaryotic Ku derived from the same 
common ancestor such as the phage protein Gam (Figure 1.10). 
 
 
Figure 1.9 Domain organisation of eukaryotic and prokaryotic Ku proteins.  Eukaryotic 
Ku proteins are generally larger and contain additional specialised domains in comparison to 
their prokaryotic counterparts.  Ku80 is the largest protein, with a vWA protein-protein 
interaction domain on the NTD, a central DNA binding / dimerisation domain and a CTD 
containing a helical arm region and also a domain implicated in interactions with DNA-PKcs.  
Ku70 has similar NTD and core regions but the CTD differs as a SAP DNA-binding domain 
is present instead of the DNA-PKcs interacting domain.  Prokaryotic Ku are considerably 
smaller and most only consist of the core DNA binding / dimerisation domain except for 
ScKu2 which contains a domain homologous to the SAP domain of Ku70 on the CTD.  
 
 
 
 
 
 
Chapter 1 - Introduction 
 24 
vWa 
SAP 
Phage Gam   Prokaryotic Ku Eukaryotic Ku 
 
Figure 1.10 Evolution of Ku proteins.  As Ku proteins can be found in all kingdoms it is 
believed their existence predates branching of prokaryotic and eukaryotic domains.  
Primordial Ku may have been a homodimeric protein that demonstrates significant 
similarities to phage Ku-like proteins (Gam) that act as linear DNA end protection proteins.  
Interactions with DNA ligases led to the two-component NHEJ seen in some prokaryotes and 
gene duplication may have produced heterodimeric prokaryotic Ku.  Additional vWA and 
SAP domains incorporation resulted in the modular architecture and functional characteristics 
seen in the Ku70/Ku80 eukaryotic Ku.  Taken from (Pitcher et al., 2007). 
 
 
Aside from NHEJ, alternative roles of prokaryotic Ku remain unknown.  Investigations of Ku 
from M. tuberculosis imply prokaryotic Ku contains similar DNA-binding characteristics as 
eukaryotic Ku, with a preference for dsDNA ends and the ability to load onto DNA dependent 
on DNA length, suggesting the ability to translocate along DNA (Weller et al., 2002).  
Eukaryotic Ku is heavily involved in telomere regulation, however no evidence exists yet for 
DNA end maintenance by prokaryotic Ku.  Although the current activity of Ku proteins in 
prokaryotes may now be confined to NHEJ, in the past Ku may have been instrumental in 
prokaryotic evolution.  It has been determined that bacteria expressing Ku homologues are 
more adept at acquiring genetic material from their surrounding environment and 
incorporating this into their own genomes (d'Adda di Fagagna et al., 2003), a feature that 
would have greatly assisted the genetic diversity now evident in nature. 
 
1.4.3 Ku proteins of Streptomyces coelicolor. 
 
Streptomyces coelicolor are Gram-positive bacteria that derive from the largest genus of 
Actinobacteria.  S. coelicolor are soil dwelling and have complex lifecycles, involving 
multicellular entities with biochemically and morphologically differentiated cell types, with  
each  individual cell type comprising a specific function (Figure 1.11) (Miguelez et al., 2000). 
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S. coelicolor are perhaps best known for their complex secondary metabolism and their 
involvement in production of several antibiotics used today (Paradkar et al., 2003). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.11 The complex lifecycle of S. coelicolor.  Entities at each individual stage are 
biochemically and morphologically different and have functions specific for each particular 
stage. Taken from (Angert, 2005). 
 
 
Colonies of S. coelicolor grow vegetatively by the formation of multigenomic hyphae that 
form branching substrate mycelium (Gehring et al., 2004).  Under stressful conditions such as 
nutrient deprivation, aerial mycelium filaments are produced that are capable of penetrating 
the surface tension at the soil interface.  The aerial filaments can differentiate into spore-
bearing structures capable of dispersal (Tyers and Buttner, 2004).  Prior to sporulation, 
regularly spaced sporulation septa divide hyphae into unigenomic prespore units that mature 
during sporulation and are released as free spores that are hydrophobic dormant bodies 
(Hirsch and Ensign, 1976).  For germination of the spores, exogenous nutrients including 
water are required (Ensign, 1978). 
 
Recently, 3 Ku homologues have been identified in S. coelicolor, known as SCO5309 (1095 
nucleotides), SCO0601 (1041 nucleotides), which are both chromosomal, and SCP1.285c 
(897 nucleotides), which is located on plasmid SCP1.  SCO5309 and SCO0601 are predicted 
to have molecular weights of approximately 39 kDa and SCP1.285c is approximately 33 kDa 
(Sayer, 2008).  All 3 Ku homologues demonstrate sequence similarities with the core region 
of eukaryotic Ku70/Ku80.  SCO0601 also contains a helix-extended region-helix (HEH) 
domain on the carboxyl-terminal extension, which is very similar to the SAP domain found 
on Ku70.  As described in Section 1.4.1, SAP domains contain positively charged amino 
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acids that interact with negatively charged helical surfaces.  They consist of a short mobile 
helix adjacent to a second helix, which is separate from a third helix that is parallel to the 
second helix (Aravind and Koonin, 2001).  It is likely that SAP domains evolved from HEH 
domains and both are thought to have similar properties.  Apart from sequence homology 
with Ku70/Ku80, which suggests a NHEJ mechanism exists in S. coelicolor, little else is 
known regarding the specific activity or other specialised functions for these proteins.  
Interestingly, SCO5309 is located adjacent to a gene that shows high sequence homology to 
the primase region of the mtligD ligase implicated in NHEJ in M. tuberculosis (Weller and 
Doherty, 2001). 
 
S. coelicolor is unlike many other prokaryotes in that it contains a linear genome and can also 
contain linear plasmids that demonstrate the ability to rapidly circularise.  These properties 
have made S. coelicolor an interesting experimental system for the investigation of telomere 
characteristics.  Streptomyces replicons are dsDNA molecules with their 5’ ends covalently 
attached to terminal proteins (Bao and Cohen, 2001; Hirochika and Sakaguchi, 1982; Kinashi 
and Shimaji, 1987; Yang et al., 2002).  Replication of Streptomyces linear plasmids proceeds 
divergently from a central site in the DNA and generates 3’-leading strand overhangs at the 
telomeres (Bao and Cohen, 2003).  Like eukaryotic telomeric regions, S. coelicolor 
chromosomal ends contain repeating sequences, however, unlike eukaryotic tandem direct 
repeats, S. coelicolor repeats contain inverted sequences.  The chromosomal arms are highly 
unstable and large chromosomal rearrangements can occur within these regions.  
Consequently, no essential genes are located within 1.2 Mb of either end of the S. coelicolor 
chromosome with the exception of argG (Redenbach et al., 1996).   Telomeres of S. 
coelicolor range in size, show high instability and telomeric DNA is often lost when replicons 
circularise (Qin and Cohen, 2002).  Deletions also commonly occur in S. coelicolor telomeric 
regions either by replicative transposition of mobile DNA, replication fork collapse at ssDNA 
breaks or exonuclease degradation when terminal proteins are absent (Volff and 
Altenbuchner, 1998).  Deletion events are also regularly associated with DNA amplifications 
that can both dramatically lower genomic stability.   
 
Unlike eukaryotic Ku70/80, there is no evidence that bacterial Ku are involved in telomere 
maintenance (Pitcher et al., 2007).  However, as S. coelicolor contains linear replicons with 
highly unstable chromosomal ends, it would be of interest to determine whether any of the Ku 
homologues demonstrate telomere regulation activities that are associated with their 
eukaryotic counterparts. 
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1.4.4 Non-homologous End Joining DNA Ligase Proteins. 
 
DNA ligases catalyse the formation of covalent bonds between adjacent 3’-hydroxyl and 5’-
phosphate groups on substrate DNA.  The reaction mechanism is dependent on a divalent 
cation (usually Mg2+) and an ATP or NAD+ cofactor that donates an adenylate group onto the 
DNA ligase to form a phosphoamide intermediate.  The adenylate group is subsequently 
transferred to the 5’-phosphate, which is then subject to nucleophilic attack from the 3’-
hydroxyl group, causing release of AMP and formation of a phosphodiester bond (Wilkinson 
et al., 2001).  Most organisms contain multiple specialised DNA ligases that function only 
during particular cellular processes including replication, recombination and repair of DNA.   
 
In eukaryotes, successful joining of DSBs during NHEJ is performed by the ATP-dependent 
DNA ligase IV in complex with XRCC4 (Hoeijmakers, 2001).  Prokaryotic NHEJ requires 
the activity of ATP-dependent LigD proteins that are often found in operons alongside Ku 
homologues (Pitcher et al., 2007).  As described in Section 1.4.2, these DNA ligases can be 
multifunctional and contain additional domains for processing DNA prior to ligation.  The 
LigD from Mycobacterium tuberculosis (MtLigD) exhibits both polymerase and nuclease 
domains in addition to the central ligase domain whereas other prokaryotes, such as Bacillus 
subtilis, contain LigD proteins with only additional nuclease regions (Aravind and Koonin, 
2001).  Biochemical experiments have confirmed that these proteins have their predicted 
enzymatic activities (Pitcher et al 2007). Other prokaryotes contain ligD genes that only 
encode ligase domains, indicating additional proteins would be required for any necessary 
DNA processing in these species.  The ligD gene of S. coelicolor (scligD) displays high 
sequence homology with the DNA ligase domain of LigD from M. tuberculosis but potential 
polymerase or nuclease domains are absent.  Interestingly, 3 genes are present in S. coelicolor 
that show homology to the polymerase region of MtLigD and a separate gene is also present 
that displays homology to the MtLigD nuclease region.  Analysis of ScLigD has revealed this 
protein is able to ligate varied DNA substrates, albeit at a relatively low rate (Sayer, 2008).  
Potentially, the inclusion of additional NHEJ proteins, such as ScKu, may enhance this rate to 
produce an efficient DSB repair pathway in vivo. 
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1.5 p53 Tumour Suppressor Protein. 
1.5.1 p53 Structure and Function. 
 
Initially identified as an oncogene, p53 is now recognised as a gene coding for a major 
tumour suppressor protein that controls an extremely complex network within multicellular 
organisms.  p53 exerts its function by directly or indirectly regulating numerous target genes 
involved in essential cellular processes that directly influence the maintenance of genomic 
stability (Laptenko and Prives, 2006).  Due to its significance, it has been termed the 
‘Guardian of the genome’ and its importance is reinforced by the fact that this protein is 
mutated in around half of all known cancer cases (Shu et al., 2006).  General p53 activity in 
unstressed cells is very low. However, following induction of stress, various pathways are 
activated that alter post-translational modifications and the stability of p53, resulting in its 
accumulation in various stable forms that allow it to perform diverse roles throughout the 
cell.  A well documented function of p53 is to act as a transcription factor that binds to 
specific consensus sequences located in regions of the genome, with subsequent alteration of 
expression of a particular gene target.  Numerous targets have been identified that play roles 
in cell cycle arrest, DNA repair, apoptosis and senescence (Appella and Anderson, 2001; 
Murray-Zmijewski et al., 2008; Oren, 2003; Vogelstein et al., 2000; Vousden, 2006).  Some 
activated p53 target genes are responsible for cell cycle arrest to prevent replication of 
potentially dangerous DNA, allowing time for decisions to be made as to whether the damage 
can be repaired or if the cell should undergo apoptosis.  Other downstream genes are directly 
involved in removing dangerous DNA lesions by DNA repair processes, and other targets are 
instrumental in the induction of apoptosis.  Transcription-independent activities of p53 in the 
cell cytosol leading to apoptosis initiation have also been revealed, which have added to the 
complexity of understanding how this protein functions (Romer et al., 2006).  Activation of 
p53 is usually dependent upon genotoxic or cellular stress that causes damage to DNA, which 
can pose a significant risk to the stability of a cell.  Although activation is crucial for many of 
the observed roles of p53, it has recently become apparent that basal inactivated p53 can also 
influence cellular activity, including regulation of self-renewal of adult neural stem cells 
(Meletis et al., 2006) and repression of CD44 cell surface proteins (Godar et al., 2008).  One 
model (Figure 1.12) has been proposed that suggests at low levels p53 functions in response 
to constitutive stress associated with growth and development to regulate necessary DNA 
repair, but, following acute stress, p53 activity is significantly increased and apoptosis 
inducing functions are activated (Vousden and Lane, 2007). 
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Figure 1.12 Determining the p53 response.  The p53 induced response depends on the type 
of stress encountered.  During low or constitutive stress, p53 may function to reduce 
oxidative damage and control repair mechanisms to restore genome stability.  Such activity 
contributes to the general health of the cell and prevents acquisition of tumourigenic 
mutations.  Following acute stress, p53 is fully induced and apoptotic pathways can be 
initiated to eliminate dangerous cells. Taken from (Vousden and Lane, 2007). 
 
 
Malignant transformation of cells requires DNA damage and oncogenic signalling, 2 stresses 
that induce p53 activity.  In non-cancerous cells, p53 will sense and react to resolve these 
errors, either by initiating DNA repair or cell death.  If p53 function is prevented, cancerous 
cells will continue to divide, which can ultimately prove catastrophic for the organism.  A 
large number of human cancers arise because of inactivation of p53 pathways, with many 
cancers resulting from mutations of p53 itself.  The majority of these are missense mutations 
occurring in the core domain of the protein that is involved in binding to DNA.  A vast array 
of different mutations have been identified in this region and only a single amino acid change 
can be enough to prevent p53-DNA binding ability (Brachmann, 2004).  A missense mutation 
can lead to prevention of crucial DNA contact, loss of local structure of the core domain or 
even unfolding of the entire core domain.  Mutant p53 can also have a dominant-negative 
effect by interfering with wild-type p53 proteins.  Although carcinogenesis usually requires 
the loss of both alleles of most tumour suppressor proteins, the dominant negative effect of 
p53 means a single mutant allele can be enough for a cell to become cancerous (Willis et al., 
2004).  Mutations in germline p53 can be hereditary and this is demonstrated in individuals 
with Li-Fraumeni Syndrome, a rare autosomal dominant hereditary disorder characterised by 
mutations in the p53 gene that greatly increase susceptibility to cancer. 
 
Chapter 1 - Introduction 
 30 
As a transcription factor, p53 binds to DNA as a homotetramer composed of modular 
domains that are crucial for its full activity.  Each monomer consists of 393 amino acids 
organised into separate functional domains (Kitayner et al., 2006): an amino-terminal 
activation domain (amino acid residues 1-67), a proline-rich region (residues 67-98) a central 
DNA binding domain (CDBD) (residues 98-303), a nuclear localisation signal containing 
region (residues 303-323), a tetramerisation (TET) domain (residues 323-363) and a carboxyl 
terminal domain containing a  basic regulatory region (363-393) (Arrowsmith, 1999; 
Okorokov and Orlova, 2009) (Figure 1.13). 
 
Figure 1.13 Schematic representation of human p53 domains.  p53 is composed of an 
amino-terminal domain (NTD), proline-rich region (pro-rich), central DNA-binding domain 
(CDBD), nuclear localisation signal (NLS), tetramerisation domain and a regulatory carboxyl 
terminal domain (CTD).  Each domain elicits a specific function that contributes to the 
diverse activity of p53. 
 
 
The NTD contains a region that regulates p53 transcriptional activities and also a region rich 
in proline amino acids that acts as a target for proteins containing SH3 domains.  This 
proline-rich area contains 5 copies of the amino acid sequence PXXP, which allows specific 
protein-protein interactions to occur in the cytosol that can instigate apoptosis (Romer et al., 
2006).  The NTD activation domain is an unfolded region containing islands of secondary 
structures that provide target binding sites for proteins that also participate in transcription 
and can induce expression of target genes.  This domain is also subjected to negative 
regulation by Mouse double minute 2 (Mdm2) and adenovirus E1B proteins.  Extensive post-
translational modifications to this domain, such as phosphorylations, affect p53 stability and 
activity (Dawson et al., 2003) and complete removal of this domain has been documented as 
stabilising sequence-specific p53 binding (Cain et al., 2000).  A recently discovered 
functional domain between the proline-rich and central domain of p53 has been found to 
contain repressing activity, but factors that interact with this domain are currently poorly 
understood (Curtin and Spinella, 2005).  
 
The first of the 2 autonomous DNA binding domains are present on p53 is the CDBD.  This 
domain spans amino acids 98-303 and is essential for binding to specific DNA sequences in 
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promoter regions of target genes referred to as p53 response elements (REs) (described in 
Section 1.5.3).  More than 90% of p53 mutations that lead to carcinogenesis occur in this 
domain and over 1300 currently known mutations lead to partial or complete loss of binding 
activity (Brachmann, 2004).  Some mutations eliminate direct contacts between p53 and 
DNA, and others destabilise the tertiary structure of p53, which prevents DNA binding 
(Bullock et al., 2000).  This region of p53 is more stable than other regions as it has high 
resistance to proteolytic degradation.  The CDBD contains an anti-parallel β-sheet and 2 
loops that are stabilised by Zn2+ to form a loop-sheet-helix motif which comprises the 
sequence-specific DNA binding determinants of the core domain.  A double salt bridge is 
located within the core domain and is thought to be important for cooperative binding 
between monomers (Dehner et al., 2005).  Structural analysis of the CDBD domain bound 
and unbound to DNA have demonstrated the conformation remains relatively unchanged 
following DNA binding (Ho et al., 2006). 
 
A tetramerisation domain is essential for controlling the quaternary structure of p53 by 
assisting the formation of homotetramers that are required for p53 DNA binding activity.  
The p53 tetramer consists of a dimer of dimers, with fully folded primary dimers but only 
partially formed inter-dimer interactions.  The monomer contains an α-helix and β-strand 
linked in a sharp turn that assembles with 3 other monomers via an anti-parallel helix-helix 
interface held together by hydrophobic interactions (Joerger and Fersht, 2008). In solution, an 
equilibrium exists between p53 dimers and tetramers, but tetramerisation dramatically 
increases in the presence of p53 REs (Romer et al., 2006).  p53’s ability to perform multiple 
functions when in its correctly folded structure is provided by an intrinsically flexible 
quaternary organisation, allowing for the diverse activities associated with p53 (Hupp and 
Lane, 1994).  A linker region containing the nuclear localisation sequence of p53 is situated 
between the CDBD and tetramerisation domain. 
 
The second DNA binding domain of p53 is the carboxyl terminal regulatory domain (CTD) 
which is located adjacent to the tetramerisation domain.  This domain binds directly to DNA 
through a sequence-independent manner and can regulate sequence-specific binding by the 
core CDBD.  The CTD is unstructured and contains high levels of serine and lysine residues 
that allow several types of modifications to occur, such as phosphorylations and acetylations.  
It is believed such modifications significantly increase p53 binding affinity for its consensus 
sequence (Bayle et al., 1995).  CTD lysine residues may also regulate p53 stability as they 
can be ubiquitinated by Mdm2, which can result in proteolytic degradation, but these same 
lysines can also act to stabilise p53 following acetylation by histone acetyl transferases.   
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Due to its physiological significance, it is of no surprise that p53 is heavily regulated to 
ensure it is only active when required.  To this effect, in unstressed cells p53 is found at very 
low levels in its latent form.  Following cellular stress signals, p53 is activated via various 
post-translational modifications that allow p53 levels to accumulate.  There are 17 serine and 
threonine residues located in the NTD, CDBD and CTD that are possible phosphorylation 
sites for kinases such as ATM, which phosphorylates serine 15, and cyclin dependent kinases 
(CDKs), which phosphorylate serine 20 (Somasundaram, 2000).  Phosphorylations generally 
decrease the turnover and increase the sequence-specific binding affinity of p53.  ATR and 
Chk1 are able to phosphorylate multiple p53 residues following DNA damage resulting from 
UV light exposure (Romer et al., 2006).  For a comprehensive review of p53 regulation see 
(Boehme and Blattner, 2009). 
 
1.5.2 Downstream Events following p53 Activation. 
 
Transactivation of p53 targets relies on the sequence-specific binding of p53 to consensus 
DNA in the promoter regions of target genes.  Products encoded by these genes are involved 
in processes including growth arrest, DNA repair, apoptosis and senescence (Itahana et al., 
2001; Romer et al., 2006; Sax and El-Deiry, 2003; Shu et al., 2006).  Sequence-specific p53-
DNA binding generally results in target gene up-regulation, however down-regulation of 
certain genes has also been documented (Li et al., 2004).  It is believed p53 interactions with 
consensus DNA may facilitate promoter opening via recruitment of chromatin remodelling 
factors or histone transacetylases, thereby allowing access for general transcription factors 
and RNA polymerase (Horn and Vousden, 2007).  Transcription can also be stimulated by 
p53 through direct interactions with Mediator complex components which facilitates pre-
initiation complex formation and also by recruitment of basal transcription factors such as 
TFIIA and TFIID. 
 
Growth arrest is the reversible prevention of cell cycle progression.  Downstream p53 target 
p21WAF1/CIP1 is a CDK inhibitor that can induce cell cycle arrest in G1 phase by eventual 
prevention E2F activation of genes involved in DNA synthesis (Sax and El-Deiry, 2003).  G1 
arrest is also achieved through p53 regulated inhibition of cyclin E through increased 
expression of hCDC4b.  p53 can induce G2 arrest by direct activation of 14-3-3σ (Bargonetti 
and Manfredi, 2002) or by inhibiting cdc25c which controls cyclin B activity. 
 
DNA repair pathways can be activated by p53 in order to restore genomic stability following 
DNA damage.  Repair pathways known to be initiated in response to p53 activation include 
NER, BER and MMR (Sengupta and Harris, 2005).  The role of p53 in NER is to induce 
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expression of genes encoding GADD45 and xeroderma pigmentosum group C and E (XPC 
and XPE). GADD45 can modulate chromatin and allow other repair components to access 
DNA, XPE localises at damaged DNA and facilitates UV photoproduct removal and XPC is 
involved in recognition of bulky adducts in DNA.  Direct interactions between p53 and 
TFIIH and the helicases XPB and XPD (Harms et al., 2004) allows p53 to directly participate 
in both NER and BER.  BER is also influenced by p53 as interactions between BER repair 
machinery and DNA polymerase β are stabilised by p53.  Two key components of MMR that 
are up-regulated following p53 activation are MutS homologue 2 (hMSH2) and proliferating 
cell nuclear antigen (PCNA).  hMSH2 is involved in mismatch recognition and binding to 
mismatched bases and PCNA regulates hMSH2 transfer to mismatched bases (Xu and 
Morris, 1999). MMR can also be regulated by p53 as expression of p53R2, a gene with 
homology to the R2 regulatory subunit of ribonucleotide reductase, is directly controlled by 
p53.  p53R2 increases the pool of free dNTPs to allow repair of DNA to proceed. 
 
p53 can initiate apoptosis either transcription-dependently or independently.  Several genes 
transcriptionally-transactivated by p53 are involved in apoptosis induction following cellular 
stress via both intrinsic and extrinsic apoptotic pathways (Fridman and Lowe, 2003).  Genes 
that trigger apoptosis following transactivation by p53 include Bcl-2 family members such as 
Bax, Puma, Noxa and Bid, and non-Bcl-2 family protein p53-apoptosis inducing factor 1 that 
can all induce the intrinsic apoptotic pathway (Yu and Zhang, 2005).  Transcription-
independent activation of apoptosis by p53 has also been identified during the intrinsic 
apoptotic pathway as p53 can directly interact with Bcl-x and other Bcl-2 proteins, which 
leads to their inhibition and the subsequent release of cytochrome c, resulting in activation of 
the caspase cascade (Fridman and Lowe, 2003).  Direct signalling by p53 to the mitochondria 
can activate Bax in the cytosol and mitochondrial p53 can induce apoptosis by activating Bak 
proteins.  Such transcription-independent mechanisms are thought to act in conjunction with 
transcription-dependent mechanisms to ensure progression into programmed cell death is 
tightly regulated.  The extrinsic apoptosis pathway is also regulated by p53 as Fas/CD95, 
DR5 death receptor loci and the Fas ligand genes are all up-regulated by p53 (Harms et al., 
2004). 
 
Irreversible cell-cycle arrest is a characteristic of cells that have undergone senescence.  This 
process can be regulated by p53 to prevent cell division in cells with damaged DNA, however 
the mechanisms of this regulation are still unclear.  It is known that Ras induced senescence 
is dependent on increases in cellular p53 and levels of p21WAF1/CIP1 are also at their highest in 
senescent cells (Itahana et al., 2001). 
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Transcriptional activation of target genes by p53 has been well established, however negative 
regulation of other genes has also been identified, leading to down-regulation following p53 
induction.  This usually occurs when a direct p53 target suppresses another gene.  p53 can 
inhibit transcription of RNA polymerases I, II and III via different mechanisms such as 
repressing transcription activators, interfering with transcription machinery complexes or  
recruitment of chromatin modifying factors, including histone deacetylase (HDAC) 
(Laptenko and Prives, 2006).  Transcriptional repression can also be dependent upon 
activation of other p53 target genes as repression of Chk1, Cyclin A2 and survivin can result 
from transcriptional activation of p21WAF1/CIP1 and subsequent cell cycle arrest. 
 
1.5.3 p53-DNA Interactions. 
 
Interactions between p53 and nucleic acids are highly versatile and show considerable 
flexibility, undoubtedly facilitating p53 to perform its diverse range of activities. The 
recognition and binding affinity of p53 for DNA is heavily influenced by the presence of 
consensus response elements in the DNA or by structural determinants conforming to non-B 
DNA.  High-affinity non-specific DNA interactions to linear dsDNA have also been revealed 
that are likely to promote location of specific response elements by locating p53 to DNA 
(McKinney et al., 2004). 
 
Perhaps the best understood mode of p53-DNA interactions is the binding of p53 to response 
elements in target gene promoter regions, leading to alterations in transcriptional activation.  
This type of interaction is complex and is determined by both sequence and topology of the 
promoter region.  These DNA elements consist of 2 palindromic decamer motifs of the 
sequence 5’-RRRCWWGYYY -3’ (where W is A or T, R is C or G and Y is C or T), usually 
separated by 0-13 base pairs (el-Deiry et al., 1993; Wang et al., 2009a).  Recently it has been 
identified that genes repressed by p53 contain an alternative sequence of 5’-
RRXCXXGXYX-XRXCXXGXYY -3’ (Wang et al., 2009a), however this repressive activity 
of p53 is still to be fully elucidated.  In nature, genomic p53 consensus sites rarely conform 
precisely to these sequences and proven sites are often significantly divergent and some sites 
only contain 1 half site or less (Kim and Deppert, 2006).  Differences among consensus sites 
influence p53 binding affinity and kinetics of gene transactivation (Resnick-Silverman et al., 
1998).  Generally, strong p53 binding sites contain obligate C and G residues, a 0 or 1 base 
pair space region between half-sites and contain less than 3 non-consensus bases (Inga et al., 
2002).  Known p53 target sites that demonstrate low similarity to the consensus sequence are 
believed to contain specific architectural features that can induce recognition and subsequent 
interaction.  Studies investigating p53 binding affinity to various consensus sequences have 
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demonstrated that binding affinity is highest for genes involved in cell cycle arrest and DNA 
repair, and lower for pro-apoptotic target genes (Weinberg et al., 2005). Therefore, it is 
strongly believed the different affinities of p53 to various DNA sequences modulates the 
activation of target genes.  It is known that at low concentrations, p53 usually transactivates 
genes involved in cell cycle arrest or DNA repair.  As p53 interacts with high affinity to 
promoters of genes such as p21 or 14-3-3α, the probability of p53 interacting with these sites 
is significantly greater than interactions with lower affinity promoter regions of apoptotic 
genes, including Bax.  Following induction of stress, p53 becomes stabilised and levels 
increase, significantly increasing the chances of binding to pro-apoptotic promoter regions 
(Weinberg et al., 2005). 
 
Following consensus DNA recognition, binding of p53 (Figure 1.14) causes DNA 
conformational changes by twisting and bending the DNA molecule by around 20° at the site 
of contact (Ho et al., 2006).  Sites in DNA that closely conform to the consensus sequence are 
predicted to show higher flexibility and allow favourable protein-DNA contacts to occur that 
increase p53 binding affinity (Weinberg et al., 2005).  DNA-binding is also dependent on the 
cellular environment, modifications to p53, chromatin architecture and other nuclear proteins. 
 
 
 
Figure 1.14 Structure of a mouse p53 DNA binding domain dimer bound to DNA.  A. 
Top view of the overall structure of p53 DNA binding domain dimer (blue and green) bound 
to DNA consensus sequence (grey).  Zinc ions are represented in yellow. B.  View of the 
same structure but with DNA helix rotated 90˚.  Image taken from (Ho et al., 2006). 
 
 
Post-translational modifications influence p53 binding affinity for its consensus sequence 
(Bayle et al., 1995).  Initial studies identified that phosphorylation of serine 392 or binding of 
PAb421 antibody to the CTD increased DNA binding, suggesting that modifications to latent 
p53 CTD following cellular stress promoted p53 binding to consensus targets (Ahn and 
Prives, 2001).  Other modifications to the CTD, such as acetylation and even complete 
removal of the CTD during in vitro studies, were also found to stimulate sequence-specific 
binding, which introduced speculation that the CTD negatively regulated this mode of DNA 
A B 
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binding and required modifications to allow p53 to bind to target sites.  Models were 
proposed that suggested the CTD prevented sequence-specific binding either by directly 
interacting with the CDBD or by altering the overall tertiary structure of p53, and that post-
translational modifications were required to stop this repression (Liu and Kulesz-Martin, 
2001).  As the CTD can also directly interact with DNA and can bind with high-affinity to 
non-specific DNA, this characteristic was also thought to prevent sequence-specific DNA 
binding as interactions with non-specific DNA would interfere with p53 binding to consensus 
binding sites (Anderson et al., 1997; Yakovleva et al., 2001).  Generally, it was accepted the 
CTD required modification to switch p53 from an inactive latent form to an active sequence-
specific DNA binding form (Kim and Deppert, 2006). 
 
Recently, it was realised there is no latency regarding p53 sequence-specific binding (Kim 
and Deppert, 2003) and that the previous model was derived from unreliable in vitro 
investigations studying p53 binding to short-linear DNA substrates (Anderson et al., 1997; 
Hupp and Lane, 1994).  It was also identified that sequence-specific binding was determined 
by DNA topology and not a conformational change in p53 itself (Gohler et al., 2002).  
Subsequent structural analysis identified that the CTD does not influence the CDBD 
conformation, casting further doubt on the latency model.  Eventually it was realised that in 
contrast to previous models, the CTD was actually essential to p53 sequence-specific binding 
as deletion of the CTD in vivo prevented binding to consensus DNA and impaired p53-
dependent transcription (McKinney et al., 2004). It was proposed that the CTD may allow 
p53 to bind sequence-independently to DNA and then slide along the DNA searching for p53 
consensus regions that p53 binds to with higher affinity. 
 
1.5.4 p53 and Non-B DNA. 
 
The CTD has not only been shown to interact with non-specific DNA, but, with the 
cooperation of the CDBD and NTD, to also promote binding to certain types of aberrant 
DNA structures in a sequence-independent manner (Lee et al., 1995; Reed et al., 1995; 
Stansel et al., 2002).  Direct recognition and interactions with damaged DNA indicates p53 
may participate in DNA repair transcription-independently by acting as a platform to recruit 
repair factors. Tight interactions with damaged DNA may prevent p53 degradation by 
alterations in p53 conformation, modification or association with other proteins. 
 
It has also been identified that p53 does not only bind to structures resulting from DNA 
damage, but also to unusual non-B DNA conformations including mismatches, bulges 
(Degtyareva et al., 2001), cruciforms, hemi-catenated DNA, three and four way junctions, 
Chapter 1 - Introduction 
 37 
telomeric t-loops and hairpins (Gohler et al., 2002; Stros et al., 2004).  Heteroduplex joint 
intermediates that form during recombination have also been identified as structure-specific 
DNA binding sites (Janz et al., 2002) as p53 can interact with transfer regions during 
recombination and exonucleolytically correct heteroduplex intermediates following strand 
invasion.  Another  type of DNA that p53 can recognise is ssDNA, and p53 is capable of 
catalysing DNA renaturation and DNA strand transfer independent of ATP (Bakalkin et al., 
1995; Bakalkin et al., 1994).  As ssDNA can also be a product of DNA damage, p53 may 
recognise these sites as potentially dangerous lesions, so the direct interaction may lead to 
initiation of the appropriate response.  Routine maintenance of genome stability by p53 in 
non-stressed cells also requires interactions with genomic DNA, particularly at sites prone to 
structural rearrangements such as sites of active metabolic processes including recombination 
intermediates and telomeric t-loops  (Kim and Deppert, 2006). 
 
As with sequence-specific binding, an intact tetramerisation domain is required for binding to 
unusual structures.  DNA junctions that form in many of these structures are believed to be 
important elements required for this structure-dependent binding (Gohler et al., 2005).  It has 
been proposed that this non-sequence specific binding by p53 may allow recruitment of 
cellular repair factors to sites of non-B DNA to remove unusual structures that may reduce 
genomic stability (Walter et al., 2005).  
 
As mentioned previously, p53 is thought to be involved in the routine maintenance of sites in 
the genome that are prone to structural rearrangements.  As described in Section 1.3.2, 
genomes contain regions of repeat sequences that are intrinsically unstable and can conform 
to unusual structures.  Recent studies (Walter et al., 2005) investigated the ability of p53 to 
interact with structures formed by CTG•CAG (referring to sequences of both strands in a 5’ – 
3’ direction) tracts that represent genomic DNA sequences involved in TRS related disorders.  
Interest in the mechanisms resulting in genome instability of CTG•CAG tracts is considerable 
as they are the cause of several human hereditary neurological diseases.  It was discovered 
that repeat tracts comprised novel p53 binding sites and that interactions were primarily 
determined by secondary hairpin structures.  The potential physiological implications are that 
TRS may represent non-canonical p53 binding sites and interactions may lead to activation of 
p53 regulated pathways.  The downstream consequences of binding may be alterations in 
transcriptional regulation of target genes or, alternatively, binding may allow p53 to 
participate directly in processes such as DNA repair.  The proposed idea of a direct 
participation in DNA repair is strengthened by correlations in binding to CTG●CAG tracts 
between p53 and the DNA MMR repair protein hMSH2 (Pearson et al., 1997).  The detected 
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interaction between p53 and CTG●CAG containing hairpins did not require activation of p53, 
therefore maintenance of such genomic stability may be a function of latent p53. 
 
Two models have been proposed by which this non-sequence specific binding of p53 may 
alter cellular events.  The first model states that binding of p53 to unusual structures may 
transactivate downstream genes, usually resulting in arrest of the cell cycle or apoptosis.  In 
this model, binding by the CTD would stimulate sequence-specific binding by the CDBD to 
specific sequences in the genome, meaning p53 would either need to be released from the 
unusual structure (Stenger et al., 1994), or require a process such as DNA looping in order to 
interact with distant sites.  The second model proposes that various species of p53 molecules 
may exist within a cell due to different post-translational modifications and that certain p53 
molecules may have more affinity towards unusual DNA structures than other species.  
Following binding to unusual structures, these p53 molecules may stimulate sequence-
specific binding by other p53 molecules or they may interact with other nuclear proteins to 
produce the required response (Somasundaram, 2000). 
 
1.6 Aims of this Study. 
 
Unusual structural elements within DNA and damage-induced lesions can strongly influence 
various cellular processes and can ultimately compromise genomic stability.  The overall aim 
of this project was to characterise macromolecular interactions that are essential to 
mechanisms believed to detect discontinuities in DNA.  The recent observation that p53 
interacts with CTG●CAG tracts that conform to secondary hairpin structures (Walter et al., 
2005) is of considerable interest as this may demonstrate a direct role for p53 in the regulation 
of unstable genomic regions.  One aim of this study was to investigate p53 DNA binding 
activity to DNAs that varied in sequence and structure, including oligonucleotides containing 
internal CTG repeat hairpins. Previously, in vitro assays have provided considerable 
information regarding p53-DNA interactions, however, significant doubt has been cast over 
the reliability of assays that require antibodies or mutated p53 molecules to detect specific 
binding.  Hence, alternative in vitro precipitation DNA binding assays were employed to 
allow determination of p53-DNA interactions to DNAs exhibiting features that may be 
recognised as dangerous.  It was also of interest to compare similar interactions in an in vivo 
environment and so a chromatin immunoprecipitation assay investigating p53-DNA binding 
was developed. 
 
Recently, 3 Ku homologues in S. coelicolor were identified but as yet, very little is known 
regarding their physiological activity.  However, it is anticipated that they constitute integral 
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roles during NHEJ in S. coelicolor by recognising and recruiting repair factors to DSBs.  The 
DNA-binding activities of recombinant ScKu proteins were investigated using in vitro DNA 
binding assays alongside a previously characterised prokaryotic Ku from M. tuberculosis 
(Weller et al., 2002) to identify similarities and differences between these Ku proteins.   
 
It was also of interest to see if NHEJ of S. coelicolor shows agreement with the current 
prokaryotic NHEJ viewpoint of homodimeric Ku participating in a two-component system.  
Structural studies would ascertain if these proteins existed as multiple protein species, and the 
ability of Ku to interact with each other and other NHEJ components was to be investigated 
using co-immunoprecipitation assays.  An additional aim was to clone recombinant scku with 
promoter DNA into S. coelicolor so that in vivo analysis of protein expression and 
macromolecular interactions could be investigated. 
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CHAPTER 2 
 
Materials and Methods 
 
 
 
 
This chapter contains details of the experimental procedures used during the entirety of this 
study.  This includes information regarding bacterial strains and plasmids used, procedures 
used to create and analyse specific plasmid and oligonucleotide DNAs, protein production 
and analysis and the biochemical techniques utilised to characterise protein functions.  
Constituents of media and buffers used are detailed in Section 2.15. 
 
2.1 Growth and Maintenance of Bacterial Strains. 
2.1.1 Bacterial Strains. 
 
This study required a range of E. coli strains specialised for different functions including  
supercompetent cells for transformation of ligation products and expression strains used 
during production of recombinant proteins (Table 2.1).  Selected strains of S. coelicolor M145 
were also used during protein expression analysis (Table 2.2). 
 
Table 2.1 Strains of E. coli used in studies. 
E. coli strain Genotype Reference 
BL21 (DE3) pLysS F- dcm ompT hsdS (rB-mB) gal λ (DE3). Novagen® 
DH5α ∆lacU169 endA1 gyrA96 relA1 hsdR17 thi-1 
supE44. 
(Sambrook et al., 
1989) 
CH3-Blue F- mcrA ∆(mrr-hsd RMS-mcrBC) φ80lacZ 
∆M15 ∆lacX74 recA1 endA1 ara ∆139 
∆(ara-leu)7697 galU galK λ-rpsL (StrR) 
nupG. 
Bioline© 
α-GOLD
 
F- deoR endA1 recA1 relA1 gyrA96 
hsdR17(rk -, mk +) supE44 thi-1 phoA 
∆(lacZYA argF)U169 Φ80lacZ∆M15 λ-. 
Bioline© 
TOP10 F- mcrA ∆(mrr-hsd RMS-mcrBC) φ80lacZ 
∆M15 ∆lacX74 recA1 deoR araD139 ∆(ara-
leu)7697 galU galK rpsL (StrR) endA1 nupG 
Invitrogen™ 
BW25113 / pIJ790 pIJ790 [oriR101] [repA101(ts)] araBp-gam-
be-exo.  Chromosome: (∆(araD-araB)567 
∆lacZ4787(::rrnB-4) lacIP-4000(1acIQ) λ- 
rpoS369(Am) rph-1 ∆(rhaD-rhaB)568 
hsdR514. 
(Datsenko and 
Wanner, 2000) 
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Table 2.2 Strains of S. coelicolor used in studies. 
S. coelicolor Genotype Reference 
M145 SCP1-, SCP2- (Hopwood et al., 
1985) 
M145 (∆ scku1) SCP1-, SCP2-, SCO5309- (scku1-) (Handley, Bowater 
& Hutchings, 
Unpublished data) 
M145 (∆ scku2) SCP1-, SCP2-, SCO0601- (scku2-) (Handley, Bowater 
& Hutchings, 
Unpublished data) 
M145 (∆ scku1 / ∆ scku2) SCP1-, SCP2-, scku1-, scku2- (Handley, Bowater 
& Hutchings, 
Unpublished data) 
 
2.1.2 Growth of Bacterial Cultures. 
 
All media constituents are described in Table 2.9. E. coli were grown on inverted 1.5% Luria 
Bertani (LB) agar plates or in liquid LB shaking at 200 rpm unless otherwise stated.  Cultures 
were grown at 37 °C except during protein over-expression (25 °C) or growth of E. coli 
BW25113 / pIJ790 prior to recombination of PCR resistance cassettes (30 °C).  S. coelicolor 
strains were grown at 30 °C on inverted Mannitol soya flour medium (SFM) or LB agar solid 
media or in liquid Tryptone soya broth (TSB) at 200 rpm. 
 
2.2 DNA Procedures. 
2.2.1 Transformation of Plasmid DNA into E. coli. 
 
Constituents of all buffers can be found in Tables 2.10 – 2.13.  Typically, plasmid DNA was 
added to 25 µl E. coli strains (Table 2.1) and incubated on ice for 30 minutes.  Bacterial cells 
were then heat shocked at 42 °C for 2 minutes and placed on ice for 2 minutes.  SOC media 
(300 µl) was added to the cells, which were then incubated at 37 °C for 1 hour at 200 rpm.  
Transformed cells (100 µl) were then plated onto selective LB agar plates and incubated 
overnight at 37 °C. 
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2.2.2 Bacterial Plasmids and Cosmids used During Studies. 
 
Table 2.3 Plasmids and Cosmids used During Studies. 
 
Plasmid name Description Source 
pET28(a) An expression vector containing an N-
terminal His·Tag®/T7·Tag® (6 His residues) 
and an optional C-terminal His·Tag® (6 His 
residues).  It contains T7 forward and 
reverse primer sites for sequencing or PCR 
screening.  PT7lac, KanR. 
Novagen® 
pRB16(b) Expression vector containing an N-terminal 
His·Tag® (10 His residues).  It contains T7 
forward and reverse primer sites for 
sequencing or PCR screening.  PT7lac, AmpR. 
Novagen® 
pRB209 SCO5301 (scku1) gene cloned into 
pET28(a). 
(Sayer, 2008) 
pRB210 SCO0601 (scku2) gene cloned into 
pET28(a). 
(Sayer, 2008) 
pRB211 SCP1.285c (scku3) gene cloned into 
pET28(a). 
(Sayer, 2008) 
pRB219 SCO7345 (scligD) gene cloned into 
pTrc99a. 
(Sayer, 2008) 
pRB141 mtku gene cloned into pET-16(b). (Weller et al., 2002) 
pUC18 Vector containing pMB1 replicon rep, bla 
gene (ampicillin resistance) and E. coli lac 
operon region consisting of CAP protein 
binding site, Plac promoter, lac repressor 
binding site and 5’-terminal of lacZ gene. 
(Yanisch-Perron et 
al., 1985) 
pL1 pUC19 containing recognition sequence for 
BbvCI restriction enzyme. 
(Gowers et al., 2005) 
pSET152 ΦC31-derived integration vector that targets 
an attB site in S. coelicolor SCO3798 gene. 
ApraR. 
(Combes et al., 
2002) 
pMS82 ΦBT1-derived integration vector that 
targets an attB site in S. coelicolor 
SCO4848 gene. HygR. 
(Gregory et al., 
2003) 
pCR-Blunt II-TOPO® A pUC derived plasmid used for cloning of 
blunt-ended DNA featuring M13 forward 
and reverse primer sites for sequencing or 
PCR screening.  PlacZα , KanR, ZeoR. 
Invitrogen™ 
St6G9 WT cosmid containing scku1. (Redenbach et al., 
1996) 
St5G5 WT cosmid containing scku2. (Redenbach et al., 
1996) 
pRB240 pCR-Blunt II-TOPO® with uncharacterised 
modification (circularised empty vector that 
does not cause lethality in E. coli). 
This study  
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The cosmids used during this study were from the Supercos-1 library that contains 
chromosomal DNA of a plasmid-free derivative of S. coelicolor A3(2) (Redenbach et al., 
1996). 
 
2.2.3 Plasmid Extraction from E. coli. 
 
Bacterial cultures containing relevant plasmid DNA were grown overnight in 10 ml LB media 
containing selective antibiotics.  Plasmids were extracted using the Promega (Madison WI, 
USA) Wizard SV+ mini-prep kit and according to the manufacturer’s protocol.  Plasmids 
were eluted with 1 x TE buffer and stored at -20 °C. 
 
2.2.4 Clean-up of Extracted Plasmids. 
 
For all experiments involving plasmid DNA and ScKu proteins, plasmids were required to be 
purified following extraction or restriction digestion to prevent significant degradation of 
ScKu proteins.  QIAquick® PCR purification Kit (Qiagen) was used according to the 
manufacturer’s spin protocol and plasmids were eluted in 1 x TE buffer and stored at -20 °C. 
 
2.2.5 Polymerase Chain Reaction (PCR). 
2.2.5.1 Amplification of Promoter Regions Following Chromatin Immunoprecipitation. 
 
PCR was performed for detection of promoter regions during Chromatin Immunoprecipitation 
(ChIP) assays (Section 2.13).  For all reactions, 22.5 µl of 1.1 x Pre-Aliquoted ReddyMix™ 
PCR Master Mix (ABgene® UK) was used.  In a final volume of 25 µl this mix contained: 
0.625 units Thermoprime Plus DNA Polymerase, 75 mM Tris-HCl (pH 8.8 at 25 °C), 20 mM 
(NH4)2SO4, 1.5 mM MgCl2, 0.01% (v/v) Tween® 20 and 0.2 mM each of dATP, dCTP, 
dGTP and dTTP.  To the mix, 2% Dimethyl sulfoxide (DMSO), 300 nM of both forward and 
reverse primers and varying volumes of template DNA were added.  All reactions were 
performed in a Mastercycler® Personal PCR machine (Eppendorf®). 
 
Table 2.4 PCR primers used to amplify genomic DNA from ChIP assays. 
Gene Forward Primer (5’-3’) Reverse Primer (5’-3’) 
p21 GTGGCTCTGATTGGCTTTCTG CTGAAAACAGGCAGCCCAAG 
Mdm2 GGTTGACTCAGCTTTTCCTCTTG GGAAAATGCATGGTTTAAATAGCC 
GAPDH GTATTCCCCCAGGTTTACAT TTCTGTCTTCCACTCACTCC 
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For the amplification of p21 and Mdm2 promoter regions, the thermal cycler program was as 
follows:  30 seconds at 98 °C for initial denaturation, then 40 cycles of: [20 second 
denaturation at 94 °C, 20 second annealing at 60 °C and 1 minute elongation at 68 °C].  
Following this cycle, a 10 minute final extension was performed at 68 °C. 
 
For the amplification of GAPDH promoter region, the thermal cycler program was as follows:   
30 seconds at 98 °C for initial denaturation, then 40 cycles of: [20 second denaturation at 94 
°C, 20 second annealing at 55 °C and 1 minute elongation at 68 °C].  Following this cycle, a 
10 minute final extension was performed at 68 °C. 
 
2.2.5.2 Amplification of DNA for Cloning. 
 
Preliminary PCRs were performed using GoTaq® Flexi DNA Polymerase (Promega) to 
ascertain optimum conditions for subsequent PCRs, which were performed using Expand 
High Fidelity PCR System (Roche).  Reaction mixes typically contained: 1.25 U GoTaq® 
DNA Polymerase, 1 x GoTaq® Flexi buffer, 1 mM MgCl2, 0 – 12% DMSO, 300 nM of both 
forward and reverse primers (Table 2.5), varying concentrations of template DNA (cosmid 
(St6G9 for scku1 or St5G5 for scku2) or S. coelicolor genomic DNA) and 0.2 mM each of 
dATP, dCTP, dGTP and dTTP. 
 
The GoTaq® Flexi PCR cycles were as follows: 3 minutes at 95 °C for initial denaturation, 
then 30 cycles of: [30 second denaturation at 95 °C, 30 second annealing at 59 °C and 2 
minute elongation at 72 °C].  Following this cycle, a 7 minute final extension was performed 
at 72 °C. 
 
Table 2.5 PCR primers used to amplify SCO5309 and SCO0601 genes.  Black text 
indicates regions of complementarity towards template DNA, blue text indicates restriction 
sites, red text indicates stop codon and green text indicates polyhistidine tag sequence. 
 
Gene Target 
Vector 
Forward Primer (5’-3’) Reverse Primer (5’-3’) 
SCO5309 pMS82 ACTAGTATACCGCAGGAA
GGAGACCGCGC 
GATATCTCAGTGATGGTGATGGTGG
TGGGCGCTGCGCCTGCGGG 
SCO5309 pSET152 TCTAGAATACCGCAGGAA
GGAGACCGCGC 
GATATCTCAGTGATGGTGATGGTGG
TGGGCGCTGCGCCTGCGGG 
SCO0601 pMS82 ACTAGTCAGGGGTGAGGC
GGCCGG 
GATATCTCAGTGATGGTGATGGTGG
TGGGCCGCGGTCGTCGTCTTCTTC 
SCO0601 pSET152 TCTAGACAGGGGTGAGGC
GGCCGG 
GATATCTCAGTGATGGTGATGGTGG
TGGGCCGCGGTCGTCGTCTTCTTC 
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DNA to be cloned into integration vectors was amplified using the Expand High Fidelity PCR 
System manufactured by Roche, using the Mastercycler® Personal PCR machine (Eppendorf).  
Reactions contained 2.6 U Expand High Fidelity Enzyme Mix, 1 x Expand High Fidelity 
Buffer (including MgCl2), 300 nM of both forward and reverse primers (Table 2.5), 20 ng 
template cosmid DNA (St6G9 for scku1 or St5G5 for scku2) and 0.2 mM each of dATP, 
dCTP, dGTP and dTTP.  The final volume was made up to 50 µl with dH2O. 
 
Expand High Fidelity PCR cycles were as follows: 3 minutes at 95 °C for initial denaturation; 
10 cycles of: [94 °C, 30 second denaturation; 59 °C, 30 second annealing; 72 °C, 2 minute 
elongation]; 20 cycles of: [94 °C, 30 second denaturation; 59 °C, 30 second annealing; 72 °C, 
2 minute, 5 seconds elongation with an accumulative 5 seconds on each cycle]; 72 °C, 10 
minute final extension. 
 
2.2.5.3 Colony PCR. 
 
PCR was used to screen transformants containing the required cloned DNA.  Single colonies 
were picked with a sterile pipette tip that was used to thoroughly mix individual Pre-
Aliquoted ReddyMixTM PCR Mix (ABgene) reaction tubes containing 300 nM of forward and 
reverse primers.  Reactions were performed using the same cycle parameters as described in 
Section 2.2.5.2 during GoTaq® Flexi PCR. 
 
2.2.6 Agarose Gel Electrophoresis. 
 
Plasmid DNA was visualised on 0.8 or 1% agarose gels in 100 ml of 1 x TAE buffer 
containing 0.5 µg / ml ethidium bromide.  An appropriate volume of 6 x loading dye was 
added to DNA and electrophoresis was performed at 120 V.  Gels were visualized with UV 
light using a transilluminator (BioRAD, Munich, Germany).  If additional staining was 
required, gels were placed in 200 ml water containing 0.5 µg / ml ethidium bromide for 20 
minutes and washed for 30 minutes in dH2O before visualisation. 
 
2.2.7 DNA Purification Following Agarose Gel Electrophoresis. 
 
Agarose gels were visualised on a transilluminator and sections of gels containing DNA 
fragments were excised using a scalpel, with minimum exposure to UV light.  DNA was then 
purified from gel sections using QIAquick Gel Extraction Kit (Qiagen) according to the 
manufacturer’s protocol.  Typically, DNA was eluted in 30 µl of elution buffer. 
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2.2.8 Cloning of scku Genes. 
2.2.8.1 Cloning scku Genes into pCR-Blunt II-TOPO®. 
 
Zero Blunt® TOPO® PCR Cloning (Invitrogen) was selected for cloning reactions as this 
strategy is highly efficient for the direct insertion of blunt-end PCR products into vector 
DNA.  These vectors would act as holding vectors prior to cloning of scku genes into 
integration vectors.  The TOPO® cloning reaction relies on the activity of topoisomerase I 
from Vaccinia virus that attaches to duplex DNA and cleaves the phosphodiester backbone, 
forming a covalent bond between the 3’ phosphate of the DNA and a tyrosyl residue of the 
topoisomerase.  This reaction can be subsequently reversed and the DNA sealed via the 5’ 
hydroxyl of the cleaved strand attacking the phospho-tyrosyl bond (Shuman, 1994).  The 
pCR-Blunt II-TOPO® vector plasmid is supplied linearised with Vaccinia virus 
topoisomerase I covalently bound to the 3’ ends of the DNA.  Additionally, pCR-Blunt II-
TOPO® encodes the lethal E. coli gene ccdB that becomes disrupted following ligation of a 
PCR product into the plasmid and prevents its expression, allowing for accurate screening of 
successful recombinants. 
 
Cloning of amplified scku genes into pCR-Blunt II-TOPO® was performed according to the 
manufacturer’s protocol:  4 µl of fresh PCR product (120 ng) was added to 1 µl of 1.2 M 
NaCl, 0.06 M MgCl2 and 1 µl of TOPO® vector and the reaction mix was incubated at 22 °C 
for 10 minutes.  2 µl of the TOPO® cloning reaction was then added to a vial of E. coli TOP10 
cells and transformed as detailed in Section 2.2.1. 
 
2.2.8.2 DNA Sequencing. 
 
Approximately 200 ng of pCR-Blunt II-TOPO® construct DNA was sequenced at Genome 
Enterprise Limited, Norwich, UK, using primers specific for SP6 and T7 promoter sites that 
can produce sequence fragments of around 1000 bases.  Sequence analysis was performed 
using DNAStar 6 (Lasergene).   
 
2.2.8.3 Cloning scku Genes into Integration Vectors. 
 
Phage-derived vectors pMS82 and pSET152 were to be used for direct integration of scku 
genes into the S. coelicolor chromosome.  For subcloning of scku genes that were situated in 
TOPO® vectors into integration vectors, both sets of vectors required 2 digestions with 
relevant restriction enzymes (Table 2.6).  Following primary digests, products were cleaned 
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(Section 2.2.4), a small sample analysed by electrophoresis (Section 2.2.6) to confirm 
digestion, and then remaining products were subjected to a second digestion.  Restriction 
digest products were subject to electrophoresis and the required DNA fragments were excised 
and purified from agarose gels (Section 2.2.7). 
 
Table 2.6 Restriction enzymes used to clone scku genes into integration vectors. 
Gene Integration Vector Restriction Enzymes 
scku1 pMS82 Spe1 and EcoRV 
scku1 pSET152 Xba1 and EcoRV 
scku2 pMS82 Spe1 and EcoRV 
scku2 pSET152 Xba1 and EcoRV 
 
 
Inserts and integration vectors were then combined at a molar ratio of 1:3 (vector: insert) and 
ligation reactions were performed at 20 °C for 16 hours that contained: 1 U of T4 DNA ligase 
and 1 X T4 DNA ligase buffer (Roche) in 10 µl reaction volumes that also contained relevant 
DNAs.  5 µl of the reaction mix was transformed into 50 µl of CH3-Blue cells (Section 2.2.1) 
and successful constructs were confirmed by colony PCR (Section 2.2.5.3) and restriction 
digest analysis. 
 
2.3 Oligonucleotide Preparation and Analysis. 
2.3.1 Preparing DNA Substrates for in vitro DNA Binding Assays. 
 
Various oligonucleotide substrates were employed during in vitro DNA binding assays.  
Single-stranded DNA (ssDNA) oligonucleotides were purchased from Eurogentec, 
resuspended in 1 x TE buffer and stored at -20 °C.  Double-stranded DNA (dsDNA) 
oligonucleotides, consisting of 1 biotinylated and 1 unbiotinylated strand, were produced by 
combining specific ssDNA oligonucleotides in a 1:4 ratio (biotinylated: unbiotinylated).  
Although excess unbiotinylated ssDNA was present in samples following annealing, wash 
procedures during assays would insure these DNAs would not interfere with experiments.  An 
exception to this was a dsDNA molecule (dsDNA+ biotin) that consisted of 2 biotinylated 
strands of which both strands were added in equal amounts during annealing.  Prior to 
annealing, KCl was added to oligonucleotides to a final concentration of 50 mM.  For 
annealing, oligonucleotides were placed in a water bath at 100 °C for 8 minutes.  
Oligonucleotides were then allowed to cool to 20 °C over 6 hours and stored at -20 °C. 
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Table 2.7 Oligonucleotide sequence and structural information.  Green text refers to 
biotinylated DNA strands, black text represents unbiotinylated DNA strands and red text 
indicates unusual structural features.  Blue circles on DNA termini represent biotin molecules 
and orange circles represent conjugated fluorescein fluorophore molecules.  All DNA 
molecules were produced as described in this section using optimal conditions and analysed 
as described in Section 2.3.2. 
 
Oligonucleotide Structure 
p53 p21-RE  
 
 
5’ B-caacGGCCATCAGGAACATGTCCCAACATGTTGAGCTCTGG- 3’ 
3’ -     CCGGTAGTCCTTGTACAGGGTTGTACAACTCGAGACC- 5’ 
 
 
 
 
 
p53 NBS1 
 
 
5’ B-caacGCTGCCTGTTTTCAGGGAGGAAGGGGATGGTAGGAGA- 3’ 
3’ -     CGACGGACAAAAGTCCCTCCTTCCCCTACCATCCTCT- 5’ 
 
 
 
 
 
p53 CTG dsDNA 
 
 
5’ B-caacCCGCGGTACCATCAGCAGCAGCAGCAGCAGCAGTACCTAAGGCCCC- 3’ 
3’ -     GGCGCCATGGTAGTCGTCGTCGTCGTCGTCGTCATGGATTCCGGGG- 5’ 
 
 
 
 
 
p53 (CTG)1 hairpin (HP) 
 
 
5’ B-caacCCGCGGTACCAT===TACCTAAGGCCCC- 3’ 
3’ -     GGCGCCATGGTAGTCATGGATTCCGGGG- 5’ 
 
 
 
 
 
p53 (CTG)3 hairpin (HP) 
 
 
5’ B-caacCCGCGGTACCAT=========TACCTAAGGCCCC- 3’ 
3’ -     GGCGCCATGGTAGTCGTCGTCATGGATTCCGGGG- 5’ 
 
 
 
 
 
p53 (CTG)7 hairpin (HP) 
 
 
5’ B-caacCCGCGGTACCAT=====================TACCTAAGGCCCC- 3’ 
3’ -     GGCGCCATGGTAGTCGTCGTCGTCGTCGTCGTCATGGATTCCGGGG- 5’ 
 
 
 
 
 
 
 
p53 (GAA)7 hairpin (HP) 
 
 
5’ B-caacCCGCGGTACCAT=====================TACCTAAGGCCCC- 3’ 
3’ -     GGCGCCATGGTAAAGAAGAAGAAGAAGAAGAAGATGGATTCCGGGG- 5’ 
 
 
 
 
 
 
 
p53 (CGG)7 hairpin (HP) 
 
 
5’ B-caacCCGCGGTACCAT=====================TACCTAAGGCCCC- 3’ 
3’ -     GGCGCCATGGTAGGCGGCGGCGGCGGCGGCGGCATGGATTCCGGGG- 5’ 
 
 
 
 
 
 
 
 
p53 (TAT)7 hairpin (HP) 
 
 
5’ B-caacCCGCGGTACCAT=====================TACCTAAGGCCCC- 3’ 
3’ -     GGCGCCATGGTATATTATTATTATTATTATTATATGGATTCCGGGG- 5’ 
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dsDNA1 
 
 
5’ B- caacTTTGAGGTGCGTGTTTGTGCCTGTCCTGGG- 3’ 
3’ -      AAACTCCACGCACAAACACGGACAGGACCC- 5’ 
 
 
 
 
  
dsDNA1+ G/T mm 
 
 
5’ B- caacTTTGAGGTGCGTGTTTGTGCCTGTCCTGGG- 3’ 
3’ -      AAACTCCACGTACAAACACGGACAGGACCC- 5’ 
 
 
 
 
 
dsDNA1+ G/A mm 
 
 
5’ B- caacTTTGAGGTGCGTGTTTGTGCCTGTCCTGGG- 3’ 
3’ -      AAACTCCACGAACAAACACGGACAGGACCC- 5’ 
 
 
 
 
 
dsDNA1+ 1 base 
 
 
5’ B- caacTTTGAGGTGC=GTGTTTGTGCCTGTCCTGGG- 3’ 
3’ -      AAACTCCACGACACAAACACGGACAGGACCC- 5’ 
 
 
 
 
 
dsDNA1+ loop 
 
 
5’ B- caacTTTGAGGTGC========GTGTTTGTGCCTGTCCTGGG- 3’ 
3’ -      AAACTCCACGTGTGTGTGCACAAACACGGACAGGACCC- 5’ 
 
 
 
 
 
dsDNA1+  bubble 
 
 
5’ B- caacTTTGAGGTGCGTGTTTGTGCCTGTCCTGGG- 3’ 
3’ -      AAACTCCACGTCATGGTCTGGACAGGACCC- 5’ 
 
 
 
 
 
dsDNA1+ biotin 
 
5’ B- caacTTTGAGGTGCGTGTTTGTGCCTGTCCTGGG-  3’ 
3’ -      AAACTCCACGCACAAACTCGGACAGGACCC-B 5’ 
 
 
 
 
dsDNA+ fluorophore 
 
5’ B- caacACTTGAATCGAGCGA-  3’ 
3’ -      TGAACTTAGCTCGCT–FL 5’ 
 
 
p53 ssDNA 
 
5’ B- caacCCGCGGTACCATTACCTAAGGCCCC- 3’ 
 
 
 
   
ssDNA1 
 
5’ B- caacTTTGAGGTGCGTGTTTGTGCCTGTCCTGGG- 3’ 
 
 
 
 
ssDNA+fluorophore 
 
5’ - FL-CCCAGGACAGGCACAAACACGCACCTCAAA- 3’ 
 
 
 
 
 
 
2.3.2 Analysis of Oligonucleotides by Native and Denaturing Gel Electrophoresis. 
  
To determine the success of oligonucleotide annealing, including incorporation of unusual 
structural features, all oligonucleotide substrates (typically 50 fmol) were analysed using 
native and denaturing gel electrophoresis.  Migration of oligonucleotides during 
electrophoresis is determined not only by size and nucleic acid composition, but also by 
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structure.  Therefore, this was a suitable method for determining if secondary structures had 
been incorporated during the annealing process (Chastain et al., 1995).  Native and denaturing 
polyacrylamide gels (10% and 12%) were produced as described (Sambrook et al., 1989).  
For native electrophoresis, an appropriate volume of native loading buffer was added to 
samples and electrophoresis was performed in Bio-Rad Mini-PROTEAN® 3 cells at 50 V for 
3 hours using 1 x TBE as running buffer.  For denaturing gels, an appropriate volume of 1 x 
stop solution was added to samples which were then heated at 100 °C for 5 minutes.  
Electrophoresis was performed in Bio-Rad Mini-PROTEAN® 3 cells at 400 V for 30 minutes 
using 1 x TBE as running buffer. 
 
2.3.3 Transfer to Membrane and Chemiluminescent Detection of Oligonucleotides. 
 
Oligonucleotides were transferred onto 0.2 µm nylon membrane (Pierce) using a semi-dry 
blotting system (Scie-Plas Ltd) according to the manufacturer’s instructions.  Membrane and 
blotting paper were soaked in 1 x TBE prior to transfer.  Transfers were performed at 400 mA 
for 40 minutes for each 10 x 8 cm gel.  Following transfer, oligonucleotides were cross-linked 
to the membrane using UV Stratalinker® 1800 (Stratagene®) using auto cross-link function.  
Chemiluminescent detection was performed using the Chemiluminescent Nucleic Acid 
Detection Module (Pierce) and according to the manufacturer’s protocol.  Luminescence was 
detected either using chemiluminescence detection program on a Universal Hood II (Bio-Rad) 
or by developing Medical X-ray film (Fuji) using Compact X4 (Xograph Imaging Systems) 
developer. 
 
2.4 Protein Over-expression and Purification. 
2.4.1 pET Expression System. 
 
The pET expression system was chosen for protein over-expression as expression can be 
directly controlled and a high yield of protein can be obtained.  E. coli BL21 (DE3) contains 
genetically engineered sites in the chromosome required to control protein expression.  A T7 
RNA polymerase gene that has been engineered onto the chromosome is used to transcribe 
the gene of interest.  Expression of the T7 RNA polymerase is regulated by both the lacI 
gene, whose product inhibits transcription of the T7 RNA polymerase gene when bound to the 
lac promoter, and also a T7 lysozyme that prevents activity at low levels (Moffatt and Studier, 
1987).  The gene to be expressed is cloned into a plasmid downstream of a T7 promoter and 
this plasmid can then be transformed into E. coli BL21 (DE3).  Expression of the gene of 
interest is greatly increased following addition of isopropyl-β-D-thiogalactopyranoside 
(IPTG), which prevents LacI binding to the lac promoter and thereby allowing continual 
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expression of T7 RNA polymerase, which then transcribes the gene of interest.    The T7 
promoter is a viral promoter and it transcribes rapidly in the presence of T7 RNA polymerase, 
thereby making large quantities of the desired protein quickly. 
 
2.4.2 Protein Over-expression. 
 
Single E. coli BL21 pLysS (DE3) colonies containing the plasmid of interest were inoculated 
into 10 ml selective LB media and grown overnight at 37 °C with shaking at 200 rpm.  
Resulting cultures were used to inoculate 1 L of selective LB media which were then grown 
at 25 °C with shaking at 200 rpm. Once growth had reached mid logarithmic growth phase 
(OD600 = 0.4 – 0.6), IPTG was added at a final concentration of 0.4 mM to induce 
recombinant protein over-expression.  Cultures were then incubated overnight at 25 °C with 
shaking at 200 rpm.  Cell pellets were harvested by centrifugation at 6000 rpm (Beckman 
Coulter™ Avanti™ centrifuge, JLA 8.1000 rotor) for 20 minutes at 4 °C.  Supernatant was 
removed and the pellet was resuspended in 100 ml of this supernatant and split into 25 ml 
aliquots and centrifuged at 5000 rpm (Beckman Coulter™ Allegra™ 25R centrifuge with TS-
5.1-500 swing bucket rotor) for 20 minutes at 4 °C.  Supernatant was removed and discarded 
and pellets stored at -80 °C. 
 
2.4.3 Protein Purification. 
2.4.3.1 Protein Extraction. 
 
Cell pellets were defrosted from storage at -80 °C and resuspended in 20 ml of 1 x binding 
buffer for every 1 L pellet.  Resuspended cells were then divided and decanted into 2 x 50 ml 
centrifuge tubes and sonicated 10 x 10 seconds with 1 minute rest on ice between each 
sonication.  Cells were centrifuged at 16000 rpm (Beckman Coulter™ Avanti™ centrifuge, 
JA 25.50 rotor) for 40 minutes at 4 °C and the supernatant was removed for purification of 
recombinant protein.  A small sample of pellet was removed and stored at -20 °C for analysis. 
 
2.4.3.2 Novagen His·Bind® Column Purification. 
 
Recombinant Ku and ligase proteins in this study contained N-terminal polyhistidine tags so 
purification could be achieved using His·Bind® columns (Novagen®).  All steps were 
performed at 4 °C following manufacturer’s instructions.  Initially, columns were washed 
with 10 ml 1 x binding buffer then 10 ml of 1 x charge buffer was added to each column and 
left to run through.  To equilibrate columns, 5 ml of 1 x binding buffer was added.  Cell 
supernatant (100 µl) (Section 2.4.3.1) was stored as sample S1 for later analysis, the 
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remaining supernatant was filtered through a 0.45 µm filter, of which 100 µl was stored as 
sample S2.  The remaining supernatant was loaded onto equilibrated columns and flow-
through was collected as sample S3.  The column was washed with 10 ml of 1 x binding 
buffer and the flow-through was collected (sample S4), followed by 10 ml of 1 x wash buffer 
(flow-through kept as sample S5).  Protein was eluted from columns using 1 x elution buffer 
in 8 x 1 ml fractions (samples F1-F8) and 2 x 2 ml fractions (F9-10).  Fractions were analysed 
(Section 2.6) to discern which contained the most protein. 
 
2.4.3.3 GE Healthcare HisTrap™ HP Purification. 
 
HisTrap™ HP cartridges (GE Healthcare) were used in conjunction with Äktaprime™ plus 
(GE Healthcare).  Initially, HisTrap™ HP cartridges were prepared by washing with 15 ml 
dH2O followed by charging with 10 ml 1 x charge buffer.  Cartridges were again washed with 
15 ml dH2O and inserted into Äktaprime™ plus.  Äktaprime™ A line was then washed with 
20 ml 1 x binding buffer (10 ml / min), followed by a cartridge wash with 50 ml 1 x binding 
buffer (5 ml / min).  Supernatant from protein extraction (Section 2.4.3.1) was filtered 
through a 0.45 µm filter and added to the cartridge at 1 ml / min, followed by a 10 ml 1 x 
binding buffer wash at 1 ml / min.  Äktaprime™ plus B line was then washed with 1 x elution 
buffer followed by A line wash with 20 ml 1 x wash buffer (10 ml / min).  Prior to protein 
elution, the cartridge was washed with 5 ml 1 x wash buffer (1 ml / min) and the fraction 
collected.  A step gradient was used to elute recombinant proteins, beginning with 100% 1 x 
wash buffer, but increasing by 20% 1 x elution buffer every 5 ml.  Elution was performed at 1 
ml / min for 30 minutes and 1 ml fractions were collected.  Äktaprime™ plus system was 
washed with dH2O and cartridges were stripped with 10 ml 1 x strip buffer and stored in 20% 
ethanol. 
 
2.4.3.4 Desalting and Buffer Exchange. 
 
PD10 columns (Amersham Biosciences) were used for buffer exchange and desalting of 
protein fractions (2.5 ml) containing the most protein.  The manufacturer’s protocol was then 
followed.  Eluted protein was either snap frozen in liquid nitrogen or glycerol was added to a 
final concentration of 20% before storage at -80 °C.  PD10 columns were washed with 20% 
ethanol and stored at 4 °C for re-use. 
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2.4.3.5 Fast Performance Liquid Chromatography (FPLC). 
 
Gel filtration chromatography was occasionally used to further purify recombinant proteins.   
A Liquid Chromatography Controller LCC-500 and HiLoad™ 16’60 Superdex™ 75 prep 
grade column (Pharmacia Biotech) were used to perform FPLC.  Protein sample fractions 
from purification processes of volumes between 1 to 2 ml were loaded into the column and 
the protein was processed at 1 ml / min.  Absorbance was recorded at 0.2 cm / min and 
protein samples were collected following filtration.   
 
2.4.3.6 Homogenisation of High Five Insect Cells. 
 
High Five insect cells (Invitrogen™) were supplied that had been infected with recombinant 
baculovirus controlling human wild-type p53 expression.  Prior to purification, cells had been 
stored at -80 °C for several months.   Purification was performed as previously described 
(Dudenhoffer et al., 1998).  Briefly, cells were washed in ice cold PBS followed by 
incubation in ice cold buffer A for 50 minutes allowing cells to swell.  Swollen cells were 
broken up using a Dounce homogeniser and samples left on ice for a further 30 minutes.  
Cells were then centrifuged at 6500 rpm (Beckman Coulter™ Allegra™ 25R centrifuge with 
TS-5.1-500 swing bucket rotor) at 4 °C for 30 minutes in order to harvest nuclei.  A small 
sample (sample A) was taken from the supernatant and the remaining pellet was resuspended 
in buffer B and stored on ice for 40 minutes.  Cells were then centrifuged at 6500 rpm at 4 °C 
for 30 minutes and supernatant was collected (sample B).  A small volume of buffer B2 was 
added to the remaining pellet and the sample was vortexed and left on ice for 30 minutes.  
The sample was again centrifuged at 6500 rpm at 4 °C for 20 minutes and supernatant 
collected (sample C). Glycerol was added to samples A, B and C to a final concentration of 
20% and stored at -80 °C. 
 
2.5 Bacterial Cell Extract Analysis. 
2.5.1 E. coli and S. coelicolor Cell Extract Harvesting. 
 
Media containing selective antibiotics were inoculated with bacterial colonies and grown for 
16 or 40 hours.  Cultures were centrifuged at 5000 rpm for 15 minutes at 4 °C (Beckman 
Coulter™ Allegra™ 25R centrifuge with TS-5.1-500 swing bucket rotor) and then 
resuspended in 1 x binding buffer containing  1 x protease inhibitors (Complete Mini, EDTA-
free, Roche).  Cells were sonicated 3 x 5 seconds, with 1 minute rest on ice between each 
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sonication, and then centrifuged at 5000 rpm for 10 minutes at 4 °C and supernatant was 
collected. 
 
2.5.2 S. coelicolor Spore Harvesting, Viability Count and Extract Analysis. 
 
For analysis of spore viability of the various S. coelicolor strains, single colonies were 
streaked on to 3 SFM plates so that the entire plate surface would be covered and were grown 
for 5 days at 30 °C.  Glycerol (2 ml of 20%) was applied to each plate and spores were 
suspended in the glycerol with a cotton bud and the resultant spore solutions were collected.  
Spores were then filtered using cotton wool and centrifuged at 5000 rpm for 15 minutes at 4 
°C.  Following supernatant decanting, spores were resuspended in 1 ml of 20% glycerol. 
 
Viability counts were attained by plating 100 µl of 10-6 and 10-12 dilutions on to non-selective 
LB plates and grown at 30 °C for 2 days.  The colonies were counted using white light on a 
Universal Hood II (Bio-Rad) and viability was expressed as the number of colony forming 
units. 
 
For spore extract harvesting, 700 µl of spore solutions were centrifuged at 5000 rpm for 10 
minutes at 4 °C and then resuspended in 500 µl of 1 x binding buffer containing 1 x protease 
inhibitors.  Solutions were decanted into 2 ml centrifuge tubes containing a small amount of 
<106 µm glass beads (Sigma-Aldrich®) and were homogenised using FastPrep-24® (MP 
Biomedicals) by 6 x 30 second cycles with 5 minutes on ice between cycles.  Solutions were 
briefly centrifuged at 2000 rpm for 30 seconds and supernatant was removed and centrifuged 
at 13000 rpm for 20 minutes at 4 °C.  Supernatants were collected and stored at -20 °C. 
 
2.6 Protein Analysis. 
2.6.1 Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE). 
 
Gels for protein analysis consisted of 10% or 12% polyacrylamide and were produced as 
described (Sambrook et al., 1989).  Electrophoresis was performed in Bio-Rad Mini-
PROTEAN® 3 cells at 150 V using 1 x Tris-glycine SDS as running buffer.  Prior to 
electrophoresis, an appropriate volume of 4 x Tris-glycine SDS-PAGE loading buffer was 
added to samples, which were then heated at 100 °C for 8 minutes.  Bio-Rad prestained SDS-
PAGE Standard Low Range was used as a molecular weight marker. 
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2.6.2 Coomassie Staining of SDS-PAGE Gels. 
 
SDS-PAGE gels were washed twice in dH2O and then stained in either Coomassie blue or 
InstantBlue (Lucerna-Chem).  For Coomassie blue development, gels were incubated for 2 
hours with gentle agitation and once stained, gels were de-stained by twice boiling in 600 ml 
of dH2O by heating in a microwave at maximum power for 10 minutes.  For InstantBlue 
staining, gels were incubated for 20 minutes and washed briefly in dH2O.  Images of gels 
were taken using white light on a Universal Hood II (Bio-Rad). 
 
2.6.3 Western Blotting. 
 
Western blots were performed using a semi-dry blotting system (Scie-Plas Ltd) and according 
to manufacturer’s instructions.  Proteins were transferred from SDS-PAGE gels onto 0.2 µm 
pure nitrocellulose membrane (Bio-Rad) (pre-soaked in 1 x blot buffer) typically at 50 mA for 
2 hours for each 9 cm x 6 cm gel.  Immunodetection was performed using a ProtoBlot® II AP 
system (Promega) following the manufacturer’s protocol.  Western blue (Promega) was used 
to develop all nitrocellulose membrane western blots. 
 
Table 2.8 Antibodies used during immunodetection of proteins. 
Protein Primary antibody Secondary antibody(s) 
p53 Mouse monoclonal p53 (DO-1) 
(1:100,000) (Santa Cruz). 
Anti-Mouse -  Alkaline Phosphatase 
(AP) conjugate (1:5000)  (Promega) / 
Anti-Mouse - Horse Raddish 
Peroxidase (HRP) conjugate (1:1250) 
(GE healthcare). 
Phosphorylated 
p53 
Mouse monoclonal Phospho-p53 
(Ser15) (1:1000) (Cell 
signalling). 
Anti-Mouse – AP conjugate (1:5000) 
(Promega) / 
Anti-Mouse – HRP conjugate (1:1250) 
(GE healthcare). 
β-actin Mouse polyclonal β-actin 
(1:1000) (Cell signalling). 
Anti-Mouse - HRP conjugate (1:1250) 
(GE healthcare). 
ScKu1, ScKu2, 
ScKu3, MtKu 
Anti-His tag (1:3000) (GE 
healthcare). 
Anti-Mouse – AP conjugate (1:5000) 
(Promega). 
ScKu1 ScKu1 rabbit polyclonal (1:1000 
– 1:10000) (Cambridge Research 
Biochemicals). 
 
Anti-Rabbit – AP conjugate (1:10000) 
(Sigma-Aldrich®). 
ScKu2 ScKu2 rabbit polyclonal (1:1000 
– 1:10000) (Cambridge Research 
Biochemicals). 
 
Anti-Rabbit – AP conjugate (1:10000) 
(Sigma-Aldrich®). 
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2.6.4 Protein Concentration Determination using Bradford Assay. 
 
Bradford assay (Bio-Rad) was used to determine protein concentrations.  The manufacturer’s 
protocol was followed with BSA used to create a standard curve.  All A595 readings were 
recorded on a BioPhotometer (Eppendorf). 
 
2.6.5 Calculating Protein Absorbance at 280 nm. 
 
During Analytical Ultracentrifuge experiments (Section 2.11), protein absorbance at 280 nm 
was measured.  U3310 spectrophotometer (Hitachi) and UV solutions application (Hitachi) 
were used to measure recombinant protein absorbance.  Parameters used were as follows – 
start wavelength 340 nm, end wavelength 200 nm, scan speed 300 nm / min and path length 
10 mm.  Protein storage buffer (200 µl) was measured as a baseline before 100 µl of protein 
was added to the same 200 µl buffer.  Absorbance was recorded at 280 nm. 
 
2.7 In vitro Streptavidin Magnetic Bead (SMB) DNA Binding Assay. 
2.7.1 In vitro SMB DNA Binding Assay Principle and Mechanism. 
 
To determine DNA binding properties of proteins investigated in this study, a new technique 
based on previous work (Palecek et al., 2004) was developed.  The basic mechanism is 
demonstrated in Figure 2.1 and all reactions were performed at 30 °C.  An appropriate amount 
of Streptavidin coated Magnetic Beads (SMBs) (Invitrogen™ Dynabeads® M-280) were 
added to 1.5 ml microcentrifuge tubes and were washed with 100 µl 1 x SMB wash buffer.  
Microcentrifuge tubes were then positioned on a Neodymium rare earth permanent magnet 
Magnetic Separation Rack (New England BioLabs® Inc.) for 1 minute to allow SMBs to 
collect in the tube adjacent to the magnet.  Supernatant was removed and discarded and this 
wash step was repeated.  SMBs were then resuspended in 25 µl of 1 x SMB wash buffer 
containing an appropriate amount of biotinylated oligonucleotides to be used as the protein 
substrate.  Oligonucleotides were added in excess so that total oligonucleotide substrate 
available in each reaction was dependent on the amount of SMBs present.  SMBs and 
oligonucleotides were incubated for 15 minutes at 25 °C with gentle agitation twice during 
this period.  Reaction tubes were then positioned on the Magnetic Separation Rack for 
approximately 1 minute to allow collection of SMBs that now had substrate oligonucleotides 
attached.  Supernatant was removed and discarded.  SMBs were then resuspended in 25 µl of 
1 x SMB wash buffer containing 500 pmol of free biotin and incubated for 10 minutes with 
gentle agitation.  Reaction tubes were again positioned on the Magnetic Separation Rack for 
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approximately 1 minute and supernatant was removed.  SMBs were then resuspended in 100 
µl of 1 x SMB wash buffer, again positioned on the Magnetic Separation Rack for 
approximately 1 minute and supernatant was removed.  A final wash step using 100 µl of 1 x 
reaction buffer was performed again using the Magnetic Separation Rack to separate SMBs 
and supernatant.  These wash steps ensured all free oligonucleotides and free biotin molecules 
were removed and would not interfere with the subsequent assay steps.  An appropriate 
amount of protein was then added to the SMBs with 3 x SMB reaction buffer and the 
necessary volume of dH2O to dilute the reaction buffer accordingly.  Varying amounts of 
BSA were included during protein addition and previous wash steps to reduce background 
binding.  Protein and SMBs were left to incubate in a thermomixer (Eppendorf) at 30 °C, 350 
rpm for 15 minutes.  Reaction tubes were then positioned back on the Magnetic Separation 
Rack and the supernatant was removed and stored for later analysis (unbound protein).  SMBs 
were twice washed in 100 µl 1 x SMB reaction buffer using the Magnetic Separation Rack to 
separate SMBs from supernatant.  To SMBs, 1 x reaction buffer containing 1% SDS was 
added in a volume equalling the total volume in which protein was initially added.  Reaction 
tubes were heated at 100 °C for 15 minutes to denature bound protein and cause its 
dissociation from oligonucleotides.  Finally, reaction tubes were positioned on the Magnetic 
Separation Rack and supernatant containing bound protein was removed and analysed. 
 
 
 
Figure 2.1 In vitro SMB DNA binding assay procedure.  Biotinylated oligonucleotides are 
added to SMBs, followed by addition of free biotin molecules (to prevent unspecific protein 
binding to SMBs).  Protein of interest is then added and incubated with oligonucleotides for 
15 minutes at 30 °C and 350 rpm.  Unbound protein is removed in supernatant following 
collection of SMB/oligonucleotides/protein with earth magnets.  Bound proteins are 
denatured with SDS, removed in supernatant and analysed with unbound protein removed 
previously. 
Streptavidin  
magnetic bead 
Biotinylated 
oligonucleotide 
Protein 
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Samples collected from DNA binding assays were analysed by SDS-PAGE, western blotting 
and immunodetection.  An image of the membrane was captured using white light on a 
Universal Hood II (Bio-Rad) and band intensities were measured using the programme 
‘ImageJ’ (National Institutes of Health).  By comparing the amount of bound protein and 
unbound protein from each sample, a percentage of protein binding was calculated.  These 
values can be further used to calculate DNA binding affinities (Section 2.7.3). 
 
2.7.2 SMB Capacity Analysis. 
 
For elucidation of oligonucleotide attachment capacity of SMB (Invitrogen™ Dynabeads® 
M-280), fluorescently labelled dsDNA and ssDNA (Table 2.7) were added to SMB under the 
same conditions as an in vitro SMB DNA binding assay (Section 2.7.1).  Following the 15 
minute incubation, beads were twice washed as described and then injected into a 96 well 
microtitre plate in appropriate volumes of 1 x SMB reaction buffer.  To measure fluorescence 
of samples, KC4 program on an FLx800 microplate fluorescence reader (BioTek©) was used 
with the following parameters: Excitation – 485 / 20 nm, emission – 516 / 20 nm, optics 
position - top and sensitivity – 80 nm.  Experiments were then performed that analysed 
fluorescent emission of SMB with either ssDNA or dsDNA attached at various amounts 
between 0 – 60 pmol. 
 
2.7.3 Dissociation Constant (Kd) Equation used During SMB DNA Binding Assays. 
 
Abbreviations –  
 
DNA = D  Protein = P  Complexed DNA/Protein = DP 
     
Total DNA = Dt Total Protein = Pt  
  
Free DNA = Df Free Protein = Pf 
 
  
Dissociation constant equations - 
 
Df + Pf ↔ DP           1 
 
[Dt] = [Df] + [DP] and [Pt] = [Pf] + [DP]     2 
 
Kd = [Df] [Pf]   or ( [Dt] - [DP] ) ( [Pt] – [DP] )    3 
 [DP]           [DP] 
 
Concentration of DNA 
when Protein Binding is 
50 % = [Dt, 50] 
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At 50% binding: [DP] = 0.5 [Pt]        or       [Pt] = 2 [DP]    4 
 
 
Kd =    ( [Dt] – [DP] )  ( 2 [DP] – [DP] )   =    [DP] ( [Dt] – [DP] )   =   [Dt] – [DP] 5 
           [DP]     [DP] 
 
 
Kd = [Dt, 50] – 0.5 [Pt]         6 
 
 
2.8 In vitro Protein-G Bead (PGB) Assay. 
 
 
The in vitro PGB assay (Figure 2.2) can detect protein-DNA interactions with various 
substrate DNA molecules.  Unlike the SMB assay also used in this study (which is restricted 
to using biotinylated DNA), protein binding to any molecule can be investigated.  The 
concept of this assay relies on protein-G coated magnetic beads that can precipitate antibodies 
specifically bound to a protein of interest that will in turn also pull-down any DNA that it is 
interacting with. Incubation times and temperatures of this assay vary depending on the 
protein studied.  All described conditions are those used in a standard experiment 
investigating ScKu proteins. 
 
Initially, an appropriate amount of protein (approximately 400 ng) was incubated with excess 
specific antibody (typically 450 ng) in a reaction solution that also included 2 µl 500 mM 
KCl, 2 µl 10 x VP buffer and an appropriate volume of dH2O (final reaction volumes were 20 
µl following DNA addition).  This solution was typically incubated at 4 °C for 20 minutes.  
Following this, an appropriate amount of DNA was added to the solution.  The amount of 
DNA added depended on sensitivity of the technique used to visualise assay results.  For 
oligonucleotides, 60 pmol of DNA was added to each reaction and for plasmid DNA 200 ng 
was added.  The amount of protein used depended on substrate DNA and was always in 
excess.  After DNA addition, samples were thoroughly mixed and incubated on ice for 30 
minutes.  For certain proteins, DNA and antibody incubations were reversed so protein and 
DNA interactions could occur prior to addition of the antibody.  During protein-DNA 
incubations, 12.5 µl of Dynabeads® Protein-G (Invitrogen™) were added to 1.5 ml 
microcentrifuge tubes and washed 3 times with 100 µl 1 x PGB buffer (using Neodymium 
rare earth permanent magnet Magnetic Separation Rack (New England BioLabs® Inc.) to 
collect PGBs and remove supernatant each time).  Following this, reaction solutions were 
added to PGBs and incubated at 10 °C at 450 rpm for 30 minutes.  The Magnetic Separation 
Rack was then used to separate PGB/antibody/protein/DNA complexes from the supernatant 
and this supernatant was removed and kept for analysis (unbound DNA).  PGBs were then 
washed 3 times with 100 µl 1 x PGB buffer.  To release bound DNA, 1% SDS was added in a 
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Antibody Protein DNA 
Protein-G 
Bead 
SDS 
total volume of 20 µl and samples were heated at 65 °C (450 rpm) for 5 minutes.  Bound 
DNA was then collected in the supernatant. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2 In vitro PGB DNA binding assay procedure.  Antibodies are incubated with 
specific proteins before substrate DNA molecules are introduced.  Protein and DNA is then 
incubated to allow protein-DNA interactions to occur.  PGBs are then introduced and can be 
used to pull down protein-DNA complexes via attached antibodies.  A magnetic force is 
applied to collect PGB/antibody/protein/DNA complexes and any unbound DNA is removed 
in the supernatant.  Following wash steps, bound DNA is released from protein with 1% SDS 
and analysed by gel electrophoresis. 
 
 
For plasmid (as binding substrate) assays, bound and unbound DNA samples were analysed 
by agarose gel electrophoresis (Section 2.2.6) and band intensities were measured using the 
programme ‘ImageJ’ (National Institutes of Health) to calculate values for percentage DNA 
bound.  For oligonucleotide assays, bound oligonucleotides were subjected to native 
polyacrylamide gel electrophoresis (Section 2.3.2), transfer to nylon membranes and 
chemiluminescent detection of biotinylated tags (Section 2.3.3). 
 
2.9 In vitro Co-Immunoprecipitation (Co-IP) Assay. 
 
The production of antibodies specific for ScKu1 and ScKu2 (Section 2.14) provided the 
opportunity to adapt the protein-DNA binding assay described in Section 2.8 to allow 
identification of interactions between both Ku proteins.  Essentially, the Co-
immunoprecipitation (Co-IP) assay is identical to the DNA binding assay except that a 
secondary protein is added to reactions instead of DNA.  Briefly, 600 ng of protein was 
incubated for 15 minutes at 4 °C with or without 600 ng of a different protein in a 20 µl 
reaction volume containing 2 µl of 1 M KCl, 2 µl 10 x VP and dH2O.  An appropriate amount 
of antibody specific for 1 protein was subsequently added and reactions were incubated for a 
further 10 minutes at 4 °C.  Reaction solutions were then added to 12.5 µl of Dynabeads® 
Protein-G (Invitrogen™) and incubated at 10 °C for 20 minutes at 450 rpm with occasional 
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agitation.  Non-precipitated protein was collected by removal of the supernatant following 
positioning of reaction tubes on a Magnetic Separation Rack (New England BioLabs® Inc.) 
and precipitated protein was collected by denaturing complexes with 15 µl of 1% SDS, 
heating at 65 °C for 10 minutes, and removing supernatant after application of the magnetic 
force.  Precipitated and non-precipitated protein was analysed by SDS-PAGE and western 
blotting.  Band intensities were measured using ‘ImageJ’ (National Institutes of Health). 
 
2.10 In vitro Ligation Assay. 
 
 
Linearisation of pUC18 was performed by digestion with either EcoR1 (overhang-ends) or 
Sma1 (blunt-ends).  T4 DNA ligase (Roche) was used to ligate plasmids with or without  
prokaryotic Ku or BSA present in 20 µl reactions containing: 1 µl T4 DNA ligase, 2 µl 10 x 
ligation buffer, 200 ng plasmid DNA, an appropriate amount of Ku or BSA proteins and 
dH2O.  Reactions were incubated at various temperatures for an appropriate length of time 
with occasional agitation.  Ligations were stopped by addition of 6 x loading buffer and 
stored at 4 °C.  Samples were then analysed by agarose gel electrophoresis (Section 2.2.6). 
 
2.11 Analytical Ultracentrifugation. 
 
 
Analytical ultracentrifugation (AUC) experiments were performed using a Beckman XL1 
analytical ultracentrifuge equipped with absorbance optics.  Sedimentation equilibration 
experiments were undertaken at 20 °C and at 9000 or 12000 rpm.  Concentration profiles 
were measured at 260 nm.  Scans were recorded every 4 h to determine when equilibrium had 
been reached.  After equilibrium had been achieved, 4 scans were recorded for each sample.  
AUC experiments and analysis of raw data was carried out by Dr Tom Clarke, UEA. 
 
2.12 Dynamic Light Scattering. 
 
Dynamic light scattering (DLS) experiments were carried out on a DynaPro 99 (Protein 
Solutions) using ‘Dynamics V6’ programme for data analysis.  Prior to analysis, protein was 
centrifuged at 5000 rpm at 4 °C for 20 minutes and supernatant used in subsequent analysis.  
Before protein measurements, 0.2 µM filtered dH2O was measured to ensure count 
fluctuations were less than 1000.  Protein was in 1 x protein storage buffer and all 
measurements were performed at 20 °C.  For all samples, acquisition times were set to 10 
seconds for a total of 20 acquisitions to measure 15 µl of 1 mg / ml protein. 
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2.13 Chromatin Immunoprecipitation (ChIP). 
2.13.1 Cross-linked Chromatin Preparation. 
 
All buffers used in chromatin preparation and ChIP assays were made with nanopure water 
and contained protease inhibitors. 
 
HeLa cells at 80% confluence (approximately 1 x 107 cells per plate) were provided on 154 
cm2 plates that had been grown at 37 °C.  A number of plates were twice irradiated with 20 J / 
m2 using a UV Stratalinker® 1800 (Stratagene®) and, following irradiation, plates were 
grown for a further 15 hours at 37 °C.  To fix cells, formaldehyde was added at 1% final 
concentration to the sides of each plate and then evenly distributed to prevent cell disturbance.  
Plates were incubated at 25 °C with gentle agitation for 10 minutes.  Following this, glycine 
was added to a final concentration of 0.125 M and was evenly distributed.  
Media/formaldehyde/glycine was removed and plates were washed with 10 ml ice cold PBS.  
Cells were scraped into 1 ml PBS containing 1 x protease inhibitors (Complete Mini, EDTA-
free, Roche) and centrifuged at 4 °C, 1200 rpm for 5 minutes.  The resulting supernatant was 
removed and the cell pellet was resuspended in 1 x SDS lysis buffer (2-3 x 106 cells / 200 µl 1 
x SDS lysis buffer), split into 400-500 µl aliquots and incubated at 4 °C for 10 minutes.  Cell 
lysates were sonicated for 12 x 30 seconds to shear chromatin, with samples kept on ice 
constantly throughout the procedure.  Following sonication, samples were centrifuged at 4 °C, 
1300 rpm for 10 minutes.  To measure yield of sheared chromatin, absorbance at OD260 of 1.5 
µl sample was measured using program ND-1000 on a Nano-drop® spectrophotometer 
(Labtech).  Chromatin was snap frozen in liquid nitrogen and stored at -80 °C. 
 
2.13.2 ChIP assay. 
 
Approximately 200 µg of prepared cross-linked chromatin fragments were diluted 1:10 in 1 x 
dilution buffer.  Chromatin (50 µg) was set aside for later analysis as ‘total chromatin input’ 
sample.  Staph A cells (100 µl) were added to samples and incubated at 4 °C with rotation for 
30 minutes.  Samples were then centrifuged at 2500 rpm for 5 minutes at 4 °C and the 
resulting supernatant removed and split into two.  An irrelevant antibody (5 µg) was added to 
one half of this sample, and 5 µg of a specific antibody was added to the other half.  Samples 
were incubated overnight at 4 °C with rotation.  Staph A cells (50 µl) were then added to both 
samples and incubated at 4 °C with rotation for 1 hour.  Following this, samples were spun at 
2500 rpm for 5 minutes at 4 °C.  Supernatant was removed and discarded and pellets were 
resuspended in 1 ml ice cold 1 x low salt buffer followed by rotation for 5 minutes and 
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centrifugation at 4000 rpm for 1 minute at 4 °C.  The supernatant was removed and the 
process was repeated with 1 x high salt buffer and then 1 x LiCl buffer.  Samples were 
washed twice with 1 x TE buffer and resuspended in 500 µl of 1 x elution buffer (including 
‘total chromatin input sample’).  Samples were incubated with rotation at 4 °C for 20 minutes 
and then centrifuged at 10000 rpm for 10 minutes.  Supernatant was removed and cross-links 
were reversed by addition of 20 µl of 5 M NaCl and incubation at 65 °C for 5 hours. 
 
Following cross-link reversal, 10 µl 0.5 M EDTA, 2 µl 1 M Tris-HCl, pH 6.5 and 2 µl of 10 
mg / ml proteinase K were added to each sample and incubated at 45 °C for 1 hour.  DNA 
was recovered by addition of 500 µl of phenol to 500 µl of sample and this mixture was 
vortexed and centrifuged at 13000 rpm for 5 minutes.  The top layer was removed and 200 µl 
of 100% EtOH was added to each sample and incubated at 25 °C for 10 minutes.  QIAquick® 
Gel Extraction Kit (Qiagen) was then used to recover DNA (according to manufacturer’s 
instructions).  DNA was eluted in 40 µl 1 x TE buffer and analysed by PCR (Section 2.2.5). 
 
2.14 Antibody Production for ScKu1 and ScKu2. 
 
1.5 mg of ScKu1 and ScKu2 were used as antigens to produce polyclonal antibodies to be 
used in future experiments.  Antibodies were produced by Cambridge Research 
Biochemicals©. 
 
2.15 Media and Buffers. 
2.15.1 Media. 
 
Table 2.9 Media used for bacterial culture. 
Media name Media constituents 
Luria-Bertani broth (LB) 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 
1% (w/v) NaCl. 
LB agar 1% (w/v) tryptone, 0.5% (w/v) yeast extract, 
1% (w/v) NaCl, 1.5% (w/v) agar. 
SOC media 2% (w/v) tryptone, 0.5% (w/v) yeast extract, 
0.05% (w/v) NaCl, 2.5 mM KCl, 10 mM 
MgCl2, 20 mM glucose, pH 7 with NaOH. 
Mannitol soya flour medium (SFM) 2% (w/v) agar, 2% (w/v) Mannitol, 2% (w/v) 
Soya flour. 
Tryptone soya broth (TSB) 3% (w/v) Oxoid Tryptone Soya Broth 
powder (CM129). 
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2.15.2 Additions to Bacterial Culture Media. 
 
All additional constituents of media were sterilised using a 0.2 µm filter.  The antibiotics used 
were:  Ampicillin (final concentration 50 µg/ml), kanamycin (final concentration 50 µg/ml), 
chloramphenicol (final concentration 34 µg/ml), apramycin (final concentration 50 µg/ml) and 
hygromycin (final concentration 50 µg/ml).  For induced expression of recombinant proteins, 
IPTG was added at a final concentration of 0.4 mM. 
 
2.15.3 Buffers Used in DNA Procedures. 
 
Table 2.10 Buffers used during analysis of DNA. 
Buffer name Buffer constituents 
1x Tris-acetate-EDTA (TAE) 40 mM Tris-acetate pH 7.8, 1 mM EDTA. 
1 x Tris-EDTA (TE) 10 mM Tris-HCl pH 8, 1 mM EDTA. 
1 x Tris-borate-EDTA (TBE) 90 mM Tris-borate, 2 mM EDTA. 
6 x native loading buffer 10 mM Tris-HCl pH 7.6, 0.03% bromophenol blue, 
0.03% xylene cyanol FF, 60% glycerol, 60 mM 
EDTA. 
1 x stop solution 20 ml deionised formamide, 400 µl 0.5 M EDTA, 
40 µl 1 M NaOH, 20 mg bromophenol blue. 
 
2.15.4 Buffers Used during Protein Procedures. 
 
Table 2.11 Buffers used in protein purification and analysis. 
Buffer name Buffer constituents 
8 x binding buffer for 
His·Bind® column / 
HisTrap™ HP cartridges 
4 M NaCl, 160 mM Tris-HCl pH 7.9, 40 mM Imidazole. 
8 x charge buffer for 
His·Bind® column / 
HisTrap™ HP cartridges 
400 mM NiSO4. 
8 x wash buffer for 
His·Bind® column / 
HisTrap™ HP cartridges 
4 M NaCl, 160 mM Tris-HCl pH 7.9, 480 mM Imidazole. 
8 x elution buffer for 
His·Bind® column / 
HisTrap™ HP cartridges 
2 M NaCl, 80 mM Tris-HCl pH 7.9, 4 M Imidazole. 
p53 purification buffer A 10 mM HEPES, pH 7.4, 1.5 mM MgCl2 , 5 mM KCl, 1 mM 
DTT, protease inhibitors. 
p53 purification buffer B 10 mM HEPES, pH 9, 1.5 mM MgCl2 , 5 mM KCl, 10 mM 
DTT, protease inhibitors. 
p53 purification buffer B2 10 mM HEPES, pH 9, 1.5 mM MgCl2 , 200 mM KCl, 10 mM 
DTT, protease inhibitors. 
1 x Tris-glycine SDS (TGS) 25 mM Tris pH 8.3, 192 mM glycine, 0.1% (w/v) SDS. 
4 x SDS-PAGE loading 
buffer 
200 mM Tris-HCl pH 6.8, 8% (w/v) SDS, 0.4% (w/v) 
bromophenol blue, 40% (w/v) glycerol, 400 mM β-
mercaptoethanol. 
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Coomassie blue 0.25 g Coomassie Brilliant Blue R-250, 90 ml methanol: H2O 
(1:1, v/v), 10 ml glacial acetic acid. 
1 x electrophoresis blotting 
buffer 
24 mM Tris-HCl pH 7.5, 192 mM glycine, 20% methanol. 
1 x Tris-buffered saline 
(TBS) 
50 mM Tris-HCl pH 7.5, 150 mM NaCl. 
1 x Tris buffered saline + 
Tween (TBST) 
50 mM Tris-HCl pH 7.5, 150 mM NaCl, 0.1% Tween® 20. 
1 x Phosphate buffered 
saline (PBS) 
10 mM Phosphate-HCl pH 7.4, 137 mM NaCl, 2.7 mM KCl. 
1 x Phosphate buffered 
saline + Tween (PBST) 
10 mM Phosphate-HCl pH 7.4, 137 mM NaCl, 2.7 mM KCl, 
0.1% Tween® 20. 
1 x protein storage buffer 20 mM Tris-HCl pH 7.5, 100 mM NaCl. 
 
2.15.5 Buffers used during in vitro Assays. 
 
Table 2.12 Buffers used during in vitro DNA binding and ligation assays. 
Buffer name Buffer constituents 
1 x SMB wash buffer 500 mM NaCl, 20 mM Tris-HCl pH 7.5, 1 mM EDTA. 
1 x SMB reaction buffer 10 mM Tris-HCl pH 7.5, 50 - 250 mM KCl, 1 mM DTT, 200 - 
400 µg/ml BSA. 
3 x SMB reaction buffer 30 mM Tris-HCl pH 7.5, 150 - 750 mM KCl, 3 mM DTT, 600 - 
1200 µg/ml BSA. 
10 x VP buffer 50 mM Tris-HCl pH 7.8, 0.1% Triton X-100. 
1 x PGB buffer 5 mM Tris-HCl pH 7.8, 50 - 250 mM KCl, 0.1% Triton X-100. 
10 x ligation buffer 660 mM Tris-HCl pH 7.5, 50 mM MgCl2, 10 mM DTT, 10 mM 
ATP. 
 
2.15.6 Buffers Used during in vivo Assays. 
 
Table 2.13 Buffers used during in vivo experiments. 
Buffer name Buffer constituents 
1 x SDS lysis buffer 50 mM Tris-HCl pH 8.1, 1% SDS, 10 mM EDTA. 
1 x dilution buffer 16.7 mM Tris-HCl pH 8.1, 167 mM NaCl, 0.01% SDS, 1.2 
mM EDTA, 1.1% Triton X-100. 
1 x low salt buffer 20 mM Tris-HCl pH 8.1, 150 mM NaCl, 0.1% SDS, 2 mM 
EDTA, 1% Triton X-100. 
1 x high salt buffer 20 mM Tris-HCl pH 8.1, 500 mM NaCl, 0.1% SDS, 2 mM 
EDTA, 1% Triton X-100. 
1 x LiCl wash buffer 10 mM Tris-HCl pH 8.1, 0.25 M LiCl, 1 mM EDTA, 1% 
NP40, 1% deoxycholate. 
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CHAPTER 3 
 
Characterising Human p53-DNA Interactions 
 
 
 
 
As a central component of several complex networks within multicellular organisms, p53 is 
undoubtedly integral to the maintenance of genomic stability.  Renowned for its activities as a 
transactivator of genes involved in cell cycle regulation, DNA repair and apoptosis, it has also 
recently been proposed that p53 may function as part of a global surveillance mechanism 
responsible for detecting and responding to genomic regions prone to potentially detrimental 
events (Walter et al., 2005).  Interactions with DNA form an integral element of the function 
of p53 and it is recognised that it can associate with DNA in diverse and versatile modes 
depending on both the DNA substrate and the status of p53 itself (Kim and Deppert, 2006).  
Interactions between p53 and consensus response elements (REs) in target gene promoters 
have been well characterised (Shu et al., 2006). However, p53 has also been shown to bind to 
DNA in a manner strongly dependent on DNA structure and also non-specifically to linear 
dsDNA (McKinney et al., 2004). 
 
Recently, secondary structures that form in TRS tracts have been suggested as natural p53 
binding sites (Walter et al., 2005).  Such activity might have considerable physiological 
implications and ultimately may influence characteristic phenotypes of some human 
hereditary neurological disorders.  Although it has been documented that latent p53 
demonstrates a strong binding affinity towards hairpin structures composed of CTG•CAG 
repeats, the consequences of such interactions remain unknown.  It has been proposed that as 
this activity is exhibited by unmodified p53, this may be evidence reinforcing the hypothesis 
that unmodified p53 is active as a regulator of genome stability. 
 
The in vitro DNA binding activity of p53 has been intensely investigated, often by using 
electrophoretic mobility shift assays (EMSAs) to analyse binding patterns of p53 to various 
DNA substrates.  As a consequence of these studies, models were proposed inferring that p53 
required modifications or even complete removal of the CTD for initiation of sequence-
specific binding (Anderson et al., 1997; Hupp and Lane, 1994), a concept that was later 
disproven as the CTD was actually found to enhance sequence-specific binding by associating 
p53 close to DNA.  As a considerable amount of the current knowledge of the DNA binding 
activity of p53 has derived from EMSAs, it would be advantageous to develop alternative 
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DNA binding assays for further characterisation of p53-DNA interactions and for verification 
of previously obtained data.  As doubt exists regarding the sensitivity of EMSAs during the 
detection of weak protein-DNA interactions (as may be the case for non-sequence specific 
binding), assays that are sensitive enough to detect and differentiate between different modes 
of these interactions would be highly beneficial. 
 
A main aim of this section of work was to optimise a recently developed in vitro streptavidin 
magnetic bead (SMB) DNA binding assay for use as a technique for investigating human p53 
interactions with DNA.  Initially, 2 types of human p53 were analysed – a full length version 
that had been over-expressed and extracted from eukaryotic insect cells, and a full length 
recombinant version that had been over-expressed and purified via a polyhistidine tag from 
prokaryotic E. coli.  As modifications have previously been implicated to influence p53-DNA 
binding, it was of considerable interest to ascertain if over expression in prokaryotic or 
eukaryotic cells affected DNA binding properties.  Prior to their use in SMB assays, 
oligonucleotides that would ultimately act as DNA binding substrates required production and 
subsequent analysis to ensure the desired products had been successfully formed.  It was also 
crucial to analyse the SMBs employed during assays to quantify elements that could 
potentially interfere with assay results, including oligonucleotide attachment capacity and 
unspecific protein binding.  Simultaneously, Protein-G beads (PGB) that form components of 
a separate in vitro DNA binding assay were also examined alongside SMBs to look for 
similar properties.  After analysis of SMB and PGB components, p53 DNA binding assays 
were performed to investigate precise activities of both types of p53, initially to determine 
optimum conditions for subsequent assays such as the effect ionic strength has on p53-DNA 
interactions.  Following comparisons of both p53s that were available, assays focused on 
interactions with unusual DNA structures, predominantly to hairpin regions, and 
identification of whether interactions were dependent upon structure or sequence. 
 
Lastly, in vivo DNA binding properties of human p53 were also investigated by utilising 
chromatin immunoprecipitation (ChIP) assays that have been developed for use in HeLa cells.  
Binding to known p53 REs in Mdm2 and p21 promoter regions were analysed alongside 
binding to GAPDH promoter (a region believed to not be a p53 target binding site).  DNA 
binding by p53 was investigated in cells that had or had not been subjected to UV irradiation 
to identify if DNA damage influenced p53-DNA binding. 
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3.1 Human p53 Protein Analysis. 
 
During this study, DNA binding activities of 2 versions of human p53 were investigated.  To 
assess the influences that post-translational modifications can exert on p53 activity, it was of 
interest to identify if human p53 derived from bacterial host cells demonstrated comparative 
activity to human p53 over-expressed in insect cell models.  Insect cells are generally 
accepted to contain advanced cellular machinery that can facilitate proper folding of 
eukaryotic-derived proteins and allow complex post-translational modifications of 
mammalian proteins.  By contrast, such modifications may not be possible in prokaryotic 
systems, and this can, ultimately, influence protein activity.  High Five insect cells 
(InvitrogenTM) that had been infected with recombinant baculovirus directing expression of 
human wild-type p53 (p53-I) were kindly supplied by Ella Kim (University of Lübeck, 
Germany).  As p53 expression was directly controlled by baculoviral transcription, cellular 
levels of recombinant p53 were significantly greater than other cellular proteins allowing 
quick extraction as described (Section 2.4.3.6), a method widely used during p53 studies 
(Dudenhoffer et al., 1998; Gohler et al., 2002; Walter et al., 2005).  A recombinant human 
wild-type p53 protein (Active Motif®) that had been over-expressed in E. coli was also 
investigated (p53-B).  This recombinant protein had an additional N-terminal polyhistidine 
tag that allowed purification via an affinity column in combination with fast performance 
liquid chromatography prior to this study. 
 
3.1.1 Insect Cell Derived Human p53 Extraction and Analysis. 
 
Prior to p53-DNA interaction assays, it was essential to ensure samples contained the 
expected p53 protein.  Human p53 was extracted from insect cells and analysed via SDS-
PAGE and Coomassie staining (Figure 3.1 A).  Analysis revealed p53 had successfully been 
extracted as a relatively intense band present at approximately 50 kDa, however a 
considerable amount of unidentified cellular proteins were also present.  A Bradford assay 
was performed, which estimated the total protein concentration to be approximately 1 µM, 
but, as this encompassed all proteins extracted, the actual concentration of p53 was 
significantly less than this. 
 
To confirm the presence of human p53 in the extracted p53-I sample, western blots were 
performed followed by immunodetection analysis using p53 (DO-1) (Santa Cruz) antibody, 
specific for amino acids 11-25 of human p53.  Western blots identified that the optimum p53 
(DO-1) dilution for analysing 5 – 0.1 pmol of p53-I was 1:100,000, indicating a high 
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sensitivity of the antibody for human p53.  Two samples of p53-I that had been extracted 
separately were analysed at varying amounts (Figure 3.1 B and C) to discover an appropriate 
amount that would produce bands of relatively high intensity without antibody binding non-
specifically to contaminating proteins. 
 
 
Figure 3.1 Electrophoretic analysis of human p53 derived from insect cells.  A.  SDS-
PAGE (using 10% polyacrylamide gels) followed by Coomassie staining of p53-I.  The 
relatively intense band at approximately 50 kDa indicates p53 was successfully obtained, 
however significant levels of contaminating proteins were present.  B.  SDS-PAGE followed 
by western blot analysis using p53 (DO-1) at 1:100,000, confirming the intense band detected 
in (A) was human p53.  C.  SDS-PAGE followed by western blot analysis using p53 (DO-1) 
at 1:100,000 of a separate extraction of p53-I. 
 
 
Decreasing amounts of p53-I to 1.5 – 0.2 pmol resulted in clear bands representing p53, with 
considerably less unknown bands either caused by non-specific immunodetection or the 
presence of p53 breakdown products.  It was noticed that the p53 band appeared to consist of 
2 bands of similar size that were detected to a similar extent by p53 (DO-1), except for p53-I 
shown in Figure 3.1 C, which appears to have a more intense lower band.  The reason behind 
detection of two bands is unknown, however it may be possible these samples contain 
multiple species of p53 exhibiting alternative modifications that may influence 
electrophoretic mobility.  It was accepted that for p53-I, amounts varying between 1.5 – 0.2 
pmol would be acceptable for future western blot analysis. 
 
3.1.2 Human Recombinant p53-B Analysis. 
 
As mentioned, an alternative recombinant human p53 protein that had been over-expressed in 
E. coli (p53-B) was also analysed during this study.  Coomassie staining had already been 
A 
B 
C 
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performed by the manufacturer, showing the p53 samples were relatively pure (Appendix I).  
The addition of an N-terminal polyhistidine tag was utilised for western blot analysis using 
anti-His antibody, in addition to immunodetection of the p53 protein using an anti-p53 
antibody, which both show the observed band was human p53.  Immunodetection performed 
by the manufacturer with the anti-p53 antibody suggests the presence of contaminating 
proteins or p53 breakdown products, however this is probably a consequence of using the 
anti-p53 at an inappropriate dilution.  It was of interest to analyse p53-B using p53 (DO-1) as 
this was the antibody selected for p53-I analysis and would be used in future western blots.  
As before p53 (DO-1) was used at 1:100,000 to analyse 0.5 pmol of both p53-B and p53-I 
(Figure 3.2). 
 
 
 
Figure 3.2 Electrophoretic and western blot analysis of p53-I and p53-B using p53 (DO-
1) during immunodetection.  Both p53-I and p53-B (0.5 pmol) were subjected to SDS-
PAGE using 10% polyacrylamide gels and western blotting followed by immunodetection 
with p53 (DO-1) antibody at 1:100,000. 
 
 
The results obtained from this analysis were unexpected.  Both p53 samples contained a band 
at approximately 50 kDa, however p53-B demonstrated reduced migration compared to p53-I, 
indicating it had a greater molecular weight.  As both p53-B and p53-I were full-length 
versions of p53 it was expected electrophoretic mobility would be similar.  Differences in 
migration may be explained - at least partially - because of the additional 14 amino acids that 
comprise the polyhistidine tag required for purification.  The molecular weight of the 
histidine residues alone may not fully justify the difference observed, but residual structural 
features in this region that may not have been fully denatured may also retard migration.  An 
alternative explanation is that p53-B and p53-I may consist of alternate splice variants of p53.  
It is known that alternative transcripts of p53 exist in humans and up to 10 p53 isoforms have 
been identified that can act synergistically or antagonistically depending on their 
conformation (Marcel and Hainaut, 2009).  If p53-B and p53-I are indeed different p53 
isoforms, it is feasible that both samples would demonstrate varied DNA binding 
characteristics during in vitro DNA binding analysis. 
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3.2 Oligonucleotide Annealing and Analysis. 
 
For protein-DNA interaction investigations with the in vitro SMB assay, various 
oligonucleotide substrates were produced that would ultimately act as potential protein-
binding substrates.  The majority of oligonucleotides used for DNA binding assays would be 
double-stranded, meaning relevant single-stranded oligonucleotides had to be annealed 
together to produce the desired products.  All substrates required at least 1 biotinylated strand 
that would attach to Dynabeads® M-280 Streptavidin-coated beads during the assays.  
Following the annealing procedure, conformations of the resulting substrates were analysed to 
ensure the appropriate molecules had been produced. 
  
DNA conformation analysis can be performed using a variety procedures, including NMR 
and dynamic programming algorithms (SantaLucia and Hicks, 2004).  During this study, 
oligonucleotide conformations were investigated using electrophoretic mobility analysis by 
native and denaturing polyacrylamide gel electrophoresis, another widely used technique for 
DNA structure analysis (Chastain et al., 1995; Cooper and Hagerman, 1987; Duckett et al., 
1988; Kahn et al., 1994).  This method relies on the reduced migration of larger DNA 
molecules or DNAs containing unusual structural features that restricts migration during 
electrophoresis.  As various DNA substrates of different sizes and conformations were 
employed during in vitro SMB assays, migration of these molecules could be directly 
compared to each other to allow identification of successful annealing. 
 
A proportion of DNA substrates used in these studies contained internal secondary structures 
and it was crucial to confirm the structures had been successfully incorporated to prevent 
unreliable data from the subsequent assays.  Hairpin structures were introduced into selected 
oligonucleotides by annealing together 2 ssDNAs that had strong base pairing at the substrate 
termini and with 1 strand containing excess bases in the central region.  Introducing central 
hairpins to oligonucleotides significantly alters the topology of the DNA molecules, and a 
resulting extended ‘Y-shaped’ conformation with pseudo-threefold symmetry is usually 
obtained (Altona et al., 1996).  The stability of the hairpin is dependent upon the base pairing 
either side of the hairpin.  Depending on factors such as protein interactions and ionic 
strength, topology of the DNA can alter and folding and stacking of helices may occur, which 
can significantly affect electrophoretic mobility.  
 
Alongside various sized dsDNA, ssDNA and dsDNA containing internal hairpin structures, 
double-stranded oligonucleotides containing alternative features including mismatches and 
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base pair insertions were also produced as these characteristics can also significantly affect 
protein-DNA interactions. 
 
3.2.1 Optimisation of Annealing Procedure. 
 
Preliminary annealing procedures involved the addition of relevant single-stranded 
oligonucleotides together in equal amounts, heating at 100 °C for 8 minutes and then allowing 
the DNAs to slowly cool to 20 °C for approximately 6 hours.  The resulting dsDNA 
oligonucleotides were analysed by native polyacrylamide gel electrophoresis (Section 2.3.2) 
and visualised by chemiluminescent detection (Section 2.3.3).  Only biotinylated DNA was 
recognised during this detection, but, as only biotinylated DNA affected the in vitro SMB 
DNA binding assays, this was adequate.  
 
Initial experiments focused on the production of double-stranded B-DNAs [p53 p21-RE], 
[p53 NBS1] and a dsDNA containing an internal hairpin - [p53 (CTG)7 HP] (all 
oligonucleotide substrates shown in Table 2.7).  Analysis of annealing revealed a high 
proportion of biotinylated ssDNA molecules present in the dsDNA samples as 2 bands 
representing dsDNA and ssDNA were present.  This was confirmed following denaturing 
electrophoresis of the same samples when only single bands, representing ssDNA, were 
observed that had migrated identically to the lower bands present in native electrophoresis 
analysis.  However, since biotinylated ssDNA contamination of dsDNA samples could have a 
considerable effect on in vitro SMB DNA binding experiments, the annealing procedure for 
producing DNA substrates required optimisation. 
 
Increasing environmental ionic strength can facilitate stabilisation of nucleic acid structures.  
The highly negative phosphate backbone of DNA can destabilise the structure of the molecule 
(Oda and Nakamura, 2000) and can negatively effect dsDNA formation.  Addition of salt 
effectively neutralises the negative repulsive charges and enhances stabilisation of the dsDNA 
conformation.  In order to facilitate annealing of dsDNAs, various concentrations of KCl 
between 50 – 250 mM were added prior to annealing.  It was determined that increasing KCl 
to 50 mM greatly improved annealing but that subsequent increases in concentration above 
this value had negligible effects to the observed improvement.  Thus, annealing efficiency 
was improved and contaminating biotinylated ssDNA was reduced (data not shown), however 
considerable amounts still remained. 
 
To further reduce contaminating biotinylated ssDNA, the use of alternative ratios of 
biotinylated ssDNA to unbiotinylated ssDNA oligonucleotides were investigated during 
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annealing.  Ratios of 1:2 and 1:4 were selected (Figure 3.3) and it was expected a higher 
amount of biotinylated ssDNA would become incorporated into dsDNA molecules due to the 
large excess of unbiotinylated ssDNA.  Although the resulting samples would contain large 
amounts of unbiotinylated ssDNA, this would not interfere with the in vitro SMB DNA 
binding assay as they would be removed during washing procedures.  Amounts of 
biotinylated ssDNA were significantly decreased in dsDNA oligonucleotide samples at a ratio 
of 1:2 of biotinylated:unbiotinylated and almost all contaminating biotinylated ssDNA were 
removed using a 1:4 ratio.  Thus, optimum annealing conditions had been identified and all 
double-stranded oligonucleotide samples investigated during the in vitro SMB DNA binding 
assays were produced using a 1:4 ratio of biotinylated:unbiotinylated DNA and at an ionic 
strength of 50 mM KCl. 
 
 
Figure 3.3 Oligonucleotide analysis following annealing of various dsDNAs under 
different conditions.  Initial annealing analysis identified significant amounts of residual 
biotinylated ssDNA in dsDNA samples.  Addition of 50 mM KCl improved annealing 
efficiency when at a ratio of 1:1 (biotinylated:unbiotinylated).  Annealing was improved 
further by increasing this ratio to 1:2 and annealing was most efficient at a 1:4 ratio.  
Successful incorporation of hairpins in specific dsDNAs was ascertained by a significant 
decrease in migration.  Sequences and structures of these oligonucleotides are described in 
Table 2.7 and dsDNA and ssDNA is indicated. 
 
 
As well as illustrating the improvements in annealing, the results also confirmed that DNAs 
were in the desired conformations as relative dsDNA migration was as anticipated.  Migration 
through the gel for [p53 p21-RE] and [p53 NBS1] was considerably less than for [p53 
ssDNA], which was expected as these substrates are double-stranded and they also contain 
more nucleotides in each strand.  The [p53 (CTG)1 HP] molecule migrated further than both 
[p53 p21-RE] and [p53 NBS1].  This oligonucleotide did contain a 3 base bulge that may 
reduce mobility, but it also contained 21 less nucleotides that will significantly increase 
migration.  Migration of [p53 (CTG)3 HP] was similar to [p53 p21-RE] and [p53 NBS1], and 
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considerably less than [p53 (CTG)1 HP], even though the net increase in nucleotides was only 
6.  This implied the hairpin secondary structure had successfully been incorporated and was 
retarding mobility.  This assumption is reinforced by [p53 (CTG)7 HP] migration as mobility 
was notably less than [p53 p21-RE1] and [p53 NBS1], even though this molecule contained 3 
less nucleotides than the dsDNAs without a hairpin.  As predicted, the introduction of internal 
hairpin structures significantly retarded electrophoretic mobility.  Interestingly, [p53 (CTG)7 
HP] contained an additional unusual band that showed dramatically retarded migration.  
Similar bands have been identified in previous studies using this molecule and it was believed 
to be conformational isomer of the dsDNA containing an internal hairpin (Walter et al., 
2005).  In this previous study, this idea was reinforced as the slower migrating band also 
appeared following re-analysis of DNA that had been initially isolated from a single band 
representing the expected DNA molecule. 
 
3.2.2 Production of Unusual Double-stranded Oligonucleotides. 
 
For protein-DNA binding experiments, various DNA substrates containing different structural 
features were produced using the optimised annealing procedure described in Section 3.3.1.  
Following annealing, all samples were analysed by native gel electrophoresis and results are 
shown in Figure 3.4. 
 
 
 
Figure 3.4 Analysis of oligonucleotides annealed using optimised conditions.  Following 
annealing, oligonucleotides were analysed by native gel electrophoresis and biotinylated 
molecules were detected by chemiluminescent detection.  Confirmation of successful 
annealing was achieved by analysis of the relative migration of each molecule.  Sequences 
and structures of these oligonucleotides are described in Table 2.5 and  dsDNA and ssDNA is 
indicated.  A. Oligonucleotides used during p53 binding analysis.  B. Oligonucleotides used 
during p53 and Ku DNA binding assays. 
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As shown in Figure 3.4 A, all dsDNA containing internal hairpins consisting of 7 triplet 
repeats had reduced mobility compared to larger double-stranded B-DNA molecules. Slight 
variations in migration of these hairpin substrates resulted from alternate sequences in the 
hairpin regions.  Oligonucleotides [p53 (CTG)7 HP] and [p53 (CGG)7 HP] migrated further 
than [p53 (GAA)7 HP] and [p53 (TAT)7 HP], potentially resulting from the higher amount of 
guanine and cytosine nucleotides providing stronger base-pairing, thereby forming a more 
compact hairpin structure that would encounter less resistance during electrophoresis.  Similar 
to [p53 (CTG)7 HP], [p53 (CGG)7 HP] contained a separate band representing DNA that has 
a very high level of retarded mobility in addition to the band representing the expected 
structure.  These additional DNA molecules could potentially be due to an alternative folding 
arrangement (Altona et al., 1996).  It is unclear why [p53 (GAA)7 HP] and [p53 (TAT)7 HP] 
do not contain structural alternatives but this may be a direct influence of  the stronger 
guanine and cytosine bonds that can form within the hairpin stem of the other DNAs that are 
more efficient at trapping altered structures.  Confirmation of retarded migration by internal 
hairpins was achieved by direct comparison with [p53 CTG dsDNA].  This dsDNA consists 
of 96 nucleotides, but it still migrated further than the hairpins consisting of 7 triplet repeats 
that have 21 fewer nucleotides.  These results strongly suggested the key hairpin structures 
had been introduced successfully. 
 
Figure 3.4 B represents oligonucleotides containing structures that result in less perceivable 
alterations in electrophoretic mobility than those previously described, as features such as 
mismatches and single base insertions are more difficult to distinguish than larger hairpin 
structures.  By comparison to [dsDNA1], [dsDNA1+ loop] had reduced migration, implying 
the presence of an unusual structure;  [dsDNA+ bubble] also had slightly reduced mobility 
when compared to [dsDNA1], which is likely to result from a series of mismatches that 
perturb the overall structure.  Unlike other dsDNA substrates, [dsDNA1+ biotin] contained 
large amounts of biotinylated ssDNA.  This was unavoidable as both ssDNAs prior to 
annealing were biotinylated and so both were added in 1:1 ratio and not the optimised 1:4 
ratio.  It also became evident following this analysis that biotin has a significant effect on 
mobility.  This can be seen by comparing [dsDNA1] and [dsDNA1+ biotin].  The extra biotin 
molecule retarded mobility to a slightly greater extent to that of [dsDNA+ bubble] even 
though it contains the same number of bases as [dsDNA1].  This idea is also supported by the 
relative lack of separation between dsDNAs and ssDNAs also evident.  The lack of separation 
between dsDNA and ssDNA can be explained as the addition of biotin is proportionally 
greater upon smaller ssDNA than larger dsDNA. 
 
 
Chapter 3 – Characterising Human p53-DNA Interactions 
 76 
3.3 Dynabeads® M-280 Streptavidin and Dynabeads® Protein-G Analysis. 
 
Two alternative approaches for investigating in vitro protein-DNA interactions were 
employed during this study that are dependent on utilising specialised magnetic beads to 
separate protein-DNA complexes from non-interacting molecules.  For the SMB assay 
(Section 2.7), Dynabeads® M-280 Streptavidin superparamagnetic beads (2.8 µm diameter) 
were used to capture biotinylated oligonucleotides that would act as substrates for added 
proteins.  These beads have a streptavidin monolayer covalently coupled to the surface to 
which biotin will attach with high-affinity (Holmberg et al., 2005).  This interaction has a 
dissociation constant of approximately 4x10-14 M, making it the strongest non-covalent 
biological interaction known.  For the PGB assay (Section 2.8), Dynabeads® protein-G 
superparamagnetic beads were used.  These beads again were 2.8 µm in diameter, but have a 
recombinant group G protein from Streptococcus covalently coupled to the surface instead of 
streptavidin.  Protein-G can capture protein-specific immunoglobulins that allow attachment 
of the protein of interest that would ultimately act as substrate for added DNA. 
 
3.3.1 Dynabeads® M-280 Streptavidin Analysis. 
3.3.1.1 Capacity Analysis. 
 
For precise measurements of protein-DNA binding affinity towards various substrate DNAs, 
it is fundamental to identify the amount of DNA that will become physically attached to a set 
amount of superparamagnetic beads.  For M-280 Streptavidin coated beads, the manufacturer 
states approximately 200 pmol of single-stranded oligonucleotides will attach to 1 mg of 
Dynabeads, and that capacity is inversely related to DNA molecule size.  No values are 
supplied for double-stranded oligonucleotides, however steric hindrance may reduce binding 
capacity for larger DNA fragments. 
 
To assess oligonucleotide capacity of SMBs, fluorescently labelled ssDNA (ssDNA+ 
fluorophore) and dsDNA (dsDNA+ fluorophore) (Table 2.7) were incubated with a set 
amount of beads under conditions used in the SMB assay and any unattached oligonucleotides 
were removed in subsequent wash steps.  The amount of oligonucleotides attached to beads 
was determined by fluorescence emission.  Initially, it was determined if the presence of 
SMBs affected fluorescence emission of known amounts of fluorescently labelled DNA.  For 
the amount of beads analysed (10 µl), fluorescence emission from 0 – 30 pmol labelled DNA 
was not significantly affected with or without beads (data not shown).  Consequently, 
oligonucleotides did not have to be removed from beads during capacity analysis 
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experiments.  To determine variation of fluorescence between labelled ssDNA and dsDNA, 
fluorescence from varying amounts of both DNAs was analysed (Figure 3.5) in wells that also 
contained identical amounts of SMBs.  The readings suggested that at low amounts there is 
little difference in fluorescence between DNAs, but at higher amounts dsDNA emitted higher 
levels of fluorescence. 
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Figure 3.5 Fluorescence emission from ssDNA and dsDNA oligonucleotides.  
Fluorescence from 0 – 60 pmol of both DNA species was measured using a FLx800 
microplate fluorescence reader.  Samples contained the relevant DNA, 10 µl of M-280 
Streptavidin-coated beads and an appropriate amount of dH2O for a final volume of 180 µl.  
Averages were taken from at least 3 readings.  Standard errors are shown. 
 
 
The difference in emission between DNA species meant direct comparisons between ssDNA 
and dsDNA during capacity analysis would not be possible.  The reasons for the observed 
difference was unknown, however variations in DNA concentrations would directly influence 
fluorescence.  For accurate quantification of bead capacity for DNA, calibrations of known 
amounts of DNA (including beads) were measured simultaneously to experiments analysing 
bead capacity.  It was predicted that as approximately 200 pmol of single-stranded 
oligonucleotides attaches to 1 mg of SMBs (10 mg / ml), that 20 pmol ssDNA would attach to 
10 µl.  For capacity analysis, 10 µl of beads were prepared and varying amounts of both 
ssDNA and dsDNA (0 – 60 pmol) were incubated as described (Section 2.7).  Importantly, 
bead-DNA complexes were washed twice to ensure unattached excess DNA was removed.  
Fluorescence emission from these samples was then measured alongside DNA removed 
during wash steps and calibration samples of known DNA amounts.  Values from calibration 
samples were used to calculate the amount of DNA attached to beads and excess DNA that 
did not attach (Figure 3.6 A and B). 
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Figure 3.6 Fluorescence emission from labelled DNA species during M-280 Streptavidin-
coated bead capacity analysis.  [ssDNA+ fluorophore] and [dsDNA+ fluorophore] (Table 
2.7) were used during analysis.  Averages were taken from at least 4 experiments.  Standard 
errors are shown.  A – ssDNA attached to beads and excess DNA removed during wash steps.  
B – dsDNA attached to beads and excess DNA removed during wash steps.  C - Comparing 
remaining ssDNA attached to beads following wash steps with the amount attached at the 
primary reading.  D - Comparing remaining dsDNA attached to beads following wash steps 
with the amount attached at the primary reading.   
 
 
It was identified that although the capacity of SMBs was similar to the manufacturer’s value, 
to ensure the expected amount of oligonucleotide attached, the DNA had to be added in 
excess, preferably by 3 times of the expected amount.  This is demonstrated as when 20 pmol 
of either DNA species is added to 10 µl beads, approximately only 12-15 pmol becomes 
attached; however, when 60 pmol of DNA is added almost 20 pmol becomes attached.  The 
results also indicate there is no significant difference between attachment of ssDNA and 
dsDNA, indicating the level of hindrance caused by the larger dsDNA molecule is low (t = 
0.97 (p > 0.05)) (60 pmol values).  It was of interest to discover if wash steps following bead-
DNA incubation disturbed DNA that was attached to SMBs.  Due to the high-affinity between 
biotin and streptavidin it was predicted that any loss of DNA would be low.  Figure 3.6 C and 
D shows that although ssDNA fluorescence emission remained almost identical to the pre-
wash reading, dsDNA demonstrated a degree of reduced emission in samples with higher 
amounts of DNA.  
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3.3.1.2 Non-specific Protein-bead Interactions. 
 
Non-specific protein binding to assay components is an important factor to address during 
immunoprecipitation experiments.  To analyse non-specific protein binding to M-280 
Streptavidin-coated beads, in vitro SMB assays with and without DNA were performed to 
detect non-specific p53 binding to beads.  Assays were performed according to Section 2.7, 
using 12 µ l of SMBs that were expected to allow approximately 24 pmol of substrate DNA to 
attach and act as substrate for 1.5 pmol of p53.  DNAs analysed included [p53 p21-RE], [p53 
NBS1] and [p53 ssDNA].  Preliminary experiments revealed integral problems for the SMB 
assay as almost 100% of p53 bound to the beads in the absence of DNA using a 
recommended buffer of 10 mM Tris, pH 7.5, 50 mM KCl, 1 mM DTT (Figure 3.7 A).  To 
reduce this unspecific binding, a separate incubation of free biotin molecules was introduced 
following bead-DNA incubation, with the aim of reducing exposed streptavidin on the bead 
surface (Figure 3.7 B).  Although non-specific p53 binding to ‘No DNA’ was reduced, a 
significant amount was still interacting with the beads.  To further reduce non-specific 
binding, BSA was introduced to the buffer used prior to addition of the protein of interest and 
during all wash steps (Figure 3.7 C).  With the introduction of BSA, non-specific protein 
binding was significantly decreased to less than 50%. 
 
 
Figure 3.7 Reducing non-specific p53 binding to M-280 Streptavidin coated beads.  
Western blot results from assays looking at p53 binding dsDNA containing its consensus 
binding site ([p53 p21-RE]), non-specific dsDNA ([p53 NBS1]), non-specific ssDNA ([p53 
ssDNA]) and to SMBs alone (No DNA).  From each assay a sample of unbound and bound 
protein is collected.  A - Results from an in vitro SMB assay with no optimisation of 
conditions.  B - Results from an in vitro SMB assay with a free biotin incubation following 
DNA addition.  C - Results from an in vitro SMB assay with addition of 400 µg / ml BSA 
incubation in all wash buffers.  D - Results from an in vitro SMB assay with both biotin and 
BSA optimisations and effects of increasing [KCl] on non-specific p53 interactions with 
SMBs. 
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Varying ionic strength can have several implications in assays involving DNA and protein 
interactions.  Increasing salt concentrations can facilitate DNA stabilisation and so 
oligonucleotides used during these assays were more likely to remain in their desired 
conformations.  As electrostatic force strongly influences intermolecular interactions between 
the negatively charged DNA phosphate backbone and basic amino acid residues in proteins, 
cation concentration in a solution significantly contributes to the thermodynamic and kinetic 
properties of the specificity and stability of protein-DNA interactions (Oda and Nakamura, 
2000).  In general, binding affinity decreases as salt concentration increases and effectively, 
weaker non-specific protein-DNA interactions can be distinguished from stronger high-
affinity interactions.  It was anticipated that increasing the concentration of KCl would also 
decrease p53-SMB non-specific interactions as this phenomenon may also be affected by 
ionic strength.  Figure 3.7 D shows results from an in vitro SMB assay investigating p53 
binding to SMBs at various KCl concentrations.  The results indicate p53-SMB interactions 
decrease as KCl increases, suggesting this interaction is ionic-strength dependent to an extent. 
 
3.3.2 Dynabeads® Protein-G Analysis. 
 
An alterative in vitro DNA binding assay used during this study employs Dynabeads® 
Protein-G beads (PGBs) to which immunoglobulins attach via their Fc part, enabling 
immunoprecipitation of proteins that may be bound to DNA.  For in vitro PGB assays 
(Section 2.8) it is important to identify if the non-specific interactions associated with the 
SMBs were also a characteristic of these different beads.  Initially, assays were performed 
independent of DNA in order to distinguish if p53 bound non-specifically to beads and to 
confirm that p53 (DO-1) would be an appropriate antibody for immunoprecipitation.  The 
manufacturer (Invitrogen™) advises to use approximately 5 µg of antibody for every 50 µl of 
PGBs used.  Previous studies on p53 have shown that 12.5 µl PGBs can be used to study 50 
ng of p53 using 100 ng of p53 (DO-1) for immunoprecipitation (Fojta et al., unpublished 
data).  As 100 ng is significantly less than the manufacturer’s recommendation (1250 ng for 
12.5 µl PGBs) it was important to confirm this amount was sufficient to immunoprecipitate 
50 ng of p53 (Figure 3.8). 
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Figure 3.8 Western blot analysis of p53-PGB non-specific interactions and 
characterising relevant p53 (DO-1) antibody amounts.  In vitro PGB assays were 
performed without the inclusion of DNA to identify if p53 bound non-specifically to PGBs.  
Various amounts of p53 and p53 (DO-1) antibody were also investigated to determine the 
appropriate amounts required for subsequent assays. 
 
 
Contrary to M-280 Streptavidin coated beads, p53 did not appear to interact with protein-G 
beads, indicating the non-specific interactions previously observed (Figure 3.7) were likely to 
be due to the presence of streptavidin.  Inclusion of an incubation of only 50 ng of p53 (DO-
1) prior to addition of 50 ng p53 was enough for almost 100% of the p53 to attach to PGBs, 
and this was increased to 100% when 100 ng of p53 (DO-1) was present.  It was also 
identified that 100 ng of p53 (DO-1) would allow 100 ng of p53 to precipitate, however this 
amount of p53 (DO-1) was not enough for attachment of 150 ng p53.  It was accepted that for 
all following in vitro PGB assays that 100 ng of p53 (DO-1) would be appropriate to allow 
immunoprecipitation of 50 ng p53. 
 
As the in vitro PGB assay analysed protein-DNA interactions by detection of bound DNA it 
was essential to confirm that PGBs with or without addition of antibodies would not 
precipitate DNA in the absence of protein.  Figure 3.9 shows results from a PGB assay 
performed to investigate non-specific attachment of linear and supercoiled pUC18 to PGBs.  
The experiments were performed as described (Section 2.8) except no protein was included. 
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Figure 3.9 In vitro PGB assay results investigating PGB and pUC18 interactions.  Linear 
pUC18 with overhang and blunt ends were analysed by electrophoresis on 1% agarose gels 
alongside supercoiled pUC18 which are shown in the first 3 lanes.  The last 4 lanes are results 
from a PGB assay exclusive of protein with or without p53 (DO-1) antibody. 
 
 
It was discovered that none of the pUC18 molecules studied demonstrated any interactions 
with PGBs or p53 (DO-1) antibody.  These findings were promising as the in vitro PGB assay 
did not require further optimisation in order to prevent non-specific interactions using the 
assay conditions tested. 
 
3.4 In vitro SMB DNA Binding Analysis of Human p53. 
 
Over the last 20 years, several studies have attempted to elucidate the versatile and complex 
interactions p53 exerts on DNA that, as yet, remain only partially understood.  It has been 
ascertained that p53-DNA interactions vary depending on both DNA sequence and structure, 
and also the status of the p53 protein itself (Kim and Deppert, 2006).  It is apparent that 
cooperation between p53s CDBD and regulatory CTD ultimately determine the mode of 
interaction that occurs with DNAs consisting of specific consensus sequences, unusual non-B 
DNAs and even linear non-specific DNAs. 
 
In vitro studies mainly executed using EMSA identified that, for initiation of sequence-
specific DNA binding activity to occur, p53 required modification or complete removal of the 
CTD, which was at first thought to function as an inhibitor of consensus sequence binding.  
This lead to the proposal of the ‘latency’ model based on the concept that unmodified p53 did 
not bind to consensus DNA.  Recently, it was shown that the CTD actually facilitated 
consensus sequence binding (McKinney et al., 2004) by localising p53 to DNA and allowing 
for diffusion in reduced dimensions, effectively disproving the ‘latency’ model with respect to 
sequence-specific interactions.  It was believed misleading data was obtained from EMSA 
assays investigating p53 binding to short linear DNA targets (Kim and Deppert, 2006), which 
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often required introduction of PAb421 antibody to differentiate between specific and non-
specific p53-DNA interactions. 
 
A previous study that employed EMSA to investigate p53 interactions with short DNAs 
(Walter et al., 2005) identified high structure-specific binding affinity of unmodified p53 to 
hairpin structures composed of CTG•CAG repeats compared to linear DNAs composed of a 
similar sequence.  These results are consistent with unmodified p53 functioning as part of a 
global genomic surveillance system that could detect unstable DNA prone to detrimental 
rearrangements.  However, for activation of p53 sequence-specific binding to linear 
consensus DNA from the Mdm2 promoter under the same experimental conditions, the 
introduction of PAb421 was required.  As ‘latent’ p53 failed to bind to consensus DNA 
during these assays, the reliability of the detected interactions between p53 and unusual 
structures may just be an artefact of employing EMSA to detect p53 binding to short DNAs. 
 
Determination of protein-DNA binding activity detected during SMB reactions initially 
requires the analysis of samples representing bound and unbound protein by SDS-PAGE and 
western blotting.  Immunodetection with protein-specific antibodies then identifies the 
amounts of protein in each relevant lane that is proportional to the intensity of the observed 
bands.  An example of how data is analysed following SMB assays is shown in Figure 3.10 
(this figure is not experimental data and will not be described.  DNA1 – DNA4 are 
hypothetical protein binding substrate DNAs). 
 
 
 
Figure 3.10 Example of the quantification of percentage binding by specific proteins 
during in vitro SMB DNA binding assays.  For each DNA substrate investigated, samples 
representing bound and unbound protein are collected and analysed by SDS-PAGE and 
western blotting.  Following immunodetection, band intensities are measured using ImageJ 
allowing for calculation of percentage binding.  A.  Western blot and immunodetection 
analysis of protein collected following an SMB assay.  B.  Data obtained following 
measurement of band intensities and conversion into values representing percentage binding.  
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Quantification of band intensities is performed using the program ImageJ (Figure 3.10) that 
allows for the identification of precise values for the amounts of protein bound or unbound.  
This method of analysis was performed during all in vitro SMB assays investigating human 
p53 binding to various oligonucleotide substrates. 
 
3.4.1 How Ionic Strength Affects Human p53-DNA Interactions. 
 
Protein-DNA interactions are often significantly dependent upon electrostatic forces in the 
surrounding environment and so, during in vitro protein-DNA binding analysis, it is important 
to relate observations to an estimate of the intracellular salt concentrations in which protein-
DNA interactions occur naturally.  Ionic strength impacts the stability of protein-DNA 
complexes as electrostatic attraction between the negatively charged phosphate backbone of 
DNA and positively charged residues on a protein’s surface often determine the strength of an 
interaction. Electrostatic attraction is particularly important during the random molecular 
association that occurs during non-specific protein-DNA interactions (Jen-Jacobson, 1997).  
Increasing the ionic strength of the surrounding environment effectively neutralises 
electrostatic attractions and only specific protein-DNA interactions influenced by alternative 
thermodynamic determinants will be maintained.  Although intracellular salt concentrations 
vary between organisms, investigations in E. coli determined the ionic environment to be 
equivalent to 160 mM K+ (Kao-Huang et al., 1977), a value that is thought to be a 
conservative estimation.  Human cellular ionic values are believed to be similar (Becker et al., 
2009). 
 
It is not possible to precisely recreate conditions equivalent to the intracellular environment 
during in vitro DNA binding analysis, however as electrostatic interactions are so crucial 
during protein binding it would be appropriate to have comparable intracellular salt 
concentrations during in vitro assays.  Previous EMSAs investigating p53-DNA interactions 
were frequently performed at salt concentrations considerably lower than the predicted 
intracellular values.  For example, concentrations of 25 mM KCl (Espinosa and Emerson, 
2001; McKinney and Prives, 2002), 50 mM KCl (Kim et al., 1997; Walter et al., 2005) or 50 
mM NaCl (Gohler et al., 2005; Gohler et al., 2002) have been utilised.  To examine how 
electrostatic forces govern p53-DNA interactions, SMB assays to determine p53 binding to 
various substrate DNAs at varying concentrations were performed.  The substrate DNAs 
initially investigated included [p53 p21-RE] (a dsDNA containing the response element from 
the p21 promoter), [p53 NBS1] (a dsDNA containing a sequence from the p21 promoter that 
is distant from the response element) and [p53 ssDNA] (a ssDNA molecule with no sequence 
from any p53 response elements).  As a control, reactions containing no DNA were also 
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analysed as non-specific p53-SMB interactions had been previously identified.  Assays 
measuring p53-DNA interactions at 50 mM and 220 mM KCl provided results that displayed 
the highest differences in activity (Figure 3.11):  
 
 
Figure 3.11 In vitro SMB analysis of human p53-B (over-expressed in bacterial cells) 
interactions with various DNAs at 50 mM and 220 mM KCl.  Averages were taken from a 
minimum of 6 experiments.  Standard errors are shown.  A.  Assays investigating human p53-
B interactions with DNAs at 50 mM KCl.  B.  Assays investigating human p53-B interactions 
with DNAs at 220 mM KCl. 
 
 
Table 3.1 Statistical analysis of results obtained during SMB assays investigating p53-B 
interactions with DNAs at 50 mM and 220 mM KCl.  Two-tailed t-test analysis was 
performed on data obtained from assays shown in Figure 3.11.  Percentage binding values for 
each DNA substrate from both assays at 50 mM and 220 mM were compared. 
 
DNA substrate t value Degrees  of freedom 
(of t) 
Critical values 
of t (p = 0.05) 
Binding 
difference 
p53 p21-RE 0.3 15 2.13 Not significant 
p53 NBS1 5.1 15 2.13 Significant 
p53 ssDNA 1.5 6 2.45 Not significant 
No DNA 5.3 7 2.37 Significant 
 
 
The results shown in Figure 3.11 highlight the considerable influence that the ionic strength 
of reaction environments has upon p53-DNA interactions and how it is difficult to distinguish 
between non-specific and specific interactions at low salt concentrations.  This is apparent 
when p53 binding to [p53 NBS1] is compared under both KCl concentrations where statistical 
analysis (Table 3.1) confirmed that there was significantly less p53 binding to this substrate at 
220 mM KCl compared to at 50 mM. However, for both [p53 p21-RE] and [p53 ssDNA], 
there was no significant difference in binding between at different ionic strengths.  As p53 
should have no specific affinity towards [p53 NBS1], it is likely the interactions seen to this 
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substrate are non-specific, and so are heavily dependent on electrostatic interactions.  
However, as p53 binding to both [p53 p21-RE] and [p53 ssDNA] remained relatively high 
even at 220 mM KCl, it expected that the observed binding is specific and, therefore, 
thermodynamically more stable.  Although p53-interactions towards these 2 DNAs may 
appear similar, the mode of binding is likely to be different as binding to [p53 p21 RE] is 
believed to be largely sequence-specific whereas binding to [p53 ssDNA] would be 
determined by structure.  This experiment has illustrated that p53 can distinguish between 
non-specific dsDNA and sequence-specific dsDNA without the requirement of modifications 
to the CTD and, therefore, it does not support previous ‘latency’ models (Anderson et al., 
1997; Hupp and Lane, 1994).  Data from these assays concerning non-specific p53 
interactions with SMBs agreed strongly with previous results (Section 3.3.1.2) in that at 
increased ionic strength, p53 association with SMBs was significantly reduced.  It was, 
therefore, concluded from these assays that salt concentrations had a considerable effect on 
p53 activity and, to allow discrimination between specific and non-specific interactions, all 
future p53 SMB assays would be performed at 220 mM KCl. 
 
3.4.2 Comparing Human p53s Derived From Eukaryotic and Prokaryotic Host cells. 
 
Speculation regarding the requirement for post-translational modifications for the induction of 
sequence-specific DNA binding by p53 has been a consistent feature of several investigations 
into p53-DNA interactions.  It was of interest to elucidate if binding activity between human 
p53 proteins derived from either eukaryotic or prokaryotic host cells exhibited varied DNA 
binding activity due to limitations of prokaryotic post-translational modifications compared to 
eukaryotes.  In vitro SMB assays were performed on 2 separate human p53 proteins that had 
been over-expressed in either insect (p53-I) or bacterial (p53-B) cell lines.  For the 
determination of precise binding activities, several DNA substrates were employed including 
[p53 p21 RE], [p53 NBS1] and [p53 ssDNA] that had been previously studied during ionic 
strength assays and, additionally, dsDNA molecules that contained internal hairpins of 
various sizes consisting of CTG repeats were also analysed.  It was of interest to determine if 
binding by p53 to CTG-hairpins that had been reported in a previous study (Walter et al., 
2005) was indeed a specific interaction or an artefact resulting from EMSA analysis.  As 
interactions towards DNAs containing internal hairpins is likely to be a structural-specific 
interaction, to ascertain the dependence of the interaction on size of the hairpin structure, 
hairpins consisting of 1 CTG repeat ([p53 (CTG)1 HP]), 3 repeats ([p53 (CTG)3 HP]) or 7 
repeats ([p53 (CTG)7 HP]) were investigated. 
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Figure 3.12 In vitro SMB analysis of human p53-I and p53-B interactions with various 
DNAs at 220 mM KCl.  Averages were taken from a minimum of 6 experiments.  Standard 
errors are shown.  A.  Assays investigating human p53-I interactions with DNAs.  B.  Assays 
investigating human p53-B interactions with DNAs. 
 
 
Table 3.2 Statistical analysis of results obtained during SMB assays investigating human 
p53-I (normal font) and p53-B (italics) interactions with various DNAs at 220 mM KCl.  
Two-tailed t-test analysis was performed on data obtained from assays shown in Figure 3.12.  
Percentage binding values of both p53 proteins towards [p53 p21 RE] were compared to 
values representing binding to alternative DNAs.  The differences between non-specific DNA 
binding and non-specific SMB binding were also compared.   
 
DNA substrates 
compared 
t value Degrees of freedom 
(of t) 
Critical values 
of t (p = 0.05) 
Binding 
difference 
p53 p21-RE v p53 
NBS1 
6.3 8 2.31 Significant 
p53 p21-RE v p53 
ssDNA 
0.9 19 2.09 Not significant 
p53 p21-RE v p53 
(CTG)1 HP 
2.5 7 2.37 Significant 
p53 p21-RE v p53 
(CTG)3 HP 
1.3 7 2.37 Not significant 
p53 p21-RE v p53 
(CTG)7 HP 
0.4 8 2.31 Not significant 
p53 NBS1 v No 
DNA 
3.1 7 2.37 Significant 
p53 p21-RE v p53 
NBS1 
8.3 28 2.05 Significant 
p53 p21-RE v p53 
ssDNA 
1.3 19 2.09 Not significant 
p53 p21-RE v p53 
(CTG)1 HP 
2.1 20 2.09 Significant 
p53 p21-RE v p53 
(CTG)3 HP 
2.6 20 2.09 Significant 
p53 p21-RE v p53 
(CTG)7 HP 
1.5 24 2.06 Not significant 
p53 NBS1 v No DNA 2.4 20 2.09 Significant 
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It can be concluded from the data shown in Figure 3.12 that both p53-I and p53-B exhibit 
almost indistinguishable DNA binding properties.  As both proteins should be identical in 
amino acid sequence, excluding the polyhistidine tag present on p53-B, the main factor 
determining variations in binding would have been thought to arise as a consequence of 
alternative over-expression systems.  As binding is very similar, the results indicate that any 
post-translation modifications present on p53-I and not on p53-B did not influence 
interactions with DNA.  Statistical analysis (Table 3.2) revealed that, for both p53s, a 
significant difference in binding was observed between [p53 p21 RE] and [p53 NBS1], 
however, both p53s did not show significant differences in binding between [p53 p21 RE] and 
[p53 ssDNA].  As the ssDNA substrate did not contain any response element sequence, this 
interaction is a structure-dependent interaction that is a recognised activity of p53.  
Interestingly, the data obtained suggests the interaction of p53 with ssDNA is similar to that 
observed with consensus dsDNA, although the naturally occurring topology of the p21 
promoter, which has not been accounted for in this assay, may induce a tighter interaction. 
 
One of the primary aims of the SMB assay was to identify if DNAs containing internal 
hairpins consisting of CTG repeats would induce p53 binding.  As p53 has natural non-
specific affinity towards linear dsDNA it was assumed that for an interaction with hairpin 
structures to be a specific interaction, then p53 binding would need to be greater than that 
observed to linear dsDNA of similar size.  Interestingly, it was recognised that the 
introduction of a single CTG repeat induced considerable p53 binding compared to non-
specific linear dsDNA, however binding remained significantly lower than sequence-specific 
binding.  The observed impact of the presence of a single trinucleotide repeat may at first 
appear cryptic, but when p53’s recognised ability to associate with mismatches in DNA is 
considered (Degtyareva et al., 2001), the finding that a 3-base bulge induces increased 
binding seems less remarkable.  The only difference observed in binding activity between 
p53-I and p53-B was towards [p53 (CTG)3 HP] as p53-I binding was not significantly 
different compared to [p53 p21 RE] binding, however p53-B was.  This difference seems of 
less importance when binding to [p53 (CTG)7 HP] is compared, as both p53s interact 
comparatively well, and are statistically not significantly different than consensus DNA 
binding.  This result implies p53-B binding to [p53 (CTG)3 HP] is an anomaly in that binding 
was unusually low in the experiments performed.  This indication is reinforced further as it 
appears that p53 binding to DNAs containing internal hairpins generally increases as the 
hairpins increase in size, and it is only binding of p53-B to [p53 (CTG)3 HP] that does not 
correspond to this consensus.  As p53 binding to hairpins consisting of 7 CTG repeats is not 
significantly different compared to consensus DNA binding, these results are comparable 
with previous findings (Walter et al., 2005) and imply similar regions that arise naturally in 
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genomes may induce p53 interactions.   The results shown in (Figure 3.12) also prove that, for 
both p53s, the non-specific interaction towards linear dsDNA is a significant result when 
compared to binding to ‘no DNA’.  This data agrees with the currently accepted model that 
non-modified p53 interacts with linear dsDNA independent of sequence, a function believed 
to facilitate location of specific regions in DNA. 
 
3.4.3 Human p53-Interactions with Unusual DNAs. 
 
It was believed previous SMB assays had detected at least 3 modes of p53 binding: sequence-
specific, structure-specific and non-specific DNA interactions.  The considerable difference in 
p53 binding to linear dsDNA containing or not containing a response element indicated that 
although p53 does show binding affinity towards dsDNA of any sequence, the association 
that occurs with sequence-specific DNA is noticeably tighter.  The observed binding to 
ssDNA and to dsDNA containing internal hairpins was expected to be largely sequence-
independent, however further clarification regarding p53 interactions with unusual DNAs was 
required.  SMB assays were carried out using dsDNAs consisting of various unusual features, 
ranging from single mismatches to DNAs with loop regions.  To further determine if p53 
interactions towards internal hairpin molecules were solely based on structure, assays were 
also performed investigating p53 binding to dsDNA containing internal hairpins consisting of 
different TRS.  For all subsequent assays, p53-B was used, but given the data reported above, 
it was expected similar observations would be made for p53-I. 
 
 
 
Figure 3.13 In vitro SMB analysis of human p53-B interactions with dsDNA containing 
unusual features at 220 mM KCl.  Averages were taken from a minimum of 3 experiments.  
Standard errors are shown.  A.  Assays investigating human p53 interactions with dsDNAs 
containing unusual features.  B.  Assays investigating human p53 interactions with DNAs 
containing internal hairpins consisting of varied TRS. 
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Table 3.3 Statistical analysis of results obtained during SMB assays investigating human 
p53-B interactions with DNAs containing internal TRS hairpins.  Two-tailed t-test 
analysis was performed on data obtained from assays shown in Figure 3.13 B.  Percentage 
binding values of p53 towards [p53 (CTG)7 HP] were compared to values representing 
binding to alternative hairpin DNAs or linear dsDNA containing CTG repeats.  p53 binding to 
linear CTG repeats was also compared to binding to non-specific dsDNA. 
 
DNA substrate t value Degrees  of freedom 
(of t) 
Critical values 
of t (p = 0.05) 
Binding 
difference 
p53  (CTG)7 HP v 
p53 (GAA)7 HP 
1.9 12 2.18 Not significant 
p53  (CTG)7 HP v 
p53 (CGG)7 HP 
2.8 12 2.18 Significant 
p53  (CTG)7 HP v 
p53 (TAT)7 HP 
2.5 12 2.18 Significant 
p53  (CTG)7 HP v 
p53 CTG dsDNA 
2.5 12 2.18 Significant 
p53 CTG dsDNA v 
p53 NBS1 
1.0 16 2.12 Not Significant 
 
 
The results shown in Figure 3.13 A indicate that p53 binding to the various substrate DNAs 
was relatively low compared to structural-dependent binding observed previously.  
Surprisingly, it was apparent that p53 had a preference towards [p53 NBS1] over [dsDNA1], 
an unexpected result as both contain non-sequence specific DNA.  The inclusion of a G/T 
mismatch in the latter led to slightly increased binding, however when a G/A mismatch was 
present, p53 binding was visibly enhanced and even greater than [p53 NBS1] binding.  This 
data correlates well with previous studies (Degtyareva et al., 2001) that found p53 bound with 
higher affinity towards A/G mismatches and with lower affinity towards G/T mismatches.  
One possibility for the preference of A/G mismatches over G/T is that the additional 
imidazole ring present when 2 purines are paired may have a more substantial impact on the 
DNA structure.  The inclusion of a single base insert or a loop region also increased p53 
binding, however not to the extent of the G/A mismatch substrate.  As the inclusion of either a 
base insert or loop structure would induce conformational changes within the DNA, p53 
binding may have been anticipated to have been higher.  A series of mismatches contained 
within the dsDNA ([dsDNA1+bubble]) also increased binding, but, again, not as extensively 
as expected.  Addition of biotin to both ends of the dsDNA [dsDNA1+biotin] also appeared to 
induce interactions with p53, however the reason for this is not clear.  As a biotin molecule is 
present at both ends of this dsDNA, it is likely it will be juxtaposed closely to the SMB, 
which would be expected to make protein binding more difficult.  However, as both ends of 
this molecule are fixed, the prospect of twisting of this DNA is possible, a feature that has 
been shown to increase p53 binding (Gohler et al., 2002; Palecek et al., 2001). 
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Although p53 does appear to demonstrate binding preference towards DNAs containing 
features likely to induce unusual conformations on the DNA, p53 binding shown in Figure 
3.13 A to the various structural derivatives of [dsDNA1] was generally low.  This is apparent 
even when [dsDNA1] was used for p53 binding substrate as it was expected p53 binding 
would be similar as that identified when [p53 NBS1] was substrate.  Apart from sequence, the 
only difference between these 2 substrates was that [dsDNA1] was 7 base pairs shorter than 
[p53 NBS1], although, at 30 base pairs, this should still be large enough to accommodate p53.  
However, if p53 has a binding preference for larger DNAs, this would explain why binding to 
[dsDNA1] and its derivates was relatively low. 
 
SMB assays were also performed that analysed p53 interactions with dsDNAs containing 
internal hairpins consisting of 7 repeats of various TRS sequences (Figure 3.13 B).  It was 
important to determine if the interactions observed towards CTG hairpins was structure-
dependent or if sequence also influenced p53 affinity.  It was found that p53 bound relatively 
tightly to all hairpin DNAs investigated, though interestingly, sequence did appear to 
influence p53-DNA binding.  Statistical analysis (Table 3.3) revealed that there was no 
significant difference between p53 binding to [p53 (CTG)7 HP] and [p53 (GAA)7 HP], 
however, significant differences were observed between [p53 (CTG)7 HP] and both [p53 
(CGG)7 HP] and [p53 (TAT)7 HP].  As all DNAs were of identical size, the differences 
observed were sequence-dependent. However, it is likely that the different sequences induced 
varying conformations on the hairpins and so, ultimately, it could be argued that the overall 
structure determined interaction strength.  Hairpins present in both [p53 (CGG)7 HP] and [p53 
(TAT)7 HP] would be very different since the CGG hairpin would be both bulky as a 
consequence of the abundance of guanine nucleotides, but also tightly associated because of 
the strong cytosine and guanine base pairing.  Contrastingly, the TAT hairpin may be 
predominantly single-stranded due to the misalignment of adenine and thymine nucleotides.   
 
Although the data indicates sequence does influence p53-hairpin interactions, it is apparent 
that binding is still relatively high irrespective of the nucleotide constituents.  The hypothesis 
that binding to hairpins is heavily structural dependent is confirmed by comparing [p53 
(CTG)7 HP] and [p53 CTG dsDNA].  Whereas both DNAs are identical in size and sequence, 
only [p53 (CTG)7 HP] contains an internal hairpin and, therefore, any differences in p53 
binding would effectively be structure-dependent.  As shown in Figure 3.13 B, p53 binding 
was significantly greater to [p53 (CTG)7 HP], reinforcing the notion that structure is the 
important determinant in p53 binding to TRS.   
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3.5 Chromatin Immunoprecipitation. 
 
Chromatin immunoprecipitation (ChIP) is an experimental technique that can detect protein 
interactions with specific genomic regions in vivo.  This method relies on the formation of a 
covalent crosslink between the protein of interest and any region of DNA that the protein is 
bound to.  Formaldehyde is commonly used for this process as it reacts with DNA bases and 
primary amines on amino acids to create a covalent crosslink between both molecules.  Cells 
are lysed following cross-linking and extracts are sonicated to shear chromatin into 0.2 – 1 kb 
fragments.  An antibody specific for the protein of interest is then used to immunoprecipitate 
protein-DNA complexes from which DNA is released by reversing cross-links with heat, and 
remaining proteins are removed with proteinase K treatment.  Techniques such as phenol: 
chloroform extraction can then be used to clean precipitated DNA, which can then be 
subjected to PCR to identify the presence of specific genomic regions if predicted binding 
sites are known.  This procedure is described in more detail in Section 2.13. 
 
In vitro human p53-DNA binding assays had indicated that genomic regions prone to 
conforming unusual secondary structures may behave as natural p53 binding sites.  In order to 
elucidate this activity further it was of interest to characterise this interaction in vivo using 
ChIP.  Prior to investigating interactions between p53 and unstable genomic regions, it was 
decided to perform ChIP assays that would detect p53 binding to known consensus sites.  
During in vitro SMB assays, a region from the p21 promoter was used as a substrate 
representing a p53 consensus binding site, therefore it was decided to investigate binding to 
this region in vivo.  The Mdm2 promoter was also investigated during ChIP assays as it has 
been identified that p53 has strong affinity towards this region (Weinberg et al., 2005).  As a 
negative control, a region from the glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
promoter was chosen as this gene is often constitutively expressed in most cells and is not 
believed to be a downstream target gene of p53.  A previous ChIP study investigating in vivo 
p53-DNA interactions (Kaeser and Iggo, 2002) also explored p53 binding to these 3 genomic 
regions and, for consistency, this current study utilised identical primers during PCR analysis. 
 
ChIP assays had previously been performed at the University of East Anglia (UEA) to detect 
in vivo transcription factor Sp1 DNA binding in HeLa cells (an immortal cell line derived 
from human cervical cancer cells) (personal communication).  Regardless of the specific 
degradation of p53 by HPV in cervical cancer cell lines, a transcriptionally active p53 that 
demonstrates sequence-specific DNA binding activity has previously been detected (Hoppe-
Seyler and Butz, 1993), but the specific transcriptional activity of endogenous p53 in viral-
induced cancers remains poorly understood.  The same study investigated the functional 
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status of endogenous p53 in HeLa cells infected with HPV18 and detected a low amount of 
p53 that possessed sequence-specific DNA binding activity that was detected using gel 
retardation assays.  Addition of exogenous wild-type p53 significantly increased p53-
mediated transcription, which indicated that the limited amount of endogenous p53 in HeLa 
cells is not enough to induce p53-mediated responses.  It was postulated that tumourigenic 
phenotypes of cervical cancers do not require the complete inactivation of p53, but that a 
threshold exists at which p53 is unable to exert its function.  Therefore, in HPV infected cells 
such as HeLa, not all intracellular p53 is functionally inactivated and that remaining 
endogenous amounts varied between cells depending on viral protein expression. 
 
3.5.1 Chromatin Analysis. 
 
A crucial step during ChIP is the fragmentation of chromatin into 0.2 – 1 kb products.  
Unsuccessful fragmentation can result in the precipitation of large DNA molecules that 
contain unspecific regions, a factor that can significantly increase background or increase the 
possibility of false-positive results.  Shearing of chromatin was performed by sonication, 
initially 10 x 30 seconds for each chromatin preparation.  Results from these experiments 
revealed that although the majority of DNA was at approximately 0.5 – 2 kb, some fragments 
remained that were over 3 kb.  The sonication procedure was optimised by reducing the 
opportunity for sample ‘foaming’ and the addition of 2 extra rounds of sonicating to all 
samples (Figure 3.14).  Chromatin fragmentation analysis was encouraging as it was apparent 
that the fragments resulting from sonication had been successfully reduced in size.  The 
smaller fragments would reduce precipitation of unspecific DNA and increase the reliability 
of ChIP results. 
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Figure 3.14 Electrophoretic analysis of chromatin fragments following shearing by 
sonication and testing for specific promoter regions by PCR.  A. – Chromatin fragments 
prepared for 2 ChIP assays following 10 x 30 seconds of sonication.  B. – Chromatin 
fragments prepared for 2 ChIP assays following 12 x 30 seconds of sonication. C. – PCR 
analysis of fragmented chromatin using primers designed to amplify p21, Mdm2 and GAPDH 
promoter regions using preliminary conditions.  Predicted promoter regions sizes are: p21 – 
105 bp, Mdm2 – 117 bp and GAPDH – 135 bp. 
 
 
Chromatin was also analysed by PCR to confirm the genomic regions under investigation 
were present in the chromatin prior to ChIP.  This also provided an opportunity to test primers 
and to identify appropriate conditions for ensuing PCRs.  Approximately 25 ng and 250 ng of 
fragmented chromatin were analysed using primers specific for p21, Mdm2 and GAPDH 
promoter regions (Figure 3.14 C).  The results indicated that the chromatin did contain all 3 
promoters and that primers were working efficiently as bands were present in the expected 
locations.  Irrelevant background products were low, however an extra band was apparent for 
GAPDH primers.  To amend this, the annealing temperature for GAPDH primers were altered 
to favour the production of the specific fragment so that PCR conditions were identical to a 
previous study amplifying these promoter regions (Kaeser and Iggo, 2002).  
 
3.5.2 In vivo p53-DNA Interactions. 
 
ChIP assays were performed as described in Section 2.13.2.  3 samples of chromatin were 
collected from each assay; the first was initial chromatin input, which was a sample of 
fragmented chromatin collected following sonication; the second was chromatin 
immunoprecipitated using p53 (DO-1) antibody specific for p53; the third was chromatin that 
was immunoprecipitated using an irrelevant mouse monoclonal antibody.  All 3 chromatin 
samples were analysed by PCR using primers designed to amplify regions of p21, Mdm2 and 
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GAPDH promoters.  Due to the significant difference in the amount of DNA in the chromatin 
input sample compared to immunoprecipitated chromatin, the input chromatin was diluted 3-
fold to decrease the differences in band intensity following electrophoresis and to allow more 
accurate analysis.  Examples of PCR analysis from 3 ChIP assays from HeLa cells not 
irradiated with UV light are shown in Figure 3.15. 
 
 
 
Figure 3.15 PCR analysis of 3 ChIP assays.  Chromatin collected following sonication 
(input chromatin) was analysed by PCR alongside chromatin immunoprecipitated using an 
antibody specific for p53 (DO-1) and an irrelevant antibody.  Primers designed to amplify 
regions of p21, Mdm2 and GAPDH promoters were used to detect the amounts of these 
regions in each sample.  The amount of input chromatin used as a PCR template was diluted 
3-fold to reduce differences in band intensities.  A, B, and C represent 3 independent assays. 
 
 
As Figure 3.15 demonstrates, the PCR products that formed depended on the initial amount of 
template DNA.  For input chromatin samples, relatively intense bands were produced 
however, reactions that depended on immunoprecipitated chromatin produced less amplified 
DNA.  An important factor was that chromatin immunoprecipitated using the irrelevant 
antibody contained very low amounts of the promoter regions studied.  This was encouraging 
as it indicated that chromatin immunoprecipitated by p53 (DO-1) was determined by a 
specific interaction between p53 (DO-1) and p53.  Further ChIP assays were performed, 
including investigations into p53-DNA in HeLa cells that had been irradiated with 20 J / m2 
UV light alongside cells not irradiated.  PCR was used to detect immunoprecipitated 
chromatin. 
 
Chapter 3 – Characterising Human p53-DNA Interactions 
 96 
0
2
4
6
8
10
p21 Mdm2 GAPDH
Promoter DNA
%
 
DN
A 
im
m
u
n
o
pr
ec
ip
ita
te
d
A
0
2
4
6
8
10
p21 Mdm2 GAPDH
Promoter DNA
%
 
DN
A 
im
m
u
n
o
pr
ec
ip
ita
te
d
B
 
Figure 3.16 Summary of ChIP results investigating p53-DNA binding to p21, Mdm2 and 
GAPDH promoter regions in non UV-irradiated and UV-irradiated HeLa cells.  
Following ChIP assays, chromatin input, chromatin immunoprecipitated using p53 (DO-1) 
and chromatin immunoprecipitated using an irrelevant antibody were analysed by PCR and 
electrophoresis on 1% gels.  Resulting band intensities were measured using ImageJ and 
percentages were calculated by comparing chromatin precipitated with p53 (DO-1) with 
chromatin input.  Averages were taken from 3 ChIP assays.  Standard errors are shown.  A. 
ChIP results analysing p53-DNA binding in non UV-irradiated HeLa cells.  B. ChIP results 
analysing p53-DNA binding in UV-irradiated HeLa cells. 
 
 
A significant difference in binding was observed between p21 and GAPDH promoter regions 
(t = 6.8 (p < 0.05)), and also between the Mdm2 and GAPDH promoter regions (t = 3.5 (p < 
0.05)) in HeLa cells not UV-irradiated (Figure 3.16 A).  Therefore, results from ChIP assays 
indicate the existence of an active p53 containing the ability to bind sequence-specifically to 
DNA in HeLa cells, agreeing with previous in vitro studies (Hoppe-Seyler and Butz, 1993).  
As both p21 and Mdm2 are recognised p53-DNA binding elements the results suggest a clear 
preference for these regions compared to non-specific DNA.  No significant difference was 
observed between p21 and Mdm2 regions (t = 2.2 (p > 0.05)). 
 
UV-irradiation appeared to influence p53-DNA to an extent, however the pattern of binding 
was similar to non UV-irradiated HeLa ChIP assays (Figure 3.16 B).  Again, p21 and Mdm2 
had significantly higher p53 binding compared to the GAPDH promoter region (t = 3.4 (p < 
0.05) and t = 3.7 (p < 0.05) respectfully), and no difference was observed between p53 
binding to p21 and Mdm2 regions (t = 0.09 (p > 0.05)).  In comparison to non UV-irradiated 
HeLa cells, all 3 promoter regions had significantly higher binding (p21 regions: t = 2.5 (p < 
0.05); Mdm2 regions: t = 2.8 (p < 0.05); GAPDH regions: 2.3 (p < 0.05)).  As the increase in 
p53 binding to all 3 regions was very similar, it cannot be concluded that p53 sequence-
specific DNA binding is increased following UV-irradiation, however it appears that p53-
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DNA interactions in general increased in these cells.  The chromatin immunoprecipitated 
containing the GAPDH promoter is likely to result from non-specific p53-DNA interactions 
via the p53 C-terminal domain, or alternatively p53 interactions with chromatin proteins.  
This non-specific chromatin may also account for a proportion of the chromatin in both p21 
and Mdm2 assays.  It was observed, however, that Mdm2 increased by the highest proportion 
following UV-irradiation as the percent chromatin bound more than doubled.  These results 
show correlation with previous ChIP studies (Kaeser and Iggo, 2002) as p53 binding to p21 
and Mdm2 promoters was significantly higher than GAPDH promoter binding, however the 
difference observed in this previous study was comparatively higher. 
 
The percentage of chromatin immunoprecipitated during the ChIP assays was relatively high 
considering endogenous p53 in HeLa cells is recognised as being poorly expressed.  
Background non-specific p53-DNA binding may account for a proportion of 
immunoprecipitated chromatin as the p53 C-terminal domain will induce interactions in a 
sequence-independent mode.  The high sensitivity of p53 (DO-1) antibody may also influence 
background binding as unspecific-protein interactions may arise if used at inappropriate 
concentrations.  Alternatively, the sensitivity of p53 (DO-1) may be one reason why such low 
levels of endogenous p53 were able to be detected and so may have been crucial for these 
assays. 
 
3.6 Discussion. 
 
The activities of human p53 require tight coordination to ensure its inhibitory effects on cell 
growth are only operational when necessary.  Post-translational modifications to specific sites 
on the p53 protein are accepted to be the principal mechanisms that govern elements 
including stability, cellular localisation and conformational changes (Woods and Vousden, 
2001).  The role of modifications including ubiquitination and phosphorylations on stability 
of p53 have been well characterised, however any direct influence that post-translational 
modifications have on the DNA binding properties of p53 remain to be fully understood.  To 
this extent, 2 human p53 proteins that had been over-expressed in eukaryotic (p53-I) or 
prokaryotic (p53-B) host cells were investigated in this study to investigate if DNA binding 
activities differed as a consequence of production.  It was believed that as prokaryotes do not 
contain advanced cellular machinery implicated in the protein modifications and folding 
required for some eukaryotic proteins, any differences observed between both p53 types could 
have resulted from differences in modifications or protein folding.  Electrophoretic analysis of 
p53-I and p53-B revealed considerable differences in migration as p53-B appeared several 
kDa greater in size compared to p53-B.  As both p53s were full-length wild-type versions of 
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human p53, this difference was not anticipated.  Although p53-B was a recombinant version 
that had an extra 14 amino acids comprising the polyhistidine tag, these additional amino 
acids did not justify the difference observed.  It is possible that the p53s analysed may have 
been alternate isoforms of p53 that arise following splicing of the human p53 gene into splice 
variants prior to cloning into the respective hosts. 
 
Prior to in vitro DNA binding analysis of both p53 types, the production of relevant 
oligonucleotide substrates was required.  For all dsDNA molecules, appropriate ssDNAs were 
annealed and then analysed by native gel electrophoresis and subsequent chemiluminescent 
detection of biotin tags.  Initially, annealing of substrates was inefficient, particularly to 
DNAs containing substantial secondary structures, and large amounts of ssDNA were present.  
This indicated that either dsDNA were unstable, and therefore denaturing, or that the 
annealing process was inefficient.  Annealing conditions were optimised by increasing the 
ionic strength of the solution environment to neutralise the repelling effect of the negatively 
charged DNA backbones and promote association of complementing strands.  Increasing the 
ratio of biotinylated: unbiotinylated ssDNAs to 1:4 respectively greatly improved 
incorporation of biotinylated ssDNA into dsDNA, resulting in excess unbiotinylated ssDNA 
that would be removed during SMB assay wash procedures.  In some instances, analysis of 
dsDNAs containing internal hairpin molecules consisting of 7 TRS displayed multiple species 
of dsDNAs, which were accepted to be conformational isomers of the same DNA molecule 
that were also detected in a previous study (Walter et al., 2005).  All DNAs that were 
employed as binding substrates during in vitro DNA binding assays were subject to structural 
analysis prior to use. 
 
It was also crucial to analyse components of DNA binding assays in advance to identify 
factors that could ultimately influence the acquired data.  DNAs that were both biotinylated 
and fluorescently tagged were used to measure the DNA attachment capacity of SMBs.  It 
was found that both ssDNA and dsDNA attached to SMBs to a similar extent, indicating that 
any hindrance caused by the larger dsDNAs did not significantly reduce attachment.  It was 
apparent however, that in order to attain the expected amount of DNA attached to SMBs, 
approximately 3 times of the manufacturers stated capacity of DNA should be incubated with 
beads.  Analysis of DNA loss following washing procedures during assays suggested that 
very little ssDNA was lost, however it was apparent that a small amount of dsDNA was 
removed as indicated by a loss in fluorescence emission.  As the interaction between biotin 
and streptavidin is one of the strongest non-covalent interactions known (Kd ~ 4x10-14 M), 
this slight loss may be explained by factors other than breakage of biotin-streptavidin bonds, 
such as DNA denaturing and the ensuing loss of the fluorescently labelled strand. 
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Non-specific protein interactions towards bead components of in vitro DNA binding assays 
would be highly disadvantageous as protein would be precipitated in conjunction with 
protein-DNA complexes independent of DNA, thereby creating false-positive results.  
Quantification of non-specific interactions towards SMBs was achieved by performing assays 
without the addition of DNA so that any protein precipitated would have been dependent on 
beads.  Under recommended conditions, non-specific binding was considerable as almost all 
human p53 attached to SMBs without DNA present.  To counteract this problem, an 
additional free biotin incubation step was introduced into the procedure in an attempt to 
reduce exposed streptavidin on the bead surface.  The introduction of BSA in assay buffers 
was also investigated as it was assumed BSA may also interact non-specifically to the bead 
surface and, therefore, help to reduce bead surface exposure for proteins.  Although 
beneficial, the most significant reduction in non-specific p53-SMB interactions was the 
increase in KCl concentration, indicating ionic strength was an important component of the 
observed interaction.  It was also believed that increases in ionic strength of reaction 
environments would enhance double-stranded oligonucleotide stability and help prevent 
denaturing by neutralising negative charges of complementary strands.  In contrast to SMBs, 
PGBs displayed no non-specific interactions with human p53 and specific antibodies were 
needed for protein precipitation.  Non-specific association of DNA to PGBs was also 
examined with or without antibodies and it was determined that DNA did not associate with 
PGBs in either situation.  Capacity analysis was also performed on PGBs to characterise 
amounts of antibody required to precipitate desired amounts of target protein. 
 
In vitro DNA binding properties of human p53 were examined using an optimised version of 
a previously developed SMB assay (Palecek et al., 2004), initially to ascertain the dependence 
on electrostatic forces during binding to various DNA substrates.  Human p53-B was 
incubated with linear dsDNA containing a p53 response element, linear dsDNA containing no 
response element and ssDNA.  It was found that at 50 mM KCl, binding to all DNAs was 
over 60% and there was no preference towards sequence-specific DNA, activity that is 
characteristic of p53 (Wolcke et al., 2003).  Percentage binding was found to be highest to 
ssDNA, a feature of p53 that has also previously been documented (Bakalkin et al., 1995; 
Bakalkin et al., 1994; Selivanova et al., 1996).  Increasing the concentration of KCl 
significantly reduced p53 binding to non-sequence specific dsDNA and ‘No DNA’ samples, 
whereas binding to the response element and ssDNA remained consistently high.  These 
results were consistent with the view that p53 can bind to DNA in different modes of varied 
strength, depending on sequence or structural characteristics.  As non-specific protein-DNA 
interactions are heavily dependent on electrostatic interactions, neutralising charges between 
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protein and DNA by increasing salt concentrations would decrease protein binding to non-
specific DNAs.  Whereas p53 binding non-specifically to DNA is determined by the CTD, 
binding to response elements in DNA is mediated primarily by the CDBD alongside 
regulation by other domains and is thermodynamically more stable. Recently a study has 
confirmed that the interaction with consensus DNA sequences enhances p53 conformational 
stability at physiological salt concentrations, but becomes abolished at 300 mM ionic strength 
(Ishimaru et al., 2009).  Therefore, p53 may also be demonstrating increased binding at higher 
KCl concentrations to consensus DNA than non-specific dsDNA as the protein may be more 
stable due to the presence of consensus DNA.  As with non-specific p53-dsDNA, binding to 
non-linear dsDNA, such as ssDNA, is thought to be CTD-dependent. However, the results 
show that this interaction is considerably stronger than CTD mediated non-specific 
interactions, indicating that alternative components alongside electrostatic forces are also 
involved in this interaction. 
 
It was also of interest to detect if p53-B and p53-I exhibited differential DNA binding 
activity.  This was achieved by performing identical assays with both p53s using substrates 
designed to detect at least 3 modes of p53-DNA interactions – sequence-specific, structure-
specific and non-specific.  The data obtained from these assays convincingly demonstrated 
that both p53s had almost identical DNA binding characteristics, suggesting that either both 
molecules were identical in conformation and modification, or that post-translational 
modifications that may have occurred in eukaryotic host cells did not significantly influence 
DNA binding.  It was also postulated previously that the apparent difference in 
electrophoretic mobility of the p53s observed during protein analysis may have arisen if p53s 
were different isomers.  However, if this is indeed the case, it is apparent that both isomers 
present display similar DNA binding characteristics. 
 
SMB assay results also implied that p53 binding to non-consensus dsDNA was significantly 
enhanced when an internal hairpin consisting of CTG repeats was present.  This interaction 
was apparently further strengthened as the size of the hairpin structure increased, findings that 
correlated strongly with a previous study that also detected a strong association of p53 
towards identical DNA substrates using an alternative approach (Walter et al., 2005).  To 
confirm this interaction was structure-specific, assays that employed similar substrates that 
contained alternative triplet repeats were investigated.  It was apparent that although p53 
bound to a high extent to all hairpin DNAs, there was significant variation that was attributed 
to sequence.  Notably, this sequence-dependence may be apparent due to the effect on the 
structure of the hairpin, meaning that ultimately this interaction was primarily structure-
dependent.  This proposal was reinforced by analysis of linear dsDNA containing TRS to 
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which p53 binding was significantly less, confirming the presence of the hairpin was key to 
p53 binding.  The physiological connotations of such interaction could be substantial as 
considering the formation of secondary structures in TRS tracts present in certain human 
hereditary neurological disorders can be multiple-times larger then DNAs investigated in this 
study, the apparent affinity of p53 towards these structures would be considerable.  Such 
activity may be an example of p53 acting as a global surveillance protein (Albrechtsen et al., 
1999; Wiesmuller, 2001) and that maintenance of unstable TRS tracts may be an important 
activity of p53. 
 
In addition to p53s documented affinity towards DNAs containing hairpin structures, other 
unorthodox features in DNA have also been reported to enhance p53-DNA binding.  Besides 
ssDNA, insertion-deletion lesion mismatches (Degtyareva et al., 2001; Lee et al., 1995), 
Holliday junctions (Subramanian and Griffith, 2005), triple-stranded DNA (Dudenhoffer et 
al., 1998) and even RNA molecules (Riley et al., 2007) are recognised as substrates with 
which p53 can interact.  Thus, the SMB assay was utilised to detect binding to dsDNA 
containing features including mismatches, insertions, loops and bubble structures.  It was 
found that although binding was generally low to these DNAs relative to previous substrates, 
a preference towards G/A mismatches, loop and bubble structures was detectable.  It was 
postulated that binding to these substrates was generally lower than anticipated because they 
were all variants of a dsDNA that was smaller than oligonucleotides previously studied.  It 
was assumed that this decrease in size reduced overall p53 binding, a concept that appeared to 
be enhanced by comparing non-specific interactions to dsDNAs of varying sizes that also 
appeared to be DNA length dependent. 
 
For determination of in vivo p53-DNA binding, ChIP assays investigating p53 interactions 
between consensus sequence DNA (p21 and Mdm2 promoter regions) and non-consensus 
DNA (GAPDH promoter region) were compared in HeLa cells that had, or had not been, 
subject to UV-irradiation.  Data obtained from ChIP assays indicated the presence of an active 
p53 capable of binding to specific genomic sites in non-UV-irradiated HeLa cells as binding 
to p21 and Mdm2 regions was significantly higher than GAPDH promoter binding.  UV-
irradiation did affect p53 binding to all genomic regions although p21 and Mdm2 remained 
significantly higher than GAPDH promoter binding.  Interestingly, precipitation of Mdm2 
appeared to increase the most following UV-irradiation, a feature that may represent a change 
in p53 activity following UV-irradiation that has altered its affinity towards different target 
sites.  However, as Mdm2 is a negative regulator of p53, it is unclear why transactivation of 
this gene would be beneficial following increased DNA damage that would arise following 
UV-irradiation. 
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As significant differences were detected between p53 and Mdm2 consensus promoter regions 
compared to the GAPDH promoter region that acted as a negative control, the results 
indicated that ChIP assays were performed successfully.  However, another explanation for 
the observed differences between p53-binding to these regions could be a direct result of the 
unusual genetics of HeLa cells.  Horizontal gene transfer from HPV has dramatically altered 
the HeLa genome that now demonstrate a hyper-triploid chromosome number, specific 
numerical deviations and 20 clonally abnormal chromosomes (Macville et al., 1999).  These 
genetic alterations result in the duplication of genes and so, as a consequence, during ChIP 
assays, certain genes will have a greater probability of being immunoprecipitated as they are 
present in higher numbers.  The influence of this aspect on results obtained during this study 
remains unknown. 
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CHAPTER 4 
 
Verification of Prokaryotic Ku and Analysis of 
DNA Binding 
 
 
 
 
Genomic stability can be greatly compromised by inappropriate DNA double-strand breaks 
(DSBs) due to their high cytotoxicity.  Non-homologous end-joining (NHEJ) is a 
comparatively error-prone repair pathway that can recognise and ligate together various DSBs 
independently of homology between DNA duplexes (Hakem, 2008).  Whereas eukaryotic 
NHEJ requires several highly coordinated proteins that each perform specific roles, 
characterised prokaryotic NHEJ consists of a two-component system comprising Ku proteins 
and a multifunctional DNA ligase.  In contrast to eukaryotic Ku70/Ku80, prokaryotic Ku are 
believed to function as homodimers that generally only contain domains similar to the central 
core DNA binding domain and dimerisation region of Ku70/Ku80 (Pitcher et al., 2007).  
DNA binding analysis of Ku from Mycobacterium tuberculosis (MtKu) has shown that 
prokaryotic Ku exhibit similar activity as eukaryotic Ku since binding affinity is high towards 
dsDNA ends, but lower towards ssDNA and closed-circular DNA (Weller et al., 2002).  In 
silico analysis of the S. coelicolor genome has revealed 3 potential homologues of Ku - 
SCO5309 (scku1), SCO0601 (scku2) and SCP1.285c (scku3) (Sayer, 2008)  that show high 
similarity to the M. tuberculosis mtku gene.  Both scku1 and scku2 are located on the 
chromosome of S. coelicolor, with scku1 positioned adjacent to scprim1 (SCO5308) (Sayer, 
2008), a gene that shows high homology to the primase region of the M. tuberculosis LigD 
gene.  However, scku3 is located on the plasmid SCP1 and is considerably smaller than scku1 
and scku2.  Sequence analysis has identified that all 3 scku genes show homology with 
eukaryotic Ku DNA binding domains, but scku2 also contains a sequence encoding for a 
domain similar to the SAP domain found on Ku70 that is involved in nucleic acid interactions 
and chromosomal organisation (Lees-Miller and Meek, 2003). 
 
Prior to investigations into the DNA-binding properties of prokaryotic NHEJ components, 
recombinant proteins that had previously been cloned into appropriate vectors (Sayer, 2008) 
were over-expressed and purified by affinity chromatography via N-terminal polyhistidine 
tags.  Proteins were then analysed primarily by SDS-PAGE and western blotting, and ScKu 
proteins were subjected to analysis by Matrix-assisted laser desorption/ionisation time-of-
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flight (MALDI-TOF) peptide mass fingerprint analysis for confirmation of the proteins 
identities. 
 
Two in vitro DNA binding assays were optimised for investigating prokaryotic NHEJ 
proteins.  The SMB assay that had previously been used during human p53 studies was again 
used, mainly to determine binding affinities towards short double-stranded and single-
stranded oligonucleotides.  Competition assays were also developed that were initially 
anticipated to generate data that would confirm preceding SMB results, however, the data 
obtained initiated new investigations into analysing DNA termini synapsis by ScKu.  SMB 
assays also revealed the high susceptibility of ScKu to proteolysis, a feature speculated to be 
important in dissociation from repaired DNA.  A separate in vitro PGB DNA binding assay 
was also employed to elucidate prokaryotic Ku interactions with various plasmid molecules.  
Interactions with linear, supercoiled and relaxed-circular plasmid DNA were examined using 
alternative conditions to verify specific binding preferences of the proteins studied.  
Importantly, ScKu interactions with oligonucleotides were also investigated using the PGB 
assay in order to establish comparisons with the previously acquired SMB data. 
 
Experiments were also performed to establish how ScKu proteins influenced activity of a 
standard DNA ligase not thought to interact with ScKu.  Ligation by bacteriophage T4 DNA 
ligase of linear plasmid DNA with overhang or blunt-ends independent of ScKu were initially 
analysed which was then compared to ligation with the inclusion of Ku proteins. 
 
4.1 Purification and Analysis of Prokaryotic Ku Proteins. 
 
Full length genes encoding scku1, scku2 and scku3 that had previously been cloned 
individually into pET28(a) plasmids (Sayer, 2008) and full length mtku that had been cloned 
into pRB141 (Malyarchuk et al., 2007; Weller et al., 2002) were available for analysis.  In 
vitro investigations into the activities of these prokaryotic gene products required the 
individual over-expression and purification of each recombinant protein.  The procedure 
employed for prokaryotic Ku over-expression was the pET expression system (Section 2.4.1) 
as high yields of protein can be obtained and this system had previously been used to over-
express prokaryotic Ku. 
 
Purification of successfully over-expressed recombinant proteins was performed using 
affinity chromatography with either Novagen His·Bind® columns or GE Healthcare 
HisTrap™ HP cartridges.  Both techniques utilised the polyhistidine tags that were present on 
the recombinant proteins.  Electrophoretic analysis by SDS-PAGE was used for primary 
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analysis of the purified protein and western blotting was performed on all recombinant 
proteins using immunodetection of the polyhistidine tags to confirm the desired protein had 
been obtained. 
 
4.1.1 Novagen His·Bind® Column Purification. 
 
Initial recombinant Ku purification was achieved using Novagen His·Bind® columns (Section 
2.4.3.2) that have a total binding capacity of 10 mg of target protein per column.  Cellular 
extracts from 1 litre cultures of E. coli over-expressing the relevant recombinant protein were 
applied to columns and, following several wash procedures, pure protein was eluted by the 
addition of imidazole to the columns.  Each purification yielded several fractions that 
contained varying amounts of recombinant proteins and contaminating proteins.  All collected 
fractions were analysed by SDS-PAGE and Coomassie staining (data not shown) to ascertain 
fractions that contained pure recombinant proteins that were to be subsequently desalted and 
analysed further. 
 
All recombinant Ku purifications were successful using His·Bind® columns, however yield 
varied significantly between proteins.  The differences in yield may have been a direct 
consequence of how well each recombinant protein was expressed in E. coli.  Values for 
concentrations and amounts of recombinant Ku proteins purified using His·Bind® columns are 
shown in Table 4.1.   
 
4.1.2 GE Healthcare HisTrap™ HP Purification. 
 
Affinity chromatography was also performed using HisTrap™ HP cartridges in conjunction 
with an Äktaprime™ plus (Section 2.4.3.3).  Although His·Bind® column purification had 
been successful, to acquire larger quantities of recombinant protein it was decided to employ 
HisTrap™ HP cartridges as total binding capacity is greater (60 mg protein) and application 
of protein samples and buffers can be readily controlled via the Äktaprime™.  The 
Äktaprime™ also enabled easy control of elution steps using gradients of increasing 
imidazole that was predicted to reduce contaminants as only recombinant proteins would 
elute at a specific percentage of imidazole.  It was discovered that using a step gradient with 
increments of 20 percent provided the most efficient method of elution.  Examples of affinity 
chromatography using HisTrap™ HP and Äktaprime™ plus are shown in Figure 4.1.  Yields 
of recombinant proteins were also improved by increasing volumes of E. coil over-expressing 
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the proteins of interest.  Typically, volumes of 3 litres were used for HisTrap™ HP 
purification. 
 
 
 
Figure 4.1 SDS-PAGE and Coomassie analysis of fractions collected during HisTrap™ 
HP purification.  10 µl of fractions were analysed in 12% polyacrylamide gels ran at 200 V 
for 1 hour.  S1 =supernatant eluate, S2 = initial 1 x binding buffer wash, S3 = 1 x wash buffer 
wash.  Fractions relate to eluted pure protein: F1-F18: fractions 1-18.  A1+A2.  Recombinant 
ScKu1 purification.  B1+B2.  Recombinant ScKu2 purification.  C1+C2.  Recombinant 
ScKu3 purification. 
 
 
HisTrap™ HP purification provided greater yields of recombinant protein than previous 
His·Bind® column chromatography as shown in Table 4.1.  This may in part be explained by 
the increases in E. coli cultures used during over-expression, but the higher capacity of the 
HisTrap™ HP cartridges would also have a considerable influence on recombinant protein 
yield.  Purity of fractions had also been improved by employing a step gradient of increasing 
imidazole. 
 
 
 
 
 
 
 
ScKu1 
ScKu2 
ScKu3 
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Table 4.1 Concentrations and total yields of all recombinant proteins over-expressed 
and purified from E. coli.  Values of total protein samples purified via His·Bind® columns 
are displayed in normal font, and protein samples purified via HisTrap™ HP are in italics. 
 
Protein Name Concentration (µg/ml) Concentration (µM) Yield (µg/L culture) 
ScKu1 34 0.9 119 
 145 3.7 169 
 217 5.6 253 
 1434 36.0 1673 
 969 25.0 1130 
ScKu2 28 0.7 98 
 84 2.2 294 
 128 3.3 149 
 385 9.8 449 
 396 10.0 462 
ScKu3 160 4.9 560 
 215 6.5 753 
 455 13.8 531 
 4976 150.0 5459 
MtKu 192 5.5 671 
ScLigD 
(monomer) 
32 0.9 110 
ScLigD (dimer) 161 2.3 564 
 
 
4.1.3 Coomassie and Western Blot Analysis. 
 
Following purification, 2.5 ml of appropriate fractions were desalted and either snap frozen in 
liquid nitrogen or had glycerol added to a final concentration of 20% and frozen on dry ice.  
Resulting protein stocks were analysed by SDS-PAGE and Coomassie staining (Figure 4.2). 
 
 
 
Figure 4.2 SDS-PAGE and Coomassie staining analysis of recombinant prokaryotic Ku 
proteins. Electrophoresis was performed using 10% polyacrylamide gels analysed at 150 V.   
A.  Analysis of 80 pmol of ScKu proteins purified via His·Bind® columns. B.  Analysis of 
varying amounts of MtKu proteins purified via His·Bind® columns. 
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Analysis of the purified proteins (Figure 4.2) showed clear, intense bands representing the 
purified recombinant protein and low levels of contaminating proteins.  Interestingly, 
electrophoretic migration of all purified Ku proteins was considerably less than expected.  
ScKu1 (39 kDa), ScKu2 (39 kDa) and ScKu3 (33 kDa) all demonstrated reduced migration, 
and similarly, MtKu (35 kDa) failed to migrate as predicted.  The addition of the polyhistidine 
tag may reduced electrophoretic migration to an extent, as for ScKu proteins, 6 histidine 
residues would increase the molecular weight by 0.84 kDa.  This, however, does not account 
for the significant reductions observed.  Due to the intensity of the bands present, it was 
expected that the relevant proteins had been successfully obtained, however, for confirmation, 
western blots were performed followed by immunodetection specific for the detection of the 
polyhistidine tags (Figure 4.3). 
 
 
 
 
Figure 4.3  Western blot analysis of recombinant ScKu proteins.  Proteins were subjected 
to SDS-PAGE using 10% polyacrylamide gels and western blotting, followed by 
immunodetection with antibodies specific for polyhistidine tags.  A total of 10 pmol of each 
protein was analysed.  A.  Western blot analysis of recombinant ScKu proteins purified via 
His·Bind® columns. B. Western blot analysis of recombinant ScKu proteins purified via 
HisTrap™ HP cartridges. 
 
 
Western blot analysis was consistent with Coomassie results as immunodetection of 
polyhistidine residues identified bands in identical positions to those previously recognised.  
This strongly suggested the bands were the required recombinant proteins.  It remains unclear 
why electrophoretic mobility of these proteins was lower than expected.  The extra molecular 
mass of the polyhistidine tag does not fully justify the observed discrepancies, although 
unusual structural features that may form in this region that are not completely denatured 
during SDS-PAGE may negatively influence mobility.  Similarly, remaining structural 
features of the Ku proteins would also affect mobility, however increasing SDS 
concentrations and altering heating procedures did not affect migration. 
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Alternatively, the unusually high isoelectric points (pIs) of the prokaryotic Ku proteins may 
also lead to reduced electrophoretic mobility. 
 
4.2 MALDI-TOF Peptide Mass Fingerprinting. 
 
Previous electrophoretic mobility analysis had identified that ScKu proteins failed to migrate 
according to predicted molecular weights.  For further characterisation and to confirm these 
proteins were as expected, Matrix-assisted laser desorption/ionisation time-of-flight (MALDI-
TOF) peptide mass fingerprint analysis was performed on all 3 ScKu proteins.   
 
MALDI-TOF is a powerful procedure that enables the molecular weight determination and 
structural characterisation of biomolecules.  This soft-ionising technique commonly utilises a 
nitrogen laser beam to analyse biomolecules that are liable to fragment when subjected to 
conventional ionising methods.  For prevention of biomolecule destruction and to facilitate 
ionisation and vaporisation, a matrix consisting of crystallised molecules such as sinapinic 
acid are employed that absorb the laser energy and become ionised.  The matrix can then 
assist biomolecule ionisation by transfer of this charge to the molecule whilst simultaneously 
protecting against the destructive laser energy (Pan et al., 2007).  The energy transferred 
promotes transition of peptide molecules from a solid state into a gaseous state and an electric 
field accelerates the resulting molecules towards an ion detector where they are detected as an 
electrical signal.  The spectrometer used for detection during ScKu analysis was time-of-
flight, which uses a pulsed laser to take individual recordings of ions following MALDI. 
 
Prior to MALDI-TOF, 60 pmol of ScKu1, ScKu2 and ScKu3 were subjected to SDS-PAGE, 
detected by Coomassie staining and then excised from the gel.  Proteins were then treated 
with trypsin to fragment into smaller peptides that were then analysed by MALDI-TOF.  In 
silico peptide mass finger printing (PMF) was employed to compare known protein sequences 
in various databases with the masses obtained from ScKu peptide analysis.  To achieve this, 
computer software translates the genome of a specific organism into proteins and theoretically 
digests these proteins into peptides to which the masses of sample peptides are compared 
(Shevchenko et al., 1996). 
 
 
 
 
 
 
 
Chapter 4 – Verification of Prokaryotic Ku and Analysis of DNA Binding 
 110 
Table 4.2 Data obtained from MALDI-TOF PMF analysis for ScKu1, ScKu2 and 
ScKu3.  Experimentally-identified ScKu peptide masses were compared with theoretical 
masses of S. coelicolor protein fragments using the Mascot search engine.  Scores above the 
threshold of 52 are significant (p < 0.05) and indicate matched genes.  Number of matches of 
peptides and sequence coverage were also calculated. 
 
Protein Matched 
Gene 
Mascot 
Score 
Score 
Threshold 
Matched 
Peptides 
Sequence 
Coverage (%) 
ScKu1 SCO5309 164 52 20 60 
ScKu2 SCO0601 238 52 27 69 
ScKu3 SCP1.285 134 52 20 58 
 
 
MALDI-TOF spectrums for the 3 ScKu proteins are located in Appendix II.  The data 
obtained from MALDI-TOF PMF (Table 4.2) conclusively established that the proteins 
analysed were the products of the Ku genes from S. coelicolor.  The expected genes were 
found to have Mascot scores considerably higher than the score threshold indicating high 
similarities.  Crucially, no other genes were found to have a score above this threshold.  
Sequence coverage scores were also very high as, for all ScKu proteins, coverage was 
between 58 – 69%, further establishing that the ScKu peptides correlated strongly with 
predicted S. coelicolor Ku proteins.  As the ScKu proteins were over-expressed in E. coli, the 
E. coli genome was also searched to identify the presence of contaminating proteins, however 
no significant matches were identified.   
 
4.3 In vitro SMB DNA Binding Analysis of Prokaryotic NHEJ Components. 
 
Previous investigations into Ku-DNA binding have yielded several interesting, and in some 
instances conflicting, reports regarding the precise DNA binding activities of this class of 
proteins.  When first identified, the heterodimeric eukaryotic Ku was reported as a dsDNA-
end binding protein that had the ability to translocate along DNA (de Vries et al., 1989).  
Further studies showed that the precise structure of DNA ends was not important and that Ku 
could interact with hairpin loops and mononucleosomes (Paillard and Strauss, 1991) 
alongside standard dsDNA termini.  The flexibility in Ku-DNA interactions was explored 
further and it was found Ku binding is largely sequence-independent and is not restricted to 
linear DNA, but can also bind to  nicked-circular DNA and, to a lesser extent, closed-circular 
DNA and single-stranded circular DNA (Blier et al., 1993). Independent studies confirmed 
that Ku can directly interact with unusual structures DNA end independently including single-
to-double strand transitions and regions of non-complementarity (Falzon et al., 1993).  It is 
generally accepted that eukaryotic Ku has low affinity for ssDNA, however data exists that 
shows Ku interacts with certain RNA molecules (Kaczmarski and Khan, 1993), implying 
further the complexity and specificity of eukaryotic Ku.  Since the discovery of prokaryotic 
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Ku homologues, studies have shown high correlation in DNA binding activity between these 
prokaryotic and eukaryotic counterparts as studies investigating Ku from M. tuberculosis 
found homodimeric Ku bound with high affinity to dsDNA but not to ssDNA or closed-
circular DNA (Della et al., 2004; Weller et al., 2002). 
 
Traditionally, in vitro Ku-DNA binding has been visualised using techniques including 
EMSA, protection assays and electron microscopy.  A relatively new in vitro SMB DNA 
binding assay (Section 2.7) that had been employed to investigate human p53 DNA binding 
activity was chosen to investigate the DNA binding activities of the 3 Ku homologues and 
DNA Ligase D (ScLigD) of S. coelicolor. To allow direct-comparison with traditional 
techniques, the DNA binding activity of the Ku homologue from M. tuberculosis was also 
investigated. 
 
4.3.1 Investigating Ku and DNA Ligase Binding to dsDNA and ssDNA. 
 
As the consensus view regarding Ku-DNA interactions is that Ku binds to dsDNA with 
significantly greater affinity than ssDNA, it was decided primary investigations would 
examine the strength with which ScKu proteins bound to dsDNA molecules compared to 
ssDNA molecules.  It is known that DNAs as small as 14 base pairs are sufficient for 
eukaryotic Ku-DNA binding and so oligonucleotides greater than 30 base pairs (Table 2.7) 
were expected to be appropriate for studying prokaryotic Ku DNA binding.  During SMB 
assays, 15 pmol of relevant protein was incubated with 20 pmol of available DNA ends, 
meaning the DNAs would not become saturated and all protein would have available DNA.  
As it is accepted that multiple Ku can interact with a single DNA molecule, this amount of 
DNA should be more than adequate to prevent Ku from not having available substrate.  
Importantly, ionic strength was determined by the concentration of KCl, which was 220 mM 
during all assays (a value previously used in SMB assays (Section 3.4)).  Results from SMB 
assays investigating ScKu, ScLigD and MtKu interactions with dsDNA and ssDNA are 
shown in Figure 4.4.  Unlike previous SMB experiments using p53, non-specific interactions 
between prokaryotic NHEJ proteins and SMBs were consistently low (<10%) and therefore 
are not shown in this section. 
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Figure 4.4 In vitro SMB DNA binding assay results investigating ScKu, ScLigD and 
MtKu interactions with dsDNA and ssDNA.  Protein samples were collected and analysed 
as stated (Figure 3.10).  Band intensities were measured and values for percentage bound 
DNA were calculated.  Assays were performed at 220 mM KCl.  Averages were taken from a 
minimum of 5 experiments.  Standard errors are shown. 
 
 
The data from SMB assays indicated considerable differences between the prokaryotic Ku 
proteins being investigated.  Considering previously studied eukaryotic and mycobacterial Ku 
bind preferentially to dsDNA (Dynan and Yoo, 1998; Weller et al., 2002), it was unexpected 
that ScKu1 demonstrated the ability to bind to ssDNA to a similar extent as dsDNA.  
Statistical analysis identified there was no significant difference (t = 0.98 (p > 0.05)) between 
ScKu1-dsDNA and ssDNA binding.  Conversely, ScKu2 demonstrated the predicted activity 
as binding to dsDNA was significantly greater than ssDNA (t = 12.6 (p < 0.05)), a result that 
showed strong similarities with MtKu activity that also bound significantly more to dsDNA (t 
= 8.3 (p < 0.05)).  Interestingly, ScKu3 bound relatively poorly to both DNA substrates, 
indicating either this protein has naturally lower affinity towards DNA than other prokaryotic 
Ku, or the recombinant protein studied was not functioning efficiently.  As the results in 
Figure 4.4 show, ScKu1-DNA and ScKu2-dsDNA binding are very high as almost all protein 
was precipitated during SMB assays when the appropriate DNA substrate was available.  
MtKu binding to DNA was generally lower than that observed with ScKu1 and ScKu2, 
indicating a difference in DNA binding abilities between prokaryotic Ku from different 
species of bacteria.  The binding of ScLigD was also analysed and it was discovered ScLigD 
could interact with ssDNA, but interacted significantly less to dsDNA (t = 7 (p < 0.05)), a 
result that contrasted entirely with ScKu2 and MtKu.  Generally, the SMB assay had detected 
differences in binding activity between the prokaryotic NHEJ components and it was of 
interest to further characterise affinities of the Ku proteins to dsDNA and ssDNA. 
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To obtain specific values regarding DNA binding affinity towards dsDNA and ssDNA 
substrate molecules, SMB assays were performed that investigated binding of prokaryotic Ku 
to varying concentrations of DNAs.  Traditional in vitro DNA binding techniques such as 
EMSA detect binding by detection of the DNA and, therefore, during affinity experiments, 
the levels of protein are varied as the amount of DNA must remain the same for visualisation.  
During SMB assays, as it is the protein that is detected, the only component of the assay that 
can be altered is the DNA.  During SMB assays, when 15 pmol of Ku protein were 
investigated in reaction volumes of 20 µl the concentrations were 0.75 µM and 20 pmol of 
DNAs were at 1.2 µM (Figure 4.5).  To elucidate at which concentrations of DNA 
prokaryotic Ku binding was at approximately 50%, concentrations of DNA was varied from 0 
– 3 µM and Ku concentrations were maintained at 0.75 µM.  Dissociation constant values 
(Kd) were calculated using an equation adapted from a previous protein-DNA interaction 
study (Wieland et al., 2001) detailed in Section 2.7.3. 
 
Figure 4.5 In vitro SMB assays investigating DNA binding affinities of prokaryotic Ku to 
dsDNA and ssDNA.  Ku concentrations were maintained at 0.75 µM whereas substrate 
DNAs were at concentrations between 0 - 3 µM.  Values for Kd were calculated using 
Equation 6 (Section 2.7.3).  Averages were taken from at least 5 experiments.  Standard errors 
are shown.  A.  Analysis of ScKu1 binding to dsDNA and ssDNA.  B.  Analysis of ScKu2 
binding to dsDNA and ssDNA.  C.  Analysis of MtKu binding to dsDNA.   
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Table 4.3 Dissociation constants (µM) for prokaryotic Ku binding to dsDNA and ssDNA. 
Values were obtained using Equation 6 (Section 2.7.3).  NF = No Fit, NDB = No Detectable 
Binding. 
 
 One Protein / DNA Two Proteins / DNA Four Proteins / DNA 
Protein dsDNA ssDNA dsDNA ssDNA dsDNA ssDNA 
ScKu1 NF 0.12 0.01 0.30 0.41 0.40 
ScKu2 NF 1.63 NF 1.81 NF 1.91 
MtKu 1.73 NDB 1.91 NDB 2.01 NDB 
 
Note: “No Fit” refers to data where the DNA binds to the protein too tightly to enable a Kd to 
be obtained using the model of 1, 2 or 4 protein molecules bound per DNA. 
 
 
As the precise mode of the prokaryotic Ku-DNA binding remains uncertain, dissociation 
constant values were calculated for 1, 2 and 4 protein binding per DNA molecule (Table 4.3).  
It was soon recognised that the values obtained for particular proteins when analysed as 
monomeric proteins were not practical as negative results were produced as a consequence of 
very tight protein-DNA interactions.  This was true for ScKu1 and ScKu2 when dsDNA was 
used as a substrate, however when dimeric or tetrameric protein binding is assumed, values 
can be obtained for ScKu1.   This occurrence may imply that multiple proteins were able to 
bind to single DNA molecules used during these assays and, therefore, the single-protein 
binding model does not fit for the ScKu proteins investigated.  As MtKu has previously been 
shown to exist as a homodimer in solution (Weller et al., 2002), it is likely the value obtained 
from calculations assuming dimeric binding is the most accurate value. 
 
4.3.2 ScKu Competition Assays. 
 
Competition assays can be used to distinguish a protein’s preference between DNA 
substrates.  Such assays are especially useful when affinity towards different DNAs has been 
found to be similar or to identify if a protein already bound to DNA can be removed and 
interact with a separate DNA molecule.  Previous SMB assays had detected that ScKu1 and 
ScKu2 bound with varied affinity towards dsDNA and ssDNA molecules, and it was 
anticipated competition assays investigating the same DNAs could provide more evidence to 
support the SMB data.  Assays were originally performed whereby ScKu1 and ScKu2 were 
initially incubated with dsDNA and then following removal of unbound Ku, either competing 
unbiotinylated dsDNA or ssDNA was added to the reactions.  Unbiotinylated DNAs were 
then removed in the subsequent wash step alongside any protein now bound to the free 
DNAs, and as with previous SMB assays, protein bound to biotinylated DNA were also 
removed and analysed.  Therefore, for each reaction, 3 samples were collected: unbound 
protein from the primary incubation with DNA-SMBs, protein bound to competing DNA and 
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protein bound to DNA-SMBs.  From the resulting analysis, percentages of protein removed 
following competition were calculated.  Surprisingly, irrespective of Ku protein or competing 
DNA, only very low amounts of ScKu protein bound to competing DNA was detectable, even 
when competing DNA was 3 times in excess of the DNA-SMBs (data not shown).  It was 
feasible that once bound to DNA, ScKu proteins may have been difficult to displace and so 
the addition of competing DNA following initial DNA incubations was ineffective.   
 
To further assess the effect of competing DNA, assays were performed whereby competing 
DNA was added concurrently with protein to the reactions.  This provided DNA-SMBs and 
free unbiotinylated DNAs with equal opportunities for ScKu binding and any interactions 
with competing DNA would not require ScKu dissociation from DNA. 
 
 
 
Figure 4.6 In vitro SMB DNA binding competition assays investigating ScKu1 and 
ScKu2 interactions to dsDNA and ssDNA.  Competing DNA was added simultaneously 
with protein to ensure no bias towards DNA attached to SMBs.  The amount of DNA-SMBs 
was maintained at 20 pmol and amounts of competing DNA varied from 0 – 60 pmol.  
Reactions were performed at 220 mM KCl.  Averages were taken from 3 experiments.  
Standard errors are shown.  A.  ScKu1 competition between dsDNA-SMBs and dsDNA or 
ssDNA.  B.  ScKu2 competition between dsDNA-SMBs and dsDNA or ssDNA. 
 
 
It would be expected that if a DNA-binding protein was incubated with equal amounts of 2 
DNAs of the same structure and sequence that binding to both DNAs would be approximately 
50%.  As shown in Figure 4.6, the effect of the addition of competing DNA to reactions 
investigating ScKu1 and ScKu2 binding to DNA was considerably lower than anticipated.  
During ScKu1 assays, when either dsDNA or ssDNA competing DNA was added in equal 
amounts as dsDNA-SMBs, binding to dsDNA-SMBs was reduced by less than 15% and when 
competing DNA was 3 times in excess of DNA-SMBs, binding to DNA-SMBs was reduced 
by less than 20%.  Correspondingly, the effect of competing DNA on ScKu2 binding was 
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even lower as when competing DNA was 3 times in excess, binding to DNA-SMBs was 
decreased by less than 15%. 
 
To ascertain the apparent preference that ScKu had for DNA-SMBs over free DNAs, several 
investigations were performed that would identify why the ScKu proteins were discriminating 
between DNAs. An important factor to ascertain was if unbiotinylated DNA could become 
physically associated with SMBs and therefore assays were repeated without the inclusion of 
biotinylated DNA, meaning any protein precipitated with SMBs would be dependent on free 
DNA physically associated with SMBs.  The results from these experiments revealed no 
ScKu were precipitated (data not shown) and, therefore, free DNA was not attaching to 
SMBs. 
 
Alternatively, it was proposed that the competing DNA may have been associating with 
DNA-SMBs either via direct interactions with the biotinylated DNA, or through bound ScKu 
proteins that theoretically may juxtapose DNA termini of free DNA and DNA-SMBs. This 
aligning of DNA termini may have been an example of ScKu replicating an essential function 
performed during NHEJ whereby a synapse is formed between 2 DNA termini of a DSB to 
form a stable intermediate for intermolecular ligation.  If true, free DNA may have been 
precipitated during SMB assays and this would explain the results obtained during 
competition assays.  In a similar technique to a previous study that successfully detected DNA 
end aligning by Ku proteins (Ramsden and Gellert, 1998),  ScKu proteins were incubated 
with biotinylated DNA and excess amounts of unbiotinylated ssDNAs modified with 5’ 
fluorophores were added to reactions.  Theoretically, if ScKu were aligning DNA-SMB with 
free DNA, free DNA would remain associated with SMB-DNA-ScKu complexes and this 
would be indicated by an increase in fluorescence emission in these reactions following wash 
steps.  To confirm this effect was ScKu dependent and not due to interactions involving only 
DNAs, simultaneous reactions without the inclusion of ScKu proteins were also performed. 
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Figure 4.7 Determining DNA termini alignment by ScKu1 and ScKu2 using modified 
SMB DNA binding assays.  ScKu proteins incubation with DNA-SMB was followed by 
addition of unbiotinylated fluorescently labelled ssDNA.  Following wash steps, any 
fluorescence detected may be caused by ScKu proteins forming synapsis between biotinylated 
and unbiotinylated DNAs.  Averages were taken from 6 experiments.  Standard errors are 
shown.  A.  Fluorescence emission from ssDNA removed after incubation with DNA-ScKu.  
B.  Fluorescence emission from ssDNA precipitated with SMB-DNA-ScKu complexes. 
 
 
The data collected from ScKu DNA termini alignment investigations indicate that the 
presence of both ScKu1 and ScKu2 did affect the amount of free ssDNA precipitated with 
SMBs (Figure 4.7 A).  This difference is most apparent when dsDNA is used for initial ScKu 
binding as significantly less fluorescent ssDNA is removed from reactions when ScKu1 is 
present (t = 6.4 (p < 0.05)) and also significantly less fluorescent ssDNA is removed when 
ScKu2 is present (t = 5.0 (p < 0.05)).  The implication that less fluorescent ssDNA is removed 
when ScKu are bound to dsDNA is enhanced in Figure 4.7 B as significantly more 
fluorescent ssDNA has been precipitated when ScKu1 or ScKu2 is attached to dsDNA (t = 
12.5 (p < 0.05) and t = 6.6 (p < 0.05),  respectively).  Results investigating free ssDNA 
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precipitation following ssDNA-SMB incubation are similar to dsDNA-SMB data, however 
ScKu2 appears to be less efficient in aligning ssDNA molecules.  Although Figure 4.7 A 
shows that there is no significant difference between removed ssDNA fluorescence emission 
between ScKu1 or ScKu2 (t = 1.5 (p > 0.05)) when initially bound to ssDNA-SMB, data in 
Figure 4.7 B illustrates that significantly less ssDNA is precipitated when ScKu2 is bound to 
ssDNA-SMB than ScKu1 (t = 8.7 (p < 0.05)).  These findings indicate ScKu1 is more 
efficient at aligning ssDNA termini compared to ScKu2, which correlates with previous SMB 
data that show ScKu1 binds to ssDNA with higher affinity.  However, ScKu2 does appear to 
increase precipitation of ssDNA even when initially bound to ssDNA-SMB, suggesting that 
although this protein may have relatively low affinity for ssDNA, interactions can still be 
detected. 
 
Results from SMB assays investigating synapsis of DNA termini by ScKu proteins may 
explain, to an extent, why competing DNAs in previous assays decreased binding to DNA-
SMB by relatively low amounts.  However, the amounts of fluorescent DNA precipitated 
when ScKu were present were not as considerable as may have been expected.  This is 
reinforced by the substantial differences in fluorescence between removed free ssDNA and 
precipitated free ssDNA.  For example, only 1.3% of free ssDNA is precipitated by ScKu1 
when initially bound to dsDNA-SMB.  One explanation for the relatively low amounts of 
precipitated DNA during synapsis SMB assays compared to results from competition assays 
is that the fluorophore present on free ssDNA molecules may have had a considerable effect 
on ScKu function.  Whereas free DNAs in competition assays have 2 free-ends available for 
alignment, fluorescent DNA only has 1 available end.  Therefore, only a single fluorescent 
DNA can be aligned with DNA-SMB.  In contrast, during competition assays several free 
DNAs can be aligned together to create complexes consisting of several DNA molecules with 
the capacity for precipitation (Figure 4.17). 
 
4.4 In vitro Protein-G Bead (PGB) Assay. 
 
The in vitro SMB DNA binding assay had revealed differential activity between the 3 ScKu 
proteins of S. coelicolor, indicating that these proteins may have alternate cellular functions, 
potentially independent of NHEJ.  To further characterise prokaryotic Ku-DNA interactions, 
an additional in vitro DNA binding assay was employed that captures DNA via 
immunoprecipitated proteins attached to Protein-G beads (PGB) (Section 2.8).  In contrast to 
the SMB assay, this assay is not restricted to biotinylated oligonucleotides, allowing larger 
DNA molecules to be used as binding substrates.  This approach considerably expands the 
scope of assessment of protein-DNA interactions as molecules exhibiting diverse 
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conformations such as linear, supercoiled, nicked-circular and relaxed-circular DNA can be 
investigated.  As DNA topology is known to significantly influence protein-DNA 
interactions, this assay may provide additional information regarding prokaryotic Ku DNA 
binding activity.  The in vitro PGB assay used in this study is an optimised version of an 
assay previously used to investigate p53 binding to various target plasmid DNAs.  In these 
previous studies, plasmid DNA was added in excess of protein and only captured DNA was 
analysed, meaning calculations of precise values for percentage DNA captured was not 
possible.  However, during this study, protein was added in excess of DNA so that saturation 
of protein was prevented and all DNA could be precipitated.  Consequently, direct 
comparison of both un-captured and captured plasmid DNA could be used to calculate 
percentages of DNA precipitated.  As described, KCl concentrations were also altered 
appropriately to reflect more realistic cellular conditions. 
 
4.4.1 Exploring the Rapid Degradation Properties of ScKu Proteins. 
 
Prior to PGB DNA binding assays, it was discovered that in the presence of plasmid DNA, 
ScKu proteins appeared to vanish following SDS-PAGE and western blot analysis.  
Subsequent analysis by Coomassie staining identified that this disappearance was a direct 
result of rapid degradation of ScKu proteins by an unknown component of the plasmid 
preparation (Figure 4.8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.8 SDS-PAGE and Coomassie staining analysis of ScKu and BSA protein 
degradation following pET28 and pUC18 exposure.  Plasmid sample (1 µl of 100 ng / µl) 
was added to 60 pmol of ScKu or BSA in a final volume of 30 µl and incubated for up to 40 
minutes.  Proteins were analysed by SDS-PAGE using 10% polyacrylamide gels.  A.  ScKu1 
degradation following pET28 exposure.  B.  ScKu3 degradation following pET28 exposure.  
C.  BSA degradation following pET28 exposure.  D.  ScKu3 and BSA degradation following 
pET28, pET28 post clean-up (PCU) or pUC18 incubation for 40 minutes. 
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As Figure 4.8 shows, both ScKu1 and ScKu3 were degraded considerably faster than BSA 
when exposed to plasmid, suggesting a component of the plasmid sample was responsible for 
the disappearance of ScKu during plasmid competition assays.  It can be seen that after 5 
minutes, both ScKu1 and ScKu3 show visible signs of degradation and the formation of 
smaller products as regular bands of lower molecular weight.  Although ScKu2 demonstrated 
higher degradation than BSA, it was found to be more stable then ScKu1 and ScKu3 
following plasmid exposure (data not shown).  The degradation may have resulted from 
protease activity to which the ScKu proteins appeared highly susceptible.  To ascertain if 
ScKu degradation could be prevented, plasmid preparations were purified further (Section 
2.2.4) and added to ScKu samples to identify if the source of degradation had been removed 
(Figure 4.8 D).  It was found purification of plasmid preparations was sufficient to prevent 
ScKu degradation and that protease activity was likely to have caused the observed 
fragmentation.  In separate experiments, degradation of a polyhistidine tagged recombinant 
MtrA protein was also investigated, however no protein reduction was observed (Appendix 
III), further indicating ScKu are unusually prone to degradation.  Potentially, the rapid 
fragmentation of ScKu proteins detected may be crucial in the removal of ScKu from DNA 
following NHEJ.  Whereas most components of the NHEJ apparatus can disassemble from 
ligated DNA and leave via passive diffusion, the Ku dimer is thought to be left encircling the 
DNA and might require proteolytic cleavage for removal (Schar et al., 1997; Walker et al., 
2001).  If ScKu are indeed highly susceptible to protease activity as implied from these 
results, the removal from DNA by proteolytic cleavage may now have additional foundation. 
 
4.4.2 ScKu-Plasmid and Oligonucleotide DNA Interactions. 
 
Preliminary assays focused on ScKu interactions with linear and supercoiled pUC18 at 
varying KCl concentrations.  Results from SMB assays reiterated the important role that ionic 
strength plays during protein-DNA interactions and so it was important to establish how KCl 
concentration affected interactions in the PGB assay.  The plasmid pUC18 was digested with 
appropriate restriction enzymes to create linear DNA with blunt-ends or 5’ linear overhang-
ends, or left undigested as a supercoiled molecule. These 3 species of pUC18 were then used 
as ScKu1, ScKu2 and ScKu3 DNA binding substrates during PGB assays.  Plasmid DNA that 
was captured by protein and subsequently immunoprecipitated was subject to electrophoretic 
analysis alongside DNA that was not immunoprecipitated (Figure 4.9), allowing for 
determination of the percentage of DNA bound to the Ku protein present.  To obtain precise 
values for the amounts of DNA captured or not captured, the ImageJ software was used to 
measure band intensities (Figure 4.10).  Typically, 400 ng of Ku protein and 250 ng of 
plasmid DNA were analysed during each assay. 
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Figure 4.9 Electrophoretic analysis of unbound and bound plasmid DNA following an in 
vitro PGB assay investigating ScKu-DNA interactions.  In each experiment 400 ng of 
relevant ScKu protein was used to capture 250 ng of either linear pUC18 with overhangs (L 
(Oh)), linear pUC18 with blunt ends (L (B)) or supercoiled pUC18 (S) with varying [KCl]. 
Bound and unbound DNA was identified after electrophoresis on 0.8% agarose.  A.  Plasmid 
DNA from ScKu1 PGB assays.  B.  Plasmid DNA from ScKu2 PGB assays.  C.  Plasmid 
DNA from ScKu3 PGB assays. 
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Figure 4.10 Calculated values of plasmid DNA collected from PGB assays described in 
Figure 4.9.  Band intensities following electrophoretic analysis were measured using ImageJ 
software.  Averages were taken from 3 experiments.  Standard errors are shown.  
 
 
The results obtained from ScKu-plasmid interactions again identified variation in activity 
between the 3 Ku proteins.  Generally, binding to plasmid DNA was very high, even when the 
concentration of KCl was increased to 250 mM (a concentration of monovalent cations 
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greater than natural cellular conditions).  ScKu1 and ScKu3 had higher DNA binding activity 
than ScKu2, which was unexpected as ScKu3 had previously shown relatively low DNA 
binding activity when oligonucleotides were used as substrates, and ScKu2 had been 
previously shown to bind with high affinity towards dsDNA.  It is possible that ScKu3 may 
show significantly greater DNA binding activity towards plasmid DNA over oligonucleotides 
and that it may only interact with larger DNA molecules.  As previous studies found Ku only 
required 14-18 base pairs for DNA binding to occur (Falzon et al., 1993), the differences 
observed may be dependent upon alternative factors such as experimental conditions. 
 
As expected, it can be seen that increases in KCl concentration directly influenced DNA 
binding of all 3 ScKu.  As non-specific protein-DNA interactions are less favourable at higher 
ionic strength, only specific interactions remain.  This effect is apparent for ScKu binding to 
all plasmid DNAs as, when KCl is increased, binding becomes reduced; however, for specific 
interactions this reduction is significantly less.  Consequently, it is apparent that both ScKu1 
and ScKu3 show a preference towards linear DNA with overhangs compared to linear DNA 
with blunt-ends, as at 250 mM KCl, binding to blunt-ends is reduced compared to overhang-
end binding (ScKu1 - t =  10.2 (p < 0.05), ScKu3 - t = 3.1 (p < 0.05)).  This preference is not 
apparent with ScKu2, indicating the nature of the DNA termini do not influence ScKu2 DNA 
interactions. 
 
Interestingly, all 3 ScKu proteins demonstrated the ability to interact with supercoiled 
plasmid, a characteristic previously not associated with eukaryotic or prokaryotic Ku (Dynan 
and Yoo, 1998; Weller et al., 2002).  At 50 mM KCl, ScKu1 binds to supercoiled DNA 
significantly less than linear DNA with blunt-ends (t = 4.7 (p < 0.05)) but at 250 mM KCl this 
difference is no longer apparent.  However, binding to overhang linear DNA remains 
significantly higher than supercoiled binding at 250 mM KCl (t = 12.4 (p < 0.05)).  These 
results imply ScKu1 binds most efficiently to linear DNA (with a preference towards linear 
DNA with overhang-ends), but can also interact to a lesser extent with supercoiled DNA.  
ScKu3 demonstrates alternate characteristics as there is no significant difference between 
binding to linear or supercoiled DNA at 50 mM KCl (t = 1.9 (p > 0.05) (comparing blunt-end 
linear and supercoiled DNA binding)) and, surprisingly, ScKu3 binds preferentially to 
supercoiled DNA over blunt-end DNA at 250 mM KCl (t = 3.6 (p < 0.05)), indicating that 
ScKu3 preferentially binds to linear DNA with overhang-ends and least favourably to linear 
DNA with blunt-ends.  In contrast, ScKu2 does not appear to have any considerable 
preference towards the different plasmid molecules though measurable differences are 
evident. 
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It is generally accepted that initial binding of Ku molecules to DNA occurs via free DNA 
termini and so interactions with closed-circular molecules is thought to be minimal.  The 
results in Figure 4.10 indicate all ScKu proteins are able to interact reasonably tightly with 
supercoiled DNA as, even at 250 mM KCl, in some instances binding was as high as 
approximately 60%.  These results were unexpected as supercoiled DNA would not have 
available free-ends to thread through the Ku dimer molecule and so ScKu may have an 
alternative mode of interacting with DNA.   
 
The in vitro PGB DNA binding assay had been used to successfully detect ScKu-DNA 
interactions and identified that the 3 ScKu proteins had varied DNA binding activity.  The in 
vitro SMB DNA binding assay had also detected varied activity between these proteins and so 
it was of interest to see if both assays would reveal comparative results if the same DNA 
molecules were used as binding substrates.  It was not possible to use plasmid DNA during 
the SMB assay as no biotinylated plasmid was available. However, due to the flexibility of 
the PGB assay, oligonucleotides could be used instead of plasmid molecules.  To this effect, 
assays were performed using identical amounts of ScKu and oligonucleotide DNA as 
described in SMB assays.  Samples of bound and unbound oligonucleotide DNA following 
individual assays were analysed by native electrophoresis, membrane transfer and subsequent 
chemiluminescent detection of biotinylated tags.  It was discovered during initial assays that 
Ku binding to oligonucleotides was not as efficient as plasmid DNA, since analysis of bound 
and unbound oligonucleotides revealed significantly more unbound DNA in relation to bound 
DNA.  Consequently, it was not possible to analyse both bound and unbound DNA 
simultaneously due to the differences in intensity following chemiluminescent detection.  
Therefore, only oligonucleotides precipitated during PGB assays were subjected to analysis. 
 
 
 
Figure 4.11 Electrophoretic analysis and chemiluminescent detection of precipitated 
oligonucleotide DNA following in vitro PGB assays investigating ScKu-DNA 
interactions.  Electrophoresis was performed at 50 V using 12% native polyacrylamide gels. 
Markers relating to dsDNA and ssDNA are shown.  A.  Initial assay using identical 
oligonucleotide substrates used during SMB assays (dsDNA produced with excess 
unbiotinylated ssDNA).  B.  Example of a PGB assay investigating ScKu binding to dsDNA 
(produced with equal amounts of biotinylated and unbiotinylated ssDNA) and ssDNA. 
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As shown in Figure 4. 12 A, it was apparent that there were considerable inconsistencies 
between both in vitro assays.  Results from SMB assays identified that ScKu1 bound to 
dsDNA and ssDNA with similar affinity, ScKu2 had significantly higher affinity towards 
dsDNA over ssDNA and ScKu3 demonstrated relatively low DNA binding activity to any 
oligonucleotide (Figure 4.4).  In contrast, only the ScKu2 data from PGB assays was 
consistent with SMB assay data. The apparent findings that ScKu1 bound weakly to dsDNA 
and that ScKu3 could interact with ssDNA contradicted the SMB findings.  It was realised 
that a significant difference between the 2 assays was that unbiotinylated oligonucleotides 
that were removed during SMB experiments would still be present in PGB assays.  During 
production of dsDNA oligonucleotide substrates (Section 2.3.1), to ensure all biotinylated 
ssDNA were incorporated into dsDNA molecules, unbiotinylated ssDNA were added in 
excess.  These are removed during SMB wash steps but would remain present during PGB 
assays.  Therefore, it was anticipated that ScKu1 binding to dsDNA was relatively weak 
compared to ssDNA in PGB assays because excess amounts of unbiotinylated ssDNA were 
also present in the reaction and these would compete for ScKu1 molecules.  It was also 
thought that ScKu2 was not affected by the excess ssDNA because ScKu2-ssDNA binding 
had previously been detected as relatively low.  To test this, dsDNA were produced at a ratio 
of 1:1 (biotinylated: unbiotinylated) in order to reduce ssDNA molecules and assays were 
repeated.  As shown in Figure 4.11 B, considerably more dsDNA was precipitated by ScKu1 
than previously detected suggesting that, as predicted, the excess contaminating ssDNA was 
directly competing for ScKu1.  ScKu2 DNA binding activity remained constant as relatively 
more dsDNA was precipitated compared to ssDNA.  Again ScKu3 appeared to bind to 
ssDNA, which was previously not detected during the SMB assay.  Apart from the apparent 
ability of ScKu3 to interact with ssDNA, the results from PGB assays investigating ScKu 
binding to oligonucleotide DNA demonstrated high agreement with SMB assay results. 
 
4.4.3 The Temperature Sensitive DNA Binding Activity of MtKu. 
 
The unexpected finding that ScKu proteins bound efficiently to closed supercoiled DNA lead 
to speculation about whether MtKu would bind to similar DNAs.  MtKu DNA binding 
activity has previously been characterised and it was identified that it bound tightly to dsDNA 
but not to ssDNA or closed-circular DNA (Weller et al., 2002).  Initial PGB assays were 
performed to investigate binding to linear pUC18 containing blunt or overhang ends under 
identical conditions to ScKu assays.  The results indicated that MtKu binding was 
considerably lower than ScKu as less than 10% of linear plasmid DNA was precipitated.  As 
MtKu had previously demonstrated DNA binding activity during in vitro SMB assays, it was 
expected MtKu would interact with linear pUC18 and so variations in assay conditions were 
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thought to account for the lack of activity.  One considerable difference between the assays 
was temperature: whereas SMB assays were performed at 30 °C, due to the longer incubation 
periods and to help maintain assay component stability, PGB assays were performed at 4 °C.  
To determine the temperature-dependence of MtKu, PGB assays were performed at 
temperatures between 4 – 40 °C (Figure 4.12 A). 
 
 
 
Figure 4.12 Using the PGB DNA binding assay to determine MtKu-DNA interactions.  
Data was collected from 3 in vitro PGB assays that were investigating MtKu binding to linear 
and supercoiled pUC18 DNAs at varying temperatures and at 50 mM KCl.  Band intensities 
regarding non-precipitated and precipitated DNA following electrophoretic analysis were 
measured using the computer software ImageJ and percentage bound values were calculated.  
Standard errors are shown.  A.  MtKu binding to linear pUC18 containing blunt or overhang 
ends at various temperatures.  B.  MtKu binding to linear and supercoiled pUC18 at 16 °C and 
25 °C. 
 
 
The results in Figure 4.12 A show that MtKu DNA binding activity is heavily dependent upon 
temperature and that DNA-binding was most efficient at approximately 25 °C.  At 
temperatures less than 16 °C and more than 40 °C binding was considerably lower, indicating 
that, MtKu has a narrower temperature range at which it is active then apparent with ScKu 
proteins.  Temperature can affect protein structure and flexibility by inducing changes in bond 
energies, and proteins are generally more flexible at higher temperatures.  This increased 
flexibility may be crucial in facilitating contact between MtKu and DNA and that this is not 
possible at lower temperatures where the protein may be more rigid and less conformationally 
favourable.   
 
It was also of interest to determine if MtKu could bind to closed DNA molecules, and so 
investigations were performed at optimum temperatures to assess this activity.  As Figure 
4.12 B shows, binding to supercoiled pUC18 was significantly less than binding to linear 
DNA with the lowest percentage binding (blunt-end linear) (16 °C – t = 5.3 (p < 0.05), 25 °C 
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– t = 17.6 (p < 0.05)).  In contrast to ScKu, MtKu binding to supercoiled pUC18 was very 
low, and binding to plasmid DNA in general was also lower as reductions in ionic strength 
were required for interactions to occur.  These results are consistent with previous MtKu 
studies (Weller et al., 2002) and, therefore, suggest that considerable differences exist 
regarding DNA binding activities between MtKu and ScKu proteins. 
 
4.4.4 Prokaryotic Ku Interactions with Relaxed Circular DNA. 
 
Unlike MtKu, ScKu proteins had been found to interact efficiently with closed supercoiled 
DNA molecules, however it was not clear which features of the DNA allowed this interaction 
to occur.  As supercoiled DNA frequently contains regions of secondary structures, including 
hairpins, it was postulated these unusual features may govern the observed interactions.  
Therefore, it was of interest to discover if ScKu could still interact with circular DNA 
molecules that contained far fewer secondary structures.  The restriction enzyme BbvC1 
cleaves the asymmetric DNA sequence 5’-CC↓TCAGG-3’ / 5’-GC↓TGAGG-3’ as indicated 
by the arrows.  Unlike many Type II restriction enzymes, BbvC1 consists of 2 different 
subunits that contain catalytic sites for DNA strand hydrolysis that act independently and 
strand-specifically.  BbvC1 mutants deficient in 1 subunit exist that cleave only 1 strand of 
the recognition sequence (Bellamy et al., 2005; Heiter et al., 2005) and, therefore, can nick 
substrate supercoiled dsDNA to produce relaxed-circular molecules.  Plasmid pL1, a 
derivative of pUC19 (Gowers et al., 2005), was available that contained the BbvC1 
recognition site.  This plasmid was subjected to mutant BbvC1 (New England BioLabs) 
digestion to produce the desired relaxed-circular DNAs that were then used as DNA binding 
substrates for prokaryotic Ku during PGB assays (Figure 4.13). 
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Figure 4.13 Calculated percentages of relaxed-circular plasmid DNA precipitated by 
prokaryotic Ku proteins during in vitro PGB assays.  ScKu assays were performed at 200 
mM KCl, MtKu assays were performed at 50 mM KCl.  Band intensities regarding non-
precipitated and precipitated DNA following electrophoretic analysis were measured using 
the computer software ImageJ and percentage bound values were calculated.  Averages were 
taken from at least 3 experiments.  Standard errors are shown. 
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Results from investigations into prokaryotic Ku binding to relaxed-circular DNA 
demonstrated high similarities with Ku binding to supercoiled DNA as both ScKu1 and 
ScKu3 bound tightly to the DNA, whereas ScKu2 and MtKu bound relatively poorly.  As 
both ScKu1 and ScKu3 could interact with circular DNA lacking secondary features, the 
binding observed during supercoiled substrate assays may not have been dependent upon 
unusual structures in the DNA.  As mentioned, Ku has previously been shown to have high 
affinity towards circular DNA containing nicks (Blier et al., 1993) and so this feature of Ku 
may be responsible for the observed binding to relaxed-circular DNA that did contain internal 
nicks.  Whether ScKu1 and ScKu3 binding to supercoiled DNA was affected by secondary 
structures, or if the mode of binding was identical to interactions with relaxed-closed DNA, it 
is apparent these Ku do not require free DNA ends.  Therefore it is of considerable interest to 
identify how Ku can bind to DNA ends are not available.  If alternative models exist for Ku 
binding, it is feasible that ScKu2 and MtKu may lack this activity and so precipitated less 
closed DNAs during the PGB assays. 
 
4.5 The Prokaryotic Ku Influence on in vitro Ligation. 
 
The recognition and recruitment activities of prokaryotic Ku are accepted to be integral to the 
NHEJ process during repair of DSBs, however a direct role in the facilitation of ligation 
remains unclear.  Although Ku may be required to promote location of an appropriate DNA 
ligase to DSBs, there have been conflicting reports regarding formation of the synapsis 
between DNA termini prior to ligation (Cary et al., 1997; Ramsden and Gellert, 1998).  In 
eukaryotic NHEJ, it is hypothesised that DNA termini synapsis is regulated by both Ku70/80 
and DNA-PKcs, but, as prokaryotes lack the DNA-PKcs, a synapse must be formed 
independently of this protein.  As described in Section 4.3.2, competition in vitro SMB DNA 
binding assays investigating DNA binding indicated ScKu was able to interact simultaneously 
with free DNA molecules and DNA molecules attached to SMBs.  To investigate further if 
prokaryotic Ku can facilitate ligation either by aligning DNA termini or by an alternative 
manner, the joining of DNA ends by T4 DNA ligase was analysed with or without the 
inclusion of prokaryotic Ku during ligation reactions.  This DNA ligase was chosen as it was 
not expected to promote any specific protein-protein interactions with the Ku proteins of 
interest. 
 
4.5.1 T4 DNA Ligase Ligation. 
 
Prior to exploring the effect of the inclusion of Ku proteins during ligation reactions, it was 
necessary to appreciate T4 DNA ligase activity independent of Ku.  Initially, pUC18 plasmids 
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were prepared and subjected to restriction digestion to produce linear DNA molecules 
containing either overhang-ends (digested with EcoR1) or blunt-ends (digested with Sma1).  
T4 DNA ligase activity is known to be strongly affected by the DNA substrate and ligation of 
DNA termini with overhang-ends is considerably more efficient than ligation of linear DNA 
with blunt-ends (Tait et al., 1980). 
 
Ligation of linear plasmids can result in closed-circular DNA (ccDNA) that exhibit migration 
characteristics that are highly dependent on the presence of intercalators such as ethidium 
bromide (EtdBr) (Bowater, 2005).  One molecule of EtdBr can insert between 2 base pairs of 
a dsDNA helix and increase the distance between these bases, causing local unwinding of the 
helix and an increase in writhe.  This means that molecules that are initially negatively 
supercoiled become increasingly relaxed and eventually positively supercoiled in the presence 
of EtdBr.  For relaxed ccDNA, the increase in writhe induces positive supercoiling and this 
causes these DNAs to migrate further during electrophoresis than linear DNAs of equal size.  
This occurs as linear molecules have no writhe and so the intercalation of EtdBr has relatively 
little effect on their migration during gel electrophoresis. Therefore, during gel 
electrophoresis in the presence of EtdBr, ligated pUC18 that is converted into closed circles 
will migrate further than linear pUC18 (Figure 4.14). 
 
 
Figure 4.14 Ligation of linear pUC18 with overhang or blunt-ends by T4 DNA ligase.  
Ligation of 200 ng of linear DNA was performed at either 4 °C or 25 °C for varying lengths 
of time (shown in minutes) depending on the rate of reaction.  Ligation products were 
analysed by electrophoresis on 0.8% agarose gels that contained EtdBr.   A.  Ligation of 
linear pUC18 with overhang-ends (created by EcoR1 digestion).  B. Ligation of linear pUC18 
with blunt-ends (created by Sma1 digestion). 
 
 
As predicted, ligation of linear DNA with overhang-ends was significantly faster then blunt-
end DNA.  As shown in Figure 4.14 A at 4 °C after 20 minutes, almost all linear pUC18 had 
been ligated into covalently closed relaxed DNA, as indicated by bands exhibiting highest 
electrophoretic motility.  In contrast, ligation of blunt-end pUC18 (Figure 4.14 B) was 
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considerably slower and, even at a higher temperature of 25 °C, less ligated product was 
formed after 6 hours than ligation of over-hang ends after only 20 minutes.  Interestingly, 
blunt-end pUC18 appeared more susceptible to forming multimer complexes as indicated by 
bands at approximately 5.4 kbp (dimers) and 8 kbp (trimers) alongside covalently closed 
relaxed DNA. 
 
4.5.2 Determining How Prokaryotic Ku Influence Ligation by T4 DNA Ligase. 
 
It was of interest to investigate the effect ScKu and MtKu proteins might have upon T4 DNA 
ligation of both blunt and overhang ended linear pUC18.  It was anticipated that the presence 
of Ku on DNA termini may influence the rate of ligation, either positively by assisting the 
alignment of DNA termini, or negatively by preventing efficient T4 DNA ligase activity. 
Initially, reactions were performed on blunt-end pUC18 with or without various amounts of 
prokaryotic Ku or BSA.  It was discovered that without Ku, ligation by T4 DNA ligase was 
identical to that shown in Figure 4.14 B, however the addition of ScKu1 or ScKu2 showed 
dramatic differences as ligation products could not be seen and a large proportion of pUC18 
remained trapped in the gel wells (data not shown).  The inclusion of ScKu3 also 
demonstrated differences as several other DNA species were detected that had significantly 
higher molecular weights than 6 kbp.  In contrast, MtKu failed to produce any ligated product 
(as previously found (Weller et al., 2002)) or cause DNA to remain in wells.  The amount of 
linear pUC18 present in these reactions did appear to decrease over time to an extent, 
however this may result from other factors including contaminating DNase proteins.  BSA 
was investigated as a control to identify if differences detected with Ku proteins were 
dependent on molecular crowding.  As results from reactions including BSA were identical to 
reactions without any additional proteins, it was accepted that the results observed with Ku 
present were indeed dependent on Ku activity.   
 
Additional experiments found pUC18 remaining in the wells was actually caused by bound 
protein that could be removed by treating samples with 1% SDS and heating at 65 °C that 
released DNA (data not shown).  Hence, all subsequent assays investigating the effect of 
prokaryotic Ku on T4 DNA ligase activity were performed with this additional step.  
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Figure 4.15 Ligation of blunt-end and overhang-end linear pUC18 by T4 DNA ligase 
with the inclusion of various amounts of prokaryotic Ku or BSA.  Ligation of 200 ng of 
linear DNA was performed at 4 °C  (over-hang) or 25 °C (blunt) for varying lengths of time 
(shown in minutes) and containing amounts of protein ranging from 0.05 - 2.5 µg in every 20 
µl reaction.  Ligations were stopped by the addition of appropriate amounts of 6 x native 
loading buffer and stored at 4 °C.   DNA was analysed on 0.8% agarose gels containing 
EtdBr.  A1 – Effect of BSA on blunt-end ligation.  A2 – Effect of BSA on overhang-end 
ligation.  B1 – Effect of ScKu1 on blunt-end ligation.  B2 – Effect of ScKu1 on overhang-end 
ligation.  C1 – Effect of ScKu2 on blunt-end ligation.  C2 – Effect of ScKu2 on overhang-end 
ligation.  D1 – Effect of ScKu3 on blunt-end ligation.  D2 – Effect of ScKu3 on overhang-end 
ligation.  E1 – Effect of MtKu on blunt-end ligation.  E2 – Effect of MtKu on overhang-end 
ligation. 
 
 
As evident in Figure 4.15, ligation by T4 DNA ligase in the presence of prokaryotic Ku 
proteins was greatly affected and in most assays, Ku appeared to completely inhibit ligation 
or induce the formation of multimer DNAs.  When compared to Figure 4.14 where ligation 
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reactions were performed without additional proteins, it is apparent that ScKu1 prevents 
circularisation of overhang-linear DNA and completely prevents ligation of blunt-end DNA.  
It is noticeable in Figure 4.15 B1 that multimers of pUC18 can still be formed when high 
amounts of ScKu1 are present, even though circularisation is prevented, suggesting ScKu1 
may facilitate joining of separate individual DNAs over joining of the same DNA.  ScKu2 
also appeared to influence ligation as although circularisation of overhang-end DNA was still 
occurring, DNA molecules of very high molecular weights were apparent when 2.5 µg of 
ScKu2 was present.  It is likely these bands represent species consisting of multiple pUC18 
molecules that have been ligated together to form large multimers.  ScKu2 did negatively 
affect ligation of blunt-end pUC18 as very little ligatable product was detected.  The inclusion 
of ScKu3 displayed variations on activity seen by ScKu1 and ScKu2 as circularisation was 
strongly inhibited when present for both pUC18 molecules, however, the facilitation of 
multimer formation of blunt-end pUC18 was evident by bands with molecular weights above 
4 kbp (Figure 4.15 D2) that become more apparent as the amount of ScKu3 increases.  It is 
also noticeable that, as time progresses, the sizes of the multimers also increases, strongly 
indicating that the T4 DNA ligase is joining together DNA termini of different pUC18 
plasmids, rather than forming ccDNA as shown when no Ku proteins are present.  Figure 4.15 
E1 and E2 show that the introduction of MtKu prevents formation of any ligated product, 
showing that the inhibitory effect exhibited by ScKu proteins is not unique to S. coelicolor Ku 
proteins.  To confirm the observed findings were a direct result of Ku activity and not a 
consequence of unspecific protein affecting reactions, for example by molecular crowding, 
BSA was also investigated.  The results in Figure 4.15 A1 and A2 were almost identical to 
assays that did not include additional proteins and none of the effects identified in the 
presence of Ku were observed.  This implies the circularisation inhibition activity is Ku-
dependent and may occur because Ku situated on the DNA ends is preventing T4 DNA ligase 
access to DNA termini. 
 
4.6 Discussion. 
 
Eukaryotic NHEJ and its components have been extensively investigated (Critchlow and 
Jackson, 1998; Weterings and Chen, 2008). The identification of NHEJ protein homologues 
in prokaryotes reversed general opinion that this process was restricted to eukaryotes.  
Although investigations into prokaryotic NHEJ have suggested that this pathway is a two-
component system comprising of a homodimeric Ku and a multi-functional ligase (Della et 
al., 2004), in silico studies on the prokaryotic S. coelicolor genome revealed the existence of 3 
separate genes homologous to eukaryotic Ku70/80 and also other genes homologous to 
proteins implicated in eukaryotic NHEJ (Sayer, 2008).  These findings imply that the 
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currently accepted two-component system of prokaryotic NHEJ may not apply to all 
prokaryotic organisms.  
 
Three Ku genes from S. coelicolor and 1 Ku gene from M. tuberculosis were successfully 
over-expressed in E. coli via the pET-expression system and purified by affinity 
chromatography using the presence of polyhistidine tags present on the resultant recombinant 
proteins.  Electrophoretic analysis of purified proteins revealed that migration of all 
prokaryotic Ku proteins was considerably lower than was expected, creating a degree of 
uncertainty regarding the actual identities of the proteins.  Western blot analysis using 
antibodies specific for polyhistidine tracts confirmed that the bands observed using 
Coomassie staining were likely to be the recombinant Ku. However, to conclusively ascertain 
the identity of the recombinant proteins, ScKu1, ScKu2 and ScKu3 were subject to MALDI-
TOF peptide mass fingerprint analysis.  The results collected from this analysis confirmed 
with a high degree of confidence that the recombinant proteins were ScKu proteins derived 
from the relevant genes and that the observed reduction in electrophoretic mobility was 
caused by unknown factors.  It was postulated that higher than average isoelectric points of 
the prokaryotic Ku proteins were influencing migration by affecting the overall charge of the 
proteins, meaning that migration of Ku was not relative to the migration of proteins that 
constituted the marker. 
 
Once analysis had confirmed the relevant recombinant Ku proteins had been attained, DNA 
binding assays were performed using 2 separate in vitro DNA binding techniques that both 
encompass the precipitation of protein-DNA complexes by magnetic bead separation.  As 
both eukaryotic and prokaryotic Ku are recognised as having high binding affinity towards 
dsDNA and comparatively low affinity towards ssDNA, initial assays concentrated on 
comparing protein binding to short dsDNA and ssDNA substrates.  It was found that the 
prokaryotic Ku proteins demonstrated considerable differences in DNA binding activity 
towards both DNA substrates.  Both ScKu2 and MtKu exhibited activity that has become a 
hallmark of Ku-DNA binding, whereby binding to dsDNA is significantly higher than to 
ssDNA.  As it has previously been documented that MtKu binds preferentially to dsDNA over 
ssDNA using EMSA (Weller et al., 2002), the agreement shown during this study indicates 
the reliability and reproducibility of the SMB assay.  Interestingly, ScKu1 had alternative 
activity, and binding was consistently high to either DNA.  Due to the strength of this 
interaction even at high ionic strength, this activity is unlikely to be non-specific, and may 
indicate an alternative role for ScKu1 that other Ku are unable to perform.  ScKu3 binding to 
short oligonucleotides was comparatively lower than all other proteins studied, however 
ensuing PGB assays did detect binding to plasmid DNAs, proving that this recombinant 
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protein was able to bind to certain DNA molecules.  Potentially, ScKu3 binding is more DNA 
length dependent than other Ku and requires larger DNA molecules to initiate binding, a 
factor that is quite contradictory considering ScKu3 is the smallest prokaryotic Ku studied.  
Another cryptic finding from SMB DNA binding analysis was that ScLigD consistently 
displayed very selective DNA binding properties as binding to ssDNA was very efficient but 
binding to dsDNA was non-existent.  Previously, it has been found ScLigD can ligate 40 base 
pair dsDNA containing an internal nick (Sayer, 2008), albeit at a relatively low rate, 
indicating ScLigD can at least bind to nicked dsDNA.  To further quantify the observed 
differences in binding activity of prokaryotic Ku, affinity investigations were employed in 
order to attain apparent Kd values that would highlight the apparent disparity in DNA binding 
activity between ScKu1, ScKu2 and MtKu towards short dsDNA and ssDNA molecules.  
When single-protein binding was assumed, dissociation constant values for ScKu1 and ScKu2 
towards dsDNA were not calculable as high concentrations of protein bound even when very 
low concentrations of DNA were available.  One factor that may contribute to this observed 
activity is that multiple proteins may bind to single DNA molecules and this would contribute 
to the very high protein binding exhibited even at low concentrations of DNA.  As Figure 
4.16 shows, if 1 protein binds to 1 DNA molecule, more DNA is required to saturate the 
protein than if 2 proteins can bind to a single DNA.  This effect is again increased if a protein 
binds as a tetramer as protein will very quickly become saturated and the addition of more 
DNA becomes ineffectual. 
 
Irrespective of the difficulties in obtaining Kd values for all proteins studied, the values that 
were acquired did correlate with experiments investigating protein percentage binding to 
dsDNA and ssDNA.  The specificity in ScKu2 binding to dsDNA and ssDNA is again 
evident, however a preference towards dsDNA over ssDNA was also noticeable for ScKu1.  
This may suggest that binding activities do not differ to the extent shown during percentage 
binding experiments as both ScKu1 and ScKu2 may prefer dsDNA, however ScKu1 can bind 
with higher affinity towards ssDNA but this difference was not detected using original 
conditions.  The MtKu Kd values were higher than both ScKu proteins, which again agreed 
with percentage binding experiments that identified MtKu as having the lowest binding 
activity excluding ScKu3. 
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Figure 4.16 The effect of single-protein or multiple-protein binding to DNA.  The mode 
of protein-DNA interaction will heavily influence Kd values obtained from binding affinity 
experiments.  If 1 protein molecule binds to 1 DNA molecule, a higher amount of DNA will 
be required to saturate protein compared to a protein that can bind multiple molecules to a 
single DNA.   
 
 
Competition assays provided unexpected findings that could have considerable implications 
in the specific cellular activities of ScKu1 and ScKu2.  Initial competition assays focused on 
the ability of competing DNA molecules to remove Ku proteins that had already formed 
complexes with DNA attached to SMB (DNA-SMB).  It was ascertained that the addition of 
free DNA post Ku incubation with DNA-SMB had negligible effects, even when free DNA 
was added in excess of DNA-SMB.  It was possible that Ku could not be removed from the 
initial protein-DNA complex and so the addition of extra DNA was ineffectual.  To examine 
this possibility, free DNAs were added simultaneously to DNA-SMB and Ku proteins so that 
both free DNA and DNA-SMB had equal opportunities for Ku binding.  Again, it was 
concluded from the results that Ku was still being precipitated along with DNA-SMB, even 
when free DNAs were added 3 times in excess of DNA-SMB.  Two likely possibilities that 
could explain the observed discrimination by ScKu were that either the DNA-SMB is 
conformationally different to free DNA as a consequence of the close association with a large 
magnetic bead, or that Ku were interacting with DNA-SMB and free DNAs simultaneously, 
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and effectively precipitating complexes of SMB-DNA-Ku-free DNAs.  A modified version of 
the SMB assay that used fluorescently labelled ssDNAs as competing molecules was utilised 
to identify if free DNA was precipitated in the presence of Ku.  During this analysis, assays 
were performed as usual except that instead of quantifying protein binding by measuring 
protein in unbound or bound samples, both samples were measured for fluorescence emission 
that was dependent on whether free DNA had been precipitated or not. The results indicated 
that the inclusion of ScKu1 and, to an extent, ScKu2 did influence precipitation of free DNA.  
This was observed by both a decrease in fluorescence in ‘removed free ssDNA’ and a slight 
increase in fluorescence emission of samples containing SMB-DNA-Ku.  It was believed 
ScKu1 had a more considerable effect on the precipitation of fluorescent ssDNA as ScKu2 
has previously been found to have significantly less affinity towards this substrate, however, 
as an unbiotinylated fluorescently labelled dsDNA was not available, only ssDNA was 
investigated. 
 
The juxtaposition of 2 DNA termini is an important strep for efficient NHEJ.  Regions of 
microhomology between DNA termini may facilitate alignment to an extent, however it is 
thought specific protein activity is crucial for this process.  Independent eukaryotic NHEJ 
studies have produced conflicting reports that either suggest Ku70/80 can form a synaptic 
complex of DNAs  (Cary et al., 1997; Ramsden and Gellert, 1998) or that DNA-PKcs is 
required for this process (DeFazio et al., 2002; Lees-Miller and Meek, 2003).  Although it 
may remain unclear how end-alignment occurs in eukaryotes, end-alignment in prokaryotes 
must be DNA-PKcs independent.  The polymerase domain of M. tuberculosis LigD contains a 
functionally analogous structural element thought to facilitate connectivity between 
discontinuous DNA ends (Pitcher et al., 2007), indicating this protein may participate in 
formation of a synaptic complex, potentially alongside Ku.  The SMB competition assays and 
subsequent fluorescence analysis during this study indicates ScKu proteins may be capable of 
synapse formation in S. coelicolor.  The results from fluorescence analysis may not justify the 
competition assay results, however, there are potential reasons for this.  Unlike free DNAs 
with 2 free-ends, as fluorescent ssDNAs have a fluorophore at one end, only one end will be 
available for alignment.  Conversely, unlabelled free DNAs could potentially form long 
complexes consisting of multiple DNAs that may be precipitated (Figure 4.17 A).  As labelled 
ssDNAs can only form a synapse consisting of 2 DNAs, the opportunity for precipitation is 
significantly lower (Figure 4.17 B).  There is also the possibility of 2 fluorescently-tagged 
ssDNAs forming a complex together that would not be precipitated.  Finally, as alignment of 
dsDNAs may be more efficient than ssDNAs (especially for ScKu2), this would explain why 
less fluorescently-labelled DNA was precipitated than anticipated. 
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Figure 4.17 Analysis of synaptic-complex formation by ScKu1 and ScKu2 using a 
modified SMB DNA binding assays.  To understand if the negligible effect of adding free 
DNAs to SMB reactions was a consequence of precipitation of free DNAs by ScKu mediated 
synapse formation, fluorescently tagged free DNA precipitation was measured in the presence 
of ScKu.  A.  Graphic representation of synaptic complex formation by ScKu.  Multimers of 
DNAs are able to form as free DNAs possess 2 free-ends.  ScKu may also be able to 
dissociate from free DNAs following translocation.  B.  SMB competition assays using 
fluorescently labelled ssDNAs – only a single ssDNA can be aligned with DNA-SMB and 
dimers of 2 labelled ssDNAs may also arise if ScKu is implicated in DNA alignment. 
 
 
Although the proposed alignment activity by ScKu1 and ScKu2 is an attractive model that 
would justify how synapsis of DNA ends could occur in prokaryotic NHEJ without the 
requirement of eukaryotic DNA-PKcs, other possibilities remain that could also explain the 
conformational differences between DNA-SMB and free DNA.  The ability of Ku to 
translocate along DNA has for a long time been a recognised activity of eukaryotic Ku 
(Paillard and Strauss, 1991).  Considering prokaryotic Ku may also translocate along DNA, 
supposedly in search of threatening DSBs, it is possible ScKu proteins were binding to free 
DNAs and effectively sliding-off due to the restrictive size of these molecules.  In contrast, 
 ScKu 
 
ScKu 
A 
B 
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DNA-SMB not only has a biotin molecule at the 5’ end, but also a large magnetic bead – an 
obstacle a protein could not surpass.  Therefore, this behaviour may also have contributed to 
the apparent preference towards DNA-SMB. 
 
Prior to analysis of prokaryotic Ku binding to plasmid DNA using an alternative PGB DNA 
binding assay, it was quickly apparent that the addition of plasmid DNA was stimulating the 
rapid degradation of ScKu proteins in a protein-specific manner.  Purification of plasmid 
DNA significantly reduced ScKu degradation, indicating that a contaminating molecule such 
as a protease was responsible for the previous observations.  As a general consensus is that 
Ku would remain encircling the DNA following DSB repair and that a process such as 
proteolytic cleavage may be necessary for dissociation (Schar et al., 1997; Walker et al., 
2001), the rapid protein-specific degradation of ScKu observed in this study may be an 
example of this process.   Accordingly, the high susceptibility of Ku towards degradation 
would support the degradation-dependent dissociation model. 
 
For characterisation of prokaryotic Ku DNA-binding activity towards larger linear DNA, 
relaxed-circular DNA and supercoiled DNA, an in vitro PGB assay was utilised that, unlike 
the SMB assay, is not restricted to biotinylated substrate molecules.  Assays detecting ScKu 
binding demonstrated that ScKu were able to bind efficiently to plasmid DNA, however, 
similarly to SMB assay results, the 3 ScKu proteins revealed differential binding activity.  At 
low ionic strength, both ScKu1 and ScKu3 bound very efficiently to all plasmid molecules 
including supercoiled DNA, however ScKu2 binding was considerably lower.  As ionic 
strength was increased, more specific interactions became apparent and it was ascertained that 
ScKu1 and ScKu3 preferred linear DNA with overhang-ends over blunt-ends.  Previous 
eukaryotic Ku studies suggest that Ku binding to DNA ends is independent of the exact 
structure or sequence (Falzon et al., 1993; Paillard and Strauss, 1991), meaning there should 
be no difference between blunt or overhang-ends.  The ability for ScKu1 and ScKu3 to 
discriminate between blunt and overhang-ends is only apparent at higher KCl concentrations 
and may explain why previous investigations have not recognised this specific activity.  
Whether the preference towards linear-overhang DNA is dependent on the structure or 
differences in sequence at the DNA termini compared to linear-blunt DNA remains uncertain.   
 
Interestingly, ScKu3 demonstrated stronger interactions with supercoiled DNA over linear 
blunt-end DNA, an unusual result considering Ku do not ordinarily interact with closed- 
DNAs (Dynan and Yoo, 1998).  The absence of available DNA ends that are believed to be 
important in Ku binding indicate that Ku may be capable of interacting with DNA in an 
alternative mode other than DNA end recognition.  Potentially, Ku may directly recognise 
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secondary structures that can arise in closed DNA molecules and these structures could thread 
through a Ku dimer channel in a similar fashion to dsDNA ends.  Consistent with this  idea, 
previous studies also identified Ku could interact in vitro with DNA independent of the 
availability of DNA ends and found certain structural features, including hairpins could 
induce Ku binding to the same extent as dsDNA with free ends (Paillard and Strauss, 1991).  
Studies have also shown that Ku can interact with circular molecules containing an internal 
nick (Blier et al., 1993) with identical affinity to dsDNA with free DNA ends, and also to 
relaxed ccDNA (but with lower affinity).  It would not be possible for Ku to bind to these 
circular DNA molecules in the currently accepted model as there is no available DNA end or 
hairpin-structures to thread through the central Ku channel.  Therefore, it is possible that Ku 
may exhibit multiple modes of DNA binding, such as dimerisation following interaction with 
DNA to allow binding to closed molecules and that this alternate mode of binding was 
required for the observed interactions with supercoiled pUC18 during the PGB assay. 
 
To discover if the observed binding to ccDNA was dependent on secondary structures, or if 
ScKu could still interact with circular DNA exhibiting reduced secondary features, relaxed-
circular DNAs were produced by restriction enzyme digestion resulting in a single nick that 
releases the stored energy of the supercoiled molecule.  The data from PGB assays using 
relaxed-circular DNA as prokaryotic Ku substrate found almost identical results as for 
supercoiled DNA, indicating that secondary structures may not have been the only 
determinant for Ku-supercoiled DNA binding.  As an internal nick in circular-DNA has 
previously been shown to initiate eukaryotic Ku binding (Blier et al., 1993), this feature may 
have influenced the observations during this experiment, however, it still remains unknown 
how Ku can bind to such DNAs if no free end or unusual structure is present. 
 
An unexpected observation was that ScKu2 consistently exhibited the least plasmid-DNA 
binding activity out of the 3 ScKu proteins, and ScKu3 (which had shown relatively low 
activity during SMB assays) actually bound efficiently to several plasmid DNAs.  Due to the 
flexibility of the PGB assay, identical substrates used during SMB assays could be used as 
substrates instead of plasmid DNA.  This provided an opportunity to assess agreement 
between both assays and it was determined that there was very high correlation between 
results, except that ScKu3 appeared to precipitate more ssDNA than previously detected 
during SMB analysis.  The comparatively low ScKu2 binding towards plasmid DNA was not 
anticipated, however potential interference from factors present in the PGB assay, such as 
antibodies, could affect protein activity.  Conversely, these factors may actually enhance 
ScKu3 activity and, thereby, increase DNA binding. 
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The PGB assay had successfully detected ScKu binding to both plasmid and oligonucleotide 
substrate and it was of interest to elucidate if MtKu had comparable activity.  Under identical 
conditions to ScKu assays, MtKu bound very poorly to any substrate DNA, however, when 
temperature was increased, MtKu binding significantly improved from less than 10% to 
approximately 90% bound to linear overhang DNA.  It was recognised that in comparison to 
ScKu that demonstrated activity over a wide temperature-range, MtKu is only efficient at 
higher temperatures.  These findings suggest that the MtKu protein is better adapted to the 
typical conditions that M. tuberculosis would be expected to survive than at lower 
temperatures.  Though the results suggested that the optimum temperature for activity was 
around 25 °C and not the anticipated 37 °C, other factors would need to be considered that 
would affect activity such as stabilising components that would be absent during in vitro 
assays.  Interestingly, the results also revealed that, similarly to ScKu, MtKu showed a 
preference towards overhang-ends compared to blunt-ends at all temperatures investigated.  
Although previous studies have found Ku binds to DNA ends independent of sequence or 
conformation (Falzon et al., 1993), the data from this study suggests prokaryotic Ku have a 
preference towards ends with overhangs, though this difference may not be detectable in less 
sensitive assays.  Although MtKu demonstrated the apparent preference towards linear DNA 
with overhang-ends as identified with ScKu1 and ScKu3, binding to supercoiled DNA was 
significantly lower and, therefore, exhibits the currently accepted view regarding Ku DNA 
binding activity. 
 
The recruitment of a multifunctional DNA ligase during prokaryotic NHEJ is currently 
accepted to be an important function of Ku.  Accordingly, it was speculated that Ku may 
influence ligation reactions either by direct interactions with a DNA ligase protein, or by 
modulating the DNA into a more favourable substrate.  Assays were developed that 
monitored T4 DNA ligase joining of linear plasmid DNA with or without prokaryotic Ku or 
BSA proteins included in reactions.  Initial observations of T4 DNA ligase activity illustrated 
that ligation of overhang-end DNA was considerably more efficient than blunt-end ligation.  
Blunt DNA also appeared to be more prone to forming multimer molecules alongside 
circularisation.  Data from assays that included prokaryotic Ku revealed that, in most 
instances, ligation of both types of linear DNA was completely inhibited when high amounts 
of Ku were present.  This inhibitory effect may in part result from the presence of Ku proteins 
located on DNA termini that directly obstruct ligation, meaning that even if prokaryotic Ku 
are able to translocate along DNA, some protein also remains at the ends of the DNA 
molecule, presumably to interact with other NHEJ components.  It was also apparent that 
although Ku were preventing circularisation of plasmid DNA, the formation of multimeric 
DNA was evident, particularly with ScKu3.  This activity has been previously documented 
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(Paillard and Strauss, 1991) with eukaryotic Ku and this occurrence was proposed to arise 
following rigidification of DNA by the presence of several internally bound Ku that inhibit 
circularisation by reducing flexibility.   
 
Similar findings were also observed in 2 earlier independent studies investigating how Ku 
affects T4 DNA ligase ligation.  In one study it was found that human Ku was highly 
effective in inhibiting the conversion of linear-blunt end DNA into covalently closed 
molecules following T4 DNA ligase incubation, also leading to the conclusion that Ku 
situated on the DNA termini interfered with the function of the ligase (Blier et al., 1993).  In a 
separate study  investigating the effect that Ku from monkey CV1 cells has on T4 DNA ligase 
activity, it was found that circularisation of plasmid DNA was prevented when Ku was 
present and that the formation of linear oligomers was favoured over circularisation (Paillard 
and Strauss, 1991).  It was suggested that Ku proteins were binding to plasmid DNA, and 
subsequent translocation along DNA allowed multiple Ku molecules to bind and effectively 
make the DNA more rigid, thereby preventing circularisation. 
 
Results from this study appear to show high correlations with previous studies as prokaryotic 
Ku considerably reduced T4 DNA ligase ligation.  Although the formation of circular DNAs 
was almost completely abolished when high amounts of Ku were present, in some instances it 
was apparent that multimer formation was still possible.  This was most noticeable with 
ScKu3 and blunt-end pUC18, however it is unclear why ScKu3 would be most efficient at 
promoting multimer formation.  Potentially, as this protein is the smallest of the prokaryotic 
Ku studied, it may obstruct T4 DNA ligase access to a lesser extent.  The ability of 
prokaryotic Ku to protect DNA ends from degradation has recently been documented (Zhu 
and Shuman, 2009).  It was proposed that although some Ku molecules translocate inwards 
from the DNA termini, the Ku protein that remain at the DSB ends prevent exonuclease 
mediated digestion of the DNA.  It is very possible the ligation inhibition identified in this 
study is related to this end-protection activity and that Ku located at DNA ends are indeed 
preventing T4 DNA ligase access. 
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CHAPTER 5 
 
Macromolecular Interactions Involving ScKu 
Proteins 
 
 
 
 
In vitro protein analysis of ScKu proteins implied that although all 3 display DNA binding 
activity that is largely characteristic of Ku proteins, clear disparity existed in their behaviour.  
There is little doubt that in vitro experiments can be hugely beneficial in the characterisation 
of protein function, however the ability to correlate in vitro data with information attained 
during in vivo analysis greatly enhances relevance to cellular function.  Accordingly, it was 
decided to augment data collected from in vitro assays with experiments that explored ScKu 
activity directly from S. coelicolor.  It was proposed that the cloning of recombinant 
polyhistidine-tagged scku into wild-type and knockout strains of S. coelicolor would be 
advantageous for the analysis of in vivo expression, complementation and macromolecular 
interactions.  The production of antibodies specific for individual ScKu was also thought be 
beneficial for identification of similar in vivo characteristics but would also provide the 
opportunity for in vitro co-immunoprecipitation (Co-IP) assays. 
 
Although recombinant versions of scku1 and scku2 genes had already been produced, to be 
sure that regulation of expression was similar to in vivo expression, promoter regions that 
controlled the expression of both genes were also required.  It was hoped that these regions 
would be situated within 200 base pairs of the start of the gene and therefore, these regions 
would also be included in the final gene products.  Gene constructs would also contain C-
terminal polyhistidine tags that although not essential, would aid additional experiments.  
Resultant gene products were to be cloned into selected phage-derived vectors that integrate 
at specific locations in the S. coelicolor chromosome. 
 
Finally, in vitro analysis of macromolecular interactions involving ScKu were performed.  
The high-specificity of the anti-ScKu immunoglobulins meant that Co-IP assays could be 
developed to ascertain if ScKu proteins function independently, or if interactions between 
different ScKu proteins could be detected.  Assays also looked at whether ScKu proteins 
could form complexes with ScLigD or if the presence of ScKu bound to DNA could enhance 
the precipitation of other S. coelicolor NHEJ proteins. 
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5.1 Cloning of Recombinant scku1 and scku2 into Integration Phage Vectors. 
 
Although his-tagged recombinant versions of scku genes had previously been produced that 
that were currently sited in pET28(a) vectors (Sayer, 2008), for analysis of accurate  in vivo 
expression properties recombinant scku genes that also contained promoter regions would be 
more appropriate.  To achieve this, primers were designed (Table 5.1) that would amplify 
specific regions on the S. coelicolor chromosome containing either scku1 or scku2 and 
approximately 200 bp of upstream DNA that was predicted to contain promoter regions 
(Figure 5.1). 
 
 
Figure 5.1 PCR cloning strategy for the production of recombinant scku1 and scku2 
genes.  Sequences for scku1 and scku2 genes including upstream regions were obtained from 
the StrepDB database.  Primers containing appropriate restriction enzyme cut-sites were 
produced that would produce amplified fragments containing 1 blunt and 1 over-hang end.  
Downstream primers also contained sequences encoding a polyhistidine tag, a stop codon and 
an EcoRV cut-site. 
 
 
Upstream primers consisted of 5’ restriction enzyme cut-sites that would produce overhang-
ends and approximately 15 – 20 nucleotides complementary to the S. coelicolor chromosome 
at sites over 200 base pairs upstream of the start of the relevant scku gene.  Downstream 
primers were designed to anneal to the 3’ end of the scku gene prior to the stop codon.  For 
both scku genes, a 5’ EcoRV cut-site was present adjacent to a sequence coding for a 
polyhistidine tag that was situated next to a stop codon and nucleotides complementary to the 
scku gene.  The resulting PCR products would consist of: 5’- Spe1 or Xba1 cut-site – scku and 
upstream region – polyhistidine – stop – EcoRV cut-site -3’.  Once amplified, recombinant 
genes were to be cloned directly into Zero Blunt® TOPO® as a holding vector to aid initial 
cloning, with analysis by PCR and sequencing to confirm cloning had been successful.  
Finally, inserts were to be removed by appropriate restriction enzyme digestion and ligated 
into Streptomyces integration vectors. 
 
Many species in the Streptomyces genus are amenable to genetic manipulation via site-
specific integration vectors derived from temperate phages.  The integrase int/attP from 
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Streptomyces phage ΦC31 is a member of the serine recombinase family of site-specific 
recombinases that forms an essential component of integration vectors, including pSET152 
(Kieser et al., 2000).  Vectors containing int/attP can integrate at an attB or attP site in the 
Streptomyces chromosome using a mechanism of recombination similar to resolvase-invertase 
family members (Stark et al., 1992).  Briefly, following recognition of recombination sites, a 
synaptic-complex is formed between the 2 DNAs.  A recombinase then cleaves the 4 DNA 
strands, which are then positioned in a recombinant format prior to rejoining of the 
phosphodiester backbone.  The ΦC31 int/attP locus contained within pSET152 integrates 
intragenically into the non-essential SCO3798 alongside pseudo-attB in certain Streptomyces 
species (Combes et al., 2002).  Vectors have also been engineered that contain the int/attP 
locus from Streptomyces phage ΦBT1 (a homo-immune relative of ΦC31) that integrate into 
an alternative attB site in the SCO4848 gene of S. coelicolor (Gregory et al., 2003).  Vectors 
including pMS82 are similar in design to pSET152 except that integration proceeds via the 
ΦBT1 int/attP instead of ΦC31.  As both vectors integrate at different chromosomal sites, the 
opportunity exists to use 2 compatible vectors in the same organism. 
 
Although in vitro assays had revealed interesting findings regarding ScKu protein activity, 
analysis of in vivo function would provide additional information about prokaryotic NHEJ.  
The introduction of recombinant versions of chromosomal-derived scku1 and scku2 into wild-
type and knockout strains of S. coelicolor (that had previously been prepared (Handley, 
Bowater and Hutchings, unpublished data)) would provide an opportunity to assess gene 
expression, complementation and macromolecular in vivo DNA interactions.  Delivery of 
recombinant scku1 and scku2 situated in integration vectors pMS82 and pSET152 could be 
achieved via conjugation between E. coli and S. coelicolor and site-specific integration of 
these genes would provide a platform for protein characterisation. 
 
5.1.1 Restriction Digest Analysis of Integration Vectors pMS82 and pSET152. 
 
Prior to cloning of scku1 and scku2 into pMS82 and pSET152, it was crucial to confirm that 
the integration vectors were as expected.  Restriction digest reactions were performed on both 
vectors using a series of selected enzymes that were known to digest at specific sites 
following sequence analysis of vectors.  Importantly, enzymes that would eventually be used 
to clone the recombinant scku genes into the integration vectors were also analysed to ensure 
only unique cut-sites were present. 
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Figure 5.2 Restriction digest analysis of integration vectors pMS82 and pSET152.  
Approximately 200 ng of vector DNA was digested with specific enzymes under appropriate 
conditions for 2 hours and analysed by electrophoresis using 1% agarose gels.  A. Analysis of 
pMS82 by separate digestion with Spe1 and EcoRV that produce a single fragment (6108 bp) 
and digestion with both EcoRV and Nco1 to produce 2 fragments (2036 bp and 4072 bp).  B.  
Analysis of pSET152 by separate digestion with Xba1 and EcoRV that produce a single 
fragment (5715 bp) and digestion with Pst1 that produces 3 fragments (27572 bp, 2341 bp 
and 802 bp). 
 
 
Restriction digest analysis (Figure 5.2) confirmed that the identities of the integration vectors 
were as expected.  Importantly, the enzymes that had been selected for future scku gene 
cloning into these vectors only cut at single locations as anticipated, meaning that the vectors 
and chosen restriction enzymes would be suitable for future cloning. 
 
5.1.2 PCR Amplification of Recombinant scku1 and scku2. 
 
Preliminary PCRs focused on determining the optimum conditions required to amplify the 
desired genomic regions from chromosomal DNA extracted from S. coelicolor using Taq 
polymerase.  The high GC-content of Streptomyces species can complicate PCRs and non-
specific annealing of primers, formation of secondary structures in primers and primer-primer 
annealing can be problematic.  An important component that can prevent secondary structure 
formation is dimethyl sulfoxide (DMSO), a polar aprotic solvent that acts by interfering with 
the self-complementarity of DNA (Chakrabarti and Schutt, 2001).  However, at high levels 
DMSO can have adverse effects by increasing mutation frequency.  To identify appropriate 
PCR conditions, reactions were performed using various concentrations of DMSO from 0 – 
12% and annealing temperatures ranging from 55 – 61 °C.  It was found that amplification 
using chromosomal DNA as a template was very inefficient for both scku1 and scku2 (Figure 
5.3 A) as no products of the expected size were produced. 
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Figure 5.3 PCR amplification of scku1 and scku2 gene products to be inserted into 
pMS82 and pSET152.  Conditions of PCRs by Taq polymerase were varied to allow 
identification of optimum reaction constituents for amplification of scku1 (~ 1.35 kbp) and 
scku2 (~ 1.3 kbp) genes.  ‘pMS82’ and ‘pSET152’ refer to the primers that were used to 
create gene products that would eventually be cloned into pMS82 and pSET152 vectors.  PCR 
products were analysed by electrophoresis on 1% agarose gels.  A.  PCR results using S. 
coelicolor chromosomal DNA as a template at 8% and 10% DMSO final concentrations.  B.  
PCR results using 2 ng and 20 ng specific cosmid DNA as reaction templates. 
 
 
Using cosmid DNA as reaction templates instead of chromosomal DNA has advantages, 
primarily as the ratio of specific DNA to unspecific DNA is significantly improved, thereby 
reducing the opportunity for unspecific primer annealing and increasing the probability of 
specific annealing.  As with chromosomal template reactions, PCRs were performed to 
establish the most efficient conditions for using st6G9 (scku1) or st5G5 (scku2) cosmid DNA 
as the template (Figure 5.3 B).  It was apparent that for scku2, a band present at 
approximately 1.3 kbp was produced following amplification with cosmid DNA that was 
thought to be the desired product.  Increasing annealing temperature enhanced the intensity of 
this band and reduced the amount of other products previously detected (Figure 5.4 A). 
Unfortunately, scku1 amplification was unsuccessful and there was no indication of any 
primer annealing.  To obtain scku2 products that were less likely to contain errors that may be 
incorporated during DNA amplification, PCRs were performed using a proofreading Pfu 
polymerase, which reduces the probability of mutations in the final PCR products.  Following 
reactions, products at approximately 1.3 kbp were gel-extracted, purified and analysed by gel 
electrophoresis (Figure 5.4 B). 
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Figure 5.4 PCR amplification of scku2 using optimum conditions and analysis of 
extracted and purified scku2 product.  Amplified DNA was analysed by electrophoresis 
using 1% agarose gels.  A.   PCR results from reactions amplifying scku2 using Taq 
polymerase at an annealing temperature of 59 °C and 6% DMSO.  B.  scku2 product gel-
extracted and purified following PCR using Pfu proofreading polymerase. 
 
 
Electrophoresis confirmed that the scku2 PCR products designed to insert into pMS82 and 
pSET152 had both been successfully extracted and purified as stocks at approximately 30 ng / 
µl.  As all PCRs that were performed to amplify scku1 had failed, it was decided at this point 
to focus all subsequent work on scku2.  
 
5.1.3 Zero Blunt® TOPO® Cloning of Recombinant scku2. 
 
Amplified scku2 (for both pMS82 and pSET152 vectors) was initially cloned into pCR- 
Blunt II- TOPO vectors.  Colony PCR was performed to identify colonies that had been 
successfully transformed with vectors containing the scku2 gene.  It was apparent that 
although both scku2-pMS82 and scku2-pSET152 were similar in size and base composition, 
scku2-pMS82 appeared less apt at producing transformants.  Initially, 3 colonies of E. coli 
that had been transformed with plasmids containing either scku2-pSET152 or scku2-pMS82 
were analysed (Figure 5.5 A). 
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Figure 5.5 Colony PCR to detect successful transformants of scku2-pMS82 and scku2-
pSET152.  PCRs were performed (Section 2.2.5.3) and amplified DNA was subsequently 
analysed by gel electrophoresis on 1% agarose gels.  Recombinant scku2 were both ~1.3 kbp.  
A.  Analysis of E. coli colonies that had been transformed with pCR-Blunt II-TOPO vectors 
containing either scku2-pMS82 or scku2-pSET152.  B.  Colony PCR analysis following 
additional cloning of pCR-Blunt II-TOPO containing scku2-pMS82 product. 
 
 
Analysis of amplified DNA implied that the 3 colonies believed to contain scku2-pSET152 
had been successfully transformed, however no colonies contained scku2-pMS82 – a 
probability that was verified by further DNA analysis of these colonies (data not shown).  
Cloning of scku2-pMS82 into pCR-Blunt II-TOPO vectors was attempted for a second time 
with alternate ratios of scku2 gene to pCR-Blunt II-TOPO vector DNA and 6 of the ensuing 
colonies were subjected to colony PCR analysis (Figure 5.5 B).  Only a single colony 
contained amplified product that was the expected molecular size of 1.3 kb. 
 
Plasmid DNA was extracted and purified from colonies that had produced positive results 
during colony PCR and analysed by gel electrophoresis (including an additional scku2-
pSET152 plasmid) alongside pRB240 (Figure 5.6 A).  The differences in electrophoretic 
mobility of empty pCR-Blunt II-TOPO vector compared to plasmids thought to contain 
scku2 genes reinforced the probability that cloning had been successful.  Digestion of cloned 
pCR- Blunt II- TOPO vectors with EcoRI would theoretically release insert DNA as 2 
EcoRI cut sites flank the region of vector that DNA can become incorporated.  Analysis of 
DNA following this digestion again suggested the presence of scku2 as bands were visible at 
approximately 1.3 kb (Figure 5.6 B).  To further ascertain the presence of scku2 in vector 
DNA, vectors were digested with relevant restriction enzymes that would eventually be used 
to sub-clone scku2 into either pMS82 or pSET152 integration vectors. 
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Figure 5.6 Electrophoretic analysis of DNA following cloning of scku2 into pCR- Blunt 
II- TOPO vectors.  Vector DNA that did or did not contain scku2-pMS82 or scku2-pSET152 
was subjected to gel electrophoresis using 1% agarose gels to determine the presence and size 
of insert DNA.  Restriction digests using relevant enzymes confirmed the anticipated inserts 
were present and also determined orientation.  A.  Electrophoretic migration of supercoiled 
vector DNA.  B.  Electrophoretic analysis of vector DNA following EcoRI restriction 
digestion to release insert DNA.  C.  Restriction digest analysis following single or double 
digests with relevant enzymes.  Expected fragment sizes are described in Table 5.1. 
 
Table 5.1 Predicted fragment sizes of pCR- Blunt II- TOPO vector DNA with or 
without scku2 inserts following restriction enzyme digestion. 
Vector DNA EcoRV EcoRV and XbaI EcoRV and SpeI 
pRB240 
 
3519 - 55, 3464 
pCR- Blunt II- 
TOPO vector + 
scku2-pMS82 
19, 4795  
or 1314, 3500 
19, 36, 1295, 3464 
 
- 
pCR- Blunt II- 
TOPO vector + 
scku2-pSET152 
19, 4795  
or 1314, 3500 
- 33, 1295, 3486 
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Single digests with EcoRV and double digests using EcoRV and either SpeI or XbaI 
confirmed that vectors contained the expected insert DNA.  It was also apparent that the 
orientation of scku2-pSET152 varied between the 4 vector samples analysed and that vectors 
A and C contained insert DNA in the opposing direction to B and D.  As there is no bias in 
orientation during blunt-end DNA cloning this occurrence was probable, however orientation 
would not affect future work as inserts would eventually be sub-cloned into integration 
vectors using specific restriction enzyme sites, meaning orientation would be controlled.  
Sequencing reactions were also carried out to ensure products had been obtained that did not 
contain mutations. 
 
5.1.4 Cloning of scku2 into pMS82 and pSET152. 
 
Sub-cloning of scku2 into both pMS82 and pSET152 integration vectors at first required the 
digestion of pCR-Blunt II-TOPO vectors containing gene inserts and integration vectors 
with 2 appropriate restriction enzymes.  Digested DNA was analysed by gel electrophoresis 
and relevant bands were then extracted and purified.  Ligation of integration vectors and 
insert DNA were performed at molar ratios of 1:1, 1:3 and 1:6 (vector: insert) using T4 DNA 
ligase at 4 °C for 16 hours.  Successful clones were identified by colony PCR and restriction 
digest analysis (Figure 5.7). 
 
 
Figure 5.7 Restriction digest analysis of pSET152 containing scku2 gene construct.  
pSET152+scku2 DNA that had been obtained from 2 transformants (A and B) were digested 
with Xba1 and EcoRV alongside pSET152 not containing scku2.  The digested DNA was 
analysed by electrophoresis on 1% agarose gels.  Bands at ~ 1.3 kb representing scku2 were 
detected in both preparations.  
 
 
Chapter 5 – Macromolecular Interactions Involving ScKu Proteins 
 150 
Restriction digest analysis of pSET152 following sub-cloning had confirmed that scku2 had 
been successfully inserted into this integration vector and this construct was now prepared for 
transformation into appropriate E. coli host strains and eventual conjugation into S. 
coelicolor.  Sub-cloning of scku2 into pMS82 had been comparatively less successful and no 
pMS82 containing scku2 were identified.  Although it would have been beneficial to have 
scku2 in both pSET152 and pMS82, in vivo protein analysis would still be possible using only 
pSET152.  For mutant S. coelicolor strains with apramycin resistance, a PCR-targeting 
approach (Section 2.2.8.4) can be used to produce pSET152+scku2 derivatives are 
hygromycin resistant and can be selected following conjugation. 
 
5.2 Scku1 and ScKu2 Immunisation and Antibody Analysis. 
 
All previous immunodetection of ScKu described in this study was achieved using antibodies 
specific for polyhistidine regions present on recombinant proteins.  As these antibodies do not 
differentiate between individual recombinant ScKu proteins, their use for 
immunoprecipitation of specific individual recombinant ScKu or detection of ScKu present in 
S. coelicolor would be problematic.  However, the development of antibodies specific for 
individual ScKu proteins would be advantageous for future studies to determine various 
features, including protein expression and identification of protein-protein interactions.  
Approximately 1.5 mg of both recombinant ScKu1 and ScKu2 were purified and used for an 
immunisation procedure that allows for the production of polyclonal antibodies (Cambridge 
Research Biochemicals) specific for both individual proteins 
 
5.2.1 Analysis of Recombinant ScKu1 and ScKu2 using Polyclonal Antibodies. 
 
The custom polyclonal antibody procedure used during immunisation of ScKu1 and ScKu2 
generates several bleeds that are obtained at various times during the process.  Repeated 
immunisation with pure protein samples produces bleeds that contain varying amounts of 
polyclonal antibodies specific for individual proteins, effectively meaning that initial bleeds 
contain fewer specific antibodies than bleeds that are obtained following repeated 
immunisations.  Prior to the procedure, a pre-bleed is also taken, which should not contain 
antibodies directed against the proteins of interest.  This pre-bleed can be directly compared 
with subsequent test-bleeds and a final harvest bleed that should contain the highest amount 
of specific antibodies.  For initial analysis of bleeds obtained during immunisation, known 
amounts of recombinant ScKu1 and ScKu2 were subject to gel electrophoresis, western 
blotting and immunodetection using polyclonal antibodies present in bleeds. 
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Due to the potential similarities of both ScKu proteins, including the polyhistidine regions 
present on both recombinant proteins, it was important to ensure specificity of antibodies by 
exposing both proteins to antibodies produced from both immunisations.  As cross-reactivity 
of antibodies would significantly impair both S. coelicolor cell extract analysis and 
immunoprecipitation experiments, it was essential to establish optimum conditions to ensure 
non-specific antibody-protein interactions were at a minimum.  Preliminary investigations to 
determine pre-immunisation bleed, primary test bleed (TB1) and test-bleed 2 (TB2) 
immunodetection of ScKu1 and ScKu2 are shown in Figure 5.8. 
 
 
Figure 5.8 Immunodetection of ScKu1 and ScKu2 with polyclonal antibodies present in 
bleeds obtained from immunisation in rabbits.  Varying amounts of recombinant ScKu1 
and ScKu2 were subjected to SDS-PAGE and western blotting.  Nitrocellulose membranes 
were then incubated in primary polyclonal antibody (1:10000) at 4 °C for 16 hours and then 
anti-rabbit secondary antibody (1:10000) for 2 hours at 22 °C.  A.  Immunodetection with pre-
immunisation antibodies.  B.  Immunodetection with test-bleed 1 (TB1).  C.  
Immunodetection with test-bleed 2 (TB2). 
 
 
Early results from immunodetection experiments revealed that antibodies in TB1 and TB2 
were successfully detecting ScKu proteins even at relatively low protein amounts of 5 pmol.  
As pre-bleeds from both immunisations consistently failed to detect any proteins, the 
observed antibody-protein binding present in TB1 and TB2 were thought to be a direct 
consequence of immunisation.  It was also apparent that contaminating E. coli proteins 
present following purification were also detected by antibodies, however, this 
immunodetection was lower than specific antibody-ScKu interactions and non-specific 
binding was largely reduced at lower levels of protein.  It was observed that antibodies were 
cross-reacting as when higher amounts of proteins were present, anti-ScKu1 was detecting 
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ScKu2 and anti-ScKu2 was detecting ScKu1 (albeit to a much lesser extent than specific 
binding).  These non-specific interactions may be dependent on either similar amino acid 
sequences of ScKu1 and ScKu2 or the polyhistidine tag present on N-terminal regions.  
Importantly, cross-reactivity was significantly decreased when protein levels were reduced, 
indicating that cross-reactivity would be low at reduced protein levels, such as in cell extracts. 
 
The most efficient immunodetection was observed with TB2 antibodies, however it was of 
interest to enhance specificity of antibody binding to ScKu proteins and to reduce background 
binding.  To this effect, antibody dilutions were increased from 1:10000 to 1:20000, 1:50000 
and 1:100000 as limited amounts of antibody tend to exhibit increased specificity for a 
particular target with highest affinity.  Recombinant ScKu1 and ScKu2 were again used to 
determine immunodetection specificity of TB2 (data not shown) and final harvest bleed 
(FHB) antibodies (Figure 5.9).  
 
 
Figure 5.9 Immunodetection of ScKu1 and ScKu2 with varying dilutions of FHB 
polyclonal antibodies obtained from immunisation in rabbits.  5 pmol of recombinant 
ScKu1 and ScKu2 were subjected to SDS-PAGE and western blotting.  Nitrocellulose 
membranes were then incubated in FHB polyclonal antibody at dilutions of 1:20000, 1:50000 
and 1:100000 at 4 °C for 16 hours.  Membranes were then exposed to anti-rabbit secondary 
antibody (1:10000) for 2 hours at 22 °C.  A.  Immunodetection with anti-ScKu1 antibodies.  
B.  Immunodetection with anti-ScKu2 antibodies. 
 
 
Increased dilutions of FHB anti-ScKu1 and anti-ScKu2 significantly increased specific 
binding to recombinant proteins and background detection of contaminating proteins was 
lowered.  Although TB2 antibodies exhibited high-specificity, FHB antibodies yielded the 
most promising results and even at 1:100,000, binding of antibodies to specific proteins 
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remained high and cross-reactivity was very low.  From this analysis it was decided that FHB 
antibodies would be most appropriate for future studies for immunodetection of endogenous 
ScKu1 and ScKu2 and immunoprecipitation assays as sensitivity and specificity was efficient 
even at elevated dilutions. 
 
5.2.2 S. coelicolor and E. coli Cell Extract Analysis using ScKu and MtrA Antibodies. 
 
The detection specificity of anti-ScKu1 and anti-ScKu2 had been proven using recombinant 
versions of S. coelicolor Ku proteins that had been used during the immunisation procedures.  
It was also of considerable interest to confirm that anti-ScKu1 and anti-ScKu2 could detect 
endogenous Ku proteins in S. coelicolor with relatively low cross-reactivity to other cellular 
proteins.  Initial assays focused on the detection of ScKu1 and ScKu2 in various strains of S. 
coelicolor that had previously been produced (Handley, Bowater and Hutchings, unpublished 
data).  Strain M145 was analysed alongside M145 deficient in ScKu1 (∆ scku1), M145 
deficient in ScKu2 (∆ scku2) and M145 deficient in both ScKu1 and ScKu2 (∆ scku1/∆ 
scku2).  Following selected growth of strains in liquid culture (SFM) for 3 days at 30 °C, cells 
were sonicated and cell extracts were collected following centrifugation.  Confirmation that 
cell extraction had been successful was achieved by Coomassie staining (Figure 5.10). 
 
 
Figure 5.10 S. coelicolor cell extract analysis by Coomassie staining.  S. coelicolor M145, 
∆ scku1, ∆ scku2 and ∆ scku1/∆ scku2 cell extracts were harvested by sonication and 
centrifugation.  Approximately 40 µg of extract from each strain was subject to SDS-PAGE 
using 10% polyacrylamide gels and Coomassie staining to confirm the presence of proteins. 
 
 
S. coelicolor cell extraction of proteins had been successful as indicated by the banding 
pattern visible in Figure 5.10.  The observation that all strains exhibited a similar pattern of 
banding was reassuring as this implied all extracts were all derived from S. coelicolor and it 
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was likely all 4 were at the same stage of growth (stationary substrate mycelium stage).  
Subsequent analysis involved immunodetection of endogenous ScKu1 and ScKu2 in all 4 
strains using appropriate conditions determined during recombinant protein immunodetection 
(Figure 5.10).  As controls, antibodies from pre-immunisation bleeds were also analysed to 
confirm detection of proteins was determined by antibodies produced following ScKu 
immunisation. Also, an anti-MtrA antibody that had been produced by the same method as 
anti-ScKu antibodies was employed as a positive control.  The MtrA protein is not implicated 
in NHEJ but is part of a two-component signal transduction system associated with signal 
recognition and adaptive responses (Zahrt and Deretic, 2000).  The S. coelicolor operon 
SCO3011-SCO3013 has recently been identified as an orthologue of the mtrAB-lpqB operon 
of M. tuberculosis (Hutchings et al., 2006) with SCO3013 sharing 75% identity with the M. 
tuberculosis mtrA gene.  The anti-MtrA antibody has been previously used to successfully 
detect MtrA in S. coelicolor M145 and, therefore, would be a suitable positive control for the 
strains analysed in this study. 
 
 
Figure 5.11 Endogenous S. coelicolor ScKu1, ScKu2 and MtrA immunodetection via 
polyclonal pre-immunisation and FHB antibodies.  50 µg of S. coelicolor M145, ∆ scku1, 
∆ scku2 and ∆ scku1/∆ scku2 cell extracts were analysed by SDS-PAGE (10% 
polyacrylamide) and western blotting.  A.  Immunodetection with FHB anti-ScKu1 or anti-
ScKu2 (1:100000).  B.  Immunodetection with pre-bleeds from rabbits immunised with 
ScKu1 or ScKu2.  C.  Immunodetection with FHB anti-MtrA. 
 
 
Analysis of S. coelicolor strains with FHB anti-ScKu1 and anti-ScKu2 predominantly 
detected 2 protein species at approximately 80 and 35 kDa (Figure 5.11 A).  As previous 
ScKu analysis had determined ScKu1 and ScKu2 have an electrophoretic mobility relative to 
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approximately 50 kDa it was expected that the observed bands were not ScKu.  Analysis with 
pre-immunisation antibodies confirmed that the observed bands were not detected by 
antibodies from ScKu immunisation as both proteins were also detected during this analysis 
(Figure 5.11 B).  Interestingly, the same bands were visible during MtrA immunodetection 
alongside bands representing MtrA (30 kDa).  This analysis confirmed that native antibodies 
that were present in rabbits prior to protein immunisation or adjuvant addition were 
responsible for detecting the 2 protein species and that this occurrence was not rabbit specific 
as the same proteins were detected with antibodies from separate rabbits.  As the anti-MtrA 
did successfully detect MtrA protein and no ScKu1 or ScKu2 were detectable in any S. 
coelicolor strains, it is likely that any ScKu present in these strains are poorly expressed under 
the growth conditions used and, therefore, are not visible following immunodetection. 
 
ScKu specific antibodies had previously been used to visualise purified recombinant ScKu1 
and ScKu2 proteins, however S. coelicolor cell extract analysis had failed to detect either 
endogenous versions in 4 separate strains.  As it was considered appropriate to use ScKu 
antibodies to detect ScKu from cell extracts samples, it was decided to over-express ScKu in 
E. coli as implemented during protein purification processes (Section 2.4) and to use specific 
antibodies to analyse recombinant ScKu present in cell extracts (Figure 5.12). 
 
 
Figure 5.12 Immunodetection of recombinant ScKu1 and ScKu2 from E. coli cell 
extracts using polyclonal FHB antibodies.  Recombinant ScKu1, ScKu2 and ScKu3 were 
over-expressed in E. coli BL21 pLysS strains from which cell extracts were harvested and 
analysed by SDS-PAGE (10% polyacrylamide), western blotting and immunodetection with 
appropriate antibodies.  A.  Immunodetection with FHB anti-ScKu1 on 5 µg of cell extract.  
B.  Immunodetection with FHB anti-ScKu2 on 70 µg of cell extract. 
 
 
Analysis of E. coli cell extracts illustrated that both anti-ScKu1 and anti-ScKu2 could be used 
successfully to detect ScKu proteins from cell extract material.  Approximately 65 µg more of 
extract was used for anti-ScKu2 analysis as lower amounts generally gave low detection rates.  
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The probable reasons why less material was required during anti-ScKu1 immunodetection 
was that ScKu1 tends to express better during over-expression (Sections 4.2.1 and 4.2.2 ) and 
anti-ScKu1 appears to have higher sensitivity than anti-ScKu2 as shown earlier in this 
chapter.  The successful detection of both ScKu1 and ScKu2 from E. coli cell extracts 
suggests that if native Ku proteins are present in S. coelicolor cell extracts (Figure 5.11) then 
they are present at low enough levels to avoid detection. 
 
5.2.3 S. coelicolor Spore Extract Analysis using ScKu Polyclonal Antibodies. 
 
 
S. coelicolor exhibit complex lifecycles that involve biochemically and morphologically 
differentiated cell types (Miguelez et al., 2000).  The S. coelicolor extracts investigated in 
Section 5.3.2 were taken from branching substrate mycelium thought to be at stationary phase 
and although Ku were not detected it is possible that expression increases at other lifecycle 
stages.  Under stress, aerial filaments differentiate into spore-bearing structures that 
eventually produce hydrophobic dormant spore bodies (Hirsch and Ensign, 1976).  As no cell 
division will occur in these dormant bodies and with no sister chromatid available, the repair 
of DSBs would not be able to proceed via homologous recombination and so NHEJ may 
predominate as the mechanism for repairing such breaks.  To determine if ScKu1 or ScKu2 
proteins are expressed in S. coelicolor spores, following growths on selective plates, spores 
were collected from the 4 S. coelicolor strains and extracts harvested using a FASTPrep 
technique to lyse cells.  As with previous S. coelicolor extracts, 50 µg of extract was analysed 
by SDS-PAGE, western blotting and immunodetection with anti-ScKu1 and anti-ScKu2 
(Figure 5.13). 
 
 
 
Figure 5.13 Immunodetection of native ScKu1 and ScKu2 from S. coelicolor spore 
extracts using polyclonal FHB antibodies.  50 µg of spore extracts from S. coelicolor 
M145, ∆ scku1, ∆ scku2 and ∆ scku1/∆ scku2 were subjected to SDS-PAGE, western blotting 
and immunodetection with relevant primary antibodies at 1:100000 dilution.  A.  
Immunodetection with FHB anti-ScKu1.  B.  Immunodetection with FHB anti-ScKu2. 
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Extracting spore extracts can be complicated due to the very durable nature of spores.  
However, Coomassie analysis (data not shown) confirmed the FASTPrep technique had 
successfully broken up spore cells and extracts rich in protein had been attained.  Similarly to 
S. coelicolor cell extract analysis, spore analysis identified very little difference in proteins 
present between the strains studied regardless of choice of antibody during immunodetection.  
As seen in previous S. coelicolor cell extract analysis (Figure 5.11), a single-band was 
consistently detected in all samples with both antibodies, however this time the unknown 
protein was larger at approximately 55 kDa.  The observation of this protein species, and loss 
of the 2 bands clearly identified previously indicates protein expression levels are different in 
S. coelicolor spores compared to stationary substrate mycelium.  Importantly, the absence of 
ScKu proteins indicates levels are too low for detection, suggesting that either these proteins 
can function at very low concentrations, or that they are not required at this life stage.  It is 
also possible expression may be induced following DSB formation and that levels will only 
be detectable in damage-induced cells. 
 
5.3 Resolving ScKu Protein Macromolecular Interactions. 
 
The 3 ScKu proteins had all exhibited DNA binding activity that would be fundamental to 
their hypothesised role during NHEJ in S. coelicolor.  Importantly, ScKu displayed this 
activity independent of each other, and considering all Ku are believed to bind to DNA as 
dimeric complexes, it would be assumed that these proteins conform to the currently accepted 
model of prokaryotic Ku (Pitcher et al., 2007) and form homodimers.  Whereas a high 
proportion of bacteria possess single copies of ku genes (Rocha et al., 2005; Wilson et al., 
2003), some bacteria, including S. coelicolor contain multiple ku genes (Kobayashi et al., 
2008), providing the possibility that these Ku proteins may function as heterodimers in a 
similar fashion to eukaryotic Ku.  Due to the structural similarity observed by individual Ku 
monomers, it is not unreasonable to suppose that different Ku from the same species could 
also interact with each other.  To understand this possibility further, biochemical analysis of 
the 3 purified recombinant ScKu proteins by dynamic light scattering was carried out to 
ascertain if multiple species of protein were present in preparations.  Co-immunoprecipitation 
assays were also developed using antibodies described in Section 5.2 that provided the 
opportunity to assess the ability for ScKu to interact and also to discover if ScKu proteins 
could interact with the DNA ligase implicated in S. coelicolor NHEJ (ScLigD).  As a final 
approach to determine protein-protein interactions using precipitation assays, the SMB DNA 
binding assay was adapted to resolve if proteins that had previously been found to interact 
poorly with specific DNAs could interact more efficiently if a protein found to bind well to 
the DNA was present in the reaction. 
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5.3.1 Dynamic Light Scattering Analysis of ScKu. 
 
Dynamic light scattering (DLS) is a technique that can be used to determine the size 
distribution of small particles in solution.  When a monochromatic and coherent beam of light 
such as a laser is scattered by particles, a time-dependent fluctuation in the scattering intensity 
can be observed due to the movement of particles by Brownian motion.  This movement 
causes the distance between scatters in the solution to change with time and these changes can 
be quantified to produce information regarding the movement of the particles. 
 
Polydispersity refers to the level of homogeneity of the sizes of particles in a solution.  High 
homogeneity (for example when percent polydispersity is less than 15%) means that particles 
can be considered to be virtually identical, however when percent polydispersity rises above 
30%, the particle population can be considered to contain species of different sizes.  When 
particle species are present that are more than a factor of 2 different in size, additional peaks 
are resolved during DLS indicating that the sample is heterogeneous and that distinct 
populations are present.  Heterogeneity can also be caused by the presence of different species 
that are unable to be resolved by DLS, meaning that species are present with sizes less than a 
factor of 2 relative to other species in the same solution.  In such instances, a single peak will 
arise that exhibits higher polydispersity (indicated by a wide peak) compared to a solution 
that only contains a single particle species (indicated by a narrow peak).  The data shown in 
Table 5.2 contains DLS data following analysis of ScKu1, ScKu2 and ScKu3.  The ‘% 
polydispersity’ values were calculated from the widths of the main peaks (Table 5.2). 
 
Table 5.2 DLS data obtained from analysis of ScKu proteins.  12 µl of 1 mg / ml protein 
in 1 x protein storage buffer (Table 2.11) were measured at an acquisition time of 10 seconds 
for a total of 20 acquisitions.  Values representing ‘% polydispersity’ were calculated from 
the main peak in each measurement.  Values < 15% indicate the presence of 1 species, values 
between 15 – 30% indicate monomers with increasing amounts of dimer present and values > 
30 % indicate highly heterogeneous species.  M = monomer, D = dimer, T = trimer. 
 
Protein ‘% Polydispersity’ Protein species 
ScKu1 49.2 M/D/T 
ScKu2 21.7 M/D 
ScKu3 18.9 M/D 
 
 
The percent polydispersity values acquired from DLS measurements suggest that all 3 ScKu 
proteins are present as more than a single species.  For both ScKu2 and ScKu3, the width of 
the main peak produced values between 15 – 30% polydispersity, which indicates both 
monomer and dimer species exist under the conditions stated (Section 2.12).  Interestingly, 
ScKu1 displayed higher percent polydispersity that is indicative of a protein existing in 
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multiple forms such as monomers, dimers and trimers.  As no other Ku proteins have been 
documented as existing in a trimeric form, it is likely this value does not truly represent the 
ScKu1 species present.  Overall, the data implies that the protein preparations are likely to 
contain both monomer and dimer molecules. 
 
5.3.2 Co-Immunoprecipitation of S. coelicolor NHEJ Components. 
 
For characterising in vitro protein-protein interactions of S. coelicolor Ku and other NHEJ 
components, a co-immunoprecipitation (Co-IP) assay was developed that employed ScKu 
specific antibodies (Section 5.2) to precipitate target proteins physically associated with the 
antibody specific ScKu bait.  Preliminary assays were performed to optimise the Co-IP assay 
(Section 2.9) and to reduce non-specific protein-bead and protein-antibody interactions from 
occurring.  Assays then focused on comparing precipitation of target proteins with or without 
the inclusion of ScKu bait proteins to which the antibody present in reactions had been raised 
against.  It was assumed that increases in precipitation of target proteins when the ScKu bait 
protein was present would be a direct consequence of a protein-protein interaction between 
ScKu bait and target protein.  Co-IP assays were primarily performed to quantify if different 
ScKu proteins could form stable heterodimer complexes and also to resolve if either ScKu1 or 
ScKu2 could enhance precipitation of ScLigD (Figure 5.14). 
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Figure 5.14 In vitro Co-IP results investigating S. coelicolor NHEJ component protein-
protein interactions.  Assays were performed to determine target protein Co-IP with or 
without antibody specific bait protein (normal font).  Values representing percentage target 
protein (in italics) precipitated in both instances were calculated using ‘ImageJ’.  Bars in 
white indicate precipitated target protein without ScKu bait protein (non-specific Co-IP) and 
bars in black indicate precipitated target protein with ScKu bait included (specific Co-IP).  
Averages were taken from a minimum of 3 experiments.  Standard errors are shown. 
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Table 5.3 Statistical analysis of results obtained during Co-IP assays investigating 
protein-protein interactions between S. coelicolor NHEJ components.  Two-tailed t-test 
analysis was performed on data obtained from assays shown in Figure 5.14.  The percentages 
of protein co-immunoprecipitated with or without incubation with antibody-specific protein 
were calculated and then directly compared to resolve differences in values. 
 
Protein 
associated 
with PGB 
Target 
protein 
t value Degrees  of 
freedom (of t) 
Critical values 
of t (p = 0.05) 
Outcome 
ScKu1 ScKu2 0.3 4 2.78 Not significant 
ScKu1 ScKu3 3.2 4 2.78 Significant 
ScKu2 ScKu3 2.7 4 2.78 Not significant 
ScKu1 ScLigD 12.5 2 4.30 Significant 
ScKu2 ScLigD 1.8 2 4.30 Not significant 
 
 
The data from Co-IP assays indicated that ScKu1 was able to precipitate both ScKu3 and 
ScLigD, however any interaction with ScKu2 was not apparent.   ScKu2 was also shown not 
to significantly increase precipitation of ScKu3 or ScLigD, implying that the interactions 
shown by ScKu1 is specific for this protein only.  The considerable co-precipitation of 
ScLigD by ScKu1 is an interesting result. Although in the context of prokaryotic NHEJ, an 
interaction between the DSB detecting ScKu and the DNA ligating ScLigD would seem 
plausible, studies of M. tuberculosis NHEJ proteins suggested that MtKu interacts with the 
polymerase domain of MtLigD during recruitment of the ligase (Pitcher et al., 2007).  As 
ScLigD does not contain a polymerase domain, it may be hypothesised that for a system 
similar to NHEJ in M. tuberculosis, ScKu would interact with S. coelicolor proteins that show 
high homology to the MtLigD polymerase domain (ScPrim1, ScPrim2 and ScPrim3) (Sayer, 
2008).  Though interactions to these proteins are yet to be elucidated, the observed interaction 
between ScKu1 and ScLigD indicates differences in interactions between S. coelicolor and M. 
tuberculosis NHEJ proteins exist. 
 
The observation that between the ScKu proteins only ScKu1 and ScKu3 appear to interact is 
intriguing.  It may be expected due to the genomic locations of these proteins that 
chromosomal ScKu1 and ScKu2 would be most likely to interact compared to the isolated 
ScKu3 on plasmid SCP1.  For conformation of ScKu1/ScKu2 interactions, ideally the roles of 
these 2 proteins would also have been reversed with ScKu2 as bait and ScKu1 as target 
protein.  Unfortunately, due to the appearance of a band at the migratory position of ScKu1 
during electrophoresis (assay antibody background (Appendix IV)) the quantification of 
ScKu1 was not possible.  In silico sequence analysis in 3 other Streptomyces species 
(Appendix V) has revealed that in these other species, 2 contain 2 ku genes (showing highest 
homology to ScKu1 and ScKu3) and 1 species contains only 1 ku gene with highest 
homology to ScKu1.  This information strongly suggests ScKu1 is capable of functioning 
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alone as a homodimer, but also that potentially it may interact with ScKu3 in 2 out of the 3 
alternative species analysed.  The absence of ScKu2 in any of the 3 other species implies S. 
coelicolor has at some point acquired this gene and that, although functionally similar to 
ScKu1 and ScKu3, it is unlikely to form complexes with these proteins and is not essential for 
all Streptomyces species.  Hence, Co-IP and in silico data indicate that prokaryotic Ku may 
not be restricted to forming homodimers as currently thought.  Although it is apparent all 3 
ScKu can bind to DNA individually, and therefore supposedly as homodimers, the observed 
interaction between ScKu1 and ScKu3 during this study, and the presence of these 2 ku genes 
in 2 other Streptomyces species indicates the ability for these Ku to heterodimerise.  The 
ability of ScKu1 and ScKu3 to form both homodimer and heterodimer complexes may allow 
these proteins to participate in different cellular activities, either during repair of different 
types of DSB, or alternative DNA metabolism processes. 
 
5.3.3 In vitro SMB DNA and Protein Interaction Analysis. 
 
The use of antibodies specific for ‘bait’ proteins during Co-IP is an effective method for 
determining if 2 different proteins can interact.  However, potential drawbacks exist regarding 
the disruptive influence that a relatively large immunoglobulin molecule may have upon 
protein function.  This effect may be exacerbated when polyclonal antibodies that cannot be 
directed against non-obtrusive epitopes are used.  Therefore, the ability to support data 
collected from such Co-IP analysis is highly advantageous.  The differential DNA binding 
activity displayed by S. coelicolor NHEJ components during SMB assays (Figure 4.4) 
provided an opportunity to develop a more natural Co-IP assay that would utilise the proteins 
DNA binding activity to allow precipitation, rather than using protein-specific antibodies.  
Effectively, a protein that had been shown to bind poorly to a specific DNA molecule was 
incubated with a protein that had been shown to bind efficiently to the same DNA.  If protein 
precipitation increased in the presence of the efficient DNA binding protein, it was thought an 
interaction was occurring between both proteins.  Initial SMB DNA and protein interaction 
assays focused on possible interactions between the 3 Ku proteins of S. coelicolor (Figure 
5.15).   
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Figure 5.15 In vitro SMB DNA binding assay results investigating protein-protein 
interactions between ScKu proteins.  Different ScKu were incubated prior to exposure to 
dsDNA1 (black) or ssDNA1 (blue) (Table 2.7) using assay conditions described in Section 
4.3.1.  Band intensities were measured using ‘ImageJ’ and percentage binding calculated.  
Results for ScKu2 and ScKu3 are shown without (-) or including stated ScKu proteins.  
Averages were taken from at least 4 experiments.  Standard errors are shown. 
 
 
Table 5.4 Statistical analysis of results obtained during SMB DNA and protein assays 
investigating ScKu protein interactions.  Two-tailed t-test analysis was performed on data 
obtained from assays shown in Figure 5.15.  The percentages of ScKu2 and ScKu3 
precipitated (with dsDNA or ssDNA) with prior incubation of alternate ScKu protein were 
compared with percentage precipitated without prior incubation. 
 
Protein 
combination 
DNA t value Degrees  of 
freedom (of t) 
Critical values 
of t (p = 0.05) 
Binding 
difference 
ScKu2 (ScKu1) dsDNA 4.0 16 2.12 Significant 
ScKu2 (ScKu3) dsDNA 3.9 16 2.12 Significant 
ScKu2 (ScKu1) ssDNA 3.3 13 2.16 Significant 
ScKu2 (ScKu3) ssDNA 0.03 14 2.15 Not significant 
ScKu3 (ScKu1) dsDNA 5.4 9 2.26 Significant 
ScKu3 (ScKu2) dsDNA 2.4 9 2.26 Significant 
ScKu3 (ScKu1) ssDNA 5.7 10 2.23 Significant 
ScKu3 (ScKu2) ssDNA 0.2 9 2.26 Not significant 
 
 
The results shown in Figure 5.15 and subsequent statistical analysis (Table 5.4) demonstrate 
that the presence of alternate ScKu proteins did affect precipitation depending on which other 
ScKu protein was present.  Previous DNA binding analysis had identified ScKu2 bound well 
to dsDNA, but comparatively less to ssDNA.  When either ScKu1 or ScKu3 was present, 
ScKu2 precipitation with dsDNA was shown to decrease.  This may be explained by 
competition between different ScKu proteins that would reduce the amount of DNA available 
for ScKu2 to bind to.  Thus, this would indicate that ScKu2 does not interact with ScKu1 or 
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ScKu3 as these proteins appear to reduce access of ScKu2 to the dsDNA.  The results attained 
representing ScKu2 precipitation when ssDNA was used as substrate appear to contradict this 
observation as although no difference was observed when ScKu3 was present (as would be 
expected as neither ScKu2 nor ScKu3 bind efficiently to ssDNA), the inclusion of ScKu1 
significantly increased ScKu2 precipitation.  This would imply an interaction between ScKu1 
and ScKu2 is possible, although as precipitation with dsDNA and previous Co-IP assays 
(Section 5.3.2) did not detect such interaction, other factors may be responsible for this 
observation.  The results concerning precipitation of ScKu3 were very encouraging as there 
was high agreement with previous antibody-dependent Co-IP analysis.  ScKu1 appeared to 
strongly increase precipitation of ScKu3 with both dsDNA and ssDNA, again suggesting an 
interaction between these 2 proteins.  Although the inclusion of ScKu2 did increase 
precipitation of ScKu3 with dsDNA, this increase was not as prominent as that observed 
when ScKu1 was present. 
 
In vitro SMB DNA binding assays had also revealed that ScLigD, an ATP-dependent DNA 
ligase from S. coelicolor believed to function during NHEJ (Aravind and Koonin, 2001; 
Doherty et al., 2001), exhibited contrasting DNA binding activity to ScKu and MtKu proteins.  
As ScLigD bound with relatively low affinity to dsDNA compared to ScKu1, ScKu2 and 
MtKu, an opportunity existed to develop the SMB assay to allow identification of protein-
protein interactions with Ku proteins, an interaction that may be crucial during NHEJ.  For 
these assays, ScKu were incubated with dsDNA and unbound protein was removed in wash 
steps, followed by the introduction of ScLigD to each individual reaction.  Reactions would 
then be incubated and bound protein precipitated as usual, however, the presence of ScLigD 
would be dependent on interactions with the Ku protein attached to the DNA and not direct 
interactions with the dsDNA.  Assays were carried out that investigated whether ScLigD 
would be precipitated following incubation of ScKu1, ScKu2 or MtKu with dsDNA. 
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Figure 5.16 In vitro SMB DNA binding assay results investigating protein-protein 
interactions between prokaryotic Ku and ScLigD.  Prokaryotic Ku were initially incubated 
with dsDNA1 (Table 2.7) followed by addition of ScLigD that has low affinity for dsDNA.  
Precipitation of ScLigD would be dependent on interactions with ScKu. Averages were taken 
from a minimum of 3 experiments.  Standard errors are shown.  A.  Example of SMB results 
(performed at 100 mM KCl) following SDS-PAGE, western blotting and immunodetection.  
Proteins can be distinguished by differences in electrophoretic migration.  B.  Summary of 
protein-protein interaction assays performed at 100 and 200 mM KCl.  Proteins in brackets 
were incubated with DNA prior to ScLigD addition.   
 
 
The results obtained from Ku-ScLigD interaction studies using the modified SMB DNA 
binding assay (Figure 5.16) indicated that when ScKu1 was bound to dsDNA, precipitation of 
ScLigD was significantly higher than when no Ku was present (t = 62 (p < 0.05)) or when 
ScKu2 was bound to dsDNA (t = 12 (p < 0.05)) (at 100 mM KCl).  These findings imply that 
ScKu1 can facilitate ScLigD association with dsDNA, probably via protein-protein 
interactions that ScKu2 is less capable of performing.  The difference in strength between 
ScKu1-ScLigD and ScKu2-ScLigD interactions is highlighted as when ionic strength was 
increased to 200 mM KCl, no ScLigD was precipitated in the presence of ScKu2, however 
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ScLigD was still precipitating when ScKu1 was present.  Assays were also performed to 
investigate potential interactions between MtKu and ScLigD, however no interactions were 
detected (data not shown). 
 
This data strongly agrees with other Co-IP data obtained during this study as ScKu1 appears 
to interact directly with ScLigD to facilitate association with DNA.  If ScLigD is indeed 
responsible for ligation of DSBs during NHEJ in S. coelicolor as expected, the findings from 
previous assays that this ligase binds poorly to dsDNA would imply that additional 
components are necessary in order for ligation to proceed.  The introduction of ScKu1 
dramatically increased the amount of ScLigD attached to dsDNA and this apparent interaction 
may reflect the specific in vivo function of ScKu1 in enhancing the opportunity for DSB 
ligation.  Why the addition of ScKu2 resulted in less considerable increases in ScLigD 
precipitation is not obvious.  Perhaps additional components are required that enhance 
ScKu2-ScLigD interactions or, alternatively, ScKu2 may facilitate ligation by a different 
ligase during NHEJ. 
 
5.4 Discussion. 
 
Two approaches were taken that will ultimately allow for detailed in vivo analysis of ScKu1 
and ScKu2 activity in S. coelicolor.  The first approach was to integrate polyhistidine tagged 
recombinant versions of scku1 and scku2 using phage-derived vectors pMS82 and pSET152 
that integrate directly into separate locations on the S. coelicolor chromosome.  Primers were 
designed that would amplify not only the appropriate scku1 and scku2 genes, but also 
approximately 200 bp of upstream DNA that would contain promoter regions to allow for 
natural levels of protein expression.  Prior to gene amplification, restriction digest analysis of 
pMS82 and pSET152 was performed and electrophoretic analysis of the resulting fragments 
agreed with the theoretical fragment molecular sizes.  PCR amplification of both scku1 and 
scku2 from S. coelicolor chromosomal DNA proved problematic and cosmid DNA was 
chosen as an alternative template.  Once appropriate reaction conditions had been attained, 
scku2 amplification was successful, however PCRs specific for scku1 failed to produce any 
product.  Although several possibilities exist for why scku1 amplification was unsuccessful, 
the high G/C content of S. coelicolor may have impaired primer function and promoted events 
such as self-folding.  As no DNA had been amplified regarding scku1, all further cloning 
concentrated exclusively on scku2.  PCR products amplified by the proofreading Pfu 
polymerase were gel-extracted, purified and subsequently cloned into pCR- Blunt II- TOPO 
vectors prior to eventual sub-cloning into pMS82 and pSET152.  Analysis by colony PCR and 
restriction digestion confirmed the desired gene products had been inserted appropriately and 
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confirmation was attained via sequencing of pCR-Blunt II-TOPO vectors containing scku2 
inserts.  Integration vectors and pCR-Blunt II-TOPO vectors containing inserts were 
digested with appropriate restriction enzymes and, following gel extraction of relevant DNAs, 
scku2 inserts were ligated into pSET152 and successful cloning was confirmed via colony 
PCR and restriction digests and sequencing. 
 
The production of antibodies specific for individual ScKu provides the opportunity to 
investigate several new aspects of the functions of these proteins.  Previous immunodetections 
had utilised the polyhistidine tags of recombinant ScKu and so the detection of native ScKu in 
S. coelicolor and the selective precipitation of specific recombinant ScKu in vitro was not 
possible with anti-his antibodies.  Antibodies specific for ScKu1 (anti-ScKu1) and ScKu2 
(anti-ScKu2) were developed by immunisation of rabbits with purified recombinant proteins 
from which polyclonal antibodies were eventually harvested. 
 
Preliminary analysis of antibodies was performed by probing known amounts of recombinant 
ScKu1 and ScKu2 with pre-immunisation bleeds, a primary test bleed (TB1) taken following 
the first immunisation and a second test bleed (TB2) that was taken after 2 immunisation 
events.  All antibodies were initially used at a dilution of 1: 10000 and varied amounts of 
ScKu protein were analysed.  Although initial results were discouraging due to a high degree 
of non-specific detection of contaminating proteins, increased antibody dilutions significantly 
reduced cross-reactivity.  It was determined that 1:100,000 dilutions, both antibodies provided 
the relatively clean results and could efficiently detect 5 pmol of recombinant protein.  As 
anticipated, final harvest bleed (FHB) antibodies exhibited the most efficient detection of 
ScKu proteins as these samples would contain the highest levels of ScKu-specific antibody 
molecules.  FHB antibodies were then employed in the detection of native ScKu1 and ScKu2 
from S. coelicolor cell extracts.  S. coelicolor strains available for analysis were: M145, M145 
∆ScKu1, M145 ∆ScKu2 and M145 ∆ScKu1/∆ScKu2.  Cell extracts obtained from these strains 
grown in liquid culture for 3 days were analysed by Coomassie staining to confirm harvesting 
had been successful and, once confirmed, extracts were subject to SDS-PAGE, western 
blotting and immunodetection with pre-bleed antibodies, FHB anti-ScKu1, anti-ScKu2 and 
FHB anti-MtrA (used as a positive control).  Two protein species at approximately 80 and 35 
kDa were consistently detected with all 3 protein antibodies including ScKu pre-bleeds, 
indicating antibodies native to the immunised rabbits were present that were specific for S. 
coelicolor proteins of these sizes.  Although anti-MtrA did detect an additional band at 30 
kDa thought to be MtrA, neither ScKu FHB antibodies revealed additional bands at the 
expected molecular weights of the ScKu proteins.  Therefore, it was assumed any ScKu1 or 
Chapter 5 – Macromolecular Interactions Involving ScKu Proteins 
 167 
ScKu2 present from the analysed cell extracts was at an amount too low for immunodetection.  
To confirm the ability of FHB anti-ScKu1 and anti-ScKu2 to detect relevant proteins from 
cell extracts, E. coli over-expressing both recombinant proteins were examined and both 
proteins were detected successfully.  As S. coelicolor exist in multiple biochemically different 
cell types, it was postulated that expression of ScKu would vary depending on the exact stage 
of this cycle.  As spores are dormant bodies that do not exhibit cell division, it was believed 
ScKu expression may be increased as NHEJ may be more prevalent in these non-dividing cell 
types.  Spore extractions were obtained and again subjected to SDS-PAGE, western blotting 
and immunodetection with FHB anti-ScKu1 and ScKu2.  A constant single-band was detected 
in all samples including anti-MtrA but no other bands appeared to show variation between the 
different strains.  Interestingly, the band that was observed exhibited different electrophoretic 
mobility to the 2 bands seen in stationary substrate mycelium extracts.  This indicates 
differences in protein expression between the 2 life cycles studied, however there was still no 
evidence of expression of ScKu1 or ScKu2.  Potentially, expression of both ScKu1 and 
ScKu2 are dependent upon the formation of DSBs, and therefore expression may only be 
detectable in damage-induced cells, a possibility that requires further investigation. 
  
Anti-ScKu1 and anti-ScKu2 immunoglobulins were also used during in vitro co-
immunoprecipitation (Co-IP) analysis investigating protein-protein interactions between 
ScKu proteins and also ScLigD.  Previous DNA binding analysis had identified all 3 ScKu 
were able to bind to DNA independently, a factor that strongly implied these proteins were 
able to form homodimer complexes.  Additional DLS data provided further evidence of this 
ability as multiple species of ScKu were detectable in protein preparations as illustrated by 
the percent polydispersity of peaks representing ScKu proteins.  Even though these proteins 
may function as homodimers, it was proposed that due to the high structural similarity of Ku 
proteins, Ku from the same organism may also heterodimerise, as evident with eukaryotic 
Ku70/80.  Co-IP analysis provided strong evidence that to a degree, ScKu do elicit the ability 
to interact with each other.  Although ScKu2 failed to precipitate ScKu1, ScKu3 or ScLigD, 
an interaction was apparent between ScKu1 and ScKu3.  ScKu1 was also shown to interact 
with ScLigD, a finding which was not anticipated considering the characterised interaction 
between MtKu and the polymerase domain of MtLigD (Pitcher et al., 2007).  Another 
surprising feature of this interaction was that it appeared to be of considerable strength and 
indeed, ScKu1 was consistently able to precipitate more ScLigD than ScKu3.  It would be 
thought that the formation of a specific heterodimer complex (as may be supposed between 
ScKu1 and ScKu3) would be stronger than an interaction between 2 unrelated proteins.  An 
important factor that may have significantly reduced ScKu1 and ScKu3 interactions would be 
that a high proportion of these proteins may already have existed as homodimers prior to 
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immunoprecipitation assays, which would inevitably negatively affect heterodimer formation.  
Perhaps to appreciate a true comparison between ScKu1-mediated precipitation of ScKu3 and 
ScLigD, ensuring both Ku preparations were in a monomeric state prior to Co-IP would be 
important. 
 
To further quantify protein-protein interactions between S. coelicolor NHEJ components, a 
modification was made to the existing SMB DNA binding assay whereby precipitation of 
proteins would either be dependent on their ability to bind to a specific DNA molecule or to 
interact with a protein that can bind to the DNA.  Although ScKu1 had been shown to bind to 
both dsDNA and ssDNA, ScKu2 was recognised as having low affinity towards ssDNA, 
ScLigD could not bind to dsDNA and ScKu3 bound poorly to both DNA substrates (Section 
4.3.1).  Therefore, if binding of these proteins to the stated DNAs was increased in the 
presence of other proteins, it would be assumed that precipitation was dependent on protein-
protein interactions.  Similarly to previous antibody-dependent Co-IP results, the presence of 
ScKu1 significantly increased ScKu3 precipitation with both DNAs.  Results also implied that 
ScKu2 could not interact with either ScKu1 or ScKu3 as precipitation of ScKu2 when dsDNA 
was available was reduced when these proteins were present.  It was assumed this was an 
example of competing proteins reducing available DNA substrates by effectively blocking 
ScKu2 binding.  Two results appeared to conflict with the concept that ScKu2 did not interact 
with other ScKu; the fact that precipitation of ScKu2 when ssDNA was substrate was 
increased when ScKu1 was present, and the increased precipitation of ScKu3 to dsDNA when 
ScKu2 was present (albeit considerably less than when ScKu1 was present).  It is possible 
that ScKu2 can indeed interact with ScKu1 and ScKu3, and that this interaction is weaker 
than ScKu1-ScKu3.  However, these observations may also be determined by alterations to 
the DNA following protein binding that allow a protein that has previously shown poor 
affinity to that particular DNA to bind as a consequence.  In silico data (Appendix V) 
reinforces the implication that ScKu1 and ScKu3 may function together as 2 out of 3 other 
Streptomyces species that have been sequenced contain homologues for these 2 proteins, but 
none contain ScKu2 homologues.  Overall, the data indicates that as well as functioning as 
homodimers, ScKu1 and ScKu3 are likely to form functional heterodimers.  The ability for 
ScKu2 to interact with other Ku proteins remains less convincing and it is possible that this 
protein may either act independently as a homodimer or it may be that this protein does not 
even contribute to NHEJ in S. coelicolor. 
 
Finally, the SMB DNA and protein interaction assay provided an opportunity to detect if 
prokaryotic Ku could interact with ScLigD.  Observations on DNA-binding interactions 
towards dsDNA and ssDNA had shown ScLigD binding to dsDNA was very low, however, 
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prokaryotic Ku bound with high affinity towards this substrate.  Assays that consisted of a 
pre-Ku incubation with dsDNA, followed by the addition of ScLigD were performed and it 
was assumed that if ScLigD was precipitated, then Ku were directly responsible for this 
occurrence.  It was found that although precipitated ScLigD was very low for ScKu2, and 
non-existent for MtKu, the presence of ScKu1 significantly increased ScLigD association 
with DNA.  This apparent protein-protein interaction was almost abolished when ionic 
strength was increased, indicating that electrostatic forces are an important factor.  A separate 
view on this observation may be that binding of ScKu1 induced conformational changes in 
the dsDNA to which ScLigD had increased affinity towards and so additional investigations 
regarding this interaction are required.  Why ScKu2 appeared to interact with ScLigD much 
less efficiently remains unclear but may reinforce the possibility ScKu2 is not important for 
NHEJ in S. coelicolor.  Alternatively, additional components may be required for a stable 
interaction to occur, or ScKu2 may even recruit an alternative ligase to DSBs for repair to 
proceed. 
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CHAPTER 6 
 
General Discussion 
 
 
 
 
The interactions that occur between proteins and nucleic acid molecules are intricate and 
dependent upon several factors.  As experimental techniques continue to advance, the general 
understanding of the precise aspects that govern different modes of protein-DNA interactions 
have become clearer.  A significant element of this study has been to develop and optimise 
alternative in vitro approaches for investigating DNA binding protein activity.  It was 
anticipated that these approaches could be used to deconvolute currently published data 
regarding in vitro DNA binding activity of the intensely studied human p53 protein and also 
to investigate functions of the comparatively unknown Ku proteins from S. coelicolor.  
Although non-related, both p53 and Ku are heavily implicated in the regulation of DNA 
repair and the ability to bind directly to DNA encompasses a crucial activity of both proteins. 
 
6.1 Characterising Human p53-DNA Interactions. 
 
The preservation of genomic integrity is a fundamental activity performed by p53 in a diverse 
range of multi-cellular organisms.  Although the heavily documented transactivation function 
of p53 is integral to genomic maintenance, p53 also exerts its effects independent of 
transcriptional regulation of target genes.  The proposition that p53 may behave as part of a 
global surveillance system that is responsible for the detection of unstable genomic regions 
further increases the apparent importance this protein has on preventing potentially 
catastrophic occurrences (Walter et al., 2005).  Direct interactions with DNA are crucial for 
p53 activity, as illustrated by the often severe consequences following mutation events in core 
DNA-binding regions (Shu et al., 2006).  In common with many DNA binding proteins, p53 
is capable of multiple modes of DNA interactions that show considerable flexibility.  The 
ability to recognise and bind to consensus DNA sequences is instrumental in the orchestration 
of gene expression of specific genes that regulate cell cycle arrest, DNA repair and apoptosis. 
This interaction is determined by both sequence and topology of the response element and is 
heavily dependent on the core DNA-binding domain (Gohler et al., 2002; Kim and Deppert, 
2006; Weinberg et al., 2005).  In addition, p53 can also interact non-specifically with linear 
DNA, a feature postulated to enhance the location of specific DNA regions by facilitating 
Chapter 6 – General Discussion 
 171 
localisation to DNA (McKinney et al., 2004), and also sequence-independently to certain non-
B DNA structures (Degtyareva et al., 2001; Stansel et al., 2002).  The structure-dependent 
mode of binding may allow p53 to partake in processes such as DNA repair independent of 
transcription by recruiting repair components to dangerous chromosomal sites (Reed et al., 
1995).  The reported ability of p53 to bind to structures formed by CTG•CAG tracts with 
affinity equal to consensus DNA binding is of considerable interest (Walter et al., 2005).  
Similar structures are thought to arise in intrinsically unstable TRS tracts that are highly prone 
to structural rearrangements (Kulkarni and Wilson, 2008; Rass et al., 2007), a feature believed 
to be the underlying cause of several human hereditary neurological diseases.  It was 
proposed from these findings that latent p53 in unstressed cells may be responsible for 
maintaining genomic integrity by regulating unstable genomic regions. 
 
This study aimed to use an alternative in vitro DNA binding assay to analyse p53-DNA 
binding to various DNAs to allow detection of sequence-specific, structure-specific and non-
specific modes of DNA interaction.  Ultimately, a priority was to determine if the currently 
published data regarding p53 binding to hairpins comprising of CTG●CAG could be 
replicated using a different assay system.  The deployment of a new in vitro approach to study 
p53-DNA binding would be highly beneficial considering the restraints of more traditional 
methods.  In vivo analysis of p53-DNA binding was also investigated during this study that 
concentrated on distinguishing between sequence-specific and non-sequence-specific binding. 
 
Prior to in vitro protein-DNA binding analysis the analysis of assay components was crucial 
to ensure consistent and accurate results were attainable.  For SMB assays, the production of 
stable oligonucleotides that were homogenous in composition was requisite and methodical 
optimisations to the annealing procedure meant the appropriate DNAs were eventually 
attainable.  Both in vitro DNA binding assays described in this study employed magnetic 
beads that were used to precipitate protein-DNA complexes.  Factors including bead capacity 
and the propensity to form non-specific interactions with protein or DNA elements required 
characterisation before experimentation.  Analysis of SMB DNA capacity indicated that the 
values specified by the manufacturer were relatively accurate although generally DNA 
attachment was slightly less than stated.  Importantly, it was recognised that, to achieve these 
values, DNA must be added in excess (by approximately 3 times).  Once attached, the tight 
biotin-streptavidin interaction ensured that DNA remained associated with SMBs even 
following several wash steps.  An important feature of SMBs that was quickly apparent was 
the non-specific interactions that occurred with some proteins.  This interaction was protein 
dependent and the magnitude of protein precipitated when no DNA was present varied 
between proteins.  The introduction of a free-biotin incubation, addition of BSA to assay 
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buffers and increased KCl in reactions considerably reduced non-specific interactions to less 
than 20%, which, although not ideal, allowed differences in p53-DNA binding to be resolved.  
In contrast, analysis of PGBs demonstrated p53 precipitation only occurred in the presence of 
p53 specific antibodies under standard assay conditions.  Capacity analysis of PGBs was also 
found to agree with the recommended protocol.  Although the PGB assay did not require 
modification, SMB analysis proved to be essential and reinforces the necessity to scrutinise 
assay components before commencing experiments of this nature. 
 
The in vitro SMB DNA binding assay was used to successfully detect 3 distinct modes of 
p53-DNA interactions.  Replicating cellular conditions in vitro is a complicated process that 
is far from being resolved, however mimicking experimentally determined intracellular ionic 
and pH values is of considerable priority.  One disadvantage with traditional EMSA analysis 
is that experimental environments are restricted by the conditions required for electrophoresis, 
whereas the relative flexibility of the SMB assay allows for more diverse conditions to be 
attained.  The ionic strength of a solution has a substantial impact on the modes of protein-
DNA interactions that can arise due to the effective neutralisation of the electrostatic 
attraction between protein and DNA components at higher ionic concentrations.  Therefore, 
non-specific interactions that generally rely heavily on charge (Jen-Jacobson, 1997) are 
reduced but stronger specific interactions that are dependent on other factors can remain .  To 
this extent, human p53 interactions towards sequence-specific linear dsDNA, non-sequence-
specific linear dsDNA and non-specific ssDNA were assessed at low and high KCl 
concentrations to discriminate between specific and non-specific DNA binding.  The data 
obtained conclusively demonstrated increasing ionic strength reduced binding to non-specific 
dsDNA but did not significantly reduce either sequence-specific binding or ssDNA binding.  
These results agreed strongly with the currently accepted models of p53-DNA binding as, 
although p53 does bind to dsDNA of any sequence (McKinney et al., 2004), the sequence-
specific oligonucleotides investigated had previously been shown to increase p53 binding 
(Walter et al., 2005) and p53 is known to bind to ssDNA with affinity equal to consensus 
DNA (Bakalkin et al., 1994).  Importantly, this data proved varied modes of DNA binding to 
short DNAs could be visualised without the requirement of p53 modifications, interferences 
with antibodies or removal of protein domains previously presumed (Anderson et al., 1997; 
Bessard et al., 1998; Hupp et al., 1992).  The ability of p53 to remain bound to sequence-
specific and ssDNA at higher KCl concentrations would almost certainly occur because of 
additional thermodynamic energies other than charge attraction involved in these interactions.  
However, studies have also shown that the presence of specific DNA molecules can act to 
stabilise p53 at high salt concentrations (Ishimaru et al., 2009).  It is possible that this factor 
may also have contributed to the persevering specific-binding at higher ionic strength. 
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Until recently, the consensus view concerning in vitro p53-DNA binding analysis was that 
p53 required specific modification or antibody interference to stimulate precise DNA binding 
activity (Bessard et al., 1998).  It is now accepted that unmodified p53 does exhibit efficient 
DNA binding properties and that modifications are not essential for discriminating between 
the varied modes of interaction (Kim and Deppert, 2003).  The precise consequences of post-
translational modifications on p53-DNA binding remain to be fully clarified now that the 
original notion that the CTD required modification has been disproven (McKinney et al., 
2004).  As modifications may influence p53 function, it was speculated that there may be 
differences in human p53-DNA binding between protein derived from eukaryotic (p53-I) or 
prokaryotic (p53-B) sources. 
 
In vitro SMB assays were performed that were designed to differentiate between p53-B and 
p53-I DNA binding activity.  As electrophoretic mobility analysis had identified differences 
in migration of these p53 proteins, it was assumed that differences in structure or sequence 
composition existed between both species.  Binding towards consensus dsDNA, non-specific 
dsDNA, ssDNA and dsDNAs containing CTG repeat hairpins up to 7 repeats in size were 
analysed and it was found that though minor differences between both p53s could be 
resolved, both exhibited almost identical DNA binding activity overall.  For both p53s it was 
identified that they bound significantly better to consensus linear DNA compared to non-
specific linear dsDNA, however no significant differences were apparent when binding was 
compared between consensus dsDNA and ssDNA.  It was also found there was no significant 
difference between sequence-specific binding and binding towards CTG hairpins consisting 
of 7 repeats.  The presence of relatively small hairpin regions generally increased binding of 
both p53s, however highest binding was detected to larger CTG hairpins - data that was 
highly comparable to a previous study that used EMSA to perceive p53 binding to DNAs 
containing hairpins (Walter et al., 2005).  As binding between both p53 species was so similar 
it was accepted that any differences between protein species did not significantly affect DNA 
binding properties. 
 
To improve understanding of the apparent structure-dependent DNA binding activity that p53 
was displaying, a myriad of different DNA molecules were produced that contained various 
unusual features, including mismatches, base inserts, loop regions and hairpin molecules 
consisting of different repeat sequences.  The results collected from this analysis were 
consistent with currently published material as a preference towards G/A mismatches 
(Degtyareva et al., 2001) and higher binding to loop regions (Stros et al., 2004) compared to 
linear DNA of the same size were observed.  It was also discovered that the size of a 
particular DNA molecule plays a central role in influencing non-specific p53-dsDNA binding 
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as from 3 non-specific dsDNAs analysed that consisted of 46 bp, 37 bp and 30 bp, p53-DNA 
binding was approximately 36%, 28% and 11%, respectively.  Consequently, it is important 
during future direct comparisons of DNAs of varied structure or sequence to maintain the 
number of base pairs at a constant value. 
 
Binding of p53 towards internal hairpins consisting of CTG repeats had been shown to be 
comparatively tighter than non-specific DNA binding and appeared similar in strength to 
consensus DNA binding.  However, it remained unclear if this binding was exclusively 
structure-specific or if sequence also influenced this interaction.  To address this, substrates 
containing internal hairpins consisting of different repeats were analysed alongside a linear 
dsDNA that contained 7 CTG repeats.  The results from these assays established that p53 can 
interact strongly with hairpins independent of repeat sequence and that the structural 
component was integral to this activity.  Importantly, binding to linear CTG repeats was 
comparable to p53 binding to non-specific DNA, reinforcing the probability that the hairpin 
structure is the overall feature determining the observed high level of binding.  Slight 
differences in binding between the TRS hairpins may in part be explained by the alternate 
conformations of hairpins that result from different base pairing strengths and non-
complementary base pairing.  If, as the data suggests, p53 can bind to hairpins structure-
dependently, it would be of interest to know what precise region of the hairpin this protein 
recognises and attaches to. 
 
ssDNA
Three-way 
junction
 
 
Figure 6.1 Diagram illustrating potential sites for p53 binding to [p53 (CTG)7 HP] 
oligonucleotide.  Sites in red indicate ssDNA regions required for formation of a central 
hairpin structure.  ssDNA is required at the top of the hairpin to allow bending of the DNA to 
allow base pairing in the hairpin and fraying bases result at the base of the hairpin due to 
energetic stress.  The region in turquoise indicates the three-way junction which is also known 
to be a DNA binding target site for p53. 
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Hairpin structures contain multiple features that have independently been found to induce 
p53-binding (Figure 6.1).  Single-stranded regions of DNA exist both at the pinnacle of the 
hairpin and at the base where fraying of strands occurs as an effect of energetic stress.  As 
shown in this study and several previous studies, ssDNA is a recognised p53 binding substrate 
and these regions in hairpins may be enough to be recognised and bound by p53.  
Alternatively, or in conjunction with ssDNA binding, the central three-way junction may also 
induce p53 binding.  Heteroduplex joint intermediates that form during recombination are 
known to be recognised by p53 independent of sequence and with high affinity (Janz et al., 
2002).  As both ssDNA binding and three-way junction binding are mediated by the CTD, it 
is probable that this domain is integral to p53-hairpin binding.  Another feature of certain 
TRS hairpins that p53 may recognise are mismatches that will induce additional 
conformational changes to the central duplex region consisting of repeats. 
 
The physiological connotations of p53-hairpin interactions could be substantial as, 
considering the formation of secondary structures in TRS tracts present in certain human 
hereditary neurological disorders can be multiple-times larger then DNAs investigated in this 
study, the apparent affinity of p53 towards these structures would be considerable.  Such 
activity may be an example of p53 acting as a global surveillance protein (Albrechtsen et al., 
1999; Wiesmuller, 2001) and that detection of unstable TRS tracts may be an important 
activity of p53. 
 
In vitro studies can determine important functions and characteristics of protein-DNA 
interactions; however, effective reproduction of the true intracellular environments in which 
these interactions occur naturally remains a distant aspiration.  The introduction of synthetic 
molecules that mimic cellular components and achieving natural ionic concentrations and pH 
conditions may increase relevance of in vitro data, but the ability to correlate in vitro findings 
with in vivo findings would form a strong foundation for any hypotheses.  Hence, part of this 
study involved an investigation into endogenous p53 DNA binding in HeLa cells using ChIP.  
Although levels of native p53 in HeLa cell are low as a consequence of viral E6 mediated 
degradation, transcriptionally active p53 is detectable (Hoppe-Seyler and Butz, 1993).  
Systems exist whereby levels of p53 can be over-expressed that increase detection efficiency, 
but unnaturally high levels of this protein has disadvantages as cellular post-translational 
modification machinery can become saturated and also growth arrest and apoptosis are often 
induced (Bessard et al., 1998).   
 
The consequence of DNA damage upon p53-DNA interactions was of considerable interest 
due to the direct relationship between p53 and DNA repair (Subramanian and Griffith, 2002).  
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Therefore, p53-DNA binding was assessed in both UV-irradiated and non-UV-irradiated 
HeLa cells in order to understand if p53-mediated alterations in gene expression of p21 
(regulator of the cell cycle), Mdm2 (regulator of p53) and the negative control GAPDH 
(glycolysis enzyme) existed.  The data collected from ChIP assays did denote that a 
transcriptionally-active p53 was present in both UV-irradiated and non-UV irradiated HeLa 
cells as significantly more p21 and Mdm2 promoter DNA was precipitated than GAPDH 
promoter DNA.  UV-irradiated HeLa cell p53 exhibited different activity as, although 
precipitation of p21 and Mdm2 promoter DNA remained significantly higher than GAPDH, 
the difference between p21 and Mdm2 was considerably reduced.  Experimental variation 
may account for a degree of the differences observed, however p53-DNA binding may 
actually have been affected by the increased levels of DNA damage that would further 
compromise genomic integrity in the already unstable HeLa cells.  As a result, an emphasis 
on repairing damaged DNA or the induction of apoptosis may supersede cell cycle arrest 
(Vousden and Lane, 2007).  This would be achieved by increasing basal p53 levels and 
thereby increasing the probability that p53 would bind to response elements that p53 has 
lower affinity for.  As DNA precipitation of all 3 promoter regions was increased following 
UV-irradiation, this may represent higher levels of intracellular p53 that would reinforce this 
theory. 
 
Irrespective of this, the data does suggest p53 activity is influenced by DNA damage but it 
cannot be concluded that p53 sequence-specific DNA binding is increased following UV-
irradiation.  It appears that p53-DNA interactions in general increased following irradiation, 
but the underlying causes that resulted in enhanced DNA precipitation require further 
investigation. 
 
6.2 Future Human p53-DNA Interaction Investigations. 
 
The in vitro SMB DNA binding assay was extensively utilised during this study to determine 
varying properties of human p53 binding to DNA.  A central part of this study was to 
examine the different modes of p53-DNA binding and to compare interactions with DNAs 
containing different structural features.  As many of the results obtained were highly 
comparable with currently published data it would be interesting to further determine the 
sensitivity of the assay.  In this study, the SMB assay was used to investigate sequence-
specific binding to only 1 known response element, however, the recent finding of the 
considerable variation in affinity towards different consensus sites (Weinberg et al., 2005) 
would make investigating p53 binding to different consensus sequences using this assay an 
interesting proposition. 
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The SMB assay could be employed further to calculate precise affinity values for binding to 
clarify if these values vary between sequence-specific and structure-specific p53-DNA 
binding.  Assays that compared binding of various p53 mutants would also be beneficial with 
a particular focus placed on determining the influence of the CTD on TRS interactions. 
 
In vivo assays were particularly informative and suggested a transcriptionally active p53 was 
present in HeLa cells.  The main aim of this work was to ultimately use a similar system to 
investigate p53-TRS binding, however designing a practical system that allows detection of 
p53 binding to authentic TRS tracts proved to be problematic.  Precipitated DNA was 
detected using PCR whereby regions of promoter DNA approximately 100 bp in length were 
amplified.  As TRS can consist of thousands of nucleotides of the same repeating sequence, 
amplification by PCR would be very difficult to perform ChIP in cells containing natural 
TRS.  The employment of smaller TRS tracts with known flanking sequences into cells may 
be a practical solution to this; however it could be argued these DNAs would not reflect 
natural TRS tracts. 
 
6.3 Determining Prokaryotic Ku Function. 
 
The eukaryotic Ku70/80 heterodimer is implicated in several cellular processes that are 
involved in the maintenance of genomic integrity (Friedl, 2002).  Perhaps the most recognised 
activity of Ku is as a critical component of NHEJ in the detection of DSBs and recruitment of 
other repair factors.  Ku are also involved in the regulation of telomeres where they are 
postulated to prevent the potentially catastrophic joining of chromosome ends (Wang and 
Vasquez, 2009) and retrotransposition.  The ability to bind directly to DNA is prerequisite for 
Ku to participate in these mechanisms and it is recognised that Ku70/Ku80 binds with high 
affinity towards dsDNA ends of varying structure or sequence (Falzon et al., 1993).  This 
apparent flexibility in DNA binding is thought to arise as Ku does not directly contact DNA 
bases and only a small number of contacts occur with the DNA backbone (Riha et al., 2006).  
Ku has also been shown to bind to RNA (Yoo and Dynan, 1998), however it is commonly 
perceived that Ku proteins have relatively low affinity to ssDNA.  Once bound, Ku does not 
always remain at the DNA termini but can translocate inwards, thereby allowing additional 
Ku proteins to attach to the same DNA molecule. 
 
In silico investigations revealed genes homologous to the eukaryotic Ku70/Ku80 in several 
prokaryotic organisms that were shown to function as homodimers in two-component NHEJ 
systems (Della et al., 2004; Weller et al., 2002).  The prokaryotic Ku homologues were found 
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to be considerably smaller than their eukaryotic counterparts and only generally consisted 
only of the central core DNA binding and dimerisation region of Ku70/Ku80. However, 
structural studies predicted that Ku form similar ring-like structures that shows close relation 
to eukaryotic Ku (Bowater and Doherty, 2006).  S. coelicolor was found to contain 3 genes 
that had sequence similarity with the core region of Ku70/Ku80 and although no data existed 
regarding precise activity, it was hypothesised that they were involved in S. coelicolor NHEJ.  
The limited studies on DNA binding activity of characterised prokaryotic Ku proteins suggest 
that activity is largely identical to eukaryotic Ku, as a preference towards dsDNA ends over 
ssDNA or closed DNA has been documented.  The apparent DNA length-dependent binding 
implies these proteins also possess ability to translocate inwards away from the DNA termini 
(Weller et al., 2002). 
 
Preliminary analysis of recombinant versions of Ku proteins revealed unusual electrophoretic 
mobility in relation to the predicted molecular weights.  For all 3 ScKu proteins and MtKu, 
migration was considerably less than expected when compared to proteins of known 
molecular weights in the marker.  Although immunodetection against the polyhistidine tags 
strengthened the view that the desired proteins had been purified, analysis of the 3 ScKu 
proteins by MALDI-TOF protein mass fingerprinting confirmed with high confidence that 
these proteins were as expected.  Factors that may have negatively influenced mobility 
include the additional histidine residues that comprise the tag or the unusually high pI values 
that mean during electrophoresis the higher than average positive charge of these proteins 
would reduce migration compared to standard proteins in the marker. 
 
The in vitro SMB DNA binding assay had successfully been utilised to obtain data regarding 
p53-DNA binding activity that was consistent with currently accepted ideas.  Therefore, this 
assay was again selected as a system to determine binding properties of prokaryotic NHEJ 
components.  Assays that concentrated on comparing interactions with short dsDNA and 
ssDNA resolved clear differences in activity between the 3 Ku proteins.  Although ScKu2 and 
MtKu exhibited a clear preference for dsDNA, ScKu1 and ScKu3 had vastly different 
activity.  The apparent lack of ScKu3 binding was at first assumed to be a consequence of 
inactive recombinant protein or that this protein has a naturally low affinity for DNA. 
However, subsequent assays using plasmids demonstrated this protein does interact with 
DNA and that the apparent low affinity observed during the SMB assay may be a direct 
consequence of ScKu3 requiring a larger DNA substrate to bind.  Perhaps the most interesting 
observation from this analysis was the consistently high ScKu1 binding to both dsDNA and 
ssDNA.  It was found that ScKu1 bound very strongly to all oligonucleotides investigated, 
including hairpins and mismatched DNA (data not shown) inferring that this protein has very 
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high flexibility during DNA binding.  Binding affinity investigations eventually revealed that 
ScKu1 showed a preference in binding towards dsDNA when lower concentrations of DNA 
were used.  Therefore, it can be concluded from these experiments that ScKu1 does exhibit 
similar binding properties as both ScKu2 and MtKu but is able to bind more tightly to all 
DNAs. 
 
Competition assays that again utilised the SMB assay produced some of the most interesting 
data from this study.  The relative lack of effect of introducing competing DNA to Ku already 
bound to DNA may have been explained by Ku being difficult to remove once attached to the 
initial DNA molecule.  However, when competing-free DNA was added simultaneously to 
DNA attached to SMBs it was found Ku still demonstrated much higher binding to DNA 
attached to SMBs.  This idea was reinforced when binding of Ku to DNA-SMB remained as 
high as 80% even when competing DNA was 3 times in excess of DNA-SMB.  Detailed 
analysis of assay components confirmed conditions during assays were as expected and it was 
concluded that there were 3 possible explanations for these observations.  The first is that the 
Ku proteins from S. coelicolor are able to translocate along DNA as observed with Ku70/80 
and, as the DNAs studied were only short, it may be possible that Ku could translocate and 
fall off the competing DNA.  The second possibility is that DNA physically attached to SMBs 
may elicit a different conformation to free DNA that is more favourable for Ku binding.  The 
third theory that would explain the perceived negligible effect of competing free DNA regards 
the potential DNA juxtaposition activity of Ku.  In eukaryotes, both Ku70/80 and DNA-PKcs 
have been implicated in the function of synapsing 2 independent DNAs (Cary et al., 1997; 
DeFazio et al., 2002; Lees-Miller and Meek, 2003; Ramsden and Gellert, 1998) but this 
process must occur independent of DNA-PKcs in prokaryotes.  To test this possibility, 
fluorescently labelled free DNAs were used to determine if Ku stimulated precipitation of 
these DNAs with SMBs.  It was found that fluorescence was reduced in primary wash step 
samples and was higher in the final precipitated samples when Ku were present in reactions.  
Both of these elements suggested Ku proteins were promoting association of free DNA with 
DNA-SMB.  It remains to be ascertained which factors were responsible for the competition 
assay observations, however it is possible all 3 ideas may have contributed to an extent. 
 
It was hoped an alternative PGB in vitro DNA binding assay would reveal more information 
regarding prokaryotic Ku-DNA interactions due to the flexibility of potential DNAs that 
could be used as substrates.  To assess similarities with SMB data, the same oligonucleotides 
were analysed using the PGB assay and, except for some binding by ScKu3 towards ssDNA, 
the results correlated highly with SMB data.  When Ku-plasmid DNA binding was analysed, 
it was found that ScKu3 binding was very efficient to both linear and supercoiled plasmid 
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(activity that was closely mirrored by ScKu1), however ScKu2 binding was comparatively 
lower.  Interestingly, ScKu1, ScKu3, MtKu and, under certain conditions ScKu2 and MtKu, 
all demonstrated a preference towards overhang-end DNA over blunt-end DNA.  This 
apparent selectivity was not expected as it is generally believed Ku interactions with DNA 
ends is independent of sequence and structure.  Potentially, regions of sequence 
complementarity on opposing ends of overhang-end DNA may allow these plasmids to 
circularise that would prevent access of DNA ends.  Ku-supercoiled DNA binding was also 
not anticipated as Ku interactions with closed-DNAs is thought to be minimal due to the lack 
of DNA ends (Dynan and Yoo, 1998).  However, structures such as hairpins that can be 
induced by supercoiling may account for increased interactions.  If such structures were 
responsible for Ku binding, it was postulated relaxed-circular DNA would show reduced 
precipitation of Ku as less structures would be present.  However, as almost identical results 
were collected it was assumed secondary structures were not wholly responsible for binding 
to supercoiled DNA.  Therefore, from this analysis it is likely Ku can bind to DNA 
independent of DNA ends or hairpin structures.  This would infer the currently accepted 
model of Ku-DNA binding of threading DNA through the central hollow channel of a Ku 
dimer does not account for the complete binding activity.  If Ku proteins are able to 
spontaneously dimerise and separate in solution, theoretically, dimerisation may occur 
following binding of a monomer which would allow interactions with circular DNA.  
However, there is currently no direct evidence for this. 
 
Alongside the detection and binding of DSBs, another characteristic of Ku is its ensuing 
recruitment of other repair factors required to process and ligate these dangerous lesions.  For 
this reason it was of interest to see if prokaryotic Ku could influence the activity of T4 DNA 
ligase, either positively by enhancing rates of ligation (perhaps by end-alignment) or 
negatively by interfering with DNA ligase activity.  It was found all prokaryotic Ku studied 
significantly altered ligation and, in the majority reactions, ligation was highly reduced or 
even completely prevented.  Potentially, Ku that had bound and remained at the DNA termini 
of the plasmids may have physically blocked T4 DNA ligase access, which would explain the 
observed reduction in ligation.  It would be assumed that, for NHEJ, such blocking would not 
occur as specific ligases may interact directly with Ku in a way that still allows ligation to be 
performed.  This apparent inhibition of T4 DNA ligase activity was also documented during 
similar experiments with eukaryotic Ku (Blier et al., 1993; Paillard and Strauss, 1991), 
suggesting divergent Ku proteins induce similar effects.  The recent identification that Ku can 
protect DNA ends (Zhu and Shuman, 2009) would provide a suitable explanation for the 
observed prevention of T4 DNA ligase activity as the presence of Ku at DNA termini would 
undoubtedly impede ligation.  Interestingly, the formation of multimer plasmid species over 
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circularisation was also evident when certain prokaryotic Ku were present, particularly with 
ScKu3.  This activity was identified in a previous study (Paillard and Strauss, 1991) with 
eukaryotic Ku and it was thought to occur following rigidification of DNA as a consequence 
of several internally bound Ku proteins that reduced flexibility. 
 
Detailed in vitro characterisation of ScKu DNA binding properties and experiments 
determining the effects on T4 DNA ligase activity had been carried out, however there is 
currently no in vivo data regarding the precise functions of ScKu proteins.  A section of this 
study has been the preparation of components for future use in the in vivo analysis of 
chromosomally-derived ScKu1 and ScKu2.  Two separate approaches were taken that could 
eventually be used in combination to investigate multiple features of these proteins, including 
expression, complementation analysis, protein-protein interactions and in vivo DNA binding.  
The first approach involved the cloning of ScKu genes (including promoter and polyhistidine 
DNA) into specific phage-derived integration vectors, pMS82 and pSET152 that could be 
used to integrate these genes onto chromosomes of S. coelicolor strains.  Expression analysis 
could provide useful information regarding at which lifecycle stages ScKu are expressed or if 
expression is increased following stresses such as UV-irradiation or exposure to high 
temperatures.  The inclusion of polyhistidine tags on protein products would allow for 
immunodetection using anti-His antibodies and for direct precipitation during co-
immunoprecipitation assays.  Restriction digest analysis of integration vectors pMS82 and 
pSET152 confirmed vector identities and scku2 was successfully amplified from cosmid 
DNA.  However scku1 consistently failed to amplify and attempts at cloning this gene were 
abandoned.    Amplified scku2 products were cloned into pCR-Blunt II-TOPO vectors, 
sequenced to confirm inserts were as expected, and subsequently subcloned into pSET152. 
 
The second approach was the production of polyclonal antibodies that could differentiate 
between ScKu1 and ScKu2 that were produced by immunising rabbits with recombinant 
proteins.  Antibodies from final harvest bleeds displayed the most specific detection of ScKu 
proteins and were able to distinguish between different ScKu under appropriate conditions.  
These antibodies were used to investigate the presence of ScKu1 and ScKu2 in cell extracts 
from E. coli over-expressing ScKu1 and ScKu2 and bands representing relevant recombinant 
proteins were detected.  Antibodies were also used to determine the presence of ScKu1 and 
ScKu2 in S. coelicolor M145, M145 ∆ScKu1, M145 ∆ScKu2 and M145 ∆ScKu1/∆ScKu2 cell 
extracts harvested at branching substrate mycelium and sporulation growth stages.  The 
results indicated that expression of ScKu1 and ScKu2 were too low for immunodetection as 
no relevant bands were visible in any strain.  
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As the 3 ScKu proteins had been shown to interact with DNA independent of each other, it 
was assumed that these proteins were capable of forming homodimer complexes and so 
conformed to the current viewpoint regarding prokaryotic Ku (Pitcher et al., 2007).  DLS data 
supported this concept as it was apparent that all 3 recombinant ScKu proteins were present as 
multiple protein species as signified by percent polydispersity values.  Irrespective of this, it 
was postulated that it may also be possible for Ku proteins to form complexes with different 
Ku proteins from the same organism.  Data from Co-IP assays that used anti-ScKu1 and anti-
ScKu2 immunoglobulins indicated that ScKu1 and ScKu3 could interact, however ScKu2 
consistently failed to precipitate any other proteins.  These experiments also revealed an 
interaction between ScKu1 and ScLigD that may be important during the recruitment of this 
DNA ligase to DSBs. 
 
For further confirmation of Co-IP findings, a separate precipitation assay was employed that 
used specific DNAs to precipitate ‘bait’ protein instead of immunoglobulins.  This modified 
version of the SMB assay produced results that were in high agreement with the previous Co-
IP assay as ScKu1 was found to significantly increase precipitation of ScKu3 and ScLigD 
when appropriate DNAs were present.  Unlike antibody-dependent Co-IP results, there was a 
suggestion that ScKu2 was also capable of interacting with ScKu1 and ScKu3, however these 
interactions were generally weaker and inconsistent so may have been experimental 
anomalies.  The discovery that an interaction exists between ScKu1 and ScKu3 was supported 
by in silico investigations as 2 out of 3 alternate Streptomyces species contained these 2 
proteins, but none contained ScKu2.  This data implies recently S. coelicolor has acquired the 
scku2 gene, possibly by horizontal gene transfer following its evolutionary divergence away 
from the other Streptomyces species.  This would explain the lack of interaction with ScKu1 
and ScKu3 and the observation that this protein also did not interact with ScLigD suggests 
this protein may not be implicated in S. coelicolor NHEJ. 
 
6.4 Future ScKu NHEJ Investigations. 
 
A significant area of this study involved the analysis of DNA binding characteristics of 
prokaryotic Ku proteins using optimised versions of recently developed in vitro assays.  
Several properties regarding interactions with different DNAs have been identified, however 
these assays could be employed further to determine more accurate values regarding binding 
affinity.  Although this was attempted during this study, the data collected was not sufficient 
to calculate precise values that would be attained by investigating an increased number of 
lower DNA concentrations.  Another important aspect of calculating Ku binding affinity 
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would be to ascertain the number of Ku that bind to a single DNA molecule of particular size 
– a feature that should be possible to determine using AUC experiments. 
 
One other area of this study that would be beneficial to explore further is the apparent DNA 
substrate synapsis activity that ScKu1 and ScKu2 proteins exhibited.  Assays investigating the 
precipitation of fluorescently labelled free DNAs by SMB-DNA-Ku complexes suggested a 
degree of alignment of DNAs was occurring, however the data was not as conclusive as 
previous competition assays suggested.  Repeats of similar assays but with the use of 
fluorescently-labelled dsDNA rather than ssDNA would be a suitable starting point to 
determine if synapsis efficiency increases with DNAs shown to induce higher levels of Ku 
binding.  Alternatively, atomic force microscopy (AFM) could be used for direct visualisation 
of any DNA bridging activity that prokaryotic Ku possess.  AFM can produce high resolution 
images of protein-nucleic acid complexes (Cary et al., 1997) and, therefore, would be 
beneficial in exploring this potential Ku function.  
 
A separate function of prokaryotic Ku that has recently been documented (Zhu and Shuman, 
2009) is the ability to protect DSB ends from exonuclease degradation.  A relatively simple 
assay could be developed where Ku proteins are initially incubated with linear DNAs 
followed by the addition of exonucleases.  Comparisons of degradation of DNAs without Ku 
addition would establish if Ku can protect DNA from enzymatic digestion and this would also 
indicate if Ku remain at the ends of DNA (as indicated during in vitro T4 DNA Ligase assays) 
as well as translocating inwards. 
 
Perhaps the most valuable in vitro achievement regarding S. coelicolor NHEJ would be the 
accurate replication of the entire S. coelicolor NHEJ apparatus capable of aligning and 
ligating 2 DNA molecules.  So far, several components have been identified aside from ScKu 
proteins including 3 primases, 2 NAD+-dependent DNA ligases, 3 ATP-dependent DNA 
ligases and 1 nuclease (Sayer, 2008).  As recombinant versions of these proteins are already 
available, the next steps would be to identify appropriate conditions in which protein activity 
is optimal to allow efficient DNA end joining activity. 
 
The cloning of recombinant scku2 into integration vector pSET152 and the production of 
antibodies specific for ScKu1 and ScKu2 has provided a platform for several potential in vivo 
investigations to examine different features of ScKu proteins.  The presence of the native 
scku2 promoter will allow natural expression levels to be determined during the various life-
stages of S. coelicolor and to establish if levels increase following induction of DNA damage 
or under various stressful conditions.  Alternatively, gene expression could be monitored 
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using reportable fusion markers inserted adjacent to various S. coelicolor genes associated 
with NHEJ that, alongside expression trends, would also aid identification of the localisation 
of proteins via fluorescent marker tracking. 
 
As previously mentioned, specific ScKu antibodies provide the opportunity to determine in 
vivo protein-protein interactions via Co-IP assays.  Due to the low cross-reactivity exhibited 
by FHB antibodies, appropriate antibodies may be used to precipitate a specific ScKu protein 
followed by immunodetection with alternate ScKu antibodies to examine if interactions 
between different ScKu proteins occur.  This analysis could provide further information 
regarding dimerisation of ScKu proteins. 
 
The pivotal role Ku plays during maintenance of eukaryotic telomeres is well established 
(Riha et al., 2006) where Ku proteins are believed to be instrumental in preventing the 
potentially catastrophic joining of chromosome ends.  No evidence exists that implicates 
prokaryotic Ku in similar maintenance of genomes but, as most prokaryotes do not have 
linear chromosomes, the protection of DNA termini is not a problem for these organisms.  
However, S. coelicolor does contain a linear genome and also linear plasmids that are capable 
of circularisation (Bao and Cohen, 2001).  As with eukaryotic chromosome ends, the 
chromosome of S. coelicolor also contains telomeres consisting of inverted repeat sequences 
with the 5’ end covalently attached to terminal proteins.  Both Tap and Tpg proteins have 
been identified as important components in the maintenance of S. coelicolor telomeres to date 
(Bao and Cohen, 2003), however it would not be surprising if ScKu were also involved in 
regulating these structures.  To this extent, specific ScKu antibodies could be used to perform 
in vivo ChIP assays to identify if ScKu directly interact with telomeric regions. 
 
The maintenance of genomic integrity is fundamental to cellular life and understanding the 
precise interactions that govern this stability is central to preventing the events that can lead to 
disease.  The complexity of macromolecular interactions requires a varied arsenal of 
techniques that can be used in conjunction to fully characterise how these mechanisms work.  
This study has used several different biochemical assays to resolve the activities of DNA 
repair proteins believed to recognise dangers to genomic stability.  The flexibility of these 
assays has provided opportunities for methodical adaptations so that additional functions have 
been resolved using similar systems.  The frequent high correlation with published data and 
high reproducibility indicate these assays would be appropriate for future protein 
investigations.
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Appendix I 
 
 
 
 
 
 
Figure AI.1 Recombinant human p53 analysis (Supplied by Active Motif).  Human p53 
(referred to in text as p53-B) was over-expressed in E. coli and purified via affinity 
chromatography.  Following SDS-PAGE, purified protein was analysed by coomassie 
staining and western blot (directed against an NTD polyhistidine tag (Anti-His) and against 
the CTD (Anti-p53)). 
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Appendix II 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure AII.1 ScKu protein data collected from MALD-TOF spectrometry.  For 
confirmation of identities of proteins over-expressed and purified during this study, mass 
spectrometry analysis was performed that verified the recombinant proteins were as expected.  
A. ScKu1 peak data.  B.  ScKu2 peak data.  C.  ScKu3 peak data. 
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Appendix III 
 
 
 
 
 
 
Figure AIII.1 SDS-PAGE and coomassie staining analysis of MtrA degradation 
following pUC18 exposure.  1 µl of 100 ng / µl of plasmid sample was added to 35 µg of 
MtrA in a final volume of 30 µl and incubated for up to 40 minutes. 
 
 
 
Appendix IV 
 
 
Figure AIV.1 Example of SDS-PAGE and western blot analysis of S. coelicolor NHEJ 
components following Co-IP protein-protein interaction analysis.  Assays were performed 
using antibodies specific for ScKu1 and ScKu2 to immunoprecipitate ScKu3 or ScLigD.  As 
controls, assays were performed without ScKu1 and ScKu2 to determine non-specific 
precipitation by antibodies.  NP – Non-precipitated protein, P – Precipitated protein. 
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 Appendix V 
 
 
 
Table AV.1 In silico analysis of Ku homology searches in Streptomyces organisms that 
have been sequenced.  Amino acid sequences for ScKu1, ScKu2 and ScKu3 were taken from 
StrepDB website and ‘BLASTP’ was used to identify homologues in Streptomyces 
avermitilis, Streptomyces griseus and Streptomyces scabies.  Sequence identities above 40% 
are shown. 
 
S. coelicolor 
ku gene 
S. avermitilis S. griseus S. scabies 
scku1 SAV_2945 ku1 (71%) 
SAV_879 ku2 (53%) 
SGR_2195 (64%) 
SGR_6689 (49%) 
SCAB29491 (67%) 
scku2 - - - 
scku3 SAV_879 ku2 (70%) 
SAV_2945 ku1 (49%) 
SGR_6689 (60%) 
SGR_2195 (49%) 
SCAB29491 (51%) 
 
 
 
